WorldWideScience

Sample records for botulism

  1. [Infant botulism].

    Science.gov (United States)

    Falk, Absalom; Afriat, Amichay; Hubary, Yechiel; Herzog, Lior; Eisenkraft, Arik

    2014-01-01

    Infant botulism is a paralytic syndrome which manifests as a result of ingesting spores of the toxin secreting bacterium Clostridium botulinum by infants. As opposed to botulism in adults, treating infant botulism with horse antiserum was not approved due to several safety issues. This restriction has led to the development of Human Botulism Immune Globulin Intravenous (BIG-IV; sells under BabyBIG). In this article we review infant botulism and the advantages of treating it with BIG-IV.

  2. Infant botulism.

    Science.gov (United States)

    Polin, R A; Brown, L W

    1979-05-01

    Infant botulism is a unique neuromuscular disease affecting infants less than six months old. It is the result of intraintestinal toxin production by C. botulinum (toxi-infection). Characteristic symptoms include constipation, lethargy, and decreased feeding. Physical examination often reveals generalized hypotonia with cranial nerve impairment. Recovery is dependent on supportive care in an intensive care setting. The relationship of this disease to the sudden infant death syndrome requires further study.

  3. [Food-borne botulism].

    Science.gov (United States)

    Nakamura, Yuko; Sawada, Mikio; Ikeguchi, Kunihiko; Nakano, Imaharu

    2012-08-01

    Botulism is a neuroparalytic disease caused by neurotoxins produced by Clostridium botulinum, and classically presents as palsies of cranial nerves and acute descending flaccid paralysis. Food-borne botulism is the most common form of botulism, and caused by preformed neurotoxins produced by Clostridium botulinum. Electrophysiological studies play an important role in the early diagnosis. Confirmation of the diagnosis is based on the detection of botulinum toxins in the patient's serum or stool. In Japan, decades ago, botulism type E occurred, though only sporadically, almost every year, but in recent years, has dramatically decreased in frequency. Botulism is a curable disease when treated early and adequately. Differential diagnosis of cranial nerves and limb muscle palsies with rapid exacerbation should include food-borne botulism.

  4. Denmark: botulism in an infant or infant botulism?

    DEFF Research Database (Denmark)

    Paerregaard, A; Angen, O; Lisby, M;

    2008-01-01

    was noted. Botulism was suspected and confirmed by testing of patient serum in a bioassay. The condition of the patient improved following administration of botulism antiserum. The clinical picture was suggestive of intestinal (infant) botulism. However, botulism acquired from consumption of food...

  5. Botulism and Diagnostic Approach

    Directory of Open Access Journals (Sweden)

    Mehmet Baysallar

    2011-06-01

    Full Text Available Summary Clostridium botulinum which causes botulism, a neuroparalytic disease, attracts attention recently because of having an important role on classification of biological warfare agents. The diagnosis of botulism is not possible with routine laboratory tests. Culture from stool and food samples or toxin detection from the same samples and sera are preferable procedures. Early diagnosis and supportive treatment are important. Botulism is a notice required disease and its neurological signs are regressive after recovery.This agent which has a much lethal toxin must be considered important and the employee must comply with the biosafety measures during laboratory testing. Key words: Clostridium botulinum; Botulism; Bacteria, anaerobic; Diagnosis [TAF Prev Med Bull 2011; 10(3.000: 343-350

  6. Infant Botulism (For Parents)

    Science.gov (United States)

    ... for it until their first birthdays. Spores of Clostridium botulinum bacteria, found in dirt and dust, can contaminate ... from the illness. Prevention Like many germs, the Clostridium botulinum spores that cause botulism in infants are everywhere ...

  7. Clinical mimics of infant botulism.

    Science.gov (United States)

    Francisco, Ann Marie O; Arnon, Stephen S

    2007-04-01

    Since 1992, Human Botulism Immune Globulin has been provided by the California Department of Health Services to infants with probable infant botulism, the intestinal toxemia form of human botulism. Human Botulism Immune Globulin became available in California in 1992-1997 within a randomized, controlled, double-blinded, pivotal clinical trial and subsequently became available nationwide in 1998-2003 in an open-label study until its licensure in October 2003 as BabyBIG. Thereafter, Human Botulism Immune Globulin remained available nationwide as an approved orphan-drug product. To achieve prompt neutralization of circulating botulinum toxin, the decision to treat with Human Botulism Immune Globulin has been based on clinical criteria that include a consistent history and physical findings of bulbar palsies, hypotonia, and weakness. After licensure, the charts of patients who did not have laboratory-confirmed infant botulism were reviewed to identify their actual diagnoses. The approximately 5% of 681 patients treated with Human Botulism Immune Globulin who did not have infant botulism fell into 5 categories: spinal muscular atrophy, metabolic disorders, other infectious diseases, miscellaneous, and probable infant botulism lacking laboratory confirmation.

  8. Waterfowl botulism in California 1969

    Data.gov (United States)

    US Fish and Wildlife Service, Department of the Interior — The San Joaquin Valley had the potential for a severe botulism outbreak, but intensive management efforts kept losses to 45,000 birds. Outbreaks in the Sacramento...

  9. Infant botulism: review and clinical update.

    Science.gov (United States)

    Rosow, Laura K; Strober, Jonathan B

    2015-05-01

    Botulism is a rare neuromuscular condition, and multiple clinical forms are recognized. Infant botulism was first identified in the 1970s, and it typically occurs in infants younger than 1 year of age who ingest Clostridium botulinum spores. A specific treatment for infant botulism, intravenous botulism immunoglobulin (BIG-IV or BabyBIG®), was developed in 2003, and this treatment has substantially decreased both morbidity and hospital costs associated with this illness. This article will review the pathogenesis of infant botulism as well as the epidemiology, clinical manifestations, diagnosis, and treatment of this condition.

  10. Food-borne botulism: still actual topic

    Science.gov (United States)

    Brola, Waldemar; Fudala, Malgorzata; Gacek, Szymon; Gruenpeter, Pawel

    2013-01-01

    Even though since the mid-1990s the number of food-borne botulism cases has systematically decreased and it now occurs in Poland relatively rarely, it is still a real epidemiological problem. There are about 30 cases of botulism in Poland a year, which ranks Poland the first among the European Union. In most cases the symptomatology of botulism is typical, however it does not always fully coincide with the one described in medical manuals which emphasise the dramatic clinical course of botulism with its frequent fatal consequences. Diagnosis of botulism may be difficult because of its rare prevalence and a variable clinical course, especially in old patients. Authors of this paper describe two cases of botulism and diagnostic problems associated with it. PMID:23391950

  11. Difficulties in Diagnosing Food-Borne Botulism

    OpenAIRE

    2012-01-01

    Botulism is a muscle-paralyzing disease caused by neurotoxins (types A–G) produced by the bacteria Clostridium botulinum. Symptoms of food-borne botulism most commonly appear 12–36 h after eating contaminated food, but the earliest neurological symptoms may in some cases start abruptly. Here, we report the cases of two patients with food-borne botulism who were admitted to the neurological emergency room as candidates for intravenous thrombolysis for acute stroke.

  12. Difficulties in diagnosing food-borne botulism.

    Science.gov (United States)

    Forss, Nina; Ramstad, Raimo; Bäcklund, Tom; Lindström, Miia; Kolho, Elina

    2012-05-01

    Botulism is a muscle-paralyzing disease caused by neurotoxins (types A-G) produced by the bacteria Clostridium botulinum. Symptoms of food-borne botulism most commonly appear 12-36 h after eating contaminated food, but the earliest neurological symptoms may in some cases start abruptly. Here, we report the cases of two patients with food-borne botulism who were admitted to the neurological emergency room as candidates for intravenous thrombolysis for acute stroke.

  13. [Infant botulism in France, 1991-2009].

    Science.gov (United States)

    King, L-A; Popoff, M-R; Mazuet, C; Espié, E; Vaillant, V; de Valk, H

    2010-09-01

    Infant botulism is caused by the ingestion of spores of Clostridium botulinum and affects newborns and infants under 12 months of age. Ingested spores multiply and produce botulinum toxin in the digestive tract, which then induces clinical symptoms. A single French case was described in the literature prior to 1991. We describe the cases of infant botulism identified in France between 1991 and 2009. All clinical suspicions of botulism must be declared in France. Biological confirmation of the disease is provided by the National reference laboratory for anaerobic bacteria and botulism at the Pasteur Institute. During this period, 7 cases of infant botulism were identified, 1 per year from 2004 to 2008 and 2 in 2009. The median age of affected infants was 119 days and all were female. All infants presented with constipation and oculomotor symptoms. All were hospitalized and required mechanical ventilation. The infants recovered from their botulism. The diagnosis of infant botulism was biologically confirmed for all patients. One 4-month-old infant was treated with a single dose of the human-derived botulism antitoxin specific for infant botulism types A and B (BabyBIG®). The infants all had different feeding habits ranging from exclusive breast feeding to a mix of formula feeding and solid food consumption. The consumption of honey, the only documented risk food for this disease, was reported for 3 of the infants. The honey had been placed on the pacifier of 2 infants and directly in the mouth of the 3rd by the mother. Infant botulism, a form of botulism that was previously rarely recognized in France, has been reported more frequently during the last 6 years. This disease remains rare but nonetheless severe. In light of recent epidemiological data, efforts to raise awareness among parents of infants and health professionals on the danger of infant botulism and particularly, its association with honey consumption seems necessary.

  14. Trial of Immune Globulin in Infant Botulism

    Directory of Open Access Journals (Sweden)

    J Gordon Millichap

    2006-02-01

    Full Text Available A 5-year, randomized, double-blind, placebo-controlled trial of the orphan drug Human Botulism Immune Globulin Intravenous (BIG-IV in 122 infants in California with confirmed infant botulism (75 caused by type A Clostridium botulinum toxin, and 47 by type B toxin was conducted at the California Department of Health Services, Richmond, CA; National Botulism Surveillance and Reference Laboratory, CDC and P, Atlanta; and Division of Biostatistics, University of California, Berkeley.

  15. Difficulties in Diagnosing Food-Borne Botulism

    Directory of Open Access Journals (Sweden)

    Nina Forss

    2012-06-01

    Full Text Available Botulism is a muscle-paralyzing disease caused by neurotoxins (types A–G produced by the bacteria Clostridium botulinum. Symptoms of food-borne botulism most commonly appear 12–36 h after eating contaminated food, but the earliest neurological symptoms may in some cases start abruptly. Here, we report the cases of two patients with food-borne botulism who were admitted to the neurological emergency room as candidates for intravenous thrombolysis for acute stroke.

  16. [Two treated cases of botulism].

    Science.gov (United States)

    Işik, N; Elibol, B; Oztekin, N S; Zileli, T

    1990-01-01

    Botulism is a severe neuroparalytic disease caused by the neurotoxins of Clostridium botulinum which exert their effects on peripheral nerve junctions. Guillain-Barre syndrome, Myasthenia Gravis, acute Poliomyelitis and diphtheria must be considered in the differential diagnosis. In this study we have discussed two patients who were treated in our clinic, the differential diagnosis and the role of anti-Cholinesterase drugs in the treatment.

  17. Prevention and Treament of Botulism

    Science.gov (United States)

    2014-01-01

    These will be discussed in the fol- lowing sections 13.2.4 Recombinant Botulinum Vaccines Improvements in recombinant DNA techniques allowed for...186. Pier CL, Tepp WH, Bradshaw M, Johnson EA, Barbieri JT, Baldwin MR (2008) Recombi - nant holotoxoid vaccine against botulism. Infect Immun 76:437...Scherman D, Bigey P (2009) Generation of high-titer neutralizing antibodies against botuli- num toxins A, B, and E by DNA electrotransfer. Infect

  18. Waterfowl botulism--a brief summary

    Science.gov (United States)

    Pearson, G.; Jensen, W.

    1994-01-01

    Botulism is a food poisoning caused by the ingestion of the toxin produced by the bacterium Clostridium botulinum of any of six strains, designated A through F. The disease, as it occurs in epidemic proportion in wild birds, is most commonly of the C type, although outbreaks caused by type E botulism have been observed on the Great Lakes.

  19. The Workshop on Animal Botulism in Europe

    NARCIS (Netherlands)

    Skarin, H.; Tevell Aberg, A.; Woudstra, C.; Hansen, T.; Löfström, Ch.; Koene, M.G.J.; Bano, L.; Hedeland, M.; Anniballi, F.; Medici, De D.; Olsson Engvall, E.

    2013-01-01

    A workshop on animal botulism was held in Uppsala, Sweden, in June 2012. Its purpose was to explore the current status of the disease in Europe by gathering the European experts in animal botulism and to raise awareness of the disease among veterinarians and others involved in biopreparedness. Anima

  20. An Outbreak of Foodborne Botulism in Ontario

    Directory of Open Access Journals (Sweden)

    Mona R Loutfy

    2003-01-01

    Full Text Available Botulism is a rare paralytic illness resulting from a potent neurotoxin produced by Clostridium botulinum. Botulism in Canada is predominately due to C botulinum type E and affects mainly the First Nations and Inuit populations. The most recent outbreak of botulism in Ontario was in Ottawa in 1991 and was caused by C botulinum type A. We report an outbreak of foodborne type B botulism in Ontario, which implicated home-canned tomatoes. The outbreak was characterized by mild symptoms in two cases and moderately severe illness in one case. The investigation shows the importance of considering the diagnosis of botulism in patients presenting with cranial nerve and autonomic dysfunction, especially when combined with gastrointestinal complaints; it also highlights the importance of proper home canning technique.

  1. Botulism in non-ruminants in Brazil

    Directory of Open Access Journals (Sweden)

    Carlos Augusto de Oliveira Júnior

    Full Text Available ABSTRACT: Botulism is an intoxication caused by the ingestion of neurotoxins secreted by Clostridium botulinum and characterized by progressive flaccid symmetrical paralysis. Among non-ruminant animals, avian species and dogs are the most commonly affected by botulism, while horses and pigs are less-commonly diagnosed with the disease. Despite the importance of this disease in animals, the Brazilian literature only includes case studies and outbreak descriptions. The aim of this study was to review the main features and to provide recent data on the occurrence of botulism in non-ruminants in Brazil.

  2. The Workshop on Animal Botulism in Europe

    DEFF Research Database (Denmark)

    Skarin, Hanna; Tevell Åberg, Annica; Woudstra, Cédric

    2013-01-01

    A workshop on animal botulism was held in Uppsala, Sweden, in June 2012. Its purpose was to explore the current status of the disease in Europe by gathering the European experts in animal botulism and to raise awareness of the disease among veterinarians and others involved in biopreparedness....... Animal botulism is underreported and underdiagnosed, but an increasing number of reports, as well as the information gathered from this workshop, show that it is an emerging problem in Europe. The workshop was divided into 4 sessions: animal botulism in Europe, the bacteria behind the disease, detection...... conclusions drawn from these discussions were that there is an urgent need to replace the mouse bioassay for botulinum toxin detection with an in vitro test and that there is a need for a European network to function as a reference laboratory, which could also organize a European supply of botulinum antitoxin...

  3. Disease investigations : Study of waterfowl botulism

    Data.gov (United States)

    US Fish and Wildlife Service, Department of the Interior — Studies were done to determine the ecology of the botulism organism Clostridium botulinum Type C and the manner of which toxin is ingested by the waterfowl so that...

  4. Botulism on the Des Lacs Refuge and control measures

    Data.gov (United States)

    US Fish and Wildlife Service, Department of the Interior — Report on botulism at Des Lacs National Wildlife Refuge. Summaries of botulism outbreaks on the refuge for 1935-1937 are included, as well as information on...

  5. Equine Botulinum Antitoxin for the Treatment of Infant Botulism

    OpenAIRE

    Vanella de Cuetos, Elida E.; Fernandez, Rafael A.; Bianco, María I.; Sartori, Omar J.; Piovano, María L.; Lúquez, Carolina; de Jong, Laura I. T.

    2011-01-01

    Infant botulism is the most common form of human botulism in Argentina and the United States. BabyBIG (botulism immune globulin intravenous [human]) is the antitoxin of choice for specific treatment of infant botulism in the United States. However, its high cost limits its use in many countries. We report here the effectiveness and safety of equine botulinum antitoxin (EqBA) as an alternative treatment. We conducted an analytical, observational, retrospective, and longitudinal study on cases ...

  6. Botulism

    Science.gov (United States)

    ... N.Y.: The McGraw-Hill Companies; 2012. http://accessmedicine.com. Accessed May 5, 2015. Goldsmith LA, et ... Y.: The McGraw-Hill Companies; 2012. http://www.accessmedicine.com. Accessed May 11, 2015. Chalk C, et ...

  7. Botulism

    Science.gov (United States)

    ... is a rare but serious illness caused by Clostridium botulinum bacteria. The bacteria may enter the body through ... them from improperly canned or preserved food. Causes Clostridium botulinum is found in soil and untreated water throughout ...

  8. Botulism

    Science.gov (United States)

    ... Ear Nose & Throat Emotional Problems Eyes Fever From Insects or Animals Genitals and Urinary Tract Glands & Growth ... the body. Children may have: Blurred or double vision A dry mouth Drooping eyelids Difficulty swallowing and ...

  9. Fatal outbreak of botulism in Greenland

    DEFF Research Database (Denmark)

    Hammer, Tóra Hedinsdottir; Jespersen, Sanne; Kanstrup, Jakob

    2015-01-01

    Botulism commonly occurs when the anaerobic, gram-positive bacterium Clostridium botulinum, under suitable conditions, produces botulinum neurotoxins. Named A-F, these toxins are the immediate causative agent of the clinical symptoms of symmetrical, descending neurological deficits, including...... recovery was complete. Microbiological assays, including toxin neutralization bioassay, demonstrated the presence of neurotoxin E in two survivors. The third survivor was shown by PCR to have the BoNT type E gene in faeces. This is the first report of cases of fatal botulism in Greenland. It underscores...

  10. Therapeutic management of botulism in dairy cattle

    Directory of Open Access Journals (Sweden)

    S. Jegaveera Pandian

    2015-11-01

    Full Text Available Aim: To report the successful recovery of few dairy cattle from botulism in response to a modified therapeutic strategy. Materials and Methods: Seventy four naturally-occurring clinical cases of bovine botulism encountered during the period of 2012-2014 which were confirmed by mouse lethality test became material for this study. Affected animals were made into three groups based on the treatment modifications made during the course of study. Results and Discussion: With the modified therapeutic regimen, 17 animals recovered after 7-10 days of treatment. Clinical recovery took 2-30 days. Animals which were not given intravenous fluid and calcium recovered uneventfully. Cattle which were already treated with intravenous fluids, calcium borogluconate, and antibiotics did not recover. They were either died or slaughtered for salvage. Conclusion: In cattle with botulism, administration of Vitamin AD3E and activated charcoal aid the clinical recovery. Besides, strictly avoiding anti-clostridial antibiotics, fluid therapy, and calcium therapy may facilitate the clinical recovery. Upon fluid administration, the pulmonary congestion existed in the ailing cattle might have worsened the anoxia. Administration of antibiotics like penicillin, aminoglycosides, and tetracyclines further worsen the neuronal paralysis by increasing the availability of botulinum neurotoxin. Cattle in early botulism have fair chances of recovery with the modified therapy.

  11. Botulismo de origem alimentar Foodbourne botulism

    Directory of Open Access Journals (Sweden)

    Natacha Deboni Cereser

    2008-02-01

    Full Text Available O botulismo alimentar ocorre pela ingestão de toxinas pré-formadas pelo Clostridium botulinum, consideradas as mais potentes dentre as toxinas conhecidas. Caracteriza-se como uma doença de extrema gravidade, de evolução aguda, provoca distúrbios digestivos e neurológicos, em conseqüência à ingestão de diversos tipos de alimentos. As conservas caseiras estão entre os alimentos que oferecem maior risco à população consumidora. Os produtos de origem animal são frequentemente associados aos surtos da doença, destacando-se os embutidos, tais como salsichas, salames, presuntos e patês. Derivados do leite e enlatados, bem como produtos fermentados, são passíveis de provocar a intoxicação. As outras formas naturais da doença são botulismo por feridas e botulismo infantil, normalmente associado ao consumo de mel contendo esporos do Clostridium botulinum.Foodbourne botulism occurs after ingestion of preformed toxins produced by the Clostridium botulinum, which has been considered one of the most potent known one. The disease, acquired after ingestion of various kinds of foods, has acute character, and provokes gastrointestinal and neurologic symptoms. Homemade canned foods are those that represent higher risk to human health. Processed meat products are frequently associated with botulism outbreaks, mainly sausages, ham and pates. Dairy and canned food, as well as fermented foods, also may be related with this disease. Still, botulism may be caused by toxin production in deep wound, named wound botulism; and after ingestion of honey contaminated with spores by infants, named infant botulism.

  12. Diplopia as the primary presentation of foodborne botulism

    Science.gov (United States)

    Khakshoor, Hamid; Moghaddam, Ali Akbar Saber; Vejdani, Amir Hossein; Armstrong, Blair K.; Moshirfar, Majid

    2012-01-01

    Foodborne botulism is a serious condition caused by Clostridium botulinum neurotoxin. Clinically, botulism presents as bilateral cranial nerve neuropathy and descending paralysis. We report a unique presentation of botulism to remind clinicians of this potentially fatal condition. In this observational case report initial evaluation showed only esodeviation. This progressed to unilateral cranial nerve six (CN VI) paresis along with systemic signs. Clinical diagnosis was made based on in-depth history and concurrent symptoms in three other patients. Foodborne botulism presenting as diplopia and unilateral motility deficits is rare and can represent a diagnostic and therapeutic challenge to the ophthalmologist. PMID:22993467

  13. Botulismo y toxina botulínica

    Directory of Open Access Journals (Sweden)

    H. Pérez Pérez

    2003-01-01

    Full Text Available El botulismo es una toxi-infección producida por la bacteria anaerobia Clostridium botulinum por medio de una potentísima toxina, la toxina botulínica, de la cual existen ocho serotipos diferentes. Ésta es capaz de provocar en humanos al menos cuatro cuadros clínicos diferentes por bloqueo de la transmisión neuromuscular, y que pueden variar en gravedad desde la casi ausencia de síntomas hasta la muerte por parálisis respiratoria. Paradójicamente, la toxina botulínica se presenta también como un arma terapéutica eficaz y segura en decenas de enfermedades, si bien gran parte de estas potenciales aplicaciones está aún en fase de investigación

  14. Food-borne botulism in Argentina.

    Science.gov (United States)

    Rebagliati, Victoria; Philippi, Romina; Tornese, Mariela; Paiva, Analia; Rossi, Laura; Troncoso, Alcides

    2009-05-01

    Botulism is a severe neuroparalytic disease caused by Clostridium botulinum toxins. Although the disease is uncommon it is a cause of great concern due to its high rate of mortality. Food-borne outbreaks of botulism occur worldwide and require immediate public health attention and acute care resources. Analysis of outbreaks showed that the food products most often involved were fermented fish products in Alaska; home-canned food, oil preservation and restaurant sauce in the rest of the United States (US) and in London and; and home-canned vegetables, airtight packed food with inappropriate refrigeration, and aerosols in Argentina. The diagnosis is based only on clinical findings matching the disease and previous exposure to suspicious food. Botulism must be immediately identified as even one case suggests the start of an epidemic and should be treated as a public health emergency. Therefore, the purpose of the following review is to recognize the risks associated with the consumption of potentially dangerous foods, and to encourage prevention by seeking to make all public health professionals aware of the dangers of this potentially lethal disease.

  15. Abnormal Neuroimaging in a Case of Infant Botulism.

    Science.gov (United States)

    Good, Ryan J; Messacar, Kevin; Stence, Nicholas V; Press, Craig A; Carpenter, Todd C

    2015-01-01

    We present the first case of abnormal neuroimaging in a case of infant botulism. The clinical findings of the patient with constipation, bulbar weakness, and descending, symmetric motor weakness are consistent with the classic findings of infant botulism. Magnetic resonance imaging (MRI), however, revealed restricted diffusion in the brain and enhancement of the cervical nerve roots. Traditionally, normal neuroimaging was used to help differentiate infant botulism from other causes of weakness in infants. Abnormal neuroimaging is seen in other causes of weakness in an infant including metabolic disorders and hypoxic-ischemic injury, but these diagnoses did not fit the clinical findings in this case. The explanation for the MRI abnormalities in the brain and cervical nerve roots is unclear as botulinum toxin acts at presynaptic nerve terminals and does not cross the blood-brain barrier. Possible explanations for the findings include inflammation from the botulinum toxin at the synapse, alterations in sensory signaling and retrograde transport of the botulinum toxin. The patient was treated with human botulism immune globulin and had rapid recovery in weakness. A stool sample from the patient was positive for Type A Clostridium botulinum toxin eventually confirming the diagnosis of infant botulism. The findings in this case support use of human botulism immune globulin when the clinical findings are consistent with infant botulism despite the presence of MRI abnormalities in the brain and cervical nerve roots.

  16. Use of sentinel mallards for epizootiologic studies of avian botulism

    Science.gov (United States)

    Rocke, T.E.; Brand, C.J.

    1994-01-01

    Captive-reared mallards (Anas platyrhynchos) were used as sentinels to study the epizootiology of avian botulism at the Sacramento National Wildlife Refuge, Willows, California (USA) from 1986 to 1989. Sentinel mallards were wing-clipped, and 40 to 50 birds were confined in 1.6-ha enclosures in 11 selected wetlands (pools). Enclosures were searched intensively three to four times weekly from July through October. Sick and dead wild and sentinel birds were collected, necropsied, and tested for type C botulism toxin. Botulism epizootics occurred in sentinel mallards in 1986, 1987, and 1989, but only a few isolated cases of botulism were detected in 1988. In most epizootics, botulism also was detected simultaneously in wild birds using the same pool outside the enclosure. Epizootics in sentinels were initiated and perpetuated in the absence of vertebrate carcasses. A sex-specific trend in the probability of intoxication was detected, with males contracting botulism at a higher rate than females. Daily mortality rates of sentinels during botulism epizootics ranged from 0.0006 to 0.0600, with a mean of 0.0190. These rates would result in the daily loss of 0.6 to 60 birds per thousand at risk. The use of sentinel birds provided an effective means of gathering site-specific epizootiologic data.

  17. Fur animal botulism hazard due to feed.

    Science.gov (United States)

    Myllykoski, J; Lindström, M; Bekema, E; Pölönen, I; Korkeala, H

    2011-06-01

    To assess the botulism hazard in fur animal feed production, 236 fur animal feed components and feed samples were analysed for Clostridium botulinum by detecting BoNT-encoding genes (botA, botB, botC, botE or botF) by PCR and for sulphite-reducing clostridia (SRC) by iron sulphite agar. The quality of the hazard analysis of critical control points (HACCP) -based in-house control system (IHCS) was evaluated with respect to botulism risk in feed plants (n=32). The overall prevalence of C. botulinum was 13% in different feed components and 5% in feed. The estimated MPN count of C. botulinum in feed components was 6.4 × 10(3)/kg at the highest and was shown to poorly correlate with SRC count. The critical control points in IHCSs were variable, and control limits were improperly set in most feed-producing plants. C. botulinum possesses a persistent safety hazard for fur animals by feed production, and control practices should be reassessed.

  18. Avian botulism in the southern San Joaquin Valley 1973

    Data.gov (United States)

    US Fish and Wildlife Service, Department of the Interior — Dead and sick waterfowl found on the Kern National Wildlife Refuge in late June, 1973, were diagnosed as positive for botulism toxin. Despite immediate control...

  19. Historical review of avian botulism at Stillwater Wildlife Management Area

    Data.gov (United States)

    US Fish and Wildlife Service, Department of the Interior — The purpose of this report is to review historical information on avian botulism at Stillwater Wildlife Management Area. This report includes incidental reports of...

  20. An Overview of Type E Botulism in China

    Institute of Scientific and Technical Information of China (English)

    SI-WU FU; CHEN-HUAI WANG

    2008-01-01

    The geographical distribution of C. botulinum type E and its associated disease, type E botulism in China, is different from that in other areas of the world. Cases of type E botulism generally arise in costal regions. In China, however, type E botulism is found primarily in the Qinghai-Tibet plateau of northwest China far from the ocean, at an altitude of approximately 4-5 kin. The foods most commonly associated with the disease are fermented grain and beans as well as raw meat. A suspected outbreak of type E botulism poisoning in the central costal region of China in the 1990s prompted the collection and analysis of samples of mud, sand, and fish from the region. The toxin produced by type E botulinum was found in these samples. Surprisingly, though, upon further analysis, the strain isolated from the samples was identified not as type E C. botulinum, but as the neurotoxigenic bacterium Clostridium butyricum.

  1. [Des Lacs National Wildlife Refuge habitat improvement to combat botulism

    Data.gov (United States)

    US Fish and Wildlife Service, Department of the Interior — This documents discusses the possibilities of ditching the Upper Des Lacs lake as a means of combating botulism on the Des Lacs National Wildlife Refuge.

  2. Waterfowl botulism in the Tulare Lake Basin California 1969

    Data.gov (United States)

    US Fish and Wildlife Service, Department of the Interior — The possibility of a major outbreak of waterfowl botulism in the Tulare Lake Basin of Kern and Kings County, California was anticipated during the summer and fall of...

  3. Avian botulism in the southern San Joaquin valley 1970

    Data.gov (United States)

    US Fish and Wildlife Service, Department of the Interior — A joint effort of the Department of Fish and' Game and the U. S. Bureau of Sport Fisheries and Wildlife contained botulism losses in the southern San Joaquin Valley...

  4. [A case of foodborne botulism in the province of Viterbo

    Directory of Open Access Journals (Sweden)

    Flavia Verginelli

    2016-06-01

    The present article follows the diagnostic therapeutic pathway of the patient, highlighting the critical points not only related to the clinic but also to the ministerial procedures for reporting a case of botulism. This case provides an opportunity to emphasize the need for greater awareness about how to prevent and correctly manage the cases of botulism, both by the general population and by physicians who faced a patient with suspected poisoning by Botulinum toxin. [Article in Italian

  5. Equine botulinum antitoxin for the treatment of infant botulism.

    Science.gov (United States)

    Vanella de Cuetos, Elida E; Fernandez, Rafael A; Bianco, María I; Sartori, Omar J; Piovano, María L; Lúquez, Carolina; de Jong, Laura I T

    2011-11-01

    Infant botulism is the most common form of human botulism in Argentina and the United States. BabyBIG (botulism immune globulin intravenous [human]) is the antitoxin of choice for specific treatment of infant botulism in the United States. However, its high cost limits its use in many countries. We report here the effectiveness and safety of equine botulinum antitoxin (EqBA) as an alternative treatment. We conducted an analytical, observational, retrospective, and longitudinal study on cases of infant botulism registered in Mendoza, Argentina, from 1993 to 2007. We analyzed 92 medical records of laboratory-confirmed cases and evaluated the safety and efficacy of treatment with EqBA. Forty-nine laboratory-confirmed cases of infant botulism demanding admission in intensive care units and mechanical ventilation included 31 treated with EqBA within the 5 days after the onset of signs and 18 untreated with EqBA. EqBA-treated patients had a reduction in the mean length of hospital stay of 23.9 days (P = 0.0007). For infants treated with EqBA, the intensive care unit stay was shortened by 11.2 days (P = 0.0036), mechanical ventilation was reduced by 11.1 days (P = 0.0155), and tube feeding was reduced by 24.4 days (P = 0.0001). The incidence of sepsis in EqBA-treated patients was 47.3% lower (P = 0.0017) than in the untreated ones. Neither sequelae nor adverse effects attributable to EqBA were noticed, except for one infant who developed a transient erythematous rash. These results suggest that prompt treatment of infant botulism with EqBA is safe and effective and that EqBA could be considered an alternative specific treatment for infant botulism when BabyBIG is not available.

  6. Equine Botulinum Antitoxin for the Treatment of Infant Botulism

    Science.gov (United States)

    Vanella de Cuetos, Elida E.; Fernandez, Rafael A.; Bianco, María I.; Sartori, Omar J.; Piovano, María L.; Lúquez, Carolina; de Jong, Laura I. T.

    2011-01-01

    Infant botulism is the most common form of human botulism in Argentina and the United States. BabyBIG (botulism immune globulin intravenous [human]) is the antitoxin of choice for specific treatment of infant botulism in the United States. However, its high cost limits its use in many countries. We report here the effectiveness and safety of equine botulinum antitoxin (EqBA) as an alternative treatment. We conducted an analytical, observational, retrospective, and longitudinal study on cases of infant botulism registered in Mendoza, Argentina, from 1993 to 2007. We analyzed 92 medical records of laboratory-confirmed cases and evaluated the safety and efficacy of treatment with EqBA. Forty-nine laboratory-confirmed cases of infant botulism demanding admission in intensive care units and mechanical ventilation included 31 treated with EqBA within the 5 days after the onset of signs and 18 untreated with EqBA. EqBA-treated patients had a reduction in the mean length of hospital stay of 23.9 days (P = 0.0007). For infants treated with EqBA, the intensive care unit stay was shortened by 11.2 days (P = 0.0036), mechanical ventilation was reduced by 11.1 days (P = 0.0155), and tube feeding was reduced by 24.4 days (P = 0.0001). The incidence of sepsis in EqBA-treated patients was 47.3% lower (P = 0.0017) than in the untreated ones. Neither sequelae nor adverse effects attributable to EqBA were noticed, except for one infant who developed a transient erythematous rash. These results suggest that prompt treatment of infant botulism with EqBA is safe and effective and that EqBA could be considered an alternative specific treatment for infant botulism when BabyBIG is not available. PMID:21918119

  7. Botulism protocols for the Don Edwards San Francisco Bay National Wildlife Refuge

    Data.gov (United States)

    US Fish and Wildlife Service, Department of the Interior — This plan gives a basic description of what avian botulism is and the locations on the Don Edwards San Francisco Bay National Wildlife Refuge where botulism...

  8. Considering the antimicrobial sensitivity of the intestinal botulism agent Clostridium butyricum when treating concomitant infections.

    Science.gov (United States)

    Fenicia, Lucia; Ferrini, Anna Maria; Anniballi, Fabrizio; Mannoni, Veruscka; Aureli, Paolo

    2003-01-01

    In Italy, neurotoxigenic Clostridium butyricum has been reported as a new agent of intestinal toxemia botulism, and most of the cases have been associated with enterocolitis. Although infections concomitant with botulism must be treated with antibiotics, this can increase the severity of botulism. We discuss the sensitivity of this agent to certain antibiotics, compared to findings on the sensitivity of C. botulinum.

  9. First report of an infant botulism case due to Clostridium botulinum type Af.

    Science.gov (United States)

    de Jong, Laura I T; Fernández, Rafael A; Pareja, Virtudes; Giaroli, Gabriel; Guidarelli, Sergio R; Dykes, Janet K; Lúquez, Carolina

    2015-02-01

    Most infant botulism cases worldwide are due to botulinum toxin types A and B. Rarely, Clostridium botulinum strains that produce two serotypes (Ab, Ba, and Bf) have also been isolated from infant botulism cases. This is the first reported case of infant botulism due to C. botulinum type Af worldwide.

  10. Toxicoinfectious botulism in commercial caponized chickens

    Science.gov (United States)

    Trampel, D.W.; Smith, S.R.; Rocke, T.E.

    2005-01-01

    During the summer of 2003, two flocks of commercial broiler chickens experienced unusually high death losses following caponizing at 3 wk of age and again between 8 and 14 wk of age. In September, fifteen 11-wk-old live capons were submitted to the Iowa State University Veterinary Diagnostic Laboratory for assistance. In both flocks, the second episode of elevated mortality was associated with incoordination, flaccid paralysis of leg, wing, and neck muscles, a recumbent body posture characterized by neck extension, and diarrhea. No macroscopic or microscopic lesions were detected in affected chickens. Hearts containing clotted blood and ceca were submitted to the National Wildlife Health Center in Madison, WI. Type C botulinum toxin was identified in heart blood and ceca by mouse bioassay tests. Enzyme-linked immunosorbent assay tests on heart blood samples were also positive for type C botulinum toxin. Clostridium botulinum was isolated from the ceca and genes encoding type C botulinum toxin were detected in cecal contents by a polymerase chain reaction test. Chickens are less susceptible to botulism as they age, and this disease has not previously been documented in broilers as old as 14 wk of age. Wound contamination by spores of C. botulinum may have contributed to the unusually high death losses following caponizing.

  11. Botulism in New South Wales, 1980-1981.

    Science.gov (United States)

    Murrell, W G; Stewart, B J

    1983-01-08

    The isolation of Clostridium botulinum from the home environment of New South Wales patients with infant botulism is reported. Of the three cases of infant botulism type B, the bacteria were isolated from soil around the dwelling in one, and from tank rainwater in another. In one case with type A, the bacteria were present in the soil, vacuum-cleaner dust, and tank rainwater. The bacteria were not detected in the environment of two adult patients and a child with C. botulinum in their stools. The home location of the patients with infant botulism, and the frequency of isolation of the bacteria from rainwater, soil and vacuum-cleaner dust in Cobar, Nyngan, some Sydney suburbs, and at five pastoral homesteads suggest that infants in rural areas are more at risk than those in large metropolitan areas. The age of the infants with diagnosed botulism in New South Wales, compared with those reported in the United States data, strongly suggests that the disease is not being fully recognised in younger infants.

  12. Food-borne botulism in the United Kingdom.

    Science.gov (United States)

    McLauchlin, Jim; Grant, K A; Little, C L

    2006-12-01

    Food-borne botulism is a rare but serious disease caused by ingestions of neurotoxin [botulinum neurotoxins (BoNTs)] produced as a result of the growth of the bacterium Clostridium botulinum in foods before consumption. The disease is rare in the United Kingdom, and only 62 cases have been recognized between 1922 and 2005. This report provides a brief review of C. botulinum and food-borne botulism as well as descriptions of the six episodes (33 cases with three deaths) of this disease that occurred in the United Kingdom between 1989 and 2005. The six incidents illustrate the importance of the risk factors of poor processing or storage of commercially prepared foods, improper home preservation of foods and travel to countries where botulism is much more common than in the United Kingdom. Even small outbreaks of food-borne botulism can precipitate a national emergency and inundate public health and acute care provision. This report provides a reminder to public health professions of the occurrence, diagnosis, treatment and control of this rare but serious food-borne disease.

  13. Cluster of Botulism among dutch tourists in Turkey, june 2008

    NARCIS (Netherlands)

    Swaan, C.M.; Ouwerkerk, van M.; Roest, H.I.J.

    2010-01-01

    In June 2008, three Dutch tourists participating in a mini-cruise in Turkey needed urgent repatriation for antitoxin treatment because of symptoms of botulism. Because there was a shortage of antitoxin in the Netherlands, an emergency delivery was requested from the manufacturer in Germany. An outbr

  14. Animal Botulism Outcomes in the AniBioThreat Project

    DEFF Research Database (Denmark)

    Woudstra, Cédric; Tevell Åberg, Annica; Skarin, Hanna

    2013-01-01

    Botulism disease in both humans and animals is a worldwide concern. Botulinum neurotoxins produced by Clostridium botulinum and other Clostridium species are the most potent biological substances known and are responsible for flaccid paralysis leading to a high mortality rate. Clostridium botulinum...

  15. Infant Botulism%婴儿肉毒中毒

    Institute of Scientific and Technical Information of China (English)

    骆海朋; 任秀; 崔生辉

    2015-01-01

    综述了国内外婴儿肉毒中毒的有关研究,从肉毒梭菌的生物学特性、婴儿肉毒中毒的流行病学、婴儿肉毒中毒的风险因素、临床症状及诊断方法进展方面进行了介绍。分析表明,婴儿肉毒中毒是一种会危及婴儿生命的疾病,需加强临床诊断和实验室的鉴定手段,并加强对婴儿肉毒中毒预防。%This paper reviews related researches on infant botulism at home and abroad and introduces the biological characteristics of Clostridium botulinum, the epidemiology of infant botulism, risk factors, clinical symptoms and progresses of diagnostic methods. The analysis shows that infant botulism is an illness threatening infants' life. It is necessary to strengthen the means of clinical diagnosis and laboratory identiifcation as well as the prevention of infant botulism.

  16. The 1971 waterfowl botulism outbreak in the Tulare Lake basin

    Data.gov (United States)

    US Fish and Wildlife Service, Department of the Interior — The efforts of the Department of Fish and Game and the U.S. Bureau of Sport Fisheries and Wildlife held botulism losses in the Tulare Lake region of the Southern San...

  17. [A case of foodborne botulism in the province of Viterbo

    OpenAIRE

    Flavia Verginelli; Silvia Dari; Silvia Aquilani

    2016-01-01

    A 57 years-old woman with gastrointestinal pain, dysphagia, diplopia, dry mouth, was diagnosed with foodborne botulism caused by Clostridium Botulinum toxin. In this case, a jar of vegetables preserved in oil was identified as the source of the intoxication. Canned peppers were produced at home by the patient according to traditional techniques, deemed appropriate as established use. Despite this, the procedure proved to be a health hazard. The present article follows the diagnostic therap...

  18. Dry mouth as an initial sign of food-borne botulism: a case report and review of the literature.

    Science.gov (United States)

    Manfredi, Maddalena; Scoditti, Umberto; Angelini, Monica; de Giampaulis, Piero; Borrini, Bianca Maria; Macaluso, Guido Maria; Pavesi, Giovanni; Vescovi, Paolo

    2011-04-01

    Botulism is a rare neuroparalytic disease caused by a potent neurotoxin produced by Clostridium botulinum. There are different clinical types of botulism. Early diagnosis of the condition is essential for effective treatment. We report a case of food-borne botulism in identical twins characterized by severe initial oral involvement and a review of the literature about the condition.

  19. Management of animal botulism outbreaks: from clinical suspicion to practical countermeasures to prevent or minimize outbreaks

    NARCIS (Netherlands)

    Anniballi, F.; Fiore, A.; Löfström, Ch.; Skarin, H.; Auricchio, B.; Woudstra, C.; Bano, L.; Segerman, B.; Koene, M.G.J.

    2013-01-01

    Botulism is a severe neuroparalytic disease that affects humans, all warm-blooded animals, and some fishes. The disease is caused by exposure to toxins produced by Clostridium botulinum and other botulinum toxin–producing clostridia. Botulism in animals represents a severe environmental and economic

  20. [Food-borne botulism: review of five cases].

    Science.gov (United States)

    Cardoso, Teresa; Costa, Manuela; Almeida, H Cristina; Guimarães, Mário

    2004-01-01

    Food-borne botulism is a disease caused by the ingestion of food contaminated with botulinum toxin, often present in smoked meat, canned food and preserved food; it can occur as sporadic case or as an outbreak. In the last decades there has been an increasing incidence of food-borne botulism in Portugal. The authors do a review of five cases of food-borne botulism, three isolated cases and 2 familiar. Four were associated with the ingestion of smoked ham and one of canned tunafish. The incubation period was 48 hours in one patient and 4 days in another, in the remaining patients it was not possible to determine this period. The clinical picture was dominated in all patients by diplopy, dysphagia, dizziness, blurred vision, dry mouth and constipation, and in two patients there were gastrointestinal complains. In one patient the electromyography findings were compatible with pre-synaptic neuromuscular blockage. A toxin type B was found in the serum of one patient and in the food involved in the two familiar cases. All patients experienced complete recovery with only symptomatic treatment. With this article the authors intend to call attention to this diagnosis, which is not rare, but difficult for someone not familiar with its presentation, being of notice that the diagnosis is essentially clinic with a strong epidemiological history, confirmed by typical electromyography findings and by the identification of the toxin involved. In Portugal there is only descriptions of clinical cases associated with the type B and the type E toxins, not being necessary the resource to the antitoxin therapy.

  1. A toxina botulínica A nas paralisias oculomotoras

    OpenAIRE

    2013-01-01

    A Toxina Botulínica A (TBA) bloqueia a transmissão neuromuscular a nível pré-sináptico, inibindo a libertação da acetilcolina (necessária para a condução de sinal nervoso) nos terminais nervosos, por bloqueio da acção do cálcio causando uma denervação funcional que pode durar cerca de 6 meses. Objectivos do estudo: desaparecimento da diplopia, de torcicolos e corrigir a limitação parcial ou total do movimento; evitar a contractura secundária.

  2. Type C botulism in swine fed on restaurant waste

    OpenAIRE

    Djeison L. Raymundo; Gomes,Danilo C.; Fabiana M. Boabaid; Edson M. Colodel; Milene Schmitz; Correa,André M.R.; Iveraldo S. Dutra; David Driemeier

    2012-01-01

    Descreve-se a epidemiologia da morte de suínos ocorrida entre 2002 e 2009 pela ingestão da neurotoxina botulínica do tipo C. A neurotoxina presente em resíduos de alimentos provenientes de cozinhas de restaurantes e hotéis, armazenados em tonéis sem abrigo do sol e administrado em cocho coletivo sem tratamento térmico prévio. Animais de diferentes idades morreram com sinais clínicos de botulismo caracterizados por paralisia flácida, emagrecimento, anorexia, fraqueza, incoordenação, dificuldad...

  3. THE INFLUENCE OF CALCIUM CHLORIDE UPON EXPERIMENTAL BOTULISM.

    Science.gov (United States)

    Hall, I C; Davis, N C

    1923-03-31

    1. Calcium chloride given subcutaneously, intraperitoneally, or intravenously has been found to have no effect upon the production of botulism following the injection of Bacillus botulinus (Strain 80B) into the peritoneal cavity of guinea pigs. 2. Treatment of Bacillus botulinus with alcohol has been found markedly to decrease its toxicity for guinea pigs. This is in conformity with the work of Bronfenbrenner and Schlesinger. 3. Toxin-free spores of Bacillus botulinus have been found pathogenic for guinea pigs. 4. No prejudice as to possible results in rabbits should be based upon the above conclusions.

  4. Wound botulism presenting as a deep neck space infection.

    Science.gov (United States)

    Gouveia, Christopher; Mookherjee, Somnath; Russell, Matthew S

    2012-12-01

    Otolaryngologists commonly evaluate patients with findings suspicious for deep space soft tissue infections of the neck. In this case, a woman with a history of injection drug use (IDU) presented with dysphagia, odynophagia, and neck pain. Multiple neck abscesses, too small to drain, were seen on imaging. Despite broad-spectrum intravenous antibiotics, she unexpectedly and rapidly developed respiratory failure requiring intubation. Further work-up diagnosed wound botulism (WB). To our knowledge, this is the first report of WB presenting as a deep neck space infection, and illustrates the importance of considering this deadly diagnosis in patients with IDU history and bulbar symptoms.

  5. Cure of experimental botulism and antibotulismic effect of toosendanin

    Institute of Scientific and Technical Information of China (English)

    Yu-liang SHI; Zhong-feng WANG

    2004-01-01

    Botulinum neurotoxins (BoNTs), a group of bacterial proteins that comprise a light chain disulfide linked aheavy chain, are the most lethal biotoxins known to mankind. By inhibiting neurotransmitter release, BoNTs causesevere neuroparalytic disease, botulism. A series of important findings in the past 10 years which displayed themolecular targets of BoNTs and hence proposed a four-step action mechanism to explain BoNT intoxication greatlyadvanced the study of antibotulismic drug. In this article, we reviewed these progresses and anti-botulismiccompounds found in recent years. These compounds function due to their facilitation on neurotransmitter releaseor to their interference on the binding, internalization, translocation, and endopeptidase activity of the toxins.Toosendanin is a triterpenoid derivative extracted from a digestive tract-parasiticide in Chinese traditional medicine.Chinese scientists have found that the compound is a selective prejunctional blocker. In spite of sharing somesimilar action with BoNT, toosendanin can protect botulism animals that have been administrated with lethal dosesof BoNT/A or BoNT/B for several hours from death and make them restore normal activity. The neuromuscularjunction preparations isolated from the rats that have been injected with toosendanin tolerate BoNT/A challenge.Toosendanin seems to have no effect on endopeptidase activity of BoNT, but blocks the toxin approach to itsenzymatic substrate.

  6. Effectiveness of carcass removal for mitigating avian botulism in prairie-pothole wetlands

    Data.gov (United States)

    US Fish and Wildlife Service, Department of the Interior — Final report on a project to determine if refuge standard operational procedures for carcass pick-up are effective at mitigating avian botulism in the Sand Lake...

  7. Frozen, Fully-Cooked Products and Botulism--Food Safety Advisory

    Science.gov (United States)

    ... Web Content Viewer (JSR 286) Actions ${title} Loading... Frozen, Fully-Cooked Products & Botulism - Food Safety Advisory In ... Clostridium botulinum , were reported in the United States. Frozen, fully-cooked products were suspected of causing these ...

  8. Bioassessment of avian botulism at Benton Lake National Wildlife Refuge, Montana

    Data.gov (United States)

    US Fish and Wildlife Service, Department of the Interior — Current detection of a botulism outbreak is dependent on the occurrence of dead or sick birds during field surveys (Reed and Rocke 1992). A recently developed...

  9. Estrabismo após toxina botulínica para fins estéticos

    Directory of Open Access Journals (Sweden)

    Marta Halfeld Ferrari Alves Lacordia

    2011-06-01

    Full Text Available RESUMO Nas últimas décadas, a toxina botulínica tem sido aplicada para fins terapêuticos em inúmeras afecções. A toxina do tipo A foi aprovada primeiramente em 1989 para o uso em estrabismo, blefaroespasmo e espasmo hemifacial de pacientes maiores que 12 anos de idade. A observação de que pacientes tratados de blefaroespasmo com toxina botulínica apresentavam um efeito adicional de diminuição das rugas de expressão inspirou estudos sobre a aplicação cosmética da toxina. Recentemente, a toxina botulínica do tipo A foi aprovada para fins estéticos. Este trabalho relata um caso de ocorrência de estrabismo após aplicação de toxina botulínica na face para fins estéticos.

  10. An outbreak of food-borne botulism in Scotland, United Kingdom, November 2011.

    Science.gov (United States)

    Browning, L M; Prempeh, H; Little, C; Houston, C; Grant, K; Cowden, J M

    2011-12-08

    An investigation is currently underway to explain an outbreak of food-borne botulism in Scotland. Three children in the same family were confirmed as having botulism following consumption of a meal made with a jar of korma sauce. Residual sauce from the jar, the jar lid and a remnant of the meal, all tested positive for Clostridium botulinum type A toxin. The children are recovering, although two remain ventilated and in intensive care unit.

  11. Epidemiologival, clinical, pathological and laboratory findings of botulism in cattle in the State of Santa Catarina

    OpenAIRE

    Luciane Orbem Veronezi

    2009-01-01

    The study was carried out through the epidemiological, clinical, pathological and laboratory findings of botulism in cattle in the state of Santa Catarina, during the period from 1987 to 2008. The data were obtained through information from the files of the Department of Animal Pathology CAV/UDESC and in the properties which the disease continued to occur. In properties with the botulism associated phosphorus deficiency cattle, the animals were kept on native pastures, in most ...

  12. Botulism in injecting drug users, Dublin, Ireland, November-December 2008.

    LENUS (Irish Health Repository)

    Ward, M

    2009-01-08

    In November and December 2008, six cases of suspect wound botulism were reported in heroin injecting drug users, all residents in Dublin, Ireland. Patients were aged between 23-42 years of age; four cases were male; one patient died shortly after admission. The patients presented to four different hospitals across the city. Botulism in injecting drug users in Ireland was last reported in 2002.

  13. Differences in the Vulnerability of Waterbird Species to Botulism Outbreaks in Mediterranean Wetlands: an Assessment of Ecological and Physiological Factors

    OpenAIRE

    Anza, I.; Vidal, D.; Feliu, J; Crespo, E.; Mateo, R

    2016-01-01

    Avian botulism kills thousands of waterbirds every year, including endangered species, but information about the differences between species in vulnerability to botulism outbreaks and the capacity to act as carriers of Clostridium botulinum is still poorly known. Here, we estimated the vulnerability to botulism of 11 waterbird species from Mediterranean wetlands by comparing the number of affected birds with the census of individuals at risk. The capacity of different species to act as carrie...

  14. RECURRENT EPISODES OF FOOD BORNE BOTULISM IN A 7-YEAR OLD BOY

    Directory of Open Access Journals (Sweden)

    Seddighi MD

    2007-02-01

    Full Text Available Objective Botulism is the acute, descending, flaccid paralysis that results when the neurotoxin of Clostridium botulinum blocks neuromuscular transmission. C botulinum toxin is the most poisonous substance that blocks neuromuscular transmission and causes death through airway and respiratory muscle paralysis; all forms of botulism manifest neurologically as asymmetric, descending, flaccid paralysis beginning with the cranial nerve musculature. Food-borne botulism results from the ingestion of food in which C botulinum has multiplied and produced its toxin.Patient We report a new case of food-borne botulism in a 7 year old boy with recurrent episodes of weakness, difficulty in swallowing and speech; bilateral ptosis and mydriasis. He had positive history of the same symptoms, documented twice before. The patient’s samples were sent for detection of toxin of Clostridium botulinum, and toxin of C. botulinum, type A was found in his stool sample, confirming our diagnosis. This case was unusual report because our patient has not history of canned food ingestion and also because recurrent episodes of paralysis in this case are unusual findings in botulism.ConclusionIn this report we want to emphasize that canned-food ingestion is not necessary for diagnosis of food-borne botulism and because delayed treatment leads to increase mortality and morbidity, treatment should be initiated promptly on the basis of clinical suspicion

  15. Lobotomies and Botulism Bombs: Beckett's Trilogy and the Cold War.

    Science.gov (United States)

    Piette, Adam

    2016-06-01

    The article argues that Beckett's Trilogy stages the effects of a lobotomy operation on a potentially politically subversive writer, and that the consequences of the operation can be traced in both the retreat of the narrator(s) of the Trilogy into the mind and into comatose mental states and in the detail of the operation itself, based on the 'icepick' lobotomies performed by neurologist Walter Freeman in the late 1940s and early 1950s. To write about extreme psychiatric situations in the post-war period is necessarily to invoke the political uses of psychosurgery with which this article engages. The article goes on to consider the figure of the brain-damaged mind as a Cold War trope in the references to botulism and the motif of the penetrated skull in The Unnamable.

  16. Type C botulism in swine fed on restaurant waste

    Directory of Open Access Journals (Sweden)

    Djeison L. Raymundo

    2012-11-01

    Full Text Available The paper addresses the epidemiologic data of the death of pigs during the period of 2002 to 2009 following the ingestion of botulinum neurotoxin type C. This neurotoxin was present in food residues originating from restaurant and hotel kitchens, stored in barrels without shelter from the sun and administered in a collective trough without prior thermal treatment. Animals which died at different ages showed clinical signs of botulism characterized by flaccid paralysis, weight loss, anorexia, weakness, lack of coordination, locomotion difficulties with the evolution of lateral recumbency with involuntary urination and defecation. No alterations were observed at postmortem and histological examination. The bioassay with serum neutralization in mice was carried out on samples of intestinal contents from pigs affected and revealed the presence of large quantities of botulinum toxin type C.

  17. Toxina botulínica no tratamento do torcicolo espasmódico: uma meta-análise

    Directory of Open Access Journals (Sweden)

    Sérgio Carlos Morais Teixeira

    1994-06-01

    Full Text Available Os autores fizeram uma meta-análise da literatura sobre o uso da toxina botulínica no tratamento do torcicolo espasmódico. Concluem que a toxina botulínica é uma medida terapêutica eficaz para a distonia cervical.

  18. Infant Botulism: a network to improve the diagnosis and treatment of a rare and under-diagnosed disease

    Directory of Open Access Journals (Sweden)

    Davide Lonati

    2008-12-01

    Full Text Available Infant Botulism is a form of human botulism in which ingested spores of Clostridium botulinum germinate, colonize the infant’s colon, in which they produce botulinum neurotoxin. After the toxin is absorbed, binding to peripheral cholinergic synapses occurs, causing flaccid paralysis. The incidence of infant botulism is low, but some underestimation is likely to exist: the disease is difficult to diagnose because its wide spectrum of clinical manifestations which are not pathognomic. Moreover, failure to recognise the disease is probably related to the low index of suspicion: in fact, the experience of clinicians is fundamental in recognising infant botulism. A specific project has been promote to improve knowledge of the disease by training physicians (pediatricians, neurologists, clinical toxicologists to look out for the possible presence of Infant Botulism cases and improving public awareness through a prevention program. Standardization of therapeutic protocol also by treatment with specific therapeutic measures will be disseminated. A staff of physicians specialized in Clinical Toxicology will be available, 24 hours a day and seven days/week in the Pavia Poison Centre – National Toxicology Information Center. According to the project, this Centre acts as Reference Center for the clinical diagnosis and the treatment of infant botulism for the correct recognition of typical syndrome, the early diagnosis and the possible therapy with particular attention to antidotic treatment. The National Reference Centre for Botulism at the Istituto Superiore di Sanità will offer a 24-hours diagnostic laboratory service to support diagnose in suspected cases of botulism.

  19. [Botulism: the agent, mode of action of the botulinum neurotoxins, forms of acquisition, treatment and prevention].

    Science.gov (United States)

    Marvaud, Jean-Christophe; Raffestin, Stéphanie; Popoff, Michel R

    2002-08-01

    The botulinum neurotoxins are produced by anaerobic, spore-forming bacteria belonging to the Clostridium genus. They are synthesised as a single chain protein (150 kDa), which is not or weakly active. The active form results from a proteolysis cleaving the precursor in a light chain (about 50 kDa) and a heavy chain (about 100 kDa), which are linked by a disulfide bridge. The heavy chain is involved in the recognition of a specific neuronal surface receptor and mediates the internalization of the light chain into the cytosol. The light chain is responsible for the intracellular activity. It catalyses the proteolysis of SNARE proteins, which are involved in the exocytosis of synaptic vesicles containing acetylcholine. Hence, the release of acetylcholine at the neuromuscular junction is blocked, leading to a flaccid paralysis. Human botulism, usually type A, B or E, is associated with intoxination, ingestion of preformed toxin in food, with digestive toxi-infection, mainly in newborns (infant botulism), or with wound contamination (wound botulism). The treatment of botulism is usually symptomatic. The specific treatment is based on the serotherapy or on the use of purified specific antibodies. The vaccination against botulism is efficient. However, since the botulinum neurotoxins are widely used for the treatment of numerous dystonias, a generalised vaccination is not conceivable.

  20. Livers provide a reliable matrix for real-time PCR confirmation of avian botulism.

    Science.gov (United States)

    Le Maréchal, Caroline; Ballan, Valentine; Rouxel, Sandra; Bayon-Auboyer, Marie-Hélène; Baudouard, Marie-Agnès; Morvan, Hervé; Houard, Emmanuelle; Poëzevara, Typhaine; Souillard, Rozenn; Woudstra, Cédric; Le Bouquin, Sophie; Fach, Patrick; Chemaly, Marianne

    2016-04-01

    Diagnosis of avian botulism is based on clinical symptoms, which are indicative but not specific. Laboratory investigations are therefore required to confirm clinical suspicions and establish a definitive diagnosis. Real-time PCR methods have recently been developed for the detection of Clostridium botulinum group III producing type C, D, C/D or D/C toxins. However, no study has been conducted to determine which types of matrices should be analyzed for laboratory confirmation using this approach. This study reports on the comparison of different matrices (pooled intestinal contents, livers, spleens and cloacal swabs) for PCR detection of C. botulinum. Between 2013 and 2015, 63 avian botulism suspicions were tested and 37 were confirmed as botulism. Analysis of livers using real-time PCR after enrichment led to the confirmation of 97% of the botulism outbreaks. Using the same method, spleens led to the confirmation of 90% of botulism outbreaks, cloacal swabs of 93% and pooled intestinal contents of 46%. Liver appears to be the most reliable type of matrix for laboratory confirmation using real-time PCR analysis.

  1. Outbreak of Botulism After Consumption of Illicit Prison-Brewed Alcohol in a Maximum Security Prison--Arizona, 2012.

    Science.gov (United States)

    Yasmin, Seema; Adams, Laura; Briggs, Graham; Weiss, Joli; Bisgard, Kris; Anderson, Shoana; Tsang, Clarisse; Henke, Evan; Vasiq, Muhammad; Komatsu, Ken

    2015-10-01

    The authors investigated the second botulism outbreak to occur in a maximum security prison in Arizona within a 4-month period. Botulism was confirmed in eight men aged 20 to 35 years who reported sharing a single batch of pruno made with potatoes. Initial symptoms included blurred vision, slurred speech, muscle weakness, ptosis, and dysphagia. All patients received heptavalent botulinum antitoxin, seven required mechanical ventilation, and all survived. The median incubation period was 29 hours. Sera from all patients and leftover pruno tested positive for botulinum toxin type A. Botulism should be considered among prisoners with cranial nerve palsies and descending, symmetric flaccid paralysis. Prison-brewed alcohol, particularly when made with potatoes, can be a vehicle for botulism and is associated with outbreaks of botulism in prisons.

  2. Rapid detection of foodborne botulism outbreaks facilitated by epidemiological linking of cases: implications for food defense and public health response.

    Science.gov (United States)

    Newkirk, Ryan W; Hedberg, Craig W

    2012-02-01

    The main objective of this study was to develop an understanding of the descriptive epidemiology of foodborne botulism in the context of outbreak detection and food defense. This study used 1993-2008 data from the Centers for Disease Control and Prevention (CDC) Annual Summaries of Notifiable Diseases, 2003-2006 data from the Bacterial Foodborne and Diarrheal Disease National Case Surveillance Annual Reports, and 1993-2008 data from the Annual Listing of Foodborne Disease Outbreaks. Published outbreak investigation reports were identified through a PubMed search of MEDLINE citations for botulism outbreaks. Fifty-eight foodborne botulism outbreaks were reported to CDC between 1993 and 2008. Four hundred sixteen foodborne botulism cases were documented; 205 (49%) were associated with outbreaks. Familial connections and co-hospitalization of initial presenting cases were common in large outbreaks (>5 cases). In these outbreaks, the time from earliest exposure to outbreak recognition varied dramatically (range, 48-216 h). The identification of epidemiologic linkages between foodborne botulism cases is a critical part of diagnostic evaluation and outbreak detection. Investigation of an intentionally contaminated food item with a long shelf life and widespread distribution may be delayed until an astute physician suspects foodborne botulism; suspicion of foodborne botulism occurs more frequently when more than one case is hospitalized concurrently. In an effort to augment national botulism surveillance and antitoxin release systems and to improve food defense and public health preparedness efforts, medical organizations and Homeland Security officials should emphasize the education and training of medical personnel to improve foodborne botulism diagnostic capabilities to recognize single foodborne botulism cases and to look for epidemiologic linkages between suspected cases.

  3. Two cases of type A infant botulism in Grenoble, France: no honey for infants.

    Science.gov (United States)

    Hoarau, Gautier; Pelloux, Isabelle; Gayot, Armelle; Wroblewski, Isabelle; Popoff, Michel-Robert; Mazuet, Christelle; Maurin, Max; Croizé, Jacques

    2012-03-01

    We report two severe cases of infant botulism diagnosed at Grenoble University Hospital, France, respectively in 2006 and 2009. Both cases were characterized by a delay in diagnosis, severe neurological manifestations and extended period of hospitalization in intensive care unit, but a complete recovery. Infant botulism is a rare but life-threatening disease. It primarily affects infants, and the main risk factor is honey ingestion. Diagnosis should be systematically evoked by pediatricians in infants suffering from constipation, fatigue, muscle weakness, difficult feeding and altered cry, but before the onset of generalized flaccid paralysis, so as to administer specific treatment (BabyBIG®, a human derived botulinum antitoxin) at an early stage of the disease when it is most effective. In conclusion, parents should be aware of the role of honey as a source of spores of Clostridium botulinum and therefore infant botulism in the first year of life.

  4. Polar poisons: did Botulism doom the Franklin expedition?

    Science.gov (United States)

    Horowitz, B Zane

    2003-01-01

    In 1845 the Franklin expedition left London with 2 ships and 134 men on board in an attempt to find the route through the Northwest Passage. The ships were built with state-of-the-art technology for their day, but provisioned with supplies from the lowest bidder. After taking on fresh provisions in the Whalefish Islands, off the coast of Greenland, the entire crew was never heard from again. Graves found on remote Beechey Island indicate that three able-bodied seamen died during the first winter. A note written on a ship's log, later found in a cairn, indicate that the expedition's leader, Sir John Franklin, died during the second winter entrapped on the ice, by which time 24 men had also perished. The remaining crew failed in their attempt to walk out of the Arctic by an overland route. In 1981 Owen Beattie, from the University of Alberta, exhumed the remains of the sailors from the three graves on Beechey Island. Elevated lead levels were found in all three sailors. While lead poisoning has been a leading theory of the cause of the crew's deaths, blamed on the crudely tinned provisions the ships carried with them from England, chronic lead exposure may only have weakened the crew, not necessarily killed them. One of three exhumed sailors also had in his intestine the spores of an unspecified Clostridium species. The theory put forth by this article is that Botulism, type E, which is endemic in the Arctic, may have been responsible for their deaths.

  5. Botulism outbreaks in natural environments — an update

    Directory of Open Access Journals (Sweden)

    Mari eEspelund

    2014-06-01

    Full Text Available Clostridium botulinum comprises a diverse group of botulinum toxin-producing anaerobic rod-shaped spore-forming bacteria that are ubiquitously distributed in soils and aquatic sediments. Decomposition of plants, algae and animals creates anaerobic environments that facilitate growth of C. botulinum, which may then enter into food webs leading to intoxication of animals. Via saprophytic utilization of nutrients, the bacteria rapidly sporulate, creating a reservoir of highly robust spores. In the present review, we focus on the occurrence of C. botulinum in non-clinical environments, and examine factors influencing growth and environmental factors associated with botulism outbreaks. We also outline cases involving specific environments and their biota. In wetlands, it has been found that some C. botulinum strains can associate with toxin-unaffected organisms—including algae, plants, and invertebrates—in which the bacteria appear to germinate and stay in the vegetative form for longer periods of time. We suggest the need for future investigations to resolve issues related to the environments in which C. botulinum spores may accumulate and germinate, and where the vegetative forms may multiply.

  6. Botulism associated with commercially canned chili sauce--Texas and Indiana, July 2007.

    Science.gov (United States)

    2007-08-03

    On July 7 and July 11, 2007, public health officials in Texas and Indiana, respectively, reported to CDC four suspected cases of foodborne botulism, two in each state. Investigations conducted by state and local health departments revealed that all four patients had eaten brands of Castleberry's hot dog chili sauce before illness began. Botulinum toxin type A was detected in the serum of one Indiana patient and in a leftover chili mixture obtained from his home. CDC informed the Food and Drug Administration (FDA) of the apparent link between illness and consumption of the chili sauce. On July 18, FDA issued a consumer advisory, and the manufacturer, Castleberry's Food Company (Augusta, Georgia), subsequently recalled the implicated brand and several other products produced in the same set of retorts (commercial-scale pressure cookers for processing canned foods) at the same canning facility. Examination of the canning facility in Georgia during the outbreak investigation had identified deficiencies in the canning process. On July 19, the U.S. Department of Agriculture Food Safety and Inspection Service (FSIS) issued a press release that announced a recall of chili and certain meat products from the Castleberry canning facility and provided recommendations to consumers. That recall was expanded on July 21 to include additional canned products. A fifth case of botulism potentially linked to one of the recalled products is under investigation in California. This report describes the ongoing investigation by members of OutbreakNet and others and the measures undertaken to control the outbreak, which is the first outbreak of foodborne botulism in the United States associated with a commercial canning facility in approximately 30 years. Clinicians should be vigilant for symptoms of botulism, including symmetric cranial nerve palsies, especially if accompanied by descending flaccid paralysis. Consumers should not eat any of the recalled chili sauce or other recalled

  7. Estrabismo após toxina botulínica para fins estéticos

    OpenAIRE

    Marta Halfeld Ferrari Alves Lacordia; Flávia Sotto-Maior Januário; Júlio César Costa Pereira

    2011-01-01

    RESUMO Nas últimas décadas, a toxina botulínica tem sido aplicada para fins terapêuticos em inúmeras afecções. A toxina do tipo A foi aprovada primeiramente em 1989 para o uso em estrabismo, blefaroespasmo e espasmo hemifacial de pacientes maiores que 12 anos de idade. A observação de que pacientes tratados de blefaroespasmo com toxina botulínica apresentavam um efeito adicional de diminuição das rugas de expressão inspirou estudos sobre a aplicação cosmética da toxina. Recentemente, a toxina...

  8. Foodborne botulism associated with home-preserved turnip tops in Italy

    Directory of Open Access Journals (Sweden)

    Fabrizio Anniballi

    2015-03-01

    Full Text Available In Italy, foodborne botulism is a rare disease mainly due to home-preserved food. In the case reported here, clinical diagnosis was performed on the basis of clinical signs and referred consumption of home-preserved turnip tops in oil. Definitive diagnosis was performed by detection of botulinum toxin in sera and neuro-toxigenic organisms in stools and leftover food. This case report highlights the need of a high medical awareness, prompt clinical diagnosis, and synergic collaboration among the health authorities for a correct management of botulism as well as disease containment.

  9. Avian morbidity and mortality from botulism, aspergillosis, and salmonellosis at Jamaica Bay Wildlife Refuge, New York, USA

    Science.gov (United States)

    Brand, C.J.; Windingstad, R.M.; Siegfried, L.M.; Duncan, R.M.; Cook, R.M.

    1988-01-01

    During the summers of 1981 and 1982, studies were conducted at Jamaica Bay Wildlife Refuge, Long Island, New York, to determine whether annual water-level drawdowns used to create shorebird habitat also led to the occurrence of avian botulism (Clostridium botulinum type C). Low levels of morbidity and mortality from avian botulism occurred on the two ponds throughout both summers, but there was no apparent relationship between the occurrence or rates of botulism losses and drawdowns of the ponds. Botulism also occurred throughout both summers on other areas of the refuge. Botulinal toxin was found in fly larvae associated with avian carcasses, including birds that did not die from botulism. Toxin was not found in other samples of aquatic biota in the ponds, although it was demonstrated in a single sample of decomposing sea lettuce (Ulva lactuca) in Jamaica Bay. Aspergillosis (Aspergillus fumigatus) and salmonellosis (Salmonella spp.) were also frequently-diagnosed causes of morbidity and mortality. We believe that botulinal toxin present in carcasses of birds dying from botulism, or produced postmortem in birds dying from other causes, on the two ponds and other areas in Jamaica Bay were a major source of botulinal toxin. Toxin could be ingested by birds through direct scavenging on carcasses, or by consumption of toxic fly larvae associated with carcasses. Diligent carcass pickup at the two ponds is recommended to reduce mortality from avian botulism.

  10. Animal Botulism Outcomes in the AniBioThreat Project. Biosecur. Bioterror

    NARCIS (Netherlands)

    Woudstra, C.; Tevell Aberg, A.; Skarin, H.; Anniballi, F.; Medici, De D.; Bano, L.; Koene, M.G.J.; Löfström, Ch.; Hansen, T.; Hedeland, M.; Fach, P.

    2013-01-01

    Botulism disease in both humans and animals is a worldwide concern. Botulinum neurotoxins produced by Clostridium botulinum and other Clostridium species are the most potent biological substances known and are responsible for flaccid paralysis leading to a high mortality rate. Clostridium botulinum

  11. Outbreak of Type A Foodborne Botulism in a Boarding School – Uganda, 2008

    Science.gov (United States)

    Viray, M. A.; Wamala, J.; Fagan, R.; Luquez, C.; Maslanka, S.; Downing, R.; Biggerstaff, M.; Malimbo, M.; Kirenga, J. B.; Nakibuuka, J.; Ddumba, E.; Mbabazi, W.; Swerdlow, D. L.

    2014-01-01

    Summary Botulism has rarely been reported in Africa. In October 2008, botulism was reported among three Ugandan boarding-school students. All were hospitalized; one died. A cohort study was performed to assess food exposures among students, and clinical specimens and available food samples were tested for botulinum toxin. Three case-patients were identified; a homemade, oil-based condiment was eaten by all three. In the cohort study, no foods were significantly associated with illness. Botulinum toxin type A was confirmed in clinical samples. This is the first confirmed outbreak of foodborne botulism in Uganda. A homemade, oil-based condiment was the probable source. Consumption of homemade oil-based condiments is widespread in Ugandan schools, putting children at risk. Clinicians and public health authorities in Uganda should consider botulism when clusters of acute flaccid paralysis are seen. Additionally, schools should be warned of the hazard of homemade oil-based condiments, and take steps to prevent their use. PMID:24576562

  12. Three outbreaks of foodborne botulism caused by unsafe home canning of vegetables--Ohio and Washington, 2008 and 2009.

    Science.gov (United States)

    Date, Kashmira; Fagan, Ryan; Crossland, Sandra; Maceachern, Dorothy; Pyper, Brian; Bokanyi, Rick; Houze, Yolanda; Andress, Elizabeth; Tauxe, Robert

    2011-12-01

    Foodborne botulism is a potentially fatal paralytic illness caused by ingestion of neurotoxin produced by the spore-forming bacterium Clostridium botulinum. Historically, home-canned vegetables have been the most common cause of botulism outbreaks in the United States. During 2008 and 2009, the Centers for Disease Control and Prevention (CDC) and state and local health departments in Ohio and Washington State investigated three outbreaks caused by unsafe home canning of vegetables. We analyzed CDC surveillance data for background on food vehicles that caused botulism outbreaks from 1999 to 2008. For the three outbreaks described, patients and their family members were interviewed and foods were collected. Laboratory testing of clinical and food samples was done at the respective state public health laboratories. From 1999 to 2008, 116 outbreaks of foodborne botulism were reported. Of the 48 outbreaks caused by home-prepared foods from the contiguous United States, 38% (18) were from home-canned vegetables. Three outbreaks of Type A botulism occurred in Ohio and Washington in September 2008, January 2009, and June 2009. Home-canned vegetables (green beans, green bean and carrot blend, and asparagus) served at family meals were confirmed as the source of each outbreak. In each instance, home canners did not follow canning instructions, did not use pressure cookers, ignored signs of food spoilage, and were unaware of the risk of botulism from consuming improperly preserved vegetables. Home-canned vegetables remain a leading cause of foodborne botulism. These outbreaks illustrate critical areas of concern in current home canning and food preparation knowledge and practices. Similar gaps were identified in a 2005 national survey of U.S. adults. Botulism prevention efforts should include targeted educational outreach to home canners.

  13. Uso da toxina botulínica para correção de estrabismo

    OpenAIRE

    Débora Mayumi Sugano; Celso Lopez Fernandez; José Ricardo Carvalho Lima Rehder

    2013-01-01

    OBJETIVO: Verificar os efeitos da aplicação da toxina botulínica tipo A para o tratamento do estrabismo. MÉTODOS: Realizou-se a aplicação de toxina botulínica tipo A (Prosigne®) em 20 pacientes acompanhados no ambulatório de oftalmologia da Faculdade de Medicina do ABC (FMABC), no período de 2006 a 2009, para o tratamento da esotropia. A aplicação foi realizada em 15 crianças com esotropias menores de 50 dioptrias prismáticas (PD) nos dois músculos retos mediais e em cinco adultos com esotrop...

  14. Toxina botulínica y fisioterapia en la parálisis cerebral infantil

    OpenAIRE

    Camilieri Rumbau, María Mercé

    2006-01-01

    Introducción: La parálisis cerebral es la causa más común de espasticidad en niños y la toxina botulínica A es un opción para su el tratamiento, ya que produce una parálisis local al ser inyectada en un músculo. Objetivo: Comprobar la eficacia de la aplicación de toxina botulínica y fisioterapia en la parálisis cerebral infantil. Material y método: Se ha realizado una búsqueda en diversas bases de datos electrónicas como son Freejournals, Doyma, Medline, Google y revistas de neuro...

  15. Outbreak of botulism in north west England and Wales, June, 1989.

    Science.gov (United States)

    Critchley, E M; Hayes, P J; Isaacs, P E

    1989-10-01

    The clinical features of 27 patients identified in an outbreak of botulism in Lancashire, England, and North Wales are reviewed. All but 1 of the patients (age range 14 months to 74 years) were admitted to hospital: 12 were treated in intensive care units, and 8 received positive pressure ventilation. 1 patient died with an aspiration pneumonia. The clinical presentations contained several unusual features, with evidence of segmental demyelination in some patients and drowsiness, sore throats, and fever in others. The widely dispersed source of intoxication with patients presenting singly to several hospitals added to the difficulties of diagnosis. Successful clinical management depends on full and early recognition both of the dangers of impaired oropharyngeal function and of the rapid neurological changes in botulism.

  16. Two outbreaks of botulism associated with consumption of green olive paste, France, September 2011.

    Science.gov (United States)

    Pingeon, J M; Vanbockstael, C; Popoff, M R; King, L A; Deschamps, B; Pradel, G; Dupont, H; Spanjaard, A; Houdard, A; Mazuet, C; Belaizi, B; Bourgeois, S; Lemgueres, S; Debbat, K; Courant, P; Quirin, R; Malfait, P

    2011-12-08

    Two family outbreaks of botulism (a total of nine cases) were identified in south-east and northern France in early September 2011. The source of infection was considered to be a ground green olive paste. Botulinum type A toxin was identified in seven cases and in the incriminated olive paste. Incorrect sterilisation techniques were observed at the artisanal producer’s workshop. These episodes highlight the potential public health threat of Clostridium botulinum linked to inadequate sterilisation of food products.

  17. Hazard analysis and possibilities for preventing botulism originating from meat products

    Directory of Open Access Journals (Sweden)

    Vasilev Dragan

    2008-01-01

    Full Text Available The paper presents the more important data on the bacteria Clostridium botulinum, the appearance of botulism, hazard analysis and the possibilities for preventing botulism. Proteolytic strains of C.botulinum Group I, whose spores are resistant to heat, create toxins predominantly in cans containing slightly sour food items, in the event that the spores are not inactivated in the course of sterilization. Non-proteolytic strains of Group II are more sensitive to high temperatures, but they have the ability to grow and create toxins at low temperatures. Type E most often creates a toxin in vacuum-packed smoked fish, and the non-proteolytic strain type B in dried hams and certain pasteurized meat products. The following plays an important role in the prevention of botulism: reducing to a minimum meat contamination with spores of clostridia, implementing good hygiene measures and production practice during the slaughter of animals, the inactivation of spores of C. botulinum during sterilization (F>3, and, in dried hams and pasteurized products, the prevention of bacterial growth and toxin forming by maintaining low temperatures in the course of production and storage, as well as the correct use of substances that inhibit the multiplication of bacteria and the production of toxins (nitrites, table salt, etc..

  18. Could blackbird mortality from avicide DRC-1339 contribute to avian botulism outbreaks in North Dakota?

    Science.gov (United States)

    Goldberg, D.R.; Samuel, M.D.; Rocke, T.E.; Johnson, K.M.; Linz, G.

    2004-01-01

    Blackbird (family lcteridae) depredation on sunflower (Helianthus annuus) crops in the prairie states of the United States has motivated the proposed use of an avicide, DRC-1339 (3-chloro-4-methylaniline), to decrease their numbers. The resulting mortality of blackbirds at wetland roosts could increase the potential of avian botulism occurring in affected marshes. To assess this possibility, we seeded (artificially placed) blackbird carcasses in selected wetlands in Stutsman County, North Dakota, during August-September 2000 and July-September 2001 to evaluate their rate of decomposition and role in initiating avian botulism outbreaks. We monitored carcasses to determine their persistence, the frequency and amount of maggots produced, and the presence of type C botulinum toxin. In 10 of our 12 study wetlands, blackbird carcasses were not rapidly removed by scavengers, thus providing substrate for maggot growth and potential production of Clostridium botulinum toxin. Decomposition of carcasses occurred rapidly, and maggot production averaged 4a??5 g per carcass within 9 days. We were unable to detect C. botulinum type C toxin in any of the 377 blackbird carcasses or the 112 samples of maggots we collected in 2000 or 2001. None of the 25 blackbird carcasses we tested contained botulinum spores, the most probable explanation for the absence of botulinum toxin production. Our results indicate that the likelihood of DRC-1339-poisoned blackbirds causing botulism outbreaks would be minimal in North Dakota wetlands during late summer and early autumn.

  19. Documented outbreaks of botulism:the impact of food-borne transmission

    Institute of Scientific and Technical Information of China (English)

    Victoria Rebagliati; Sabrina Chianelli; Mariela Tornese; Laura Rossi; Alcides Troncoso

    2008-01-01

    Botulism is a severe neuroparalytic disease caused by Clostridium botulinum's toxins.Although the disease is uncommon,causes great concern due to its high rate of mortality;foodborne outbreaks of botulism occur world-wide and require immediate public health and acute care resources.This study had a review of outstanding out-breaks published;Journals articles related to the subject.From the outbreaks analysis we found the most in-volved food products were:fermented fish products in Alaska;home canning food,oil preservation and restau-rant sauce in London and USA;home canned vegetables,food airtight packed with inappropriate refrigeration and aerosols in Argentina.In conclusion,the diagnosis is based only on clinical findings matching the disease and previous exposure to suspicious food.Botulism must be immediately identified as one case suggests an epi-demic and should be treated as a public health emergency.Therefore the purpose of the following review is to recognize the associated risks with the consumption of potentially dangerous foods,to help work our way on pre-vention for every public health professional to be aware of the dangers of this potentially lethal disease.

  20. Presence of Clostridium botulinum spores in Matricaria chamomilla (chamomile) and its relationship with infant botulism.

    Science.gov (United States)

    Bianco, María I; Lúquez, Carolina; de Jong, Laura I T; Fernández, Rafael A

    2008-02-10

    Nowadays, infant botulism is the most important form of human botulism in some countries. This illness affects infants younger than 52 weeks of age. The infection occurs in the intestinal tract; therefore, ingestion of Clostridium botulinum spores with food is proposed. In some countries, people use chamomile tea as a household remedy for intestinal colics and given this tea to infants. Chamomile can be contaminated with C. botulinum and could be a vehicle of its spores. Our aim was to study the prevalence and spore-load of C. botulinum in chamomile. We analysed 200 samples; the 7.5% of them were contaminated with botulinum spores. However, prevalence of these spores was significantly higher in chamomile sold by weight in herbal stores (unwrapped chamomile) than prevalence in chamomile sold in tea bags (p=0.0055). The spore-load detected in all positive samples was 0.3-0.4 spores per gram of chamomile. We identified C. botulinum types A, B, and F in the 53.3%, 6.7%, and 13.3%, respectively. Chamomile (principally, unwrapped chamomile) is a potencial vehicle of C. botulinum spores, and ingestion of chamomile tea could represent a risk for infant botulism.

  1. A Family Outbreak of Foodborne Botulism Following Consumption of Home-Canned Doogh in Hamadan, West of Iran

    Directory of Open Access Journals (Sweden)

    Hashemi

    2015-02-01

    Full Text Available Background Food-borne botulism is one of the potentially fatal forms of food poisoning, usually caused by ingestion of home-canned vegetables, fruits and fish products. Objectives The aim of this study was to report an outbreak of botulism due to homemade doogh in Hamadan, Iran. Patients and Methods During an outbreak, 10 members of a family referred to the hospital because of food poisoning. All patients had a history of consumption of doogh, a traditional drink. After careful physical examination, all of them were hospitalized. Botulism was suspected in all patients except for the first patient. Results The first patient was a 76-year-old man who died after 12 hours of admission due to respiratory distress. Nine subsequent patients were diagnosed as botulism with the following symptoms: diplopia (90%, dizziness (70%, nausea and vomiting (80%, ptosis (60%, symmetric weakness of extremities (60%, dysarthria (30%, chest discomfort (30%, mydriasis (20%, dysphasia (20% and dry mouth (20%. All of the nine patients received botulinum antitoxin and improved during 5-15 days of hospitalization. Conclusions Immediate diagnosis based on careful history and physical examination are essential for management of botulism. People should be notified about proper food handling and preparation of traditional homemade foods.

  2. New insight in the epidemiology of avian botulism outbreaks: necrophagous flies as vectors of Clostridium botulinum type C/D.

    Science.gov (United States)

    Anza, Ibone; Vidal, Dolors; Mateo, Rafael

    2014-12-01

    Avian botulism outbreaks spread through the bird carcass-maggot cycle, in which Clostridium botulinum and blowflies interact to ensure their reproduction in a mutualistic relationship where neurotoxin/spore-bearing maggot is one of the keystones. Here we investigated the hypothesis that adult blowflies may also play a significant role in botulism outbreaks by carrying C. botulinum cells between carcasses. We carried out a field experiment placing bird carcasses free of C. botulinum type C/D in containers only accessible to necrophagous flying insects in wetlands where avian botulism outbreaks were occurring and in control sites. Additionally, we performed laboratory trials to evaluate if blowflies may carry C. botulinum type C/D and for how long. Maggots bearing C. botulinum type C/D developed in 27.5% of carcasses placed in wetlands during botulism outbreaks. Calliphoridae flies in laboratory trials were able to transfer C. botulinum between two points and excreted it in their spots for up to 24 h after an infective feeding. Our results confirm that adult necrophagous flies play a role in the spreading of botulism outbreaks, which have implications in the epidemiology of this disease.

  3. Tratamiento de la sonrisa gingival con la toxina botulínica tipo A: caso clínico

    Directory of Open Access Journals (Sweden)

    Levy Nunes

    2015-10-01

    Full Text Available La toxina botulínica ha sido señalada recientemente en la literatura como una opción de tratamiento para la corrección de la sonrisa gingival. Este reporte de caso relata la experiencia de los autores en un caso de sonrisa gingival asociada a 4 mm de exposición gingival e hipermovilidad de la musculatura elevadora del labio superior, tratado con el uso de toxina botulínica. Controles periódicos y evaluaciones de la exposición gingival fueron realizados mensualmente tras la aplicación. El tratamiento con toxina botulínica de tipo A puede ser considerado como una posible alternativa de tratamiento en este tipo de casos.

  4. Evidencia y uso actual de toxina botulínica en patología otorrinolaringológica

    OpenAIRE

    Caro L,Jorge; Fuentes L,Nicolás; Iñiguez C,Rodrigo

    2015-01-01

    A partir de los primeros usos terapéuticos de la toxina botulínica su utilización se ha extendido a variadas ramas de la medicina incluyendo la otorrinolaringología. Se considera un medicamento seguro en manos de profesionales capacitados y su utilización se realiza a través de un procedimiento mínimamente invasivo con efectos adversos leves y transitorios. Se usa en un amplio número de patologías otorrinolaringológicas y de cabeza y cuello. Actualmente la toxina botulínica A representa la pr...

  5. Toxina botulínica no tratamento da dor Toxina botulínica en el tratamiento del dolor Botulinum toxin in pain treatment

    OpenAIRE

    Orlando Carlos Gomes Colhado; Marcelo Boeing; Luciano Bornia Ortega

    2009-01-01

    JUSTIFICATIVA E OBJETIVOS: A toxina botulínica (TxB), uma das mais potentes toxinas bacterianas conhecidas, tem reconhecidamente ação terapêutica eficaz no tratamento de algumas síndromes dolorosas. Entretanto, algumas de suas indicações ainda estão em fase de comprovação com relação a sua eficácia. O objetivo deste estudo foi revisar o histórico, propriedades farmacológicas e aplicações clinicas da TxB, quando empregada no tratamento de dores de diferentes origens. CONTEÚDO: A TxB é o produt...

  6. Intoxicação experimental de bovinos com toxina botulínica tipo D

    Directory of Open Access Journals (Sweden)

    Colbachini L.

    1999-01-01

    Full Text Available Realizou-se uma intoxicação experimental em bovinos, pela administração oral, com diferentes doses de toxina botulínica tipo D. O objetivo foi determinar o tempo de permanência da toxina no sangue circulante de bovinos, pela detecção da toxina no soro mediante bioensaio em camundongos, e de verificar a presença da toxina no fígado, no baço, nos rins e no coração, e no conteúdo ruminal de bovinos que morreram e/ou foram sacrificados. Utilizaram-se 12 bovinos, mestiços, divididos em quatro grupos de três animais cada. Os grupos I, II e III receberam 200DL50/ml, 21.300DL50/ml e 63.200DL50/ml de toxina botulínica, respectivamente, e o grupo IV manteve-se como controle. A toxina foi detectada principalmente no soro dos bovinos pertencentes aos grupos II e III que receberam altas doses do inóculo tóxico, nos quais a toxina permaneceu por um período de um a sete dias após o aparecimento dos primeiros sinais clínicos da doença. A toxina não foi detectada no fígado, no baço, nos rins e no coração, mas o foi no conteúdo ruminal de um bovino do grupo II. A toxina botulínica foi mais facilmente detectada no soro do que nos órgãos dos bovinos, sendo encontrada principalmente quando o animal ingeriu muita toxina, durante a fase inicial da doença e por um período de sete dias.

  7. Botulism Clostridium botulinum type C in ducks in Uruguay

    OpenAIRE

    2009-01-01

    El botulismo en aves es una toxi-infección producida por la ingestión de toxina botulínica preformada o esporas de Clostridium botulinum. El agente produce gran mortalidad en aves acuáticas y se encuentra presente en la mayoría de los países del mundo. El objetivo del presente trabajo es informar una mortandad debido a toxi-infección por C. botulinum tipo C en patos de un criadero del Departamento de Salto. La sintomatología clínica que presentaban los animales fue disnea, respiración a pico ...

  8. Ineffectiveness of 3,4-diaminopyridine as a therapy for type C botulism.

    Science.gov (United States)

    Siegel, L.S.; Price, J.I.

    1987-01-01

    Clostridium botulinum neurotoxins inhibit acetylcholine release at neuromuscular junctions. Agents stimulating neurotransmitter efflux, such as 3,4-diaminopyridine (3,4-DAP), could be useful for botulism therapy. Treatment with 3,4-DAP (8 mg/kg hourly, beginning 3 hr after toxin injection) failed to increase the survival times of mice receiving 10, 20 or 40 LD50 type C, but did prolong the survival of those receiving 20 LD50 type A. This difference in 3,4-DAP efficacy may reflect variations in the molecular mechanism of action of types A and C botulinum neurotoxins.

  9. Toxina botulínica y su empleo en la patología oral y maxilofacial Botulinum toxin and its use in oral and maxillofacial pathology

    OpenAIRE

    Martínez-Pérez, D

    2004-01-01

    Resumen: Las toxinas botulínicas son exotoxinas de la bacteria formadora de esporas Clostridim botulinum y los agentes causantes del botulismo. Cuando se inyecta en el músculo produce una parálisis flácida. El efecto clínico está directamente relacionado con la dosis y debe ajustarse para cada caso concreto. La Toxina botulínica ha demostrado en los más de veinte años en que se está utilizando que es un fármaco seguro. Las indicaciones de la toxina botulínica en la actualidad incluyen todas a...

  10. National Outbreak of Type A Foodborne Botulism Associated With a Widely Distributed Commercially Canned Hot Dog Chili Sauce

    Science.gov (United States)

    Juliao, Patricia C.; Maslanka, Susan; Dykes, Janet; Gaul, Linda; Bagdure, Satish; Granzow-Kibiger, Lynae; Salehi, Ellen; Zink, Donald; Neligan, Robert P.; Barton-Behravesh, Casey; Lúquez, Carolina; Biggerstaff, Matthew; Lynch, Michael; Olson, Christine; Williams, Ian; Barzilay, Ezra J.

    2015-01-01

    Background On 7 and 11 July 2007, health officials in Texas and Indiana, respectively, reported 4 possible cases of type A foodborne botulism to the US Centers for Disease Control and Prevention. Foodborne botulism is a rare and sometimes fatal illness caused by consuming foods containing botulinum neurotoxin. Methods Investigators reviewed patients’ medical charts and food histories. Clinical specimens and food samples were tested for botulinum toxin and neurotoxin-producing Clostridium species. Investigators conducted inspections of the cannery that produced the implicated product. Results Eight confirmed outbreak associated cases were identified from Indiana (n = 2), Texas (n = 3), and Ohio (n = 3). Botulinum toxin type A was identified in leftover chili sauce consumed by the Indiana patients and 1 of the Ohio patients. Cannery inspectors found violations of federal canned-food regulations that could have led to survival of Clostridium botulinum spores during sterilization. The company recalled 39 million cans of chili. Following the outbreak, the US Food and Drug Administration inspected other canneries with similar canning systems and issued warnings to the industry about the danger of C. botulinum and the importance of compliance with canned food manufacturing regulations. Conclusions Commercially produced hot dog chili sauce caused these cases of type A botulism. This is the first US foodborne botulism outbreak involving a commercial cannery in >30 years. Sharing of epidemiologic and laboratory findings allowed for the rapid identification of implicated food items and swift removal of potentially deadly products from the market by US food regulatory authorities. PMID:23097586

  11. Botulism in Brazil, 2000-2008: epidemiology, clinical findings and laboratorial diagnosis Botulismo no Brasil, 2000-2008: epidemiologia, achados clínicos e diagnóstico laboratorial

    OpenAIRE

    Ruth Estela Gravato Rowlands; Christiane Asturiano Ristori; Giselle Ibette S. Lopez Lopes; Ana Maria Ramalho de Paula; Harumi Sakuma; Raquel Grigaliunas; Roberto Lopreato Filho; Dilma Scala Gelli; Maria Bernadete de Paula Eduardo; Miyoko Jakabi

    2010-01-01

    Botulism is a rare and potentially lethal illness caused by Clostridium botulinum neurotoxin. We describe the findings of a laboratorial investigation of 117 suspected cases of botulism reported to the surveillance system in Brazil from January 2000 to October 2008. Data on the number and type of samples analyzed, type of toxins identified, reporting of the number of botulism cases and transmission sources are discussed. A total of 193 clinical samples and 81 food samples were analyzed for de...

  12. Toxina Botulínica, considerações em Medicina Dentária

    OpenAIRE

    Teixeira, Natacha Betânia Alves

    2014-01-01

    Projeto de Pós-Graduação/Dissertação apresentado à Universidade Fernando Pessoa como parte dos requisitos para obtenção do grau de Mestre em Medicina Dentária A toxina botulínica (TB) foi durante muito anos considerada um promotor de doença. No presente é considerada um agente terapêutico versátil para o tratamento de distúrbios musculares. O seu mecanismo de ação ocorre ao nível da fenda sináptica do músculo esquelético e leva a uma desnervação parcial e funcional dos neurónios motores, a...

  13. Avian botulism type E in waterbirds of Lake Michigan, 2010–2013

    Science.gov (United States)

    Chipault, Jennifer G.; White, C. LeAnn; Blehert, David S.; Jennings, Susan K.; Strom, Sean M.

    2015-01-01

    During 2010 to 2013, waterbird mortality surveillance programs used a shared protocol for shoreline walking surveys performed June to November at three areas in northern Lake Michigan. In 2010 and 2012, 1244 total carcasses (0.8 dead bird/km walked) and 2399 total carcasses (1.2 dead birds/km walked), respectively, were detected. Fewer carcasses were detected in 2011 (353 total carcasses, 0.2 dead bird/km walked) and 2013 (451 total carcasses, 0.3 dead bird/km walked). During 3 years, peak detection of carcasses occurred in October and involved primarily migratory diving and fish-eating birds, including long-tailed ducks (Clangula hyemalis; 2010), common loons (Gavia immer; 2012), and red-breasted mergansers (Mergus serrator; 2013). In 2011, peak detection of carcasses occurred in August and consisted primarily of summer residents such as gulls (Larus spp.) and double-crested cormorants (Phalacrocorax auritus). A subset of fresh carcasses was collected throughout each year of the study and tested for botulinum neurotoxin type E (BoNT/E). Sixty-one percent of carcasses (57/94) and 10 of 11 species collected throughout the sampling season tested positive for BoNT/E, suggesting avian botulism type E was a major cause of death for both resident and migratory birds in Lake Michigan. The variety of avian species affected by botulism type E throughout the summer and fall during all 4 years of coordinated surveillance also suggests multiple routes for bird exposure to BoNT/E in Lake Michigan.

  14. Botulismo em bovinos leiteiros no Sul de Minas Gerais, Brasil Botulism in dairy cattle in southern Minas Gerais, Brazil

    Directory of Open Access Journals (Sweden)

    Geraldo Márcio da Costa

    2008-10-01

    Full Text Available Neste trabalho descreve-se um surto de botulismo decorrente da ingestão de milho contaminado em um sistema de produção de leite, em regime de confinamento, na região Sul de Minas Gerais. O rebanho era composto por 148 vacas holandesas lactantes de alta produção, confinadas em tempo integral e alimentadas com dieta completa, composta de silagem de milho e concentrado. Foram afetados 38 bovinos, verificando-se letalidade de 100%. Amostras de conteúdo intestinal, ruminal e fígado de sete animais necropsiados e amostras de água dos bebedouros e do milho utilizado na alimentação foram submetidas ao bioensaio e à soroneutralização para a detecção de toxina botulínica. Toxinas dos tipos C e D foram detectadas nas amostras de conteúdo intestinal, ruminal e milho. O surto descrito mostra que o milho estocado em condições inadequadas pode ser um fator de risco para a ocorrência da doença.An outbreak of bovine botulism in a dairy herd caused by ingestion of contaminated maize, in southern Minas Gerais, Brazil is described. The herd was composed by 148 lactating cows of high milk production fed with diet based on maize ensilage and concentrate in a free stall system. Thirty eight cows were affected, with 100% of fatality rate. Samples from intestine, rumen and liver of necropsied cattle and drinking water and maize were submitted to the mouse bioassay and soroneutralization tests for detection of Clostridium botulinum toxins. Types C and D toxins were detected in samples from intestinal and rumen contents and maize. The reporter of an outbreak of botulism in cattle associated with an unusual source of toxin, shows that stocked maize in inadequate conditions is a factor of risk for the occurrence of the botulism in dairy cattle.

  15. Genomic Epidemiology of Clostridium botulinum Isolates from Temporally Related Cases of Infant Botulism in New South Wales, Australia.

    Science.gov (United States)

    McCallum, Nadine; Gray, Timothy J; Wang, Qinning; Ng, Jimmy; Hicks, Leanne; Nguyen, Trang; Yuen, Marion; Hill-Cawthorne, Grant A; Sintchenko, Vitali

    2015-09-01

    Infant botulism is a potentially life-threatening paralytic disease that can be associated with prolonged morbidity if not rapidly diagnosed and treated. Four infants were diagnosed and treated for infant botulism in NSW, Australia, between May 2011 and August 2013. Despite the temporal relationship between the cases, there was no close geographical clustering or other epidemiological links. Clostridium botulinum isolates, three of which produced botulism neurotoxin serotype A (BoNT/A) and one BoNT serotype B (BoNT/B), were characterized using whole-genome sequencing (WGS). In silico multilocus sequence typing (MLST) found that two of the BoNT/A-producing isolates shared an identical novel sequence type, ST84. The other two isolates were single-locus variants of this sequence type (ST85 and ST86). All BoNT/A-producing isolates contained the same chromosomally integrated BoNT/A2 neurotoxin gene cluster. The BoNT/B-producing isolate carried a single plasmid-borne bont/B gene cluster, encoding BoNT subtype B6. Single nucleotide polymorphism (SNP)-based typing results corresponded well with MLST; however, the extra resolution provided by the whole-genome SNP comparisons showed that the isolates differed from each other by >3,500 SNPs. WGS analyses indicated that the four infant botulism cases were caused by genomically distinct strains of C. botulinum that were unlikely to have originated from a common environmental source. The isolates did, however, cluster together, compared with international isolates, suggesting that C. botulinum from environmental reservoirs throughout NSW have descended from a common ancestor. Analyses showed that the high resolution of WGS provided important phylogenetic information that would not be captured by standard seven-loci MLST.

  16. Infant botulism

    Science.gov (United States)

    ... life-threatening disease caused by a bacteria called Clostridium botulinum. It grows inside a baby's gastrointestinal tract. ... Clostridium botulinum is a spore-forming organism that is common in nature. The spores may be found in ...

  17. A penicillin- and metronidazole-resistant Clostridium botulinum strain responsible for an infant botulism case.

    Science.gov (United States)

    Mazuet, C; Yoon, E-J; Boyer, S; Pignier, S; Blanc, T; Doehring, I; Meziane-Cherif, D; Dumant-Forest, C; Sautereau, J; Legeay, C; Bouvet, P; Bouchier, C; Quijano-Roy, S; Pestel-Caron, M; Courvalin, P; Popoff, M R

    2016-07-01

    The clinical course of a case of infant botulism was characterized by several relapses despite therapy with amoxicillin and metronidazole. Botulism was confirmed by identification of botulinum toxin and Clostridium botulinum in stools. A C. botulinum A2 strain resistant to penicillins and with heterogeneous resistance to metronidazole was isolated from stool samples up to 110 days after onset. Antibiotic susceptibility was tested by disc agar diffusion and MICs were determined by Etest. Whole genome sequencing allowed detection of a gene cluster composed of blaCBP for a novel penicillinase, blaI for a regulator, and blaR1 for a membrane-bound penicillin receptor in the chromosome of the C. botulinum isolate. The purified recombinant penicillinase was assayed. Resistance to β-lactams was in agreement with the kinetic parameters of the enzyme. In addition, the β-lactamase gene cluster was found in three C. botulinum genomes in databanks and in two of 62 genomes of our collection, all the strains belonging to group I C. botulinum. This is the first report of a C. botulinum isolate resistant to penicillins. This stresses the importance of antibiotic susceptibility testing for adequate therapy of botulism.

  18. Occurrence of C. botulinum in healthy cattle and their environment following poultry botulism outbreaks in mixed farms.

    Science.gov (United States)

    Souillard, R; Le Maréchal, C; Hollebecque, F; Rouxel, S; Barbé, A; Houard, E; Léon, D; Poëzévara, T; Fach, P; Woudstra, C; Mahé, F; Chemaly, M; Le Bouquin, S

    2015-10-22

    Ten cattle farms located in an area with a recent history of poultry botulism outbreaks were investigated to evaluate the occurrence of toxigenic C. botulinum in healthy cattle. Environmental samples in the 10 cattle farms and bovine fecal contents in farms with a confirmed environmental contamination were collected. Detection of C. botulinum toxin genes C, D, C/D, D/C and E was performed using real-time PCR. 4.9% (7/143) of the environmental samples collected in the 10 investigated cattle farms were positive for C. botulinum type C/D. Theses samples (boot-swabs in stalls and on pasture and water of a stream) were collected in 3 different farms. One cow dung sample and 3 out of 64 fecal contents samples collected in a single farm were also positive for C. botulinum type C/D. This study demonstrates that cattle are probably indirectly contaminated via poultry botulism in the area and that they can be intermittent carrier of C. botulinum type C/D after poultry botulism outbreaks in mixed farms.

  19. Presence of Clostridium botulinum and botulinum toxin in milk and udder tissue of dairy cows with suspected botulism.

    Science.gov (United States)

    Böhnel, H; Gessler, F

    2013-04-13

    Clostridium botulinum is an anaerobic spore-forming bacterium prevalent in the environment, and causes botulism in man and animals via toxins. Dairy cattle may be contaminated or infected by feed, water or other environmental factors. Milk may also carry the pathogen. Hence, milk and udder samples need to be tested. The number of clinical cases of bovine botulism in Germany has been increasing since the mid-1990s. Besides routine samples, additional 99 milk samples from 37 farms, and 51 udder samples from 51 farms from sick animals presumably affected by botulism were tested microbiologically by the mouse bioassay. Milk from three farms (8.1 per cent) contained botulinum toxin, and from two (5.4 per cent) bacterial states of C botulinum. Ten udder samples (19.6 per cent) contained toxin, and 7 (13.7 per cent) bacterial forms, including one case where both toxin and bacteria were found. The findings are discussed. Positive milk samples containing botulinum toxin or bacteria raise concern of food safety for the human consumer. Pathological udder samples may show either infection prior to, or contamination after death.

  20. Uso da toxina botulínica para correção de estrabismo

    Directory of Open Access Journals (Sweden)

    Débora Mayumi Sugano

    2013-10-01

    Full Text Available OBJETIVO: Verificar os efeitos da aplicação da toxina botulínica tipo A para o tratamento do estrabismo. MÉTODOS: Realizou-se a aplicação de toxina botulínica tipo A (Prosigne® em 20 pacientes acompanhados no ambulatório de oftalmologia da Faculdade de Medicina do ABC (FMABC, no período de 2006 a 2009, para o tratamento da esotropia. A aplicação foi realizada em 15 crianças com esotropias menores de 50 dioptrias prismáticas (PD nos dois músculos retos mediais e em cinco adultos com esotropia secundária à paralisia ou paresia do VI nervo, somente no músculo antagonista ao acometido. A incidência de efeitos indesejáveis também foi avaliada. O tempo de seguimento mínimo foi de três meses. RESULTADOS: Três crianças com esotropia foram submetidas a uma segunda aplicação, totalizando 18 aplicações. Destas, 14 aplicações realizaram no mínimo seis meses de acompanhamento. A idade média no momento da aplicação, no grupo das crianças foi de 1,89(±0,54 anos. O desvio convergente médio antes da aplicação foi de 36,67(±6,18 PD; após uma semana foi de -5,06(±23,05 PD, e após três meses foi de 17,50(±14,51 PD. Aos seis meses de acompanhamento cerca de 50% (7/14 das aplicações apresentaram desvio menor que 10 PD. As complicações apresentadas foram: blefaroptose em 38,89% (7/18 das aplicações e desvio vertical em 11,11% (2/18. Quanto aos pacientes adultos, foram realizadas sete aplicações em cinco pacientes. Neste grupo, o desvio esotrópico médio antes da aplicação foi de 46,43(±23,40 PD; após uma semana foi de 30,71(±30,61 PD; e após 3 meses foi de 41,20(±30,82 PD. Apenas um paciente com paresia apresentou satisfação com o resultado. CONCLUSÃO: Houve melhora do estrabismo com redução do desvio ocular nas crianças após aplicação da toxina botulínica tipo A (Prosigne®.

  1. Clinical features of botulism%肉毒杆菌中毒的临床特点

    Institute of Scientific and Technical Information of China (English)

    买买提依明; 马卫英; 热西旦; 颜静; 杨宛霖; 傅毅; 陈生弟

    2013-01-01

    Objective To explore the clinical features of botulism.Methods The clinical data of 5 patients with botulism were retrospectively analyzed.Results All the five cases were onset due to take homemade stinky tofu,and among them three cases were in a collectivity food poisoning.The mean latency was 3.4 days.Initial symptoms were slurred speech 3 cases,dysphagia 3 cases,dizziness 3 cases,fatigue and diarrhea 2 cases respectively,while dyspnea and poor appetite 1 case.As the disease progressed,all 5 cases experienced dizziness and blurred vision,and occurred ptosis,ophthalmoplegia and generalized weakness 4 cases,chest distress,dyspnea and diplopia 3 cases.Botulinum antitoxins A and B were given after confirmation of the diagnosis,symptomatic therapies including oxygen inhalation,anti-infection,maintenance of hydroelectrolytic equilibrium etc.were applied as well.Finally,4 cases were significantly improved,however,two of them remained mild dysphagia,and the rest 1 case was no effective (the treatment was late).Conclusions The symptoms of nervous system damage are occurred in patients with botulism.Dizziness,cerebral nerves and muscle palsy are its main manifestations.Early application of botulinum antitoxins treatment is effectual.%目的 探讨肉毒杆菌中毒的临床特点.方法 回顾性分析5例肉毒杆菌中毒患者的临床资料.结果 本组5例患者均因食用自制臭豆腐发病,其中3例为群体发病.发病潜伏期平均3.4d.首发症状分别为言语不清3例、吞咽困难3例、头晕3例、无力和腹泻2例,呼吸困难1例;随着病程进展,5例患者均出现头晕、视物模糊,出现眼睑下垂、睁眼困难、全身无力和肌力下降4例,胸闷、呼吸困难和复视3例.给予A型和B型肉毒抗毒素治疗,同时给予吸氧、抗感染和维持水电解质等对症治疗.经治疗病情好转4例,其中2例遗留轻度吞咽困难,无效1例(治疗较晚).结论 肉毒杆菌中毒多出现神经系统损害的症状,

  2. THE EFFECT OF ANESTHESIA AND OF SEDATIVES ON THE SERUM THERAPY OF EXPERIMENTAL BOTULISM.

    Science.gov (United States)

    Bronfenbrenner, J J; Weiss, H

    1924-03-31

    When guinea pigs are fed large amounts of botulinus toxin, they develop symptoms of intoxication within 6 hours and die usually within 12 hours after the feeding of toxin. If very large amounts of toxin are introduced intraperitoneally, the animals may show symptoms of intoxication at the end of the 1st hour and die usually within 2 hours following the administration of toxin. If these animals are placed under anesthesia following the administration of toxin, the intoxication proceeds much more slowly. Anesthesia, by ether, is effective in this manner whether the toxin is given per os or intraperitoneally. The life of guinea pigs kept under ether after the administration of lethal amounts of toxin is prolonged by a period approximately equal to that during which the administration of the anesthetic is continued. When anesthesia is discontinued, the intoxication proceeds at its usual rate. It appears, therefore, that administration of ether delays the rate of intoxication but does not alter the toxin or the nature of the mechanism of intoxication. Anesthesia thus delays the progress of intoxication not only when administered immediately after the intake of toxin, but when administered much later after the intoxication has already progressed far enough to cause definite objective symptoms of poisoning. At this late stage of intoxication, the unsupported serum therapy of botulism in guinea pigs usually remains without effect. If, however, the animals are anesthetized at this time and kept under the influence of ether for some time, antitoxin therapy becomes effective. Indeed the antitoxin treatment can be delayed further for several hours, provided the animal is kept under anesthesia during the interval. Results of a similar nature were obtained with luminal sodium, nitrous oxide-oxygen mixture, and morphine used in place of ether. In view of the fact that the published data indicate that botulinus antitoxin has thus far failed to give beneficial results in the

  3. The same clade of Clostridium botulinum strains is causing avian botulism in southern and northern Europe.

    Science.gov (United States)

    Anza, Ibone; Skarin, Hanna; Vidal, Dolors; Lindberg, Anna; Båverud, Viveca; Mateo, Rafael

    2014-04-01

    Avian botulism is a paralytic disease caused by Clostridium botulinum-produced botulinum neurotoxins (BoNTs), most commonly of type C/D. It is a serious disease of waterbirds and poultry flocks in many countries in Europe. The objective of this study was to compare the genetic relatedness of avian C. botulinum strains isolated in Spain with strains isolated in Sweden using pulsed-field gel electrophoresis (PFGE). Fifteen strains were isolated from Spanish waterbirds using an immunomagnetic separation technique. Isolates were characterized by PCR, and all were identified as the genospecies Clostridium novyi sensu lato and eight harboured the gene coding for the BoNT type C/D. PFGE analysis of the strains revealed four highly similar pulsotypes, out of which two contained strains from both countries. It also showed that outbreaks in wild and domestic birds can be caused by the same strains. These results support a clonal spreading of the mosaic C. botulinum type C/D through Europe and give relevant information for future epidemiological studies.

  4. Blefarospasmo essencial e espasmo hemifacial: características dos pacientes, tratamento com toxina botulínica A e revisão da literatura

    OpenAIRE

    Schellini Silvana Artioli; Matai Olívia; Igami Thais Zamudio; Padovani Carlos Roberto; Padovani Carlos Pereira

    2006-01-01

    OBJETIVO: Conhecer as características dos portadores de blefarospasmo essencial e espasmo hemifacial, assim como a resposta ao tratamento utilizando toxina botulínica A. MÉTODOS: Trinta e quatro portadores de blefarospasmo essencial ou espasmo hemifacial foram avaliados quanto a idade, sexo, queixas oculares, tempo de existência da doença, tipo de comprometimento, complicações e resultado do tratamento com toxina botulínica A. RESULTADOS: A mediana da idade dos pacientes foi de 63 anos e a mé...

  5. Botulismo tipo C em perus em Minas Gerais, Brasil Type C botulism in turkeys in Minas Gerais, Brazil

    Directory of Open Access Journals (Sweden)

    Francisco Carlos Faria Lobato

    2009-02-01

    Full Text Available O botulismo é uma intoxicação causada pela ingestão das toxinas produzidas pelo Clostridium botulinum, que acomete mamíferos e aves e é caracterizado por um quadro de paralisia flácida. Neste trabalho, é descrito um surto de botulismo em perus, ocorrido no município de Santa Luzia, região metropolitana de Belo Horizonte, Minas Gerais. Os animais apresentavam incoordenação motora, paralisia flácida das patas, asas e pescoço. Em um intervalo de 24 horas, todos os 29 animais do plantel vieram a óbito. Na necropsia, observou-se a presença de larvas de mosca no inglúvio. Nos soros coletados, foi identificada a toxina botulínica tipo C pelo teste de soroneutraliza��ão em camundongos.Botulism is an intoxication caused by the ingestion of toxins produced by Clostridium botulinum. It affects mammals and birds, and is characterized by flaccid paralysis of the limbs. This report describes an outbreak of botulism in turkeys of various ages in the city of Santa Luzia, state of Minas Gerais, Brazil. The animals showed incoordination followed by flaccid paralysis involving the muscles of the legs, wings and neck. Within 24 hours, all 29 (100% turkeys died. The post-mortem examination revealed the presence of fly larvae in the crop and the C. botulinum type C toxin was demonstrated in the sera of two affected animals by serum neutralization test.

  6. Barbiturate ingestion in three adult captive tigers (Panthera tigris and concomitant fatal botulism of one : clinical communication

    Directory of Open Access Journals (Sweden)

    J. H. Williams

    2011-05-01

    Full Text Available Zoo animals, including tigers, have been reported to suffer from barbiturate intoxication, with pentabarbitone being most commonly recorded. Clinical signs range from mild ataxia to general anaesthesia with recovery over hours to days with several factors affecting hepatic barbiturate metabolism and tissue partitioning. Botulism is an often fatal intoxication in man, animals, birds and certain fish. The occurrence in carnivores is uncommon to rare, with only 2 reports found of botulism in felids. This report relates to 3 adult captive cohabiting tigers that simultaneously developed signs of abdominal discomfort, progressive ataxia, recumbency and comatose sleep resembling stage 2 anaesthesia, alternating with periods of distracted wakefulness and ataxic movements. These signs occurred 4 days after being fed the carcass of a horse that had ostensibly died of colic and not been euthanased. The male tiger that was the dominant animal in the feeding hierarchy was worst affected and had to be given intravenous fluids. The female that was lowest in hierarchy was unaffected. After 48-72 hours of treatment at the Onderstepoort Veterinary Academic Hospital the females could eat and made an uneventful recovery. The male tiger showed partial recovery but died during the night a few hours after drinking water on his return to the owner. Necropsy revealed severe oesophageal dilation and impaction with decaying grass; some of this material and water were present in the pharynx and trachea, and had been aspirated causing acute widespread bronchopneumonia. Colon content tested negative for common pesticides but, together with liver, tested positive for barbiturate. Serum taken on the day of admission had tested negative for barbiturate and the residual serum from the 3 animals later tested negative for botulinum toxin. Colon and oesophageal content from the male at necropsy were positive for Clostridium botulinum toxin type C by the mouse bioassay

  7. Regional variations in home canning practices and the risk of foodborne botulism in the Republic of Georgia, 2003.

    Science.gov (United States)

    Tarkhashvili, N; Chokheli, M; Chubinidze, M; Abazashvili, N; Chakvetadze, N; Imnadze, P; Kretsinger, K; Varma, J; Sobel, J

    2015-04-01

    Foodborne botulism is a severe, paralytic illness caused by ingestion of preformed neurotoxins produced by Clostridium botulinum. In 2003, we conducted a population-based household survey of home canning practices to explore marked regional variations in botulism incidence in the Republic of Georgia (ROG). We designed a cluster sampling scheme and subdivided each of the 10 regions of the ROG into a variable number of strata. Households were selected from each stratum using a two-step cluster sampling methodology. We administered a questionnaire about home canning practices to household members responsible for food preparation. Using multivariate logistic regression analysis, we modeled high (eastern ROG) against low (western ROG) incidence areas. Overall, we surveyed 2,742 households nationwide. Home canning with a capping device hermetically sealing the lid covering the jar was practiced by 1,909 households (65.9%; 95% confidence interval [CI]: 59.8 to 72.1%). Canning was more prevalent in regions of low botulism incidence (34 versus 32%; P canning vegetables and consuming them (adjusted odds ratio [aOR] = 2.1; 95% CI: 1.3 to 3.5) and adding any of the following ingredients to the jar at time of preparation: >1 tablespoon of salt per liter (aOR = 5.1; 95% CI: 1.2 to 22.6); vinegar (aOR = 2.2; 95% CI: 1.3 to 3.7), and greens (aOR = 5.6; 95% CI: 1.7 to 18.2). The following practices were associated with a decreased risk in high-botulism areas: >57 jars canned per household annually (aOR = 0.5; 95% CI: 0.3 to 0.9), covering or immersing vegetables in boiling water before placing them into the jar (aOR = 0.3 95% CI: 0.2 to 0.6), covering or immersing vegetables in boiling water after placing them into the jar (aOR = 0.4; 95% CI: 0.2 to 0.9), or adding garlic (aOR = 0.2; 95% CI: 0.1 to 0.5) or aspirin (aOR = 0.1; 95% CI: 0.1 to 0.2) to the jar at the time of preparation.

  8. Regional Variations in Home Canning Practices and the Risk of Foodborne Botulism in the Republic of Georgia, 2003

    Science.gov (United States)

    TARKHASHVILI, N.; CHOKHELI, M.; CHUBINIDZE, M.; ABAZASHVILI, N.; CHAKVETADZE, N.; IMNADZE, P.; KRETSINGER, K.; VARMA, J.; SOBEL, J.

    2015-01-01

    Foodborne botulism is a severe, paralytic illness caused by ingestion of preformed neurotoxins produced by Clostridium botulinum. In 2003, we conducted a population-based household survey of home canning practices to explore marked regional variations in botulism incidence in the Republic of Georgia (ROG). We designed a cluster sampling scheme and subdivided each of the 10 regions of the ROG into a variable number of strata. Households were selected from each stratum using a two-step cluster sampling methodology. We administered a questionnaire about home canning practices to household members responsible for food preparation. Using multivariate logistic regression analysis, we modeled high (eastern ROG) against low (western ROG) incidence areas. Overall, we surveyed 2,742 households nationwide. Home canning with a capping device hermetically sealing the lid covering the jar was practiced by 1,909 households (65.9%; 95% confidence interval [CI]: 59.8 to 72.1%). Canning was more prevalent in regions of low botulism incidence (34 versus 32%; P 1 tablespoon of salt per liter (aOR = 5.1; 95% CI: 1.2 to 22.6); vinegar (aOR = 2.2; 95% CI: 1.3 to 3.7), and greens (aOR = 5.6; 95% CI: 1.7 to 18.2). The following practices were associated with a decreased risk in high-botulism areas: >57 jars canned per household annually (aOR = 0.5; 95% CI: 0.3 to 0.9), covering or immersing vegetables in boiling water before placing them into the jar (aOR = 0.3 95% CI: 0.2 to 0.6), covering or immersing vegetables in boiling water after placing them into the jar (aOR = 0.4; 95% CI: 0.2 to 0.9), or adding garlic (aOR = 0.2; 95% CI: 0.1 to 0.5) or aspirin (aOR = 0.1; 95% CI: 0.1 to 0.2) to the jar at the time of preparation. PMID:25836400

  9. Dor miofascial dos músculos da mastigação e toxina botulínica

    OpenAIRE

    Dall' Antonia, Magali; Netto, Regina Martins de Oliveira; Sanches,Monique Lalue; GUIMARÃES,Antonio Sérgio

    2013-01-01

    JUSTIFICATIVA E OBJETIVOS: Disfunção temporomandibular (DTM) abrange um conjunto de alterações craniofaciais, que pode envolver a articulação temporomandibular (ATM), os músculos da mastigação e/ou estruturas associadas. As DTM musculares são as mais frequentes e um dos seus subtipos compreende a dor miofascial. A toxina botulínica tipo A (BoNT A), tem sido objeto de estudos no controle da dor, incluindo dor miofascial, e está relacionada ao mecanismo de alívio da dor, não somente nos recepto...

  10. Toxina botulínica no tratamento da dor Toxina botulínica en el tratamiento del dolor Botulinum toxin in pain treatment

    Directory of Open Access Journals (Sweden)

    Orlando Carlos Gomes Colhado

    2009-06-01

    Full Text Available JUSTIFICATIVA E OBJETIVOS: A toxina botulínica (TxB, uma das mais potentes toxinas bacterianas conhecidas, tem reconhecidamente ação terapêutica eficaz no tratamento de algumas síndromes dolorosas. Entretanto, algumas de suas indicações ainda estão em fase de comprovação com relação a sua eficácia. O objetivo deste estudo foi revisar o histórico, propriedades farmacológicas e aplicações clinicas da TxB, quando empregada no tratamento de dores de diferentes origens. CONTEÚDO: A TxB é o produto da fermentação do Clostridium Botulinum, uma bactéria anaeróbia Gram-positiva. Comercialmente, as TxB existem nas formas A e B, agentes biológicos obtidos laboratorialmente. A TxB, uma neurotoxina que possui alta afinidade pelas sinapses colinérgicas, ocasiona bloqueio na liberação de acetilcolina pelo terminal nervoso, sem alterar a condução neural de sinais elétricos ou síntese e armazenamento de acetilcolina. Comprovadamente, a TxB pode enfraquecer seletivamente a musculatura dolorosa, interrompendo o ciclo espasmo-dor. Com relação à dor, varias publicações têm demonstrado a eficácia e segurança da TxB-A no tratamento da cefaleia tipo tensão, migrânea, dor lombar crônica e dor miofascial. CONCLUSÕES: A TxB-A é segura e bem tolerada em desordens dolorosas crônicas, onde regimes de farmacoterapia podem sabidamente provocar efeitos colaterais. Outra vantagem é a redução do uso de analgésicos e o tempo de ação de 3 a 4 meses por dose. Entretanto pesquisas futuras serão necessárias para se estabelecer a eficácia da TxB-A em desordens dolorosas crônicas e seu exato mecanismo no alivio da dor, bem como seu potencial em tratamentos multifatoriais.JUSTIFICATIVA Y OBJETIVOS: La toxina botulínica (TxB, una de las más potentes toxinas bacterianas de que se tiene conocimiento, posee una reconocida acción terapéutica eficaz en el tratamiento de algunos síndromes dolorosos. Sin embargo, algunas de sus

  11. Development and Validation of a New Reliable Method for the Diagnosis of Avian Botulism

    Science.gov (United States)

    Le Maréchal, Caroline; Rouxel, Sandra; Ballan, Valentine; Houard, Emmanuelle; Poezevara, Typhaine; Bayon-Auboyer, Marie-Hélène; Souillard, Rozenn; Morvan, Hervé; Baudouard, Marie-Agnès; Woudstra, Cédric; Mazuet, Christelle; Le Bouquin, Sophie; Fach, Patrick; Popoff, Michel; Chemaly, Marianne

    2017-01-01

    Liver is a reliable matrix for laboratory confirmation of avian botulism using real-time PCR. Here, we developed, optimized, and validated the analytical steps preceding PCR to maximize the detection of Clostridium botulinum group III in avian liver. These pre-PCR steps included enrichment incubation of the whole liver (maximum 25 g) at 37°C for at least 24 h in an anaerobic chamber and DNA extraction using an enzymatic digestion step followed by a DNA purification step. Conditions of sample storage before analysis appear to have a strong effect on the detection of group III C. botulinum strains and our results recommend storage at temperatures below -18°C. Short-term storage at 5°C is possible for up to 24 h, but a decrease in sensitivity was observed at 48 h of storage at this temperature. Analysis of whole livers (maximum 25 g) is required and pooling samples before enrichment culturing must be avoided. Pooling is however possible before or after DNA extraction under certain conditions. Whole livers should be 10-fold diluted in enrichment medium and homogenized using a Pulsifier® blender (Microgen, Surrey, UK) instead of a conventional paddle blender. Spiked liver samples showed a limit of detection of 5 spores/g liver for types C and D and 250 spores/g for type E. Using the method developed here, the analysis of 268 samples from 73 suspected outbreaks showed 100% specificity and 95.35% sensitivity compared with other PCR-based methods considered as reference. The mosaic type C/D was the most common neurotoxin type found in examined samples, which included both wild and domestic birds. PMID:28076405

  12. Emergence of suspected type D botulism in ruminants in England and Wales (2001-2009), associated with exposure to broiler litter.

    NARCIS (Netherlands)

    Payne, J.H.; Hogg, R.A.; Otter, A.; Roest, H.I.J.; Livesey, C.T.

    2011-01-01

    Scanning surveillance by the Veterinary Laboratories Agency revealed the emergence of suspected botulism in ruminants in 2003, presented as flaccid paralysis. From 2003 to 2009, 168 cattle and 19 sheep incidents were recorded, with mortality between 5 and 80 per cent. All sheep incidents and 95 per

  13. Toxina botulínica y su empleo en la patología oral y maxilofacial Botulinum toxin and its use in oral and maxillofacial pathology

    Directory of Open Access Journals (Sweden)

    D. Martínez-Pérez

    2004-06-01

    Full Text Available Resumen: Las toxinas botulínicas son exotoxinas de la bacteria formadora de esporas Clostridim botulinum y los agentes causantes del botulismo. Cuando se inyecta en el músculo produce una parálisis flácida. El efecto clínico está directamente relacionado con la dosis y debe ajustarse para cada caso concreto. La Toxina botulínica ha demostrado en los más de veinte años en que se está utilizando que es un fármaco seguro. Las indicaciones de la toxina botulínica en la actualidad incluyen todas aquellas patologías que resultan de la hiperfunción muscular y la disfunción autonómica.Abstract: Botilinum toxins are exotoxins of the bacteria that form the Clostridium botulinum spores and the causative agents of botulism. When injected into the muscle flaccid paralysis is produced. The clinical effect is directly related with the dose and is should be adjusted for each particular case. over the last twenty years that it has been in use, the botulinum toxin has shown itself to be a reliable drug. Current indications for the use of botulinum toxin include all those pathologies which are the results of muscle hyperfunction and autonomic dysfunction.

  14. The Botulism of animal and its distribution in China%中国动物肉毒中毒及其生态分布

    Institute of Scientific and Technical Information of China (English)

    苏露; 傅思武

    2013-01-01

    肉毒中毒是由肉毒梭菌引起的食物中毒症,是一种人畜共患病,动物肉毒中毒常常是动物食人含有肉毒毒素的食物或饲料而引起,病死率高.本文通过对我国动物肉毒中毒的发生、中毒机理、发病特征及流行分布、预防措施等方面进行了概述,以期为今后畜牧业肉毒中毒的防治提供参考依据.%Botulism, as an anthropozoonosis, was arosed by the Clostridium botulinum toxin. Animal botulism was often occurred by taken food or fodder which contain botulinum toxin, and the mortality was high. The article reviewed the botulism of animal and its occur, poisoning mechanism, pathogenic features, distribution and preventive measure in China, in order to provide reference data for Botulism control and preventive measures.

  15. Blefarospasmo essencial e espasmo hemifacial: características dos pacientes, tratamento com toxina botulínica A e revisão da literatura

    Directory of Open Access Journals (Sweden)

    Schellini Silvana Artioli

    2006-01-01

    Full Text Available OBJETIVO: Conhecer as características dos portadores de blefarospasmo essencial e espasmo hemifacial, assim como a resposta ao tratamento utilizando toxina botulínica A. MÉTODOS: Trinta e quatro portadores de blefarospasmo essencial ou espasmo hemifacial foram avaliados quanto a idade, sexo, queixas oculares, tempo de existência da doença, tipo de comprometimento, complicações e resultado do tratamento com toxina botulínica A. RESULTADOS: A mediana da idade dos pacientes foi de 63 anos e a média, de 61 anos, sem diferença quanto ao sexo; 66,66% possuíam espasmo hemifacial e 33,33%, blefarospasmo essencial. Vários pacientes apresentavam também olho seco. A melhora com a utilização da toxina botulínica A ocorreu em 91,30% dos pacientes tratados. As complicações com o tratamento foram ptose palpebral (8,33% e desvio da rima bucal (8,33%. CONCLUSÃO: O blefarospasmo essencial e o espasmo hemifacial geralmente acometem idosos, de ambos os sexos. O tratamento com a toxina botulínica A é eficiente, com índice muito baixo de complicações.

  16. Botulismo tipo C em ganso ocorrido em Minas Gerais, Brasil Type C botulism in a goose at Minas Gerais, Brazil

    Directory of Open Access Journals (Sweden)

    Francisco Carlos Faria Lobato

    2008-08-01

    Full Text Available Botulismo é uma intoxicação causada pela ingestão das toxinas produzidas pelo Clostridium botulinum, que acomete mamíferos e aves, caracterizando-se por um quadro de paralisia flácida. Neste trabalho, é descrito um caso de botulismo em ganso, ocorrido no município de Santa Luzia, região metropolitana de Belo Horizonte, no Estado de Minas Gerais. Ao exame clínico, o animal apresentava-se com um quadro de paralisia flácida dos músculos do pescoço, das pernas e asas, além de apresentar ainda desprendimento de penas. A necropsia não revelou lesões significativas. Foi colhido o soro do animal e submetido ao teste de soroneutralização em camundongo, que identificou a toxina de C. botulinum tipo C.Botulism is an intoxication caused by the ingestion of toxins produced by Clostridium botulinum, that affects mammals and birds, characterized by a flaceid paralysis. This report describes a case of botulism in a goose in Santa Luzia, Minas Gerais State, Brazil. Clinical examinations showed dropping feathers and flaccid paralysis involving the muscles of the wings, legs and neck. post-mortem examination showed no significant gross or macroscopic lesions C. botulinum type C toxin was demonstrated in the serum of the affected animal through serum neutralization test in mice.

  17. Investigations into an Outbreak of Botulism Caused by Clostridium botulinum Type C/D in Laying Hens.

    Science.gov (United States)

    Skarin, Hanna; Lindgren, Ylva; Jansson, Désirée S

    2015-06-01

    This case report describes a recent botulism outbreak in commercial laying hens with a history of increased mortality and flaccid paralysis. Routine diagnostic gross examination and microscopy from seven hens were inconclusive, but botulinum neurotoxin (BoNT) in peripheral blood was neutralized with both type C and type D antitoxins in the mouse bioassay. During a farm visit, 10 additional hens from a 34-wk-old flock on the farm were selected for clinical examination and further sampling. Nine hens were observed in sternal recumbency, with flaccid paralysis of the neck, drooping wings and tail, inability to escape, and bilateral ptosis, and one hen showed nonspecific clinical signs. Samples from cecum and liver were collected, and the gene coding for BoNT was detected by PCR in all 10 cecal samples and in four of the liver samples. Clostridium botulinum mosaic type C/D was isolated from 5 out of 10 hens from either cecum or liver, and the isolates were subjected to pulsed-field gel electrophoresis subtyping. All five isolates produced the same banding pattern, which was identical or showed >90% similarity to isolates from three different outbreaks on broiler farms in Sweden and Denmark during the 2007-10 period. However, they were clearly distinguishable from the predominantly reported pulsotype associated with avian botulism outbreaks in Europe. The authors are unaware of any previous report of C. botulinum mosaic type C/D isolates from laying hens.

  18. Beneficial effects of botulinum toxin type A in trigeminal neuralgia Beneficio de la toxina botulínica tipo A en neuralgia del trigemino

    Directory of Open Access Journals (Sweden)

    Carlos Zúñiga

    2008-09-01

    Full Text Available Botulinum toxin has been thoroughly studied as a potential tool in the treatment of several pain syndromes. Therefore, we assessed the clinical effects of botulinum toxin type A injections in 12 patients with otherwise unresponsive idiopathic trigeminal neuralgia. Patients were infiltrated with 20-50 units of botulinum toxin in trigger zones. Those who presented with mandibular involvement were also infiltrated in the masseter muscle. The patients were assessed on a weekly basis using the Visual Analogic Scale for pain. Ten of our patients reported a significant benefit from botulinum toxin injections, with reduction or even disappearance of pain, and remained pain free for as long as 60 days. Our findings suggest that botulinum toxin may represent a useful therapeutic tool in the management of patients with this entity.La toxina botulínica ha sido estudiada en forma exhaustiva como una potencial herramienta en el tratamiento de múltiples síndromes dolorosos. Por lo tanto, evaluamos los efectos clínicos de la aplicación de toxina botulínica tipo A en 12 sujetos con neuralgia trigeminal idiopática resistente a manejo farmacológico. Se aplicaron en dichos sujetos entre 20 y 50 unidades de toxina botulínica tipo A en las zonas gatillo. Además se infiltró el músculo masetero en aquellos que presentaban involucro mandibular. Los sujetos fueron evaluados semanalmente con una escala visual análoga para dolor. Diez de los sujetos reportaron un beneficio significativo con el uso de toxina botulínica, con reducción e incluso desaparición del dolor, permaneciendo libres de dolor por un periodo de hasta 60 días. Nuestros hallazgos sugieren que la toxina botulínica puede representar una herramienta terapéutica útil en el manejo de pacientes con esta entidad.

  19. 肉毒中毒症疫苗的研究现状%Current Status of Research on Botulism Vaccines

    Institute of Scientific and Technical Information of China (English)

    彭国瑞; 彭小兵; 李旭妮; 杜吉革; 蒋玉文

    2016-01-01

    用于预防肉毒中毒症的传统疫苗有灭活菌苗和类毒素疫苗,近年来对于重组亚单位疫苗、重组嵌合体疫苗和 DNA 疫苗等研究成为热点,文章着重对这些新型疫苗的发展现状进行了综述,以期为相关研究提供借鉴。%The traditional vaccines included inactivated vaccines and toxoid vaccines,and the new types of vaccines included recombinant subunit vaccines,recombinant chimeric vaccines and DNA vaccines.In order to provide reference for development on botulism vaccines,this paper reviewed the current status of research on these vaccines which had been developed rapidly in recent years.

  20. Actualización sobre aplicaciones de la toxina botulínica en estética facial

    Directory of Open Access Journals (Sweden)

    J.M. Alcolea López

    Full Text Available En la actualidad, la toxina botulínica (TB es parte importante en los tratamientos médico-estéticos de la cara. Este trabajo hace una aproximación didáctica, con fines prácticos formativos, sobre el manejo de la TB para el rejuvenecimiento facial en el ejercicio de la Cirugía Plástica y Estética. Entender la anatomía del envejecimiento es clave para manejar de forma integral la TB junto con otras técnicas de la especialidad destinadas a combatir el envejecimiento, considerándolo en su conjunto. Resumimos los conocimientos actuales sobre el empleo de las inyecciones de TB en el tercio superior de la cara.

  1. Genetic characterization and comparison of Clostridium botulinum isolates from botulism cases in Japan between 2006 and 2011.

    Science.gov (United States)

    Kenri, Tsuyoshi; Sekizuka, Tsuyoshi; Yamamoto, Akihiko; Iwaki, Masaaki; Komiya, Takako; Hatakeyama, Takashi; Nakajima, Hiroshi; Takahashi, Motohide; Kuroda, Makoto; Shibayama, Keigo

    2014-11-01

    Genetic characterization was performed for 10 group I Clostridium botulinum strains isolated from botulism cases in Japan between 2006 and 2011. Of these, 1 was type A, 2 were type B, and 7 were type A(B) {carrying a silent bont/B [bont/(B)] gene} serotype strains, based on botulinum neurotoxin (BoNT) production. The type A strain harbored the subtype A1 BoNT gene (bont/A1), which is associated with the ha gene cluster. The type B strains carried bont/B5 or bont/B6 subtype genes. The type A(B) strains carried bont/A1 identical to that of type A(B) strain NCTC2916. However, bont/(B) genes in these strains showed single-nucleotide polymorphisms (SNPs) among strains. SNPs at 2 nucleotide positions of bont/(B) enabled classification of the type A(B) strains into 3 groups. Pulsed-field gel electrophoresis (PFGE) and multiple-locus variable-number tandem-repeat analysis (MLVA) also provided consistent separation results. In addition, the type A(B) strains were separated into 2 lineages based on their plasmid profiles. One lineage carried a small plasmid (5.9 kb), and another harbored 21-kb plasmids. To obtain more detailed genetic information about the 10 strains, we sequenced their genomes and compared them with 13 group I C. botulinum genomes in a database using whole-genome SNP analysis. This analysis provided high-resolution strain discrimination and enabled us to generate a refined phylogenetic tree that provides effective traceability of botulism cases, as well as bioterrorism materials. In the phylogenetic tree, the subtype B6 strains, Okayama2011 and Osaka05, were distantly separated from the other strains, indicating genomic divergence of subtype B6 strains among group I strains.

  2. Tratamento do blefaroespasmo e distonias faciais correlatas com toxina botulínica: estudo de 16 casos

    Directory of Open Access Journals (Sweden)

    Carvalho Roberto Murillo Limongi de Souza

    2003-01-01

    Full Text Available OBJETIVO: Analisar a eficácia do tratamento com Botox® e estudar o comportamento destes pacientes após aplicações sucessivas, dando ênfase ao possível efeito de tolerância após o uso prolongado deste medicamento. MÉTODOS: Foi realizado estudo prospectivo em 16 pacientes com distonias faciais no ambulatório de Oftalmologia, no Setor de Plástica Ocular do Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, entre abril de 1998 a março de 1999. Todos os pacientes foram submetidos ao exame oftalmológico completo, neurológico e tomografia computadorizada de crânio. Os pacientes com sintomas importantes de espasmo foram tratados com aplicação da toxina botulínica tipo A (Botox®. Dez pacientes eram do sexo feminino. A idade média foi 64,75 anos. RESULTADOS: Dentre as distonias faciais, o espasmo hemifacial foi o mais encontrado, num total de 8 pacientes.O índice de sucesso do Botox®foi de 87,5 %, com duração média do efeito de 30 a 90 dias, variando de acordo com o número de aplicações. CONCLUSÕES: O tratamento dos espasmos faciais com a toxina botulínica mostrou-se eficaz em 87,5 % de nossos pacientes.

  3. Neurotoxins from Clostridium botulinum (serotype A) isolated from the soil of Mendoza (Argentina) differ from the A-Hall archetype and from that causing infant botulism.

    Science.gov (United States)

    Caballero, P; Troncoso, M; Patterson, S I; López Gómez, C; Fernandez, R; Sosa, M A

    2016-10-01

    The type A of neurotoxin produced by Clostridium botulinum is the prevalent serotype in strains of Mendoza. The soil is the main reservoir for C.botulinum and is possibly one of the infection sources in infant botulism. In this study, we characterized and compared autochthonous C. botulinum strains and their neurotoxins. Bacterial samples were obtained from the soil and from fecal samples collected from children with infant botulism. We first observed differences in the appearance of the colonies between strains from each source and with the A Hall control strain. In addition, purified neurotoxins of both strains were found to be enriched in a band of 300 kDa, whereas the A-Hall strain was mainly made up of a band of ∼600 kDa. This finding is in line with the lack of hemagglutinating activity of the neurotoxins under study. Moreover, the proteolytic activity of C. botulinum neurotoxins was evaluated against SNARE (soluble N-ethylmaleimide-sensitive factor-attachment protein receptor) proteins from rat brain. It was observed that both, SNAP 25 (synaptosomal-associated protein 25) and VAMP 2 (vesicle-associated membrane protein) were cleaved by the neurotoxins isolated from the soil strains, whereas the neurotoxins from infant botulism strains only induced a partial cleavage of VAMP 2. On the other hand, the neurotoxin from the A-Hall strain was able to cleave both proteins, though at a lesser extent. Our data indicate that the C.botulinum strain isolated from the soil, and its BoNT, exhibit different properties compared to the strain obtained from infant botulism patients, and from the A-Hall archetype.

  4. Qualidade de vida e custos diretos em pacientes com blefaroespasmo essencial e espasmo hemifacial, tratados com toxina botulínica-A

    Directory of Open Access Journals (Sweden)

    Osaki Midori Hentona

    2004-01-01

    Full Text Available OBJETIVO: Avaliar os custos e a qualidade de vida dos pacientes com blefaroespasmo essencial e espasmo hemifacial, submetidos à terapia com a toxina botulínica-A. MÉTODOS: Vinte e oito pacientes, sendo 16 com blefaroespasmo essencial e 12 com espasmo hemifacial, tratados com toxina botulínica-A, foram avaliados por meio de dois instrumentos: o SF-36 e a Escala de Disfunção de Blefaroespasmo. Os custos foram calculados segundo o número de unidades da toxina utilizadas por cada paciente no período de um ano. RESULTADOS: O custo total direto foi estimado em 1081,62 reais por ano (±89,39 para blefaroespasmo essencial e 618,06 reais por ano (±60,06 para espasmo hemifacial, para tratamento ambulatorial (p<0,001. Antes do tratamento, todos os domínios do SF-36 foram significantemente piores em ambas as doenças. Sob tratamento efetivo com toxina botulínica-A, os aumentos nos índices do SF-36 evidenciaram mudanças nas taxas de saúde geral da população em estudo, com diferença estatisticamente significante entre as respostas pré e pós-tratamento (p<0,05. Relacionando-se o SF-36 com Escala de Disfunção de Blefaroespasmo, foram observadas nos casos de blefaroespasmo essencial, relações significantes positivas (capacidade funcional, estado geral, aspecto emocional e aspectos sociais, ao passo que nos pacientes com espasmo hemifacial não foi encontrada nenhuma correlação. CONCLUSÃO: Este estudo demonstra notável impacto negativo das doenças na qualidade de vida desses pacientes, e uma significante melhora em ambas as doenças após tratamento com toxina botulínica-A. Além disso, os dados fornecem subsídios para justificar o alto custo da aquisição da toxina botulínica-A, devido a seus consideráveis benefícios para a qualidade de vida.

  5. Efecto protector de la toxina botulínica en colgajos cutáneos The protective effect of botulinum toxin on skin flaps

    Directory of Open Access Journals (Sweden)

    C.X. Astudillo Carrera

    2011-06-01

    Full Text Available Los colgajos cutáneos de patrón vascular randomizado son de gran utilidad en Cirugía Reconstructiva; un aporte vascular adecuado es el factor más importante para la supervivencia de los mismos. Realizamos un estudio experimental levantando un total de 36 colgajos en el dorso de 9 conejos (4 en cada conejo: a 9 controles, b 9 con aplicación de toxina botulínica tipo A transoperatoria a lo largo del colgajo, c 9 con toxina botulínica tipo A aplicada 7 días antes del procedimiento quirúrgico, y, d 9 con aplicación de toxina botulínica tipo A transoperatoria más epinefrina. El análisis de los colgajos se realizó a través de imágenes digitales que se examinaron con el programa ImageJ. Efectuamos el análisis estadístico con la prueba T de Student. La evaluación final de los colgajos se realizó al séptimo día, tiempo en el cual se obtuvo: a una media de área necrótica en los controles del 72.17 ± 3.9% ; b en los que se aplicó toxina botulínica transoperatoria el porcentaje de aérea necrótica fue del 5.09 ± 1.2% p = 0.032; c en aquellos en los que la toxina botulínica se aplicó 7 días antes del procedimiento se reportó necrosis del 24.97 ± 2.7% p = 0.041 y d en los que se aplicó toxina botulínica transoperatoria más epinefrina el porcentaje de necrosis fue del 23.90 ± 3.9% p = 0.045. Concluimos que la toxina botulínica tipo A actúa como protector contra el proceso de sufrimiento-isquemia de los tejidos, debido a su acción vasodilatadora, recomendando su aplicación al inicio del procedimiento quirúrgico.Random-pattern cutaneous flaps are very useful in Reconstructive Surgery; an adequate vascular contribution is an important factor for the survival of the flaps. We designed an experimental study elevating a total of 36 dorsal flaps, divided in 4 groups: a 9 were controls, to which 0.9% physiological solution was applied, b 9 with a transoperatory application of type A botulinum toxin throughout the length of

  6. Botulism in Brazil, 2000-2008: epidemiology, clinical findings and laboratorial diagnosis Botulismo no Brasil, 2000-2008: epidemiologia, achados clínicos e diagnóstico laboratorial

    Directory of Open Access Journals (Sweden)

    Ruth Estela Gravato Rowlands

    2010-08-01

    Full Text Available Botulism is a rare and potentially lethal illness caused by Clostridium botulinum neurotoxin. We describe the findings of a laboratorial investigation of 117 suspected cases of botulism reported to the surveillance system in Brazil from January 2000 to October 2008. Data on the number and type of samples analyzed, type of toxins identified, reporting of the number of botulism cases and transmission sources are discussed. A total of 193 clinical samples and 81 food samples were analyzed for detection and identification of the botulism neurotoxin. Among the clinical samples, 22 (11.4% presented the toxin (nine type A, five type AB and eight with an unidentified type; in food samples, eight (9.9% were positive for the toxin (five type A, one type AB and two with an unidentified type. Of the 38 cases of suspected botulism in Brazil, 27 were confirmed by a mouse bioassay. Laboratorial botulism diagnosis is an important procedure to elucidate cases, especially food-borne botulism, to confirm clinical diagnosis and to identify toxins in food, helping sanitary control measures.Botulismo é uma doença rara e potencialmente letal, resultante da ação de uma neurotoxina produzida pelo Clostridium botulinum. No presente estudo, estão descritos os resultados da investigação laboratorial de 117 casos suspeitos de botulismo notificados ao sistema de vigilância, ocorridos no Brasil no período de janeiro de 2000 a outubro de 2008. Os dados obtidos sobre as fontes de transmissão, os tipos de toxina identificados e de amostras analisadas serão discutidos. Foram analisadas 193 amostras clínicas e 81 amostras de alimentos para detecção e identificação de neurotoxina botulínica. Entre as amostras clínicas, 22 (11,4% amostras apresentaram resultado positivo para toxina (nove do tipo A, cinco do tipo AB e em oito o tipo não foi identificado e entre as amostras de alimentos, oito (9,9% foram positivas (cinco do tipo A, uma do tipo AB e em duas o tipo n

  7. Tratamiento del Síndrome de Dolor Miofascial con Toxina Botulínica tipo A Botulinum toxin type A in the management of Myofascial pain syndrome

    OpenAIRE

    de Castro, M.; L. Cánovas; B. García-Rojo; P. Morillas; J. Martínez-Salgado; A. Gómez-Pombo; A. Castro-Méndez

    2006-01-01

    Introducción: El síndrome de dolor miofascial (SDM) se caracteriza por áreas dolorosas de la musculatura esquelética y por la evidencia clínica y electromiográfica de contracción de bandas musculares sobre las cuales existe un punto cuya presión desencadena un dolor intenso local y referido (punto gatillo). La fisiopatología es incierta pero una posible explicación sería la lesión del músculo por microtraumatismos, sobreuso o espasmo prolongado. La toxina botulínica la produce el microorganis...

  8. Abordaje en fisioterapia tras toxina botulínica en parálisis cerebral infantil : revisión sistemática

    OpenAIRE

    Martín Díaz, María

    2016-01-01

    RESUMEN: Objetivo: El objetivo del trabajo es realizar una revisión sistemática, mediante estudios publicados recientemente, acerca de la eficacia del tratamiento de fisioterapia tras la aplicación de toxina botulínica en niños con parálisis cerebral. Introducción: La parálisis cerebral es una lesión persistente pero no variable del sistema nervioso central que origina un tono muscular patológico. La espasticidad es muy frecuente y conlleva limitaciones en las actividades de la vida diari...

  9. Resultados funcionais da aplicação da toxina botulínica tipo A em pacientes com acidente vascular cerebral

    OpenAIRE

    Vanessa Ribas Massia

    2009-01-01

    O Acidente Vascular Cerebral (AVC), junto com as demais doenças cerebrovasculares, é a terceira causa de óbito em países desenvolvidos e a principal causa de incapacidade em adultos. A espasticidade é a seqüela motora mais incapacitante, limitando as atividades funcionais. A toxina Botulínica (TB) tem se mostrado uma opção terapêutica benéfica, eficaz e segura. Pacientes submetidos à aplicação de TB devem iniciar um tratamento fisioterapeutico a fim de estabelecer a função perdida, tornando-o...

  10. Desarrollo de miastenia gravis tras administración de toxina botulínica en el síndrome de dolor miofascial

    Directory of Open Access Journals (Sweden)

    M.ª F. Muñoz Velázquez

    2015-06-01

    Full Text Available El síndrome de dolor miofascial (SDM es una patología muscular dolorosa que se define como dolor local o referido asociado a la presencia de nódulos palpables hipersensibles en el trayecto de ese músculo y constituye una patología frecuente en las consultas de dolor crónico. La toxina botulínica es una exotoxina producida por el Clostridium botulinum, cuyos serotipos A, B y F tienen utilidad clínica (fundamentalmente tipo A- Botox®, Dysport®. Se trata de una de las neurotoxinas más potentes que existen. Se utiliza como uso compasivo en el tratamiento del síndrome de dolor miofascial. El efecto beneficioso analgésico del uso de la toxina se origina de reducir la hiperactividad muscular pero estudios recientes sugieren que esta neurotoxina puede tener efectos analgésicos directos diferentes de sus acciones neuromusculares. Su uso no está exento de riesgos. Los efectos adversos se relacionan con la migración de la toxina y son en general leves o moderados y pasajeros. Se han descrito casos de debilidad muscular prolongada e incluso cuadros de miastenia gravis, síndrome de Eaton Lambert desencadenados por el uso de la toxina. Presentamos el caso clínico de un varón afecto de síndrome de dolor miofascial del cuadrado lumbar y psoas tratado con infiltraciones con toxina botulínica. Tras la mejoría del cuadro clínico muscular se desarrolla diplopía y ptosis palpebral reiterante, siendo diagnosticado de miastenia gravis. Revisamos la etiopatogenia del síndrome de dolor miofascial y de la miastenia gravis, así como el uso de la toxina botulínica y sus relaciones entre ellos. Concluimos que es necesaria una anamnesis detallada previa a la utilización de toxina botulínica sobre patología muscular o signos de debilidad muscular.

  11. Desarrollo de miastenia gravis tras administración de toxina botulínica en el síndrome de dolor miofascial

    OpenAIRE

    M.ª F. Muñoz Velázquez; R. Zueras Batista; R. Abalo Delgado; A. Rincón Vázquez; B. Quintana Gordon

    2015-01-01

    El síndrome de dolor miofascial (SDM) es una patología muscular dolorosa que se define como dolor local o referido asociado a la presencia de nódulos palpables hipersensibles en el trayecto de ese músculo y constituye una patología frecuente en las consultas de dolor crónico. La toxina botulínica es una exotoxina producida por el Clostridium botulinum, cuyos serotipos A, B y F tienen utilidad clínica (fundamentalmente tipo A- Botox®, Dysport®). Se trata de una de las neurotoxinas más potentes...

  12. Hemimasticatory spasm treated with botulinum toxin: case report Espasmo hemimastigatório tratado com toxina botulínica: relato de caso

    Directory of Open Access Journals (Sweden)

    Hélio A.G. Teive

    2002-06-01

    Full Text Available We describe a female patient with hemimasticatory spasm, a rare movement disorder due to dysfunction of the motor trigeminal nerve of unknown origin. This patient had an excellent response to botulinum toxin therapy.Relatamos o caso de paciente feminina com espasmo hemimastigatório, distúrbio do movimento raro decorrente de disfunção da porção motora do nervo trigeminal, de etiologia desconhecida. A paciente teve excelente resposta clínica ao tratamento com toxina botulínica.

  13. Custos e eficácia da toxina botulínica tipo A no tratamento do blefaroespasmo essencial e espasmo hemifacial

    OpenAIRE

    Lasalvia,Cintia Gomes Galvão; Pereira,Luciano de Sousa; Cunha,Marcos Carvalho da; Kitadai,Silvia Prado Smit

    2006-01-01

    OBJETIVO: Avaliar os custos do tratamento para blefaroespasmo essencial e espasmo hemifacial com toxina botulínica tipo A (Dysport®), correlacionando-os com sua eficácia terapêutica. MÉTODOS: Análise de 50 prontuários de pacientes com blefaroespasmo essencial e espasmo hemifacial, submetidos à terapia com Dysport®, no período de abril de 2002 a maio de 2004 no setor de Óculo-Plástica da Santa Casa de São Paulo. Dos 50 pacientes, 27 apresentavam blefaroespasmo essencial e 23 espasmo hemifacial...

  14. Wound Botulism in Injection Drug Users: Time to Antitoxin Correlates with Intensive Care Unit Length of Stay

    Directory of Open Access Journals (Sweden)

    Offerman, Steven R

    2009-11-01

    Full Text Available Objectives: We sought to identify factors associated with need for mechanical ventilation (MV, length of intensive care unit (ICU stay, length of hospital stay, and poor outcome in injection drug users (IDUs with wound botulism (WB.Methods: This is a retrospective review of WB patients admitted between 1991-2005. IDUs were included if they had symptoms of WB and diagnostic confirmation. Primary outcome variables were the need for MV, length of ICU stay, length of hospital stay, hospital-related complications, and death.Results: Twenty-nine patients met inclusion criteria. Twenty-two (76% admitted to heroin use only and seven (24% admitted to heroin and methamphetamine use. Chief complaints on initial presentation included visual changes, 13 (45%; weakness, nine (31%; and difficulty swallowing, seven (24%. Skin wounds were documented in 22 (76%. Twenty-one (72% patients underwent mechanical ventilation (MV. Antitoxin (AT was administered to 26 (90% patients but only two received antitoxin in the emergency department (ED. The time from ED presentation to AT administration was associated with increased length of ICU stay (Regression coefficient = 2.5; 95% CI 0.45, 4.5. The time from ED presentation to wound drainage was also associated with increased length of ICU stay (Regression coefficient = 13.7; 95% CI = 2.3, 25.2. There was no relationship between time to antibiotic administration and length of ICU stay.Conclusion: MV and prolonged ICU stays are common in patients identified with WB. Early AT administration and wound drainage are recommended as these measures may decrease ICU length of stay.[West J Emerg Med. 2009;10(4:251-256.

  15. Avaliação da fenda palpebral após aplicação de toxina botulínica tipo A em pacientes com distonias faciais

    Directory of Open Access Journals (Sweden)

    Mariana Eleonora Pereira Cunial

    2012-12-01

    Full Text Available OBJETIVO: Avaliar a medida da fenda palpebral em pacientes com blefaroespasmo essencial benigno (BEB e espasmo hemifacial (EHF após a aplicação periocular de toxina botulínica tipo A. MÉTODOS: Foram estudados pacientes portadores de BEB e EHF submetidos à injeção periocular de toxina botulínica tipo A pela técnica inner orbital de aplicação. Os pacientes foram fotografados em PPO antes da aplicação e catorze dias depois dela. A fenda palpebral foi mensurada nestas imagens por meio de processamento computadorizado de imagens, utilizando o programa ImageJ. As alterações da fenda palpebral foram observadas comparando-se as medidas obtidas no pré e pós-aplicação. RESULTADOS: Comparando-se as imagens obtidas com o programa ImageJ, houve aumento estatisticamente significante (p<0,001 da fenda palpebral em 14 olhos (51,8% após a aplicação de injeção periocular da toxina botulínica e nenhuma das imagens analisadas apresentou diminuição da fenda palpebral. CONCLUSÃO: No presente estudo, os pacientes portadores de distonias faciais apresentaram aumento de fenda palpebral estatisticamente significante após aplicação periocular de toxina botulínica tipo A.

  16. Retargeting Clostridium difficile Toxin B to Neuronal Cells as a Potential Vehicle for Cytosolic Delivery of Therapeutic Biomolecules to Treat Botulism

    Directory of Open Access Journals (Sweden)

    Greice Krautz-Peterson

    2012-01-01

    Full Text Available Botulinum neurotoxins (BoNTs deliver a protease to neurons which can cause a flaccid paralysis called botulism. Development of botulism antidotes will require neuronal delivery of agents that inhibit or destroy the BoNT protease. Here, we investigated the potential of engineering Clostridium difficile toxin B (TcdB as a neuronal delivery vehicle by testing two recombinant TcdB chimeras. For AGT-TcdB chimera, an alkyltransferase (AGT was appended to the N-terminal glucosyltransferase (GT of TcdB. Recombinant AGT-TcdB had alkyltransferase activity, and the chimera was nearly as toxic to Vero cells as wild-type TcdB, suggesting efficient cytosolic delivery of the AGT/GT fusion. For AGT-TcdB-BoNT/A-Hc, the receptor-binding domain (RBD of TcdB was replaced by the equivalent RBD from BoNT/A (BoNT/A-Hc. AGT-TcdB-BoNT/A-Hc was >25-fold more toxic to neuronal cells and >25-fold less toxic to Vero cells than AGT-TcdB. Thus, TcdB can be engineered for cytosolic delivery of biomolecules and improved targeting of neuronal cells.

  17. Distonia laríngea: relato de caso e tratamento com toxina botulínica Laryngeal dystonia: case report and treatment with botulinum toxin

    Directory of Open Access Journals (Sweden)

    Victor José Barbosa Santos

    2006-06-01

    Full Text Available Distonia laríngea, ou disfonia espasmódica, é caracterizada por contrações involuntárias e inapropriadas da musculatura responsável pela fonação, sendo a do tipo adutora a mais comum. Caracteriza-se por quebras fonatórias, sendo seu diagnóstico confirmado por videolaringoestroboscopia. O tratamento de escolha é feito com a aplicação direta de toxina botulínica nos músculos responsáveis pelo movimento incoordenado. O objetivo desse trabalho é relatar o caso de uma paciente com diagnóstico de distonia laríngea do tipo adutora, tratada com toxina botulínica e discutir as vantagens e observações descritas na literatura a respeito desse tratamento.Laryngeal dystonia or spasmodic dysphonia is characterized by involuntary and innapropiate spasms of vocal muscles, having the adductor type as the most common one. It is chacterized by strain-strangled voice with pitch breaks. Diagnosis is made by means of videolaryngostroboscopic exam. The treatment of choice is done with botulinum toxin directly injected in the muscles responsible for the mismatched movement. The aim of this study is to report on an adductor- type dysphonia patient and to discuss the advantages and observations about this treatment reported in the literature.

  18. Improvement in laboratory diagnosis of wound botulism and tetanus among injecting illicit-drug users by use of real-time PCR assays for neurotoxin gene fragments.

    Science.gov (United States)

    Akbulut, D; Grant, K A; McLauchlin, J

    2005-09-01

    An upsurge in wound infections due to Clostridium botulinum and Clostridium tetani among users of illegal injected drugs (IDUs) occurred in the United Kingdom during 2003 and 2004. A real-time PCR assay was developed to detect a fragment of the neurotoxin gene of C. tetani (TeNT) and was used in conjunction with previously described assays for C. botulinum neurotoxin types A, B, and E (BoNTA, -B, and -E). The assays were sensitive, specific, rapid to perform, and applicable to investigating infections among IDUs using DNA extracted directly from wound tissue, as well as bacteria growing among mixed microflora in enrichment cultures and in pure culture on solid media. A combination of bioassay and PCR test results confirmed the clinical diagnosis in 10 of 25 cases of suspected botulism and two of five suspected cases of tetanus among IDUs. The PCR assays were in almost complete agreement with the conventional bioassays when considering results from different samples collected from the same patient. The replacement of bioassays by real-time PCR for the isolation and identification of both C. botulinum and C. tetani demonstrates a sensitivity and specificity similar to those of conventional approaches. However, the real-time PCR assays substantially improves the diagnostic process in terms of the speed of results and by the replacement of experimental animals. Recommendations are given for an improved strategy for the laboratory investigation of suspected wound botulism and tetanus among IDUs.

  19. Botulismo em bovinos de corte e leite alimentados com cama de frango Botulism in beef and dairy cattle fed with poultry litter

    Directory of Open Access Journals (Sweden)

    Iveraldo S. Dutra

    2005-06-01

    Full Text Available Surtos de botulismo causados pelos tipos C e D da toxina botulínica são freqüentes no país, estando originalmente associados à osteofagia e à ingestão de alimentos e água contaminados. No presente trabalho são descritos os aspectos epidemiológicos, clínico-patológicos e laboratoriais de sete surtos da intoxicação em bovinos de corte e leite alimentados com cama de frango, ocorridos nos estados de São Paulo e Minas Gerais entre 1989 e 2000. Cinco surtos ocorreram em rebanhos de corte confinados ou criados extensivamente e suplementados com o subproduto, e dois em propriedades leiteiras. De um total de 1.535 animais alimentados regularmente com a cama de frango, 455 (29,64% morreram em um período que variou de 2 a 4 semanas. A morbidade nos sete surtos estudados variou de 3,47 a 100%, da mesma forma que a mortalidade. Em uma das propriedades a letalidade foi de 60,52%, e em todos os outros surtos ela foi acima de 88,43%; em três propriedades o coeficiente foi de 100%. Os sinais clínicos de paralisia progressiva, dificuldade na locomoção, decúbito e estado mental aparentemente normal, diminuição do tônus da musculatura da língua e cauda, sialorréia e dificuldade respiratória caracterizaram o quadro clínico. À necropsia de 30 animais não foi observada qualquer alteração macroscópica digna de nota. A presença de esporos de Clostridium botulinum foi detectada em amostras de cama de frango colhidas nas sete propriedades. Nas amostras de fígado, líquido ruminal e intestinal, provenientes dos 30 animais necropsiados, foi possível detectar toxinas botulínicas tipos C (5 ou D (9, ou classificada como pertencente ao complexo CD (1, em pelos menos um dos materiais provenientes de 15 animais, confirmando assim o diagnóstico clínico-patológico e epidemiológico de botulismo.Outbreaks of botulism caused by type C and D of the botulinum toxin are frequent in Brazil, and are associated with bone chewing and ingestion of

  20. Clinical analysis of three cases with infant botulism and review of literature%婴儿肉毒中毒三例并文献复习

    Institute of Scientific and Technical Information of China (English)

    张捷; 徐文瑞; 赵曼曼; 吴晔; 张欣; 张春雨; 王颖; 刘雪芹; 卢珊

    2016-01-01

    目的 探讨婴儿肉毒中毒病例的临床特点及诊疗经过.方法 对北京大学第一医院2015年5月收治的3例临床诊断婴儿肉毒中毒患儿的临床资料进行回顾性分析,分别以“infant,botulism”和“婴儿、肉毒中毒”为主题词检索PubMed、万方数据库、中国期刊全文数据库和中国维普数据库,检索时间均从建库起至2015年11月.结果 3例婴儿肉毒中毒患儿4~8月龄,女2例、男1例.均以纳差、精神反应差急性起病,既往智力、运动发育正常,无明确毒物接触史.体格检查均见:肌力、肌张力减低,腱反射正常引出,眼球活动不灵活,瞳孔散大、对光反射减弱或消失,面部表情减少,哭声弱,吞咽困难为主要表现,而意识状态相对较好.通过行粪便细菌分离鉴定及PCR分型鉴定,2例证实为B型肉毒梭菌感染.文献检索共检索到446条外文文献,52条中文文献.全世界报道的婴儿肉毒中毒病例3 000多例.国内多为综述性文章,有较多食源性肉毒中毒病例报告,婴儿肉毒中毒国内仅2000年有1例报道.结论 婴儿肉毒中毒多无明确暴露史,常表现为弛缓性瘫痪、颅神经麻痹,还具有瞳孔散大、对光反射消失等瞳孔括约肌受累的典型表现.粪便肉毒梭菌分离鉴定及肉毒毒素检测可明确诊断.婴儿肉毒中毒在国内少见,可能与国内医务人员对该病的认识及检验水平不足有关,可能存在被低估的情况.%Objective To analyze the clinical characteristics and diagnosis of three cases with infant botulism.Method Clinical data of three clinically diagnosed cases with infant botulism in May 2015 in Peking University First Hospital were retrospectively analyzed.Literature search at databases of PubMed,Wanfang,China National Knowledge Infrastructure and VIP with the key words" infant AND botulism".The date of literature retrieval was from the database founding to November 2015.The characteristics of infant botulism

  1. Uso de toxina botulínica paravertebral para detener la progresión de escoliosis en pollos pinealectomizados: la columna vertebral como sistema de tensegridad

    Directory of Open Access Journals (Sweden)

    Álvaro González-Miranda

    Full Text Available Antecedentes y Objetivos. La escoliosis idiopática infantil no tiene un tratamiento satisfactorio que permita reducir la importante morbilidad y mortalidad asociada a los casos más severos y progresivos de la enfermedad. El desarrollo de procedimientos que puedan ralentizar la progresión de la enfermedad durante el desarrollo del niño puede influir favorablemente en el crecimiento y retrasar el tratamiento definitivo de la deformidad al momento de la madurez músculoesquelética. Presentamos un estudio sobre la influencia de la toxina botulínica en el desarrollo de deformidad en un modelo animal de escoliosis progresiva. Material y método. Utilizamos 52 pollos Broiler hembra, en los que se practicó pinealectomía para producir escoliosis. Comparamos la evolución de la deformidad entre un grupo control y un grupo intervención asignado a recibir toxina botulínica paravertebral en la concavidad de la curva, bajo control electromiográfico. Realizamos estudios radiográficos y anatomopatológicos de los animales para evaluar los resultados. El grado de escoliosis se midió utilizando el método del ángulo de Cobb. Resultados. Cinco animales no sobrevivieron al estudio (1 en el grupo control y 4 en el de intervención. En el grupo control observamos una deformidad media de 32.9º (n= 25 y en el grupo intervención de 18.8º (n=22, encontrando diferencias estadísticamente significativas (p < 0.05. Por tanto, la aplicación de toxina botulínica en la concavidad de la deformidad de pollos pinealectomizados frena la progresión de escoliosis. Conclusiones. La consideración de la columna vertebral y sus tejidos blandos asociados como una estructura de tensegridad puede explicar el fenómeno mediante el desequilibrio generado entre los componentes de tensión (músculos y ligamentos y compresión (vértebras que conforman el sistema. Estos resultados justifican nuevos estudios en investigación clínica para explorar una nueva alternativa

  2. Influência da toxina botulínica tipo A na função lacrimal de pacientes com distonias faciais

    Directory of Open Access Journals (Sweden)

    Fernanda Castro de Oliveira

    2010-10-01

    Full Text Available OBJETIVO: Avaliar a influência da toxina botulínica na função lacrimal de pacientes com distonias faciais. MÉTODOS: Pacientes com diagnóstico de espasmo hemifacial ou blefaroespasmo essencial em atividade foram clinicamente avaliados e responderam questionário de desconforto ocular (OSDI e foram submetidos aos testes de Schirmer I e basal, tempo de ruptura do filme lacrimal e clearance da lágrima para avaliação da função lacrimal. No dia seguinte, os pacientes receberam tratamento padronizado com toxina botulínica. O questionário e todos os exames iniciais foram repetidos 30 dias após o tratamento pelo mesmo examinador. RESULTADOS: Foram incluídos 26 pacientes no estudo, sendo 15 (57,7% com espasmo hemifacial e 11(42,3% com blefaroespasmo essencial. Nos pacientes com espasmo hemifacial a média de idade foi 70,9 ± 13,3 anos e a relação masculino/feminino foi de 1:1,5. Nos pacientes com blefaroespasmo essencial a mé­dia de idade foi 68,9 ± 8,4 anos com predomínio do sexo feminino (90,9%. Após o tratamento o escore do OSDI e os valores dos testes de Schirmer I e basal diminuíram significantemente nos dois grupos. O valor médio da ruptura do filme lacrimal aumentou significantemente nos dois grupos. No teste do clearance da lágrima houve um aumento no número de olhos que apresentaram drenagem completa da lágrima após o tratamento nos dois grupos. CONCLUSÃO: O tratamento com toxina botulínica melhorou os sintomas de olho seco em pacientes com distonias faciais. Apesar da porção aquosa da lágrima ter diminuído, as alterações no piscar aumentaram a estabilidade e melhoraram a drenagem da lágrima.

  3. Aberrações ópticas de alta ordem em pacientes com distonias faciais tratados com toxina botulínica

    Directory of Open Access Journals (Sweden)

    Mariann Midori Yabiku

    2011-12-01

    Full Text Available OBJETIVO: Avaliar as aberrações ópticas de alta ordem em pacientes com distonias faciais tratados com toxina botulínica tipo A. MÉTODOS: Pacientes com diagnóstico clínico de espasmo hemifacial ou blefaroespasmo essencial em atividade foram submetidos ao exame biomicroscópico e à análise de frente de ondas através do aberrômetro Alcon LADARvision®, sob midríase medicamentosa. A seguir, foram tratados com injeções de toxina botulínica tipo A. Após um mês, a análise de frente de ondas foi repetida da mesma forma e pelo mesmo oftalmologista. As aberrações de alta ordem foram comparadas antes e após o tratamento. O teste T pareado foi utilizado para comparar os valores numéricos antes e após o tratamento. RESULTADOS: Foram incluídos no estudo um total de 11 pacientes, 6 com blefaroespasmo essencial (54,5% e 5 com espasmo hemifacial (45,5%. Nos pacientes com espasmo hemifacial foram analisados apenas o lado acometido, totalizando 17 olhos com espasmo. A idade variou de 50 a 72 anos, com média de 65,9 ± 8,2 anos. Oito pacientes eram do sexo feminino (72,7%, sendo a relação masculino/feminino de 1:2,6. A média do "root mean square" (RMS das aberrações de alta ordem foi 0,68 antes e 0,63 após um mês do tratamento (p=0,01. A média da aberração esférica foi de 0,23 e 0,17 antes e após o tratamento respectivamente (p=0,01. Não houve diferenças estatisticamente significantes nos demais tipos de aberrações de alta ordem após o tratamento (p>0,05. CONCLUSÃO: O tratamento com toxina botulínica A pode diminuir as aberrações esféricas em pacientes com distonias faciais.

  4. The Changes and Significance of Electroencephalogram in the Alimentary Botulism%食物性肉毒中毒患者的脑电图改变及其意义

    Institute of Scientific and Technical Information of China (English)

    刘燕敏

    2011-01-01

    Objective To discuss the changes and significance of electroencephalogram in the alimentary botulism. Methods EEG data of 32 patients diagnosed with alimentary botulism were retrospectively analyzed. Results 22 among the 32 patients with alimentary botulism had abnormal EEG, the rate was 68. 75 %. The EEG abnormalities were characterized by the local or diffuse slow wave, a wave ante location, and low tension in the background activity. Conclusion EEG can be considered as one of the diagnostic instruments of the alimentary botulism, especially in the state of midrange and severe poisoning. EEG can be considered as valuable indicator to evaluate the severity of the alimentary botulism. EEG's dynamic monitoring can be considered as one of the indicators to judge the pathogen tic condition turnover of the alimentary botulism.%目的 探讨食物性肉毒中毒患者脑电图(EEG)的变化及其意义.方法 回顾性分析32例临床确诊为食物性肉毒中毒患者的EEG资料.结果 32例食物性肉毒中毒患者中有22例EEG异常,异常率为68.75%,主要表现为局限性或弥漫性慢波化、a波前移、背景活动呈低电压状态.不同程度食物性肉毒中毒患者EEG异常率间差异有统计学意义(P=0.025).结论 EEG可作为食物性肉毒中毒的诊断手段之一,尤其在中度、重度中毒时;EEG可作为判断食物性肉毒中毒严重程度的指标;EEG的动态监测可判断食物性肉毒中毒的病情转归.

  5. Diplopia após injeção de toxina botulínica tipo A para rejuvenescimento facial

    Directory of Open Access Journals (Sweden)

    Márcia Melo de Oliveira Rassi

    2012-06-01

    Full Text Available Relato de 4 casos de pacientes encaminhadas ao serviço de Ortóptica deste Hospital, que apresentaram diplopia após a injeção de toxina botulínica tipo A para rejuvenescimento facial. Nas medidas de ângulo do estrabismo em posições diagnósticas todas apresentaram microestrabismo paralítico, sendo duas por déficit da função do músculo oblíquo inferior e duas por déficit de função de músculo reto lateral. Baseados nos casos descritos, aconselha-se aos profissionais que fazem uso desta toxina para fins de rejuvenescimento facial que estejam atentos para a diplopia como efeito colateral.

  6. Considerações acerca de dois casos de botulismo ocorridos no Estado da Bahia Comments on two cases of botulism in the State of Bahia, Brazil

    Directory of Open Access Journals (Sweden)

    Maria Aparecida Araújo Figueiredo

    2006-06-01

    Full Text Available Relato de dois casos, incluindo um óbito, associados ao botulismo, onde houve dificuldade no diagnóstico da doença e falta de integração entre a vigilância sanitária e a vigilância epidemiológica. O objetivo é alertar profissionais para a seriedade deste agravo e refletir sobre as práticas de vigilância da saúde encontradas.A report on two cases of botulism, one fatal, in which disease diagnosis was difficult and collaboration between public health and epidemiological surveillance services was poor. The objective of this report is to warn professionals of the seriousness of this disease and to reflect on existing public health surveillance practices.

  7. Botulinum toxin: mechanisms of action Toxina botulínica: mecanismos de ação

    Directory of Open Access Journals (Sweden)

    Dirk Dressler

    2005-03-01

    Full Text Available This review describes therapeutically relevant mechanisms of action of botulinum toxin (BT. BT's molecular mode of action includes extracellular binding to glycoproteine structures on cholinergic nerve terminals and intracellular blockade of the acetylcholine secretion. BT affects the spinal stretch reflex by blockade of intrafusal muscle fibres with consecutive reduction of Ia/II afferent signals and muscle tone without affecting muscle strength (reflex inhibition. This mechanism allows for antidystonic effects not only caused by target muscle paresis. BT also blocks efferent autonomic fibres to smooth muscles and to exocrine glands. Direct central nervous system effects are not observed, since BT does not cross the blood-brain-barrier and since it is inactivated during its retrograde axonal transport. Indirect central nervous system effects include reflex inhibition, normalisation of reciprocal inhibition, intracortical inhibition and somatosensory evoked potentials. Reduction of formalin-induced pain suggests direct analgesic BT effects possibly mediated through blockade of substance P, glutamate and calcitonin gene related peptide.O propósito deste artigo é uma revisão dos mecanismos de ação da toxina botulínica (TB relevantes para a compreensão do seu uso terapêutico. A ação da TB a nível molecular consiste na sua ligação extracelular a estruturas glicoprotéicas em terminais nervosos colinérgicos e no bloqueio intracelular da secreção de acetilcolina. A TB interfere no reflexo espinal de estiramento através do bloqueio de fibras musculares intrafusais causando redução da sinalização aferente veiculada por fibras Ia e II e do tono muscular. Portanto, o efeito da TB pode estar relacionado não somente à paresia muscular mas também à inibição reflexa espinal. A TB promove ainda o bloqueio de fibras autonômicas para músculos lisos e glândulas exócrinas. Apesar de ocorrer alguma difusão sistêmica após a aplica

  8. Treatment of cervical dystonia with botulinum toxin in a patient with myasthenia gravis Tratamento de distonia cervical com toxina botulínica em uma paciente com miastenia gravis

    Directory of Open Access Journals (Sweden)

    MARCIA RUBIA R. GONÇALVES

    1999-09-01

    Full Text Available We report the case of a 49-year-old woman who has the rare combination of myasthenia gravis and cervical dystonia. She was treated with botulinum toxin type A with good response and no evidence of deterioration of the myasthenic symptoms. We therefore conclude that it is possible to use botulinum toxin in the presence of defective neuromuscular transmission.Relatamos o caso de uma mulher de 49 anos com rara combinação de miastenia gravis e distonia cervical tratada com toxina botulínica tipo A, apresentando boa resposta e nenhuma evidência de piora do quadro miastênico. A partir dessas observações concluimos que é possível o uso de toxina botulínica na presença de doença da transmissão neuromuscular.

  9. Home Canning and Botulism

    Science.gov (United States)

    ... 1. Use proper canning techniques. Make sure your food preservation information is always current with up-to-date, ... the following sources: The National Center for Home Food Preservation USDA Complete Guide to Home Canning The state ...

  10. History of Bioterrorism: Botulism

    Medline Plus

    Full Text Available ... and Incidents Radiation Emergencies Clinicians Coping with Disaster Crisis & Risk Communication Health Alert Network (HAN) Laboratory Information Older Adults Preparation & ...

  11. History of Bioterrorism: Botulism

    Medline Plus

    Full Text Available ... Skip directly to site content Start of Search Controls Search Form Controls Search The CDC Cancel Submit Search The CDC ... V W X Y Z # Start of Search Controls Search Form Controls Search The CDC Cancel Submit ...

  12. History of Bioterrorism: Botulism

    Science.gov (United States)

    ... Guide Reaching At-Risk Populations MedCon Video: "The History of Bioterrorism" Recommend on Facebook Tweet Share Compartir ... as bioterrorist weapons. Watch the Complete Program "The History of Bioterroism" (26 min 38 sec) Watch Specific ...

  13. History of Bioterrorism: Botulism

    Medline Plus

    Full Text Available ... Emergencies Clinicians Coping with Disaster Crisis & Risk Communication Health Alert Network (HAN) Laboratory Information Older Adults Preparation & ... Biological Warfare and Terrorism: The Military and Public Health Response," co-produced by the United States Army ...

  14. Study of Waterfowl Botulism

    Data.gov (United States)

    US Fish and Wildlife Service, Department of the Interior — A total of 55 invertebrate samples were collected from July 1, 1974 to June 30, 1975. Two samples were toxic out of five analyzed. The four year contract for...

  15. History of Bioterrorism: Botulism

    Medline Plus

    Full Text Available ... Radiation Emergencies Clinicians Coping with Disaster Crisis & Risk Communication Health Alert Network (HAN) Laboratory Information Older Adults Preparation & Planning Situation ...

  16. Facts about Botulism

    Science.gov (United States)

    ... Specific Hazards Bioterrorism A-Z Anthrax (Bacillus anthracis) Arenaviruses Treatment & Infection Control Specimen Submission & Lab Testing Education & ... hemorrhagic fevers (filoviruses [e.g., Ebola, Marburg] and arenaviruses [e.g., Lassa, Machupo]) Yersinia pestis (plague) Fact ...

  17. History of Bioterrorism: Botulism

    Medline Plus

    Full Text Available ... Education What's New Emergency Preparedness and You Video: "The History of Bioterrorism" Recommend on Facebook Tweet Share ... or can be used as bioterrorist weapons. Watch the Complete Program "The History of Bioterroism" (26 min ...

  18. History of Bioterrorism: Botulism

    Medline Plus

    Full Text Available ... Coping with Disaster Crisis & Risk Communication Health Alert Network (HAN) Laboratory Information Older Adults Preparation & Planning Situation Awareness Social Media Surveillance Training & Education What's New Emergency Preparedness ...

  19. History of Bioterrorism: Botulism

    Medline Plus

    Full Text Available ... Coping with Disaster Crisis & Risk Communication Health Alert Network (HAN) Laboratory Information Older Adults Preparation & Planning Situation ... Email CDC-INFO U.S. Department of Health & Human Services HHS/Open USA.gov Top

  20. Emergency treatment of botulism food poisoning:one case report%肉毒杆菌食物中毒急诊救治一例

    Institute of Scientific and Technical Information of China (English)

    周航亮; 邓腊明

    2014-01-01

    肉毒杆菌食物中毒是由肉毒杆菌释放的肉毒毒素引起严重的神经肌肉中毒症状。该病初期常因临床表现为急性胃肠道中毒症状引起误诊而耽误治疗,严重者导致患者死亡。及早明确诊断和临床对症治疗是成功救治该病的关键。该文总结分析1例肉毒杆菌食物中毒患者的急诊救治过程。经过详细询问该患者的发病史和进食史,进行全面的体格检查、常规检验、影像辅助检查和实验室血浆肉毒毒素检测分析并结合临床症状,该患者确诊为肉毒毒素中毒。在未明确肉毒毒素亚型情况下,对患者大剂量注射A、B型抗肉毒毒素,辅助抗感染和营养恢复神经功能的综合治疗取得较好的治疗效果。患者发病第7日症状好转,救治26 d后康复出院。%Botulism food poisoning is characterized with severe neurotoxic symptoms induced by botu-linum toxin released by botulinum. Constantly,patients with botulism food poisoning could be misdiagnosed or receive delayed treatment due to gastrointestinal symptoms as early clinical manifestations,even leading to death. Therefore,early diagnosis and effective treatment determine the success of fighting against this disease. In this article,the diagnosis and treatment of one case of botulism food poisoning were retrospectively reviewed. After detail inquiry of onset and dietary habit,comprehensive physical examination,routine and imaging test, plasma botulinum toxin detection and combined with clinical symptoms,the patient was diagnosed as botulinum toxin poisoning. In the absence of the exact subtype of botulinum toxin,combined therapy of a large-dose injec-tion of types A and B anti-botulinum toxin,anti-infection therapy and nutritional recovery of neurological func-tion can achieve desirable therapeutic effect. The symptoms were improved at 7th days after treatment. The pa-tient was discharged after 26 days treatment.

  1. Botulismo em ruminantes causado pela ingestão de cama-de-frango Botulism in ruminants being fed with poultry litter

    Directory of Open Access Journals (Sweden)

    Francisco Carlos Faria Lobato

    2008-08-01

    Full Text Available Botulismo é uma intoxicação causada pela ingestão das toxinas produzidas pelo Clostridium botulinum, que acomete mamíferos e aves. Neste trabalho é descrito um surto de botulismo em ruminantes, ocorrido em duas propriedades localizadas no município de Patos, no Estado da Paraíba, Brasil. Em uma das propriedades, de um total de 88 bovinos, 85 (96,6% vieram a óbito. Na segunda, morreram 145 ovinos (96,7%, 233 caprinos (57,8% e 30 bovinos (96,8%. Os animais acometidos apresentavam paralisia progressiva, dificuldade de locomoção, sialorréia e dispnéia. A morte ocorreu entre 24 e 48 horas após o início dos sinais, por parada cardio-respiratória. Nenhuma alteração significativa foi observada no exame post-mortem. O diagnóstico de botulismo foi confirmado pela demonstração das toxinas C e D no conteúdo intestinal e na cama-de-frango utilizada na alimentação dos animais, pela técnica de soroneutralização em camundongos.Botulism is a poisoning caused by the ingestion of toxins produced by Clostridium botulinum, that infects mammals and birds. This article reports an outbreak of botulism in two different flocks of ruminants at Paraíba, Brazil. In one, 85 out of 88 (96.6% cattles died. In the other, 145 (96.7% sheeps, 233 (57.8% goats and 30 (96.8% cattles died. Clinical signs were progressive paralysis, difficulties in moving, sialorrhoe and dyspnoe. Death occurred 24 to 48 hours after the beginning of clinic signs and at post-mortem examination no noteable changes were observed. Type C and D toxins were demonstrated in the intestinal contents and poultry litter by neutralization test in mice.

  2. Tratamento da doença de Hailey-Hailey com toxina botulínica tipo A Hailey-Hailey disease treatment with Botulinum toxin type A

    Directory of Open Access Journals (Sweden)

    Giancarlo Rezende Bessa

    2010-10-01

    Full Text Available Duas irmãs com doença de Hailey-Hailey, com lesões recorrentes - uma em axilas e outra em região inguinal -, e resposta limitada aos tratamentos clássicos. Elas foram tratadas com aplicação de toxina botulínica tipo A. Observamos que houve importante melhora na paciente tratada na região inguinal e remissão completa na paciente em cujas axilas sofreram tratamento. Além disso, foi possível poupar uso de antibióticos sistêmicos e corticoides tópicos. O alto custo é um fator restritivo para uso rotineiro e estudos maiores são necessários para definir eficácia e relação custo-benefício dessa intervenção.Two sisters with recurrent lesions, one on axillae and other on the groin, and with limited response to classical treatments were treated with injections botulinum toxin type A. We observed marked improvement in the patient treated in the groin and complete remission in the patient treated in the axillae. It was possible to spare the use of systemic antibiotics and topical corticosteroids. The high cost is a restrictive factor to routine use and large studies are necessary to access efficacy and cost benefit profile.

  3. Botulism Outbreaks due to Clostridium Botulinum in Cattle and Dairy Products%奶牛和乳制品中的肉毒杆菌

    Institute of Scientific and Technical Information of China (English)

    赵伟; 毕鉴琨; 陈尚武; 任发政

    2013-01-01

    本文回顾了全球范围内牛的肉毒中毒事件和因食用乳及乳制品引发的人的肉毒中毒事件,分析了肉毒污染的可能原因.重点阐述了乳及乳制品中的肉毒毒素或肉毒杆菌引起人肉毒中毒或感染肉毒杆菌及引发乳品加工链中肉毒污染的风险,并对如何防控乳及乳制品发生肉毒污染提出了建议举措.%The botulism outbreaks due to Clostridium botulinum worldwide in cattle and dairy products were reviewed,and the possible reasons for these outbreaks were analyzed.The risk of milk in the transmission of the neurotoxin or C.botulinum into humans or the dairy chain was mainly discussed.Control of growth and toxin Production by C.Botulinum in Milk and dairy Products was proposed.

  4. Tratamiento del Síndrome de Dolor Miofascial con Toxina Botulínica tipo A Botulinum toxin type A in the management of Myofascial pain syndrome

    Directory of Open Access Journals (Sweden)

    M. Castro

    2006-03-01

    Full Text Available Introducción: El síndrome de dolor miofascial (SDM se caracteriza por áreas dolorosas de la musculatura esquelética y por la evidencia clínica y electromiográfica de contracción de bandas musculares sobre las cuales existe un punto cuya presión desencadena un dolor intenso local y referido (punto gatillo. La fisiopatología es incierta pero una posible explicación sería la lesión del músculo por microtraumatismos, sobreuso o espasmo prolongado. La toxina botulínica la produce el microorganismo Clostridium botulinum en condiciones anaeróbicas y se trata de una de las sustancias más potentes que se conocen. Material y métodos: Se trata de un estudio observacional prospectivo en el que hemos estudiado la aplicación de la toxina botulínica tipo A en el tratamiento del síndrome de dolor miofascial en una serie de 20 pacientes. Todos los pacientes fueron sometidos a una infiltración diagnóstica de la musculatura lumbar o del músculo piramidal con 8 ml de ropivacaína al 0,2% y 6 mg de fosfato sódico de betametasona y 6 mg de acetato de betametasona. Para la localización de los músculos utilizamos referencias anatómicas y administramos de 3 a 5 ml de contraste hidro-soluble para asegurarnos mediante fluoroscopia de la correcta localización de la aguja. La administración de toxina botulínica se realizó siguiendo el mismo método utilizado en las infiltraciones diagnósticas. Decidimos utilizar una dosis de 250 U de Dysport® en cada músculo a infiltrar sin pasar en ningún caso de 1000 U para un mismo paciente. La eficacia del tratamiento se basó en el control del dolor según la Escala Visual Analógica basal (EVA 1, a los 15 días (EVA 15, a los 30 días (EVA 30 y a los 90 días (EVA 90 de las infiltraciones y el test de Lattinen evaluado antes del tratamiento (TLT 1 y al final del estudio (TLT 2. Todos los pacientes fueron preguntados acerca de posibles efectos secundarios. Finalmente se registró el grado de

  5. Eficácia do resfriamento da pele no alívio da dor desencadeada pela injeção de toxina botulínica tipo A nas distonias faciais

    Directory of Open Access Journals (Sweden)

    Paula Barros Bandeira de Mello Monteiro

    2012-12-01

    Full Text Available OBJETIVO: Avaliar a eficácia do resfriamento da pele com gelo no alívio da dor desencadeada pela injeção de toxina botulínica tipo A na região periocular em pacientes portadores de distonia facial. MÉTODOS: Neste estudo prospectivo, 13 pacientes receberam injeção de toxina botulínica tipo A em região glabelar (m. prócero e periocular (m. orbicular para tratamento de distonia facial. Antes das aplicações, um lado da região glabelar foi resfriado com gelo durante 5 minutos, enquanto no outro lado foi aplicada pomada Epitezan®, funcionando como placebo. A aplicação foi feita primeiramente no lado resfriado. Após a aplicação em cada um dos lados os pacientes foram instruídos a dar uma nota para a dor desencadeada pela injeção, em uma escala de 0 a 10 onde 0 era ausência de dor e 10 a dor mais intensa. RESULTADOS: A média das notas dadas pelos pacientes à dor desencadeada pela injeção no lado onde foi aplicado placebo foi 3,92 ± 3,28. No local onde foi aplicado gelo a média das notas foi de 2,92 ± 2,18 (p < 0,0166. A média da diferença entre notas dos dois grupos foi de 1,0. CONCLUSÃO: No presente estudo o resfriamento da pele com gelo foi eficaz no alívio da dor desencadeada pela aplicação de toxina botulínica tipo A na região periocular em pacientes portadores de distonia facial.

  6. Injeção de toxina botulínica intradetrusora no tratamento de bexiga neurogênica refratária a anticolinérgicos: influência da urodinâmica e morfologia vesical

    OpenAIRE

    Ronaldo Alvarenga Alvares

    2014-01-01

    OBJETIVOS: Avaliar se a cistografia e urodinâmica podem ajudar a prever quais pacientes com hiperatividade detrusora neurogênica (HDN) refratária a anticolinérgicos respondem melhor ao tratamento com injeção intradetrusora de toxina botulínica-A (TB-A). Assim como a eficácia e qualidade de vida em relação ao tratamento. MÉTODOS: Trinta e quatro pacientes com lesão medular (LM) foram avaliados prospectivamente. Todos esvaziavam a bexiga por cateterismo intermitente limpo (CIL), apresentavam in...

  7. Reabilitação funcional e analgesia com uso de toxina botulínica A na síndrome dolorosa regional complexa tipo I do membro superior: relato de casos

    OpenAIRE

    Lauretti,Gabriela Rocha; Veloso,Fabrício dos Santos; Mattos,Anita Leocádia de

    2005-01-01

    JUSTIFICATIVA E OBJETIVOS: Freqüentemente, soma-se ao quadro de alodínia e hiperalgesia em pacientes portadores de Síndrome Dolorosa Regional Complexa (SDRC) tipo I a incapacidade funcional do segmento acometido. Relatam-se dois casos de SDRC em que a aplicação de toxina botulínica-A como fármaco coadjuvante contribuiu na recuperação funcional motora do membro acometido. RELATO DOS CASOS: Duas pacientes portadoras de SDRC tipo I foram inicialmente avaliadas para controle da dor no membro supe...

  8. Tratamiento de epicondilitis refractaria con neurotoxina botulínica tipo A libre de complejo proteínico Treament of refractory epicondilitis with botulin neurotoxin type A free of protein complex

    OpenAIRE

    B. Santos; E. Calderón; P. Ordóñez; R. García-Hernández; L. M. Torres

    2013-01-01

    Introducción: La epicondilitis o "codo de tenista" es un cuadro que se caracteriza por dolor en la inserción proximal del músculo extensor radial corto del carpo. El tratamiento de este cuadro clásicamente se ha basado en fisioterapia e infiltración con corticoides, así como el uso de ortesis. La cirugía se recomienda cuando las estrategias conservadoras no controlan los síntomas después de 6-12 meses de tratamiento. La toxina botulínica es una opción terapéutica cuando fracasan medidas conse...

  9. Eficácia da aplicação da pomada EMLA® no alivio da dor desencadeada pela injeção de toxina botulínica tipo A no tratamento do blefaroespasmo essencial benigno

    Directory of Open Access Journals (Sweden)

    Nadia Ajub Moysés

    2011-04-01

    Full Text Available OBJETIVO: Demonstrar a eficácia da aplicação da pomada EMLA® (EMLA no alívio da dor desencadeada pela injeção de toxina botulínica tipo A (BTX no tratamento do blefaroespasmo essencial benigno (BEB. MÉTODOS: Estudo prospectivo, com a participação de 13 pacientes submetidos à aplicação de toxina botulínica na região periocular bilateral no tratamento de BEB. Aplicou-se a pomada EMLA na região periocular direita e placebo na esquerda antes das aplicações. Após a aplicação solicitou-se ao paciente uma nota de 0 a 10 referente à intensidade da dor. RESULTADOS: No lado em que foi aplicada a pomada EMLA, a média da intensidade da dor referida pelo paciente foi de 5,77±3,00 enquanto que no lado em que foi aplicado placebo, foi de 5,62±2,63 (p=0,92. CONCLUSÃO: Não se obteve uma redução estatisticamente significante da dor referida durante a aplicação de BTX em pacientes portadores de BEB após a aplicação da pomada EMLA.

  10. Avaliação do filme lacrimal de pacientes com distonia facial durante tratamento com toxina botulínica tipo A Lacrimal film evaluation of patients with facial dystonia during botulinum toxin type A treatment

    Directory of Open Access Journals (Sweden)

    Patricia Grativol Costa

    2006-06-01

    Full Text Available OBJETIVO: Determinar o efeito da toxina botulínica no filme lacrimal em pacientes com distonia facial. MÉTODOS: Foram incluídos 24 pacientes portadores de blefaroespasmo essencial e espasmo hemifacial que receberam aplicação de toxina botulínica tipo A que foram submetidos à propedêutica do filme lacrimal previamente à aplicação e após, com 7 e 30 dias. RESULTADOS: Houve diminuição das queixas de olho seco trinta dias após a aplicação, entretanto, o tempo de ruptura do filme lacrimal e o teste de Schirmer não demonstraram variação significativa entre os períodos pré-tratamento e 1 mês da aplicação. Em relação ao teste de coloração com rosa bengala, todos os olhos que coraram no pré-tratamento, melhoraram na última avaliação. CONCLUSÃO: A injeção de toxina botulínica pode aliviar as queixas de olho seco nos pacientes com distonia facial pela provável ação de inibição do orbicular na sua função de bomba lacrimal.PURPOSE: To determine the effect of botulinum toxin injection in the eyelid on lacrimal film in patients with facial dystonia. METHODS: Twenty-four patients with essential blepharospasm and hemifacial spasm were submitted to botulinum toxin injection and lacrimal film tests were performed before the application and after seven and thirty days. RESULTS: There was improvement in symptoms of dry eye and rose bengal test, however, the breakup time and Schirmer's test did not show significant variation between pretreatment and after 1 month of follow-up. CONCLUSION: The dry eye symptoms in patients with facial dystonia may be attenuated by botulinum toxin due to its possible inhibitory effect on the orbicular muscle leading to a decrease in lacrimal pump.

  11. Outbreak of type C botulism in chickens in Pancas city, Espírito Santo state, BrazilSurto de botulismo tipo C em frangos na cidade de Pancas, Espírito Santo, Brasil

    Directory of Open Access Journals (Sweden)

    Rodrigo Otávio Silveira Silva

    2013-03-01

    Full Text Available This work aims to describe an outbreak of botulism in poultry (Gallus gallus domesticus, in Pancas City, Espírito Santo State, Brazil. The birds were derived from a subsistence property with approximately 150 domestic fowls. The owner reported finding some birds lying on the floor and others exhibiting limited mobility. Ten animals in agony were euthanized, necropsied and had their blood serum collected. About 72 hours after the onset of clinical signs, 144 (96% animals of the creation had already died. No postmortem changes were found at necropsies. Clostridium botulinum type C toxins were detected in the sera of euthanized chickens by mice neutralization tests. The observation of clinical signs, absence of post-mortem lesions and the result of mouse neutralization tests confirmed the diagnosis of botulism caused by C. botulinum type C. Unfortunately, the source of toxins was not found. O presente trabalho tem como objetivo descrever um surto de botulismo em aves domésticas (Gallus gallus domesticus, ocorrido na cidade de Pancas, estado do Espírito Santo, Brasil. As aves eram oriundas de uma propriedade de subsistência com aproximadamente 150 frangos domésticos. O proprietário relatou encontrar algumas aves caídas no chão e outras apresentando dificuldade de locomoção. Dez animais em estado agônico foram eutanasiados, submetidos à necropsia e coleta de soro sanguíneo. Em 72 horas após o início dos sinais clínicos, 144 (96% animais da criação já haviam vindo a óbito. Nenhuma alteração post-mortem foi encontrada durante a necropsia. Foi possível detectar a toxina botulínica tipo C por soroneutralização em camundongos no soro dos animais eutanasiados. A observação da sintomatologia clínica, ausência de lesões à necropsia e o resultado da soroneutralização permitem confirmar o diagnóstico de botulismo por Clostridium botulinum tipo C.

  12. Botulinum toxin for treatment of cocontractions related to obstetrical brachial plexopathy Toxina botulínica para tratamento das co-contrações relacionadas à plexopatia braquial obstétrica

    Directory of Open Access Journals (Sweden)

    Carlos O. Heise

    2005-09-01

    Full Text Available Botulinum toxin type A was recently introduced for treatment of biceps - triceps muscle cocontraction, which compromises elbow function in children with obstetrical brachial plexopathy. This is our preliminary experience with this new approach. Eight children were treated with 2 - 3 U/kg of botulinum toxin injected in the triceps (4 patients and biceps (4 patients muscle, divided in 2 or 3 sites. All patients submitted to triceps injections showed a long-lasting improvement of active elbow flexion and none required new injections, after a follow-up of 3 to 18 months. Three of the patients submitted to biceps injections showed some improvement of elbow extension, but none developed anti-gravitational strength for elbow extension and the effect lasted only three to five months. One patient showed no response to triceps injections. Our data suggest that botulinum toxin can be useful in some children that have persistent disability secondary to obstetrical brachial plexopathy.A toxina botulínica do tipo A foi introduzida recentemente para o tratamento das co-contrações entre os músculos biceps e triceps, que comprometem a função do cotovelo nas crianças com plexopatia braquial obstétrica. Apresentamos nossa experiência preliminar com esta abordagem. Oito crianças foram tratadas com 2 - 3 U/kg de toxina botulínica injetada nos músculos triceps (4 pacientes e biceps (4 pacientes, divididas em 2 ou 3 sítios. Todos os pacientes submetidos a injeções no triceps apresentaram melhora persistente da flexão do cotovelo e nenhum precisou de novas aplicações após seguimento de 3 a 18 meses. Três pacientes submetidos a aplicações no biceps apresentaram melhora na extensão do cotovelo, mas nenhum adquiriu força antigravitacional e o efeito durou apenas 3 a 5 meses. Um paciente não respondeu às injeções. Nossos dados sugerem que a toxina botulínica pode ser útil no tratamento de algumas crianças com seqüelas de plexopatia braquial

  13. Síndrome de Frey por submaxilectomía y tratamiento con toxina botulínica Frey syndrome secondary to submaxillectomy and botulinic treatment

    Directory of Open Access Journals (Sweden)

    Alejandra Baéz

    2007-10-01

    Full Text Available El síndrome de Frey (SF se caracteriza por rubor, calor y sudación en la región maseterina y geniana durante las comidas. El SF se observa en el 20-60% de los pacientes sometidos a parotidectomía. Presentamos un caso con SF secundario a la ablación de la glándula submaxilar en un varón de 30 años de edad, sin antecedentes patológicos, que consultó en el año 2000 por adenopatía cervical izquierda. La misma fue biopsiada y la anatomía patológica informó carcinoma medular de tiroides. El paciente presentaba múltiples metástasis hepáticas y pulmonares, motivo por el cual recibió tratamiento quimioterápico con cisplatino plus doxorrubicina (seis ciclos con respuesta completa, finalizando dicho esquema en marzo del 2002. En julio del 2002 se realizó tiroidectomía total más vaciamiento ganglionar izquierdo con resección de la glándula submaxilar. Durante la cirugía se lesionó la rama mentoniana del nervio cervicofacial, rama del VII par craneal. En septiembre del 2004 consultó por episodios de sudación durante las comidas en la región submaxilar izquierda. Se realizó prueba de Minor y luego se procedió a aplicar toxina botulínica tipo A en la región afectada, a razón de 2.5 UI por punto (cm², a un total de 17 puntos. El control a los 21 días demostró más de un 95% de efectividad en la resolución del SF. El efecto duró un año, y una segunda reinfiltración mostró similar respuesta. No hallamos descripciones anteriores de SF en región submaxilar; se presenta su tratamiento satisfactorio con toxina botulínica tipo A.A case of Frey syndrome (FS secondary to submaxillar gland exeresis is presented and the results of the treatment with botulinum toxin (BTX type A. FS is a condition of sweating cheek and preauricular area during mealtime as a sequel detected in about 20-60% of patients after parotidectomy. The clinical symptoms include swelling, flushing and hyperhidrosis. The treatment choice for this condition is

  14. Retracción palpebral en patología de graves : Cirugía vs tratamiento con toxina botulínica. Revisión bibliográfica

    OpenAIRE

    Luna, Laura Lorena

    2016-01-01

    Se realizó una completa revisión bibliográfica de la patología de Graves, poniendo especial atención en la orbitopatía y sus manifestaciones oftalmológicas. Se hizo especial mención de la retracción palpebral que es la manifestación más frecuente de la orbitoptía buscando comparar, dependiendo de cada paciente y en que fase de la misma se encuentre, cual de estos dos tratamientos es el más adecuado: si una reparación quirúrgica o el tratamiento con toxina botulínica. Departamento de Cirugí...

  15. Correção de estrabismo paralítico por injeção de toxina botulínica Management of paralytic strabismus by injection of botulinum toxin

    Directory of Open Access Journals (Sweden)

    Raquel Wattiez

    2000-02-01

    Full Text Available Objetivo: Avaliar a ação da toxina botulínica em paralisias adquiridas de VI e III nervos. Pacientes e métodos: Foram tratados com toxina botulínica 15 pacientes, com diagnóstico de paralisia de VI e III nervos, aguda ou crônica. Foram estudados de forma prospectiva, durante os meses de agosto de 1998 a maio de 1999. O estudo incluiu, além da avaliação do estrabismo, avaliação oftalmológica completa. Os pacientes foram acompanhados por um período de 2 a 7 meses após a última aplicação. Resultados: Onze pacientes (73% apresentaram paralisias do VI nervo e 4 pacientes (27%, paralisias de III nervo. Seis casos foram agudos (40% e 9 casos (60%, crônicos. Cinco dos 6 casos agudos (83% conseguiram controlar o desvio com a toxina botulínica como único tratamento e obter fusão. Dos 9 casos crônicos, 2 casos (22% corrigiram o desvio só com a toxina, os outros 7, além da aplicação, foram submetidos à cirurgia, dos quais 4 casos (46% foram corrigidos e os outros 3 casos (32% não. Conclusão: Concluímos que nos casos em que houve força muscular residual, após a paralisia, e bom potencial de fusão, a toxina botulínica foi o melhor tratamento, pois foi possível controlar o desvio e obter fusão, sem cirurgia.Purpose: To evaluate the treatment by injection of botulinum toxin in acquired sixth and third nerve palsies. Methods: Fifteen patients were treated with botulinum toxin. They were studied prospectively during nine months, between August, 1998 and May, 1999. In addition to the strabismus examination, a complete ophthalmological evaluation was performed. The patients were followed for 2 to 7 months after the last injection or surgical procedure. Results: Eleven patients (73% presented with sixth nerve palsy and four (27% with third nerve palsy. Six cases were acute (40% and 9 cases (60% were chronic. Five acute cases (83% obtained ocular alignment and controlled the deviation with toxin. Two of nine chronic cases (22

  16. Estudo comparativo entre toxina botulínica e bupivacaína para infiltração de pontos-gatilho em síndrome miofascial crônica Estudio comparativo entre toxina botulínica y bupivacaína para infiltración de puntos-gatillo en síndrome miofascial crónica Comparative study between botulin toxin and bupivacaine for triggering-points infiltration in chronic myofascial syndrome

    Directory of Open Access Journals (Sweden)

    Eduardo Keiichi Unno

    2005-04-01

    Full Text Available JUSTIFICATIVA E OBJETIVOS: Existem controvérsias sobre a eficácia da toxina botulínica em relação ao anestésico local para infiltração de pontos-gatilho. O objetivo deste estudo é comparar o efeito analgésico da toxina botulínica com o da bupivacaína, para infiltração em pontos-gatilho de síndrome miofascial crônica. MÉTODO: Foram avaliados 20 pacientes, divididos em dois grupos. Os pacientes do G1 (n = 10 receberam 25U de toxina botulínica e os do G2 (n = 10, bupivacaína a 0,25%, em um a três pontos-gatilho, sendo 0,5 mL por ponto. Os pacientes foram avaliados semanalmente, durante 8 semanas. Foram associados 35 mg de orfenadrina, e 300 mg de dipirona, a cada 8 horas, e os pacientes foram submetidos à estimulação elétrica transcutânea, duas vezes por semana, durante 1 hora por sessão. A intensidade da dor foi avaliada através da escala numérica verbal e a qualidade da analgesia, pelo paciente, nos momentos zero (antes da injeção, e após 30 minutos, 1, 2, 3, 4, 5, 6, 7 e 8 semanas. Os resultados foram submetidos à análise estatística (Mann-Whitney e Exato de Fisher. RESULTADOS: Após 30 minutos da aplicação e com 1 e 4 semanas, a intensidade da dor no G1 foi menor que no G2. Após 2, 3, 5, 7 e 8 semanas da infiltração, não houve diferença significativa entre os grupos. A qualidade da analgesia foi considerada melhor pelos pacientes do G1 que do G2, exceto após 2 semanas. CONCLUSÕES: O efeito analgésico foi melhor com toxina botulínica (25 U que com bupivacaína a 0,25% para infiltração de pontos-gatilho.JUSTIFICATIVA Y OBJETIVOS: Existen controversias sobre la eficacia de la toxina botulínica con relación al anestésico local para infiltración de puntos-gatillo. El objetivo de este estudio es comparar el efecto analgésico de la toxina botulínica con el de la bupivacaína, para infiltración en puntos-gatillo de síndrome miofascial crónica. MÉTODO: Fueron evaluados 20 pacientes, divididos en

  17. Denmark: Botulism in an infant or infant botulism?

    DEFF Research Database (Denmark)

    Pærregaard, A; Angen, Øystein; Lisby, M

    2008-01-01

    with preformed neurotoxin could not be excluded. The food history revealed consumption of a commercially produced banana/peach puree which was suspected as a possible source, and based on a precautionary principle this product was recalled. The case description illustrates a risk-management dilemma between...

  18. Botulism: a laboratory investigation on biological and food samples from cases and outbreaks in Brazil (1982-2001 Botulismo: investigação laboratorial de amostras biológicas e de alimentos de casos e surtos no Brasil (1982-2001

    Directory of Open Access Journals (Sweden)

    Dilma Scala GELLI

    2002-12-01

    Full Text Available Laboratory investigation of botulism from 1982 to 2001 confirmed the occurrence of eight positive outbreaks/cases of botulism in Brazil. From those, type A botulism was observed in seven of them. Biological material of one case (serum and feces was positive in the first step of the bioassay, but the amount of sample was not sufficient for typification. One of the outbreaks that occurred in 2001 was negative for botulinum toxin in samples of serum, gastric washing and feces, collected eight days before the onset of the symptoms in the affected person who was clinically diagnosed as presenting the disease. Other two cases presenting compatible clinical diagnoses presented negative results. However, in those cases, the collection of samples was (1 after antiserum administration or (2 later than eight days of the onset of symptoms. Investigation was performed by mouse bioassay, as described in the Compendium of Methods for the Microbiological Examination of Foods (compiled by American Public Health Association - APHA11, using specific antiserum from Centers for Disease Control (CDC, USA.A investigação laboratorial de botulismo durante 1982-2001, confirma a ocorrência de surtos/casos de botulismo no Brasil. Dentre estes, a toxina botulínica tipo A foi encontrada em 7. O material biológico de 1 caso (soro e fezes foi positivo para a primeira etapa do bioensaio, mas a quantidade do material não foi suficiente para a sua tipificação. Um surto, ocorrido em 2001, foi negativo para a presença de toxina botulínica em amostras de soro, lavado gástrico e fezes coletadas antes de 8 dias da instalação dos sintomas na pessoa afetada com diagnóstico clínico compatível com a doença. Outros 2 casos com diagnóstico clínico compatível foram negativos, porém nestes a coleta de amostras foi (1 depois da administração de anti-soro ao paciente e (2 em período superior a 8 dias do início dos sintomas. A investigação laboratorial foi realizada

  19. Uso de toxina botulínica para tratamiento de la hipertrofía del músculo masetero Use of botulinum toxin for treatment of hypetrophy of the masseter muscle

    Directory of Open Access Journals (Sweden)

    F. González Magaña

    2012-09-01

    Full Text Available Definimos la hipertrofia del músculo masetero como el crecimiento excesivo de la masa muscular de dicho músculo, de presentación subclínica y de etiología multifactorial. Presenta una incidencia entre los 20 a 40 años sin predilección de sexo. Desde que en 1880 Legg la describiera por primera vez, se han intentado múltiples tratamientos, desde los médicos hasta los quirúrgicos, siendo el tratamiento con toxina botulínica el de mayor aceptación en la actualidad. El objetivo del presente artículo es realizar una revisión bibliográfica y proveer una herramienta para el médico que se enfrente a la hipertrofia del músculo masetero, además de presentar un caso clínico unilateral y la técnica empleada para su tratamiento. Como método diagnóstico en el paciente empleamos TAC de cráneo y macizo facial con cortes finos a 1 mm, así como de la región maseterina y aplicamos toxina botulínica de acuerdo a la zona de seguridad propuesta por Nam-Ho Kim y en base a los puntos anatómicos que indica el mismo protocolo, a dosis de 50 U en intervalos de 3 meses. Empleamos también TAC postoperatorio como medio de evaluación del resultado. Los tratamientos médicos con toxina botulínica son variables en sus dosis, aplicaciones y técnicas, así como en los diferentes productos disponibles en el mercado. En nuestro caso, el resultado fue clínicamente satisfactorio, cubriendo en su totalidad las expectativas del paciente. Proponemos que la protocolización del paciente, las dosis adecuadas, el tiempo entre aplicaciones y los sitios anatómicos correctos de inyección, llevan a la corrección de la hipertrofia del músculo masetero.Masseter muscle hypertrophy is an overgrowth of muscle mass with subclinical presentation and multifactorial etiology, with an incidence between 20 to 40 years and without sex predilection. In 1880 Legg describes this pathology for the first time and since then have been reported and attempted to formally

  20. Tratamiento de epicondilitis refractaria con neurotoxina botulínica tipo A libre de complejo proteínico Treament of refractory epicondilitis with botulin neurotoxin type A free of protein complex

    Directory of Open Access Journals (Sweden)

    B. Santos

    2013-02-01

    Full Text Available Introducción: La epicondilitis o "codo de tenista" es un cuadro que se caracteriza por dolor en la inserción proximal del músculo extensor radial corto del carpo. El tratamiento de este cuadro clásicamente se ha basado en fisioterapia e infiltración con corticoides, así como el uso de ortesis. La cirugía se recomienda cuando las estrategias conservadoras no controlan los síntomas después de 6-12 meses de tratamiento. La toxina botulínica es una opción terapéutica cuando fracasan medidas conservadoras. Material y métodos: Presentamos 3 pacientes diagnosticados previamente de epicondilitis de más de 6 meses de evolución y que habían sido sometidos de forma ambulatoria a los tratamiento habituales sin éxito, a los cuales se les administró toxina botulínica A libre de complejo proteico (50 UI en un solo punto de aplicación. Se evaluó la intensidad del dolor en ambos pacientes usando una escala analógica visual (EVA, en la que el 0 representa ningún dolor y 10 significa el dolor más intenso que han experimentado tanto a la palpación como con la maniobra de extensión resistida de la muñeca. Resultados: Se obtuvo una reducción importante del dolor en los 3 pacientes tratados al primer mes de su administración, con resolución total del mismo a los 3 meses. Este beneficio se mantuvo al menos durante los 6 meses de estudio. Conclusiones: La epicondilitis refractaria a tratamientos conservadores puede ser tratada eficazmente con toxina botulínica A libre de complejo proteínico.Introduction: Epicondylitis or "tennis elbow" is a condition characterized by pain in the proximal insertion of the extensor Carpi radialis brevis muscle. Treatment of this condition has classically been based on physiotherapy and infiltration with corticosteroids, as well as the use of orthoses. Surgery is recommended when the conservative strategies do not control symptoms after 6-12 months of treatment. Botulin toxin is a therapeutic option when

  1. Tratamiento de la cefalea tensional con toxina botulínica tipo A Botulinum toxin type A for the treatment of tension-type headache

    Directory of Open Access Journals (Sweden)

    D. Arbaiza

    2006-06-01

    Full Text Available Objetivos: Determinar el tiempo de inicio de la analgesia, la eficacia y la seguridad de la aplicación de la toxina botulínica tipo A (TB-A en pacientes con cefalea tensional (CT. Material y métodos: Criterios de inclusión: Edad de 18-70 años, diagnóstico de CT de acuerdo a la International Headache Society, dos o más episodios de CT por mes durante por lo menos 3 meses, CT no controlado con el tratamiento estándar, examen neurológico normal y firma de un consentimiento informado. Variables: Intensidad de la cefalea (IC, frecuencia de presentación de la cefalea (FC, duración de cefalea (DC, sensibilidad a la digitopresión (SDP de la musculatura pericraneal, número de puntos dolorosos (NPD de la musculatura pericraneal, tiempo de inicio de la analgesia (TIA, tiempo hasta el efecto máximo de la analgesia (TMA y disminución de la utilización de analgésicos (DUA. Evaluaciones en los días 0, 15 y 30. Se aplicaron 50 U TB-A en la musculatura pericraneal. Los pacientes pudieron continuar con su terapia analgésica previa de acuerdo a la evolución de la cefalea. Resultados: Se reclutaron 20 pacientes, todos de sexo femenino, con una edad promedio de 47 años. La IC de 2,15 en la primera evaluación disminuyó a 1,05 y 0,9 en la segunda y tercera evaluaciones (p=0,009 y 0,008. La FC de 10,25 días disminuyó a 3,6 y 2,75 días (p=0,008 y 0,012. La DC de 2,3 horas diarias disminuyó a 1,3 y 1,1 (p=0,009 en las dos. La SDP de 1,55 disminuyó a 0,5 y 0,55 (p=0,008 en las dos. El NPD de 2,65 disminuyó a 0,8 y 0,6 (p=0,010 y 0,006. El TIA fue de 8 días y el TMA fue de 25 días. La DUA de 5 disminuyó a 1,9 y 1,5. El 35% de los pacientes presentaron un evento adverso probable, y de una intensidad leve a moderada. Conclusiones: La TB-A es un tratamiento simple, efectivo y seguro para el control de la CT La técnica de aplicación estandarizada es un método fácil de reproducir. Se requieren estudios para valorar el número de punciones y

  2. Toxina botulínica no tratamento de estrabismo horizontal em crianças com paralisia cerebral Botulinum toxin treatment for horizontal strabismus in children with cerebral palsy

    Directory of Open Access Journals (Sweden)

    Mônica Fialho Cronemberger

    2006-08-01

    Full Text Available OBJETIVO: Avaliar a eficácia da toxina botulínica no tratamento de estrabismo horizontal em crianças com paralisia cerebral. MÉTODOS: Um grupo de 24 pacientes com paralisia cerebral e estrabismo horizontal (17 esotropias variando de 25delta a 45delta e 7 exotropias variando de 20delta a 45delta, com idades variando entre 6 a 156 meses, foram tratadas com toxina botulínica (34 músculos retos mediais e 14 retos laterais. As crianças foram submetidas a exame oftalmológico completo. A injeção de toxina, utilizando-se a pinça de Mendonça, foi realizada sob sedação. O seguimento foi realizado mediante avaliação aos 7 dias, 15 dias e a seguir mensalmente. O resultado foi considerado bom quando se obteve desvio To evaluate the efficacy of botulinum toxin injection in the treatment of horizontal strabismus in children with cerebral palsy. METHODS: A group of 24 patients, age 6 - 156 months, with cerebral palsy and horizontal strabismus (17 esotropias ranging from 25 to 45 PD and 7 exotropias ranging from 20 to 45 PD were treated with botulinum toxin (34 medial rectus and 14 lateral rectus muscles. The children underwent full ophthalmic examination. The injection treatment was performed after sedation using Mendonça's forceps. The follow-up was done after 7 days, 15 days and monthly. Deviation less or equal of 10 PD after 6 months of follow-up was considered successful. However, if patients did not achieve this result a second application could be performed. RESULTS: In the group of esotropia (n=17 47.1% had successful results with only one application after two years of follow-up. All of these patients had previous deviation less than or equal to 35 PD. In the exotropia group a single injection was not sufficient to achieve successful result. The side effects included: subconjutival hemorrhage in 4 (16.7% patients, transient vertical deviation in 4 (16.7% and transient ptosis in 22 (91.7%. CONCLUSION: The use of botulinum toxin was a

  3. Comparação entre cirurgia e aplicações unilaterais e bilaterais de toxina botulínica para o tratamento dos estrabismos Comparison between surgery and unilateral and bilateral injections of botulinum toxin to treat strabismus

    Directory of Open Access Journals (Sweden)

    Maria de Lourdes M. M. Villas Boas

    2001-10-01

    Full Text Available Objetivo: Comparar a eficácia de 3 formas de tratamento para estrabismos de pequeno e médio ângulos: cirurgia, aplicações unilaterais e bilaterais de toxina botulínica. Métodos: Foram estudados 97 pacientes, divididos em três grupos. No grupo I foi feito um estudo prospectivo no qual 44 pacientes receberam injeção unilateral da toxina botulínica tipo A; no grupo II, 24 pacientes receberam injeção bilateral da toxina, e no grupo III foi feito estudo retrospectivo de 29 pacientes previamente operados de estrabismo. A eficácia dos tratamentos foi estudada segundo o percentual de correção do desvio ocular e segundo o índice de sucesso terapêutico, definido como um desvio residual de até 10 DP (dioptrias prismáticas. Resultados: Os percentuais de correção dos desvios horizontais, para longe, no 3º mês, foram: grupo I = 50,9%; grupo II = 55,8% e grupo III = 77,0%. Para perto, foram: 48,6%, 49,2% e 72,8%, respectivamente. Os índices de sucesso terapêutico foram: grupo I = 57,1%; grupo II = 68,4% e grupo III = 72,4%. Conclusão: Concluiu-se não ter havido diferença estatisticamente significativa entre os percentuais de correção do desvio ocular e o índice de sucesso terapêutico entre os três grupos estudados.Purpose: To compare the efficacy of three types of treatment for strabismus: surgery, unilateral and bilateral botulinum toxin injections. Methods: To compose groups I and II, a prospective study was carried out observing the pretreatment measurement of the deviation, repeated after 7, 30 and 90 days after the injection. To compose group III, a retrospective study was carried out. Results: The percentage of horizontal deviation correction for distance, in 3 months, was: group I = 50.9%; group II = 55.8%, and group III = 77.0%; for near, 48.6%, 49.2% and 72.8% respectively.The therapeutic success rate, defined as residual deviation of 10 PD (prism diopter or less, was: group I = 57.1%; group II = 68.4% and group III

  4. Botulinum toxin A in the treatment of blepharospasm: a 10-year experience Toxina botulínica tipo A no tratamento do blefaroespasmo: experiência de 10 anos de utilização

    Directory of Open Access Journals (Sweden)

    Laura Silveira-Moriyama

    2005-06-01

    Full Text Available To evaluate the long-term effect of botulinum toxin type A (BTX in the treatment of blepharospasm, a retrospective analysis was conducted from the patients seen at the Movement Disorders Clinic of the Department of Neurology, Hospital das Clínicas, University of São Paulo School of Medicine from 1993 to 2003. A total of 379 treatments with BTX were administered to 30 patients with blepharospasm. Sixty six per cent of the subjects had used oral medication for dystonia and only 15% of them reported satisfactory response to this treatment. Ninety three per cent of the patients showed significant improvement after the first BTX injection. There was no decrement in response when compared the first and the last injection recorded. Adverse effects, mostly minor, developed at least once in 53% of patients. Six patients (20% discontinued the treatment but there was no case of secondary resistance.Para avaliar os efeitos a longo prazo da toxina botulínica tipo A (BTX no tratamento do blefaroespasmo foi realizado estudo retrospectivo no Ambulatório de Distúrbios do Movimento da Clínica Neurológica do Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo de 1993 a 2003. Um total de 379 aplicações de BTX foram administradas a 30 pacientes com blefaroespasmo. Previamente ao tratamento com toxina botulínica 63% dos pacientes utilizaram medicação oral para blefaroespasmo, mas apenas 15% referiu resposta satisfatória a este tratamento. Noventa e três por cento dos pacientes tiveram resposta significativa à primeira aplicação de BTX. Não houve decremento na resposta quando comparada a primeira à última aplicação registrada dos pacientes. Efeitos adversos, em sua maioria leves, ocorreram pelo menos uma vez durante o tratamento em 53% dos pacientes. Seis pacientes interromperam o tratamento, mas não houve nenhum caso de resistência secundária.

  5. Aplicación de la toxina botulínica A para el tratamiento del síndrome de Frey Application of botulinum toxin A for the treatment of Frey’s Syndrome

    Directory of Open Access Journals (Sweden)

    J. Mareque Bueno

    2008-10-01

    Full Text Available El síndrome Aurículo-temporal también conocido como sudoración gustativa o síndrome de Frey, es una entidad caracterizada por sudoración y enrojecimiento de la piel del territorio inervado por el nervio aurículo-temporal durante las comidas. El síndrome de Frey es probablemente una secuela inevitable en la cirugía de la glándula parótida. Una vez que se presenta se perpetua durante toda la vida si no se realiza tratamiento. Realizando el test de Minor tras cirugía sobre la glándula parótida ha sido publicado que el 100% son positivos, y que el 50% son sintomáticos percibiendo la sudoración durante las comidas, y alrededor de un 15% consideran sus síntomas graves. En el siguiente articulo presentamos los resultados de nuestro estudio que consistió en la inyección intradérmica de toxina botulínica A a nuestros pacientes con síndrome de Frey y el seguimiento. Los resultados han sido desaparición de los síntomas durante un periodo medio de 16 meses con cierta variabilidad individual. Con estos resultados podría considerarse la inyección de toxina botulínica A como ténica de elección para el síndrome de Frey ya establecido.The auriculotemporal syndrome, also known as gustatory sweating or Frey’s syndrome, is a condition characterized by sweating and flushing of the cutaneous territory innervated by the auriculotemporal nerve while eating. Frey’s syndrome is probably an inevitable sequela of parotid gland surgery. Once it appears, it persists for the rest of the patient’s life if not treated. It has been reported that performance on the Minor test after parotid gland surgery is 100% positive and 50% of patients are symptomatic, experiencing sweating during meals. About 15% consider their symptoms serious. In this article we present the results of our study of the treatment of Frey’s syndrome by intradermal injection of botulinum toxin A and the follow-up of the patients. The patients’ symptoms disappeared during

  6. Toxina botulínica: relación entre tipo de paciente y duración del efecto Toxina botulínica: a relação do tipo de paciente com a duração de afeito Botulinum toxin: relation between patien type and duration of the effect

    Directory of Open Access Journals (Sweden)

    M. De Maio

    2008-03-01

    Full Text Available El uso de la Toxina Botulínica es frecuente en procedimientos de Cirugía Cosmética. Sin embargo, todavía quedan muchos aspectos que necesitan ser aclarados tales como los tipos de pacientes y la duración de su efecto. Si agrupamos los pacientes en diferentes modelos según su función muscular, podremos predecir la duración de ese efecto e informar adecuadamente a los pacientes. Estos modelos los denominamos cinético, hipercinético y hipertónico. El modelo cinético es el de aquellos pacientes que presentan una concordancia entre su expresividad facial y sus emociones y que muy probablemente solo necesitarán un tratamiento al año. El modelo hipercinético incluye a aquellos pacientes que no mueven sus músculos de acuerdo con su mímica; sus músculos faciales se contraen más rápidamente. En este caso la duración del tratamiento variará de los 4 a los 6 meses. El modelo hipertónico lo encontramos en aquellos pacientes que son incapaces de relajar sus músculos faciales, en los que la duración del tratamiento solo será de 2 a 3 meses. Esto es lo que puede hacer que en estos casos el tratamiento defraude tanto al paciente como al médico. Mediante esta comprensión del comportamiento muscular, cada paciente debe ser encajado en su grupo correspondiente de acuerdo a sus características musculares, lo que nos permitirá predecir la duración del efecto y guiar futuros tratamientos.The use of Botulinum Toxin is frequent in non surgical cosmetic procedures. Many aspects, though, still need clarification such as patient types and the duration of effect. By grouping the patients in different muscle pattern, the duration can be predicted and informed to patients. These groups consist of kinetic, hyperkinetic and hypertonic patterns. The kinetic pattern indicates that patients present a concordance with facial expression and emotions and they will probably need only one treatment per year. The hyperkinetic pattern refers to patients who

  7. Actualización sobre aplicaciones de la toxina botulínica en estética facial Update on the use of botulinium toxin in facial aesthetics

    Directory of Open Access Journals (Sweden)

    J.M. Alcolea López

    2011-03-01

    Full Text Available En la actualidad, la toxina botulínica (TB es parte importante en los tratamientos médico-estéticos de la cara. Este trabajo hace una aproximación didáctica, con fines prácticos formativos, sobre el manejo de la TB para el rejuvenecimiento facial en el ejercicio de la Cirugía Plástica y Estética. Entender la anatomía del envejecimiento es clave para manejar de forma integral la TB junto con otras técnicas de la especialidad destinadas a combatir el envejecimiento, considerándolo en su conjunto. Resumimos los conocimientos actuales sobre el empleo de las inyecciones de TB en el tercio superior de la cara.Currently, botulinum toxin (BT plays an important role in aesthetic-medical treatments of the face. This paper provides a didactical approach for practical training purposes, concerning the use of BT for facial rejuvenation when practising Plastic and Aesthetic Surgery. It is essential to understand the anatomy of ageing in order to integrate TB in combination with other techniques of the speciality employed to combat ageing by considering it as a whole. This paper resumes the current knowledge about the use of TB injections in the upper third of the face.

  8. Avaliação de um programa de aplicação de toxina botulínica tipo A em crianças do Vale do Jequitinhonha com paralisia cerebral

    Directory of Open Access Journals (Sweden)

    Grazielle Fernandes da Silva

    2013-07-01

    Full Text Available O objetivo do estudo foi avaliar os efeitos de um programa público de aplicação de toxina botulínica tipo A (TBA na espasticidade muscular, amplitude de movimento, qualidade da marcha, independência funcional e qualidade de vida de crianças e adolescentes com paralisia cerebral (PC. Foi realizado um estudo quase experimental que avaliou os efeitos do emprego da TBA, aplicada três vezes, com intervalos de três meses, em 14 crianças com PC. Estas foram avaliadas através da Escala Modificada de Ashworth, Goniometria Manual, Physician Rating Scale, Inventário de Avaliação Pediátrica de Incapacidade (PEDI e Questionário do Cuidador da Criança (QCC. Foi observada redução da espasticidade, aumento da amplitude de movimento, melhora das habilidades funcionais de autocuidado e mobilidade do PEDI e das áreas de cuidado pessoal, conforto e interação/comunicação do QCC. O programa de aplicação de TBA em crianças e adolescentes com PC, realizado em um núcleo de reabilitação público do Vale do Jequitinhonha, foi efetivo para a população beneficiada.

  9. Reabilitação funcional e analgesia com uso de toxina botulínica A na síndrome dolorosa regional complexa tipo I do membro superior: relato de casos Rehabilitación funcional y analgesia con uso de toxina botulínica A en el síndrome doloroso regional compleja tipo I del miembro superior: relato de casos Functional rehabilitation and analgesia with botulinum toxin A in upper limb complex regional pain syndrome type I: case reports

    Directory of Open Access Journals (Sweden)

    Gabriela Rocha Lauretti

    2005-04-01

    Full Text Available JUSTIFICATIVA E OBJETIVOS: Freqüentemente, soma-se ao quadro de alodínia e hiperalgesia em pacientes portadores de Síndrome Dolorosa Regional Complexa (SDRC tipo I a incapacidade funcional do segmento acometido. Relatam-se dois casos de SDRC em que a aplicação de toxina botulínica-A como fármaco coadjuvante contribuiu na recuperação funcional motora do membro acometido. RELATO DOS CASOS: Duas pacientes portadoras de SDRC tipo I foram inicialmente avaliadas para controle da dor no membro superior direito. Ambas apresentavam incapacidade para abrir a mão e dor pela escala analógica numérica (EAN de 10 em repouso ou quando a mão ou os dedos eram passivamente manipulados. Iniciou-se seqüência de 5 bloqueios, do gânglio estrelado ipsilateral a intervalos semanais, com clonidina e lidocaína. Simultaneamente, durante a realização do terceiro bloqueio do gânglio estrelado, foram administrados 75 UI de toxina botulínica-A nos músculos flexores das falanges e da articulação do punho. Uma semana após a aplicação da toxina botulínica-A, as pacientes apresentavam relaxamento das falanges e punho, relatavam facilidade para execução da fisioterapia passiva e a dor classificada foi como 2 (EAN à manipulação passiva. Ao término da realização da seqüência de bloqueios do gânglio estrelado, as pacientes foram submetidas a 3 sessões semanais de administração por via venosa regional de clonidina, lidocaína e parecoxib. Após 8 meses de avaliação, as pacientes apresentaram 70% e 80% de recuperação motora e funcional do membro acometido. CONCLUSÕES: A aplicação por via muscular de toxina botulínica A resultou em melhora da movimentação do membro acometido, analgesia auxiliando na sua recuperação funcional.JUSTIFICATIVA Y OBJETIVOS: Frecuentemente, se suman al cuadro de alodínia e hiperalgesia en pacientes portadores de Síndrome Doloroso Regional Complejo (SDRC tipo I la incapacidad funcional del segmento

  10. O uso da toxina botulínica no tratamento da distonia laríngea (disfonia espasmódica: estudo preliminar com doze pacientes Use of botulinum toxin in the treatment of laryngeal dystonia (spasmodic dysphonia: preliminary study of twelve patients

    Directory of Open Access Journals (Sweden)

    Hélio A. G. Teive

    2001-03-01

    Full Text Available A distonia laríngea (disfonia espasmódica é distúrbio do movimento caracterizado por contrações involuntárias da musculatura laríngea envolvida no processo de vocalização. A utilização da toxina botulínica no tratamento da distonia laríngea trouxe consideráveis benefícios clínicos. Descrevemos os resultados preliminares do uso terapêutico da toxina botulínica no tratamento da distonia laríngea em 12 pacientes. Após investigação clínica, os pacientes foram submetidos a videolaringoestroboscopia para confirmação diagnóstica e as injeções de toxina botulínica foram realizadas através de punção da membrana cricotireóidea em direção ao músculo tireoaritenóideo, com uso de eletromiografia. A maioria dos pacientes submetidos ao tratamento com toxina botulínica apresentou melhora significativa da distonia laríngea (83% dos casos, com duração média do efeito de quatro meses, sem efeitos colaterais significativos.Laryngeal dystonia (spasmodic dysphonia is a movement disorder characterized by involuntary contractions of laryngeal muscles involved with vocalization. The introduction of botulinum toxin in the treatment of laryngeal dystonia had a major clinical impact due to the striking improvement of symptoms. We report the preliminary results of therapeutical use of botulinum toxin in the treatment of twelve patients with laryngeal dystonia. After an extensive clinical evaluation, the patients underwent a videostroboscopic exam for diagnostic confirmation. Botulinum toxin was injected in the cricothyreoid membrane, directed towards the thyreoaritenoid muscle, with the aid of eletromyography needles. Most of patients who underwent botulinum toxin injection had a significant improvement of their symptoms (83%, with effects lasting for four months in average and without important side effects.

  11. Benefícios da aplicação de toxina botulínica associada à fonoterapia em pacientes disfágicos graves Benefits of botulinum toxin associated to swallowing therapy in patients with severe dysphagia

    Directory of Open Access Journals (Sweden)

    Fernanda Teixeira Menezes

    2012-06-01

    Full Text Available Estudo de casos para caracterizar os benefícios da aplicação de toxina botulínica em glândulas salivares, associada à fonoterapia em pacientes disfágicos graves. Foram analisados cinco prontuários de pacientes neurológicos, em uso exclusivo de via alternativa de alimentação, com idades entre 17 e 70 anos, sendo quatro do gênero masculino e um do gênero feminino. Do total, quatro pacientes eram traqueostomizados. Foi considerado como critério de inclusão apresentar disfagia grave, com manifestações clínicas de escape extra oral e/ou acúmulo de saliva em cavidade oral e aspiração traqueal maciça de saliva, com limitação da fonoterapia. Quanto à avaliação clínica da deglutição, foram coletados dados pré e pós-fonoterapia associada à aplicação de toxina botulínica, quanto aos seguintes aspectos: mobilidade e força das estruturas orofaríngeas (lábios, língua, bochechas, elevação laríngea, grau da disfagia, uso de via alternativa de alimentação e traqueostomia. Quanto aos resultados pós- fonoterapia foi observado, em quatro pacientes, melhora da mobilidade e força de lábios, língua, bochechas e laringe. Quatro pacientes apresentaram deglutição funcional e um teve modificação do grau de gravidade da disfagia. Desta forma, a maioria foi capaz de receber dieta exclusiva por via oral e apenas um permaneceu com dieta mista, ou seja, gastrostomia e dieta via oral na consistência pastosa. Todos os pacientes traqueostomizados tiveram a cânula de traqueostomia removida. O estudo mostrou que o tratamento descrito acima contribui para a reabilitação da deglutição, reintrodução de alimentos por via oral e retirada da cânula de traqueostomia.Case report with the aim to characterize the benefits of botulinum toxin injection into salivary glands in association with swallowing therapy in patients with severe dysphagia. The medical records of five neurological patients (four male and one female, aged

  12. Actualización sobre aplicaciones en estética de la toxina botulínica en el tercio inferior de la cara Update on aesthetic applications of botulinum toxin in the low third of the face

    Directory of Open Access Journals (Sweden)

    J.M. Alcolea López

    2011-06-01

    Full Text Available La aplicación de la toxina botulínica (TB en el tercio inferior de la cara requiere conocimiento anatómico preciso y entrenamiento riguroso debido a la compleja interacción muscular con las manifestaciones de la expresión y de la mímica, principalmente de la nariz y de la boca. Conocer sus indicaciones en esta parte de la cara puede ser un buen complemento terapéutico, tanto para la Cirugía Estética, como en la aplicación, por ejemplo, de láseres para el resurfacing en rejuvenecimiento cutáneo o bien conjuntamente con materiales de relleno. En otras ocasiones, el tratamiento con TB puede ser una buena opción por sí mismo, como alternativa de técnicas quirúrgicas más agresivas.The application of the Botulinum toxin (BT in the low third of the face needs anatomical precise knowledge and rigorous training due to the complex muscular interaction with the manifestations of the expression and of the mime, principally of the nose and of the mouth. To know his indications in this part of the face can be a good therapeutic complement for Aesthetic Surgery and for example, with the use of laser resurfacing in cutaneous rejuvenation or together with dermal fillers. Other times, treatment with BT can be a good option itself, as alternative to more aggressive surgical technologies.

  13. Botulismo bovino: comprovação laboratorial do diagnóstico clínico, período 1986-1989 Bovine botulism: laboratorial confirmation of clinical diagnosis during the period 1986-1989

    Directory of Open Access Journals (Sweden)

    Lucia Baldassi

    1991-10-01

    Full Text Available Num período de 4 anos (1986-1989 foram processados 517 materiais correspodentes a 235 casos com diagnóstico clínico de botulismo de bovinos, dos Estados de São Paulo, Mato Grosso, Mato Grosso do Sul, Minas Gerais, Goiás, Bahia, Pará, Maranhão, Distrito Federal e Roraima (Brasil. Exames laboratoriais foram realizados com o intuito de confirmar a suspeita clínica, detectando a toxina nos materiais correspondentes aos casos supracitados. Os tipos de toxina verificados foram "C" e "D" presentes no fígado e conteúdos de estômago e intestinos, que perfaziam o maior número das amostras remetidas. O pequeno número de casos confirmados leva à suposição de que outras enfermidades devem estar envolvidas nessas mortes, ainda que se considere possíveis resultados falso negativos.Five hundred and seventeen specimens relating to a total of 235 clinical cases of bovine botulism occurring over period of four years (1986-1989 were studied. These samples came from the States of S. Paulo, Mato Grosso, Mato Grosso do Sul, Minas Gerais, Goiás, Bahia, Pará, Maranhão, Distrito Federal and Roraima. Laboratorial tests were performed on these samples with a view to toxin detection. Toxin types C and D were detected being found in the liver and in gastric and intestinal contents. The small number of confirmed cases led to the supposition of the participation of other diseases in these deaths reported, even if false negative cases are taken into account.

  14. Clinical efficacy of two concentrations of diluted botulism toxin A for blepharospasm%两种不同浓度的A型肉毒素注射治疗眼睑痉挛的观察对比

    Institute of Scientific and Technical Information of China (English)

    赵敏; 孙重

    2016-01-01

    目的:观察两种不同浓度的A型肉毒素( BTX-A )治疗眼睑痉挛的疗效及不良反应。方法:将220例440眼患者(2013-01/2015-01来我科确诊为眼睑痉挛患者)随机分为高浓度组110例和低浓度组110例,分别采用40 U/mL和25 U/mL浓度局部注射到上下眼睑轮匝肌、皱眉肌、降眉肌、降眉间肌。观察两组BTX-A的用量、治疗效果、维持时间及不良反应。结果:高浓度组BTX-A的用量为48.33±4.02U,低浓度组BTX-A的用量为28.51±3.42U,差异有统计学意义( P<0.05),而高浓度组与低浓度组术后疗效评估、起效时间和疗效持续时间无统计学意义(P>0.05),高浓度组出现不同程度上睑下垂16例,低浓度组出现2例,差异有统计学意义(P<0.01)。两组均未出现中毒和药物过敏症状,上睑下垂发生后通常在3~6 wk内逐渐恢复,严重可以给予盐酸奈甲唑林点眼缓解。结论:两种不同浓度的BTX-A局部注射治疗眼睑痉挛的疗效是肯定的,鉴于对上睑下垂并发症的评估,推荐使用低浓度注射。%Abstract?AIM: To assess the efficacy and adverse reactions of two concentrations of diluted botulism toxin A ( BTX-A) for blepharospasm.?METHODS:Totally 220 patients (440 eyes) confirmedas blepharospasm in our department ( from January 2013 to January 2015 ) , were divided randomly into two groups:110 in high concentration group and 110 in low concentration group.The two groups were given local injections with 25 U/mL or 40 U/mL concentration of botulism toxin type A to the upper and lower eyelids orbicular muscle, corrugator, reducing eyebrow muscle and procerus respectively.We observed dosage of two groups, the treatment effect, the duration of the effect and the incidence of adverse reactions.?RESULTS: The high concentration group was given the BTX-A with 48.33 ±4.02U, the low concentration group was given the BTX-A with

  15. Botulinum toxin type A in the treatment of hemifacial spasm: an 11-year experience Toxina botulínica tipo A no tratamento do espasmo hemifacial: 11 anos de experiência

    Directory of Open Access Journals (Sweden)

    Egberto Reis Barbosa

    2010-08-01

    Full Text Available In order to evaluate the long-term effect of botulinum toxin type A (BTX in the treatment of hemifacial spasm (HFS, a retrospective analysis of patients treated at the Movement Disorders Unit of the Division of Neurology, Clinical Hospital, University of São Paulo, School of Medicine from 1993 to 2004 was made. A total of 808 injections with BTX were administered to 54 patients with HFS. The mean duration of improvement per application was 3.46 months and the mean rate of improvement using subjective judgement by the patient was of 83%. Adverse effects, mostly minor, were observed in 64.8% of patients at least once along the period of follow-up and the most frequent of them was orbicularis oris paralysis (38.8%. There was no decrement in response when compared the first and the last injection recorded.Para avaliar o efeito em longo prazo da toxina botulínica tipo A (TXB no tratamento do espasmo hemifacial (EHF, foi feita uma análise retrospectiva de pacientes tratados no Ambulatório de Distúrbios do Movimento da Divisão de Clínica Neurológica - Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo no período de 1993 a 2004. Um total de 808 aplicações de TXB foram administradas a 54 pacientes com EHF. A duração média de melhora foi de 3,46 meses e a taxa média de melhora segundo avaliação subjetiva do paciente foi de 83%. Efeitos adversos, em sua maioria menores, foram observados em 64,8% dos pacientes ao menos uma vez durante o seguimento e o mais freqüente foi paralisia do orbicular da boca (38,3%. Não se observou decremento na resposta quando se comparou a primeira com a última aplicação anotada.

  16. Botulinum toxin type A in refractory chronic migraine: an open-label trial Toxina botulínica tipo A no tratamento da enxaqueca refratária: um estudo aberto

    Directory of Open Access Journals (Sweden)

    Carla Menezes

    2007-09-01

    Full Text Available Botulinum toxin type A (BT-A has been described as an important strategy to various types of pain such as cervical dystonia, myofascial pain syndrome and headache. Although BT-A efficacy has not been proven in tension type headache, its use in migraine continues controversial. In this open trial, we evaluated the efficacy of BT-A in refractory migraine. BT-A was injected in patients diagnosed with migraine who had previously used three classes of prophylactic drugs by at least one year with no response. The most important improvement was observed within 30 days, but pain intensity and frequency of headache had been decreased until the end of three months of follow up. Side effects of BT-A were mild and self limited. We conclude that BT-A seems to be a safe and effective treatment to refractory migraine patients.Toxina botulínica tipo A (TB-A tem sido descrita como importante estratégia para diversos tipos de dor como cefaléia e dores relacionadas a distonia cervical ou síndrome miofascial. Embora a eficácia da TB-A não tenha sido demonstrada na cefaléia do tipo tensional, seu uso na enxaqueca continua controverso. Nesse estudo avaliamos a eficácia da TB-A na enxaqueca refratária. TB-A foi injetada em pacientes com enxaqueca que fizeram tratamento prévio com no mínimo três classes de medicamentos profiláticos, sem resultados satisfatórios. A melhora mais significativa dos pacientes foi observada após 30 dias de aplicação de TB-A, enquanto intensidade da dor e freqüência de cefaléia continuaram reduzidas até o final de três meses de seguimento. Os efeitos colaterais observados após a aplicação de TB-A foram moderados e auto-limitados. Os nossos dados mostram que TB-A parece ser um tratamento seguro e eficaz para pacientes com enxaqueca refratária.

  17. Botulinum toxin type A for refractory post-stroke shoulder pain Toxina botulínica do tipo A no tratamento do ombro doloroso após AVC

    Directory of Open Access Journals (Sweden)

    Glícia Pedreira

    2008-06-01

    Full Text Available Botulinum toxin type A (BTX-A has been used to treat several neurological conditions such as sialorrhea, hyperhydrosis, dystonia, hemifacial spasm, spasticity and pain. Although spasticity has been successfully treated with BTX-A, few are the authors studying the use of BTX-A to treat shoulder pain secondary to stroke. In order to study if BTX-A is effective to treat post-stroke shoulder pain, we followed up during 4 months 16 patients with sustained shoulder pain. Patients received BTX-A according to previous discussion with the rehabilitation group to determine the muscles and dose to be injected and were evaluated by the join range of motion and analogic pain scale. There was decrease of pain during shoulder motion, mainly during the movements of extension and rotation. We conclude that BTX-A is a safe and efficacious therapy.A toxina botulínica do tipo A (TB-A tem sido utilizada com sucesso para o tratamento de várias enfermidades neurológicas, tais como sialorréia, hiperidrose, distonia, espasmo hemifacial, espasticidade e dor. Embora espasticidade seja tratada com sucesso após o advento da TB-A, poucos são os autores que utilizaram a TB-A no tratamento da dor no ombro espástico secundária a acidente vascular cerebral (AVC. Com o objetivo de estudar a eficácia da TB-A no tratamento da dor no ombro secundária a AVC, foram acompanhados 16 pacientes com esta enfermidade associada à dor refratária no ombro espástico. Os pacientes receberam TB-A de acordo com dose e pontos de injeção definidos previamente pelo grupo de reabilitação e foram avaliados pelos ângulos de abertura da articulação do ombro e escala de avaliação analógica de dor. Houve melhora da dor à movimentação da articulação do ombro, principalmente nos movimentos de rotação e extensão. Concluímos que a TB-A é uma terapêutica segura e eficaz para o tratamento do ombro doloroso secundário a AVC.

  18. Toxina botulínica no blefaroespasmo, no espasmo hemifacial e na distonia cervical: resultados em 33 pacientes Botulinum toxin in blepharospasm, hemifacial spasm and cervical dystonia: results in 33 patients

    Directory of Open Access Journals (Sweden)

    Sérgio Ap. Novis

    1995-09-01

    Full Text Available Avaliamos os resultados terapêuticos obtidos com o emprego de toxina botulínica do tipo A em 33 pacientes com distonia (12 com blefaroespamo; 10 com espasmo hemifacial e 11 com torcicolo espasmódico. Utilizamos uma escala de pontuação de gravidade antes de cada aplicação, sendo reavaliados duas semanas após, seguindo a mesma escala. Entre os com blefaroespasmo, oito eram mulheres e quatro homens; a média de idade foi 57,7 anos; a média do tempo de doença de quatro anos; três tinham história similar na família; nove eram essenciais e três fizeram uso de neurolépticos (distonia tardia. A dose média empregada ficou em 51,3 U, com a duração média do efeito benéfico de 2,8 meses. Do total de 22 aplicações (injeções e reinjeções, 14 (63,7% tiveram resultado ótimo, 5 (22,7% bom e três (13,6% nulo. Naqueles com espasmo hemifacial, oito eram mulheres e dois homens; a média de idade foi 52,6 anos; a média do tempo de doença 7,4 anos; oito eram essenciais e dois pós-páralíticos. A dose média empregada ficou em 32 U. Do total de 15 aplicações, todos (100% tiveram resultado ótimo, com a duração média do efeito benéfico de 3,4 meses. Nos pacientes com distonia cervical, oito eram homens e três mulheres; a média de idade foi 44,2 anos; a média do tempo de doença 12,2 anos; seis eram essenciais, três fizeram uso de neuroléptico e dois tinham história familiar. A dose média empregada ficou em 238,6 U, com a duração média do efeito benéfico de 4,7 meses. Do total de 20 aplicações, 18 (90% tiveram resultado bom, 1 (5% regular e 1 (5% nulo. Ptose palpebral, paresia facial e disfagia foram os efeitos colaterais mais encontrados. Concluímos que a toxina botulínica revelou-se eficaz no tratamento destas condições.The effects of botulinum toxin type A were studied in 33 patients with dystonia (12 blepharospasms, 10 hemifacial spasms and 11 spasmodic torticollis. A rate scale was used to evaluate the severity

  19. Toxina botulínica tipo A tópica con iontoforesis para el tratamiento de la hiperhidrosis axilar: Efecto y persistencia Topic type A botulinum toxin with iontophoresis in the treatment of armpit hyperhidrosis: effect and persistency

    Directory of Open Access Journals (Sweden)

    J.F. Silva-Gavarrete

    2011-09-01

    Full Text Available La sobreproducción de sudor se denomina hiperhidrosis (HH y frecuentemente conlleva en el ser humano tanto problemas dermatológicos como de índole social. En la actualidad, existen múltiples tratamientos para controlar la HH axilar, siendo entre ellos el uso de la terapia con Toxina Botulínica tipo A (TXB-A uno de los más efectivos, con la limitante de que la toxina tiene que ser inyectada mediante múltiples punciones en la axila, por lo que tiende a ser un tratamiento rechazado por los pacientes. La iontoforesis es un método que utiliza corriente galvánica y se emplea de forma clínica para la introducción transdermal de medicamentos. Realizamos un ensayo clínico simple ciego sobre 10 pacientes a los que se les aplicó gel inerte mezclado con Toxina Botulínica tipo A (TXB-A de la marca Dysport® mediante una sesión de iontoforesis en una axila al tiempo que en la otra axila se les aplicó la TXB-A de forma tradicional, inyectada. Los resultados fueron evaluados con el Minor Test (Test Yodo-almidón comparativamente en ambas axilas y en cada paciente a los 10 días, 2 meses y 5 meses de la aplicación. Empleamos el mismo número de unidades y la misma dilución de TXB-A tanto para la administrada vía tópica, como para la inyectada. Los resultados presentaron una disminución de la HH axilar en ambas axilas durante todo el estudio, siendo la forma inyectada la que más altos porcentajes de efecto presentó. En general un 74.67% de disminución de la secreción sudoral para la forma tópica con iontoforesis y un 90.33% para la forma inyectada. En cuanto a la duración del efecto, ambas aplicaciones tuvieron resultados estadísticamente significativos para la persistencia del efecto a los 5 meses. Por lo tanto, en base al presente trabajo, concluimos que la TXBA aplicada tópicamente mediante iontoforesis mejora la HH axilar y además presenta una persistencia del efecto de un mínimo de 5 meses.The overproduction of sweat by the

  20. Avaliação da fenda palpebral após aplicação de toxina botulínica tipo A em pacientes com distonias faciais Evaluation of palpebral fissure after botulinum toxin type A injection in patients with facial dystonias

    Directory of Open Access Journals (Sweden)

    Mariana Eleonora Pereira Cunial

    2012-12-01

    Full Text Available OBJETIVO: Avaliar a medida da fenda palpebral em pacientes com blefaroespasmo essencial benigno (BEB e espasmo hemifacial (EHF após a aplicação periocular de toxina botulínica tipo A. MÉTODOS: Foram estudados pacientes portadores de BEB e EHF submetidos à injeção periocular de toxina botulínica tipo A pela técnica inner orbital de aplicação. Os pacientes foram fotografados em PPO antes da aplicação e catorze dias depois dela. A fenda palpebral foi mensurada nestas imagens por meio de processamento computadorizado de imagens, utilizando o programa ImageJ. As alterações da fenda palpebral foram observadas comparando-se as medidas obtidas no pré e pós-aplicação. RESULTADOS: Comparando-se as imagens obtidas com o programa ImageJ, houve aumento estatisticamente significante (pPURPOSE: To evaluate the measurement of palpebral fissure in patients with facial dystonias before and after periocular injection with botulinum toxin type A. METHODS: We studied patients with benign essential blepharospasm and hemifacial spasm underwent periocular injection of botulinum toxin type A by the inner orbital technique of application. Patients were photographed 14 days before and after application. The palpebral fissure was measured in these images by means of computerized image processing using the program ImageJ. The palpebral fissure changes were observed by comparing the measurements obtained before and after application. RESULTS: Comparing the images obtained with the program ImageJ, there was a statistically significant increase (p <0.001 of the palpebral fissure in 14 eyes (51,8% after the application of periocular injection of botulinum toxin and the images analyzed showed no decrease of the palpebral fissure. CONCLUSION: In this study, patients with facial dystonias showed increased palpebral fissure periocular statistically significant after application of botulinum toxin type A.

  1. Efectos de la toxina botulínica A (Botox® intraarticular en la artrosis de rodilla avanzada Effects of intraarticular Botulinum Toxin A (Botox® on refractory knee osteoarthritis

    Directory of Open Access Journals (Sweden)

    P. Fenollosa Vázquez

    2011-12-01

    Full Text Available Objetivos: la osteoartritis es la enfermedad articular más común y una de los problemas de salud más frecuentes y sintomáticos en la madurez y senectud. Este trabajo describe nuestra experiencia clínica con inyecciones intraarticulares de toxina botulínica tipo A (TBA en dolor de rodilla artrósico y refractario. Materiales y métodos: doce mujeres con gonartrosis avanzada y refractaria, acudieron a consulta para el manejo del dolor de rodilla de moderado a severo. Las pacientes estuvieron en seguimiento 16 semanas, durante las que la mejoría de su estado fue valorado comparando el dolor basal respecto al dolor en el momento de la visita mediante diferentes escalas estandarizadas. Simultáneamente, se evaluaron la funcionalidad, la cantidad de medicación analgésica diaria y los efectos secundarios. Resultados: el consumo de medicación decreció de 3,6 a 2 tomas/día. No se observaron efectos secundarios. Conclusión: se evidenció un alivio del dolor que se inició en la semana 2 y se mantuvo hasta 12 semanas tras la inyección de TBA. La mediana del cambio de la escala total de WOMAC y de la EVA fue de -7,5 y -1,9 respectivamente, con una disminución significativa del dolor a las 16 semanas. No se registraron cambios en la escala WOMAC en 5 pacientes, mientras que 3 casos mostraron un descenso en dicha escala mayor del 20% y los en los 4 restantes fue superior al 40%. Las que respondieron a la infiltración notaron una mejora en las actividades de la vida diaria gracias a este alivio. El consumo de medicación decreció de 3,6 a 2 tomas/día. No se observaron efectos secundarios.Objective: osteoarthritis is the most common joint disease and it is among the most disabling health problems for middle aged and older people. Purpose: to test the effects of a single intraarticular injection of Botulinum Toxin A (BTA on refractory knee osteoarthritis. Material and method: twelve women (mean age: 72 with refractory knee osteoarthritis who

  2. Custos e eficácia da toxina botulínica tipo A no tratamento do blefaroespasmo essencial e espasmo hemifacial Costs and efficacy of type A botulinum toxin for the treatment of essential blepharospasm and hemifacial spasm

    Directory of Open Access Journals (Sweden)

    Cintia Gomes Galvão Lasalvia

    2006-10-01

    Full Text Available OBJETIVO: Avaliar os custos do tratamento para blefaroespasmo essencial e espasmo hemifacial com toxina botulínica tipo A (Dysport®, correlacionando-os com sua eficácia terapêutica. MÉTODOS: Análise de 50 prontuários de pacientes com blefaroespasmo essencial e espasmo hemifacial, submetidos à terapia com Dysport®, no período de abril de 2002 a maio de 2004 no setor de Óculo-Plástica da Santa Casa de São Paulo. Dos 50 pacientes, 27 apresentavam blefaroespasmo essencial e 23 espasmo hemifacial. Informações sobre grau de satisfação, queixas e custos pessoais foram obtidas mediante questionário. Os custos do medicamento e dos materiais foram pesquisados no almoxarifado e na farmácia da Santa Casa. Quanto ao custo das consultas, utilizou-se a tabela de pagamento do SUS. Para a estatística foram utilizados os testes de Wilcoxon e Mann-Whitney. RESULTADOS: O custo total anual do tratamento foi de R$ 1.239,32 para o blefaroespasmo essencial e R$ 661,72 para o espasmo hemifacial. Para o paciente, o custo anual foi de R$ 145,48 para o blefaroespasmo essencial e R$ 126,07 para o espasmo hemifacial. Para o hospital, o custo anual foi de R$ 1.095,84 para o blefaroespasmo essencial e R$ 535,65 para o espasmo hemifacial. O tratamento com Dysport® promoveu melhora funcional significativa nos dois grupos. CONCLUSÃO: O procedimento tem custo elevado, principalmente devido ao preço da toxina. Entretanto, pela análise econômica da saúde fica demonstrado que o procedimento possui excelente relação custo-benefício.PURPOSE: To evaluate the costs and efficacy of type A botulinum toxin in the treatment of essential blepharospasm and hemifacial spasm. METHODS: Pacients with essential blepharospasm and hemifacial spasm had their files analyzed. All patients were treated with type A botulinum toxin (Dysport® between April 2002 and May 2004 at the Oculoplastic Clinics of "Santa Casa de São Paulo". Twenty-seven patients presented essential

  3. Does botulinum toxin improve the function of the patient with spasticity after stroke? Toxina botulínica proporciona melhora funcional em pacientes com espasticidade secundária a acidente vascular cerebral?

    Directory of Open Access Journals (Sweden)

    Eduardo Cardoso

    2007-09-01

    Full Text Available Post-stroke spasticity is an important cause of disability in adults, due to muscle hyperactivity, which results in limb stiffness and muscle spasm. The prognosis for these patients depends on several features such as early management and adequate physical therapy to avoid muscle shortening, pain, and their consequences. Although several papers have shown that intramuscular injections of botulinum toxin type A (BT-A decreases spasticity in post-stroke patients, few authors have demonstrated functional improvement after this therapy. In order to assess if individualized BT-A injections improves upper limb function in post-stroke spastic patients, we prospectively followed 20 consecutive patients of 18 years of age or more with spastic hemiparesis secondary to stroke. Fulg-Meyer scale modified for upper limbs, measure of functional independence (MFI, Ashworth modified scale, and goniometry were applied in the beginning of the investigation and in the 16th and 32nd weeks. BT-A was applied at baseline and in the 16th week. All subjects were submitted to rehabilitation therapy. All patients showed improvement according to Ashworth modified scale and increase in the range of motion, which were sustained until the 32nd week (pEspasticidade secundária a acidente vascular cerebral (AVC é importante causa de incapacidade em adultos. O prognóstico para estes pacientes depende de vários fatores como tratamento precoce e terapia física adequada, evitando encurtamento muscular, dor e outras conseqüências. Vários estudos têm demonstrado que aplicacões intramusculares de toxina botulínica do tipo A (TxB-A reduzem a espasticidade após AVC, entretanto poucos autores observaram melhora funcional de membros superiores com esta terapêutica. Para determinar se aplicações individualizadas de TxB-A melhoram a função no membro superior espástico de pacientes com hemiparesia secundária a AVC, acompanhamos 20 pacientes com história de AVC entre 6 meses

  4. Lamsiekte (botulism: Solving the aetiology riddle

    Directory of Open Access Journals (Sweden)

    Rudolph D. Bigalke

    2012-04-01

    Full Text Available The reason or reasons why it took Sir Arnold Theiler so many years to unravel the riddle of the aetiology of lamsiekte in cattle and whether P.R. Viljoen’s lifelong grudge for receiving insufficient credit from Theiler for his research contribution was justified are analysed in this paper. By 1912, Theiler knew that Duncan Hutcheon had advocated the use of bonemeal as a prophylactic against the disease in the early 1880s. Hutcheon’s colleague, J.D. Borthwick, had shown conclusively in a field experiment in 1895 that lamsiekte did not occur in cattle fed a liberal allowance of bonemeal; and bone-craving had been identified by Hutcheon and several farmers as being associated with the occurrence of the disease (a ‘premonitory’ sign. Hutcheon regarded a phosphate deficiency of the pastures as the direct cause of lamsiekte. However, Theiler did not accept this, was convinced that intoxication was involved and developed a ‘grass toxin’ theory. Viljoen (1918 also latched onto the grass toxin theory. He did not believe that osteophagia existed, stating categorically that he had not observed it on the experimental farm Armoedsvlakte where > 100 cases of lamsiekte had occurred during the > 3 years that he spent there. Moreover, he did not believe in the prophylactic value of bonemeal. However, careful analysis of a subsequent publication, of which he was a co-author, revealed that in late 1918 and early 1919 he reproduced the disease by drenching cattle with blowfly pupae and larvae as well as with crushed bones from decomposing bovine carcasses. For this breakthrough he did not get proper credit from Theiler. Reappointed to study lamsiekte on Armoedsvlakte in the autumn of 1919, Theiler, probably already aware that the toxin he was seeking was in the decomposing bones or carcass material rather than the grass, deliberately ‘walked with the cattle’ on the farm to encounter a classic manifestation of bone-craving (osteophagia. The penny then immediately dropped. Theiler, actually rationalising an hypothesis that was about four decades old, did so with a vengeance. Within less than two years he had reproduced lamsiekte by exposing cattle with natural bone-craving to rotten carcass material, had chemical proof that the grazing was phosphorus-deficient, had developed a satisfactory bonemeal prophylactic dosage programme, and the bacterial toxin concerned – perhaps the trickiest contribution – had been produced in culture. Hence the table was set for the later development of an excellent lamsiekte vaccine.

  5. Botulismo de origem alimentar Foodbourne botulism

    OpenAIRE

    Natacha Deboni Cereser; Fernanda Malva Ramos Costa; Oswaldo Durival Rossi Júnior; Décio Adair Rebellatto da Silva; Vitor da Rocha Sperotto

    2008-01-01

    O botulismo alimentar ocorre pela ingestão de toxinas pré-formadas pelo Clostridium botulinum, consideradas as mais potentes dentre as toxinas conhecidas. Caracteriza-se como uma doença de extrema gravidade, de evolução aguda, provoca distúrbios digestivos e neurológicos, em conseqüência à ingestão de diversos tipos de alimentos. As conservas caseiras estão entre os alimentos que oferecem maior risco à população consumidora. Os produtos de origem animal são frequentemente associados aos surto...

  6. Acute infantile motor unit disorder. Infantile botulism?

    Science.gov (United States)

    Clay, S A; Ramseyer, J C; Fishman, L S; Sedgwick, R P

    1977-04-01

    Eight infants with an acute reversible motor unit disorder are described, including two infants from whom Clostridum botulinum type A was isolated from stool specimens. The clinical spectrum includes constipation, cranial nerve deficits, pupillary involvement, and generalized hypotonic weakness. There were no deaths, and all infants have had complete clinical recovery. A characteristic electromyographic (EMG) pattern was present in part until clinical recovery. This distinctive pattern consisted of brief, small, abundant for power exerted motor unit potentials. This EMG pattern in the context of the clinical syndrome may well be diagnostic for acute infantile motor unit disorder.

  7. Comparação entre os métodos de injeção de toxina botulínica em músculo ocular externo com o uso do eletromiógrafo e com o uso da pinça de Mendonça Electromyograph assistance and Mendonça's forceps - a comparison between two methods of botulinum toxin A injection into the extraocular muscle

    Directory of Open Access Journals (Sweden)

    Tomás Fernando Scalamandré Mendonça

    2005-04-01

    Full Text Available OBJETIVO: Comparar dois métodos de aplicação de toxina botulínica A (TBA em músculo ocular externo: com auxílio de eletromiógrafo (EMG e com a pinça de Mendonça. MÉTODOS: Foram analisados no Departamento de Oftalmologia da UNIFESP 29 pacientes que apresentavam estrabismo e baixa acuidade visual em um olho. Foram divididos em dois grupos: grupo I - 17 pacientes que receberam a toxina botulínica A por meio de injeção com auxílio da pinça de Mendonça e grupo II - 12 pacientes que receberam a toxina botulínica A por injeção guiada pelo eletromiógrafo. Os pacientes dos dois grupos foram avaliados no 7º e no 14º dia após aplicação. Compararam-se os resultados dos dois grupos neste período de tempo. Os testes de correlação de Friedman e Mann-Whitney foram usados para análise estatística. RESULTADOS: Houve diferença estatística entre as médias de desvio pré-aplicação e em pelo menos um período (7º ou 14º dia após aplicação, tanto no grupo dos pacientes em que foi utilizada a pinça, quanto no grupo de pacientes em que foi utilizado o eletromiógrafo. Não houve diferença estatística dos desvios pré-aplicação e pós-aplicação entre os dois grupos. CONCLUSÃO: Os dois métodos de aplicação da toxina botulínica A são equivalentes e portanto, o uso da pinça de Mendonça pode ser método alternativo ao uso do eletromiógrafo, para guiar a injeção de toxina botulínica A.PURPOSE: To compare two methods of botulinum toxin A (BTA injection into the extraocular muscle (EOM: the electromyographically (EMG guided injection and the injection using Mendonça's forceps. METHODS: Twenty-nine (29 patients with strabismus and low visual acuity in one eye were examined at the Department of Ophthalmology of UNIFESP. They were divided into 2 groups - group I with 17 patients receiving the botulinum toxin A injection using Mendonça's forceps, and group II with 12 patients receiving the toxin with electromyographical

  8. Toxina botulínica tipo A para el manejo del dolor en pacientes con síndrome de dolor miofascial crónico Botulinum toxin type A for the management of pain in patients with chronic myofascial pain

    Directory of Open Access Journals (Sweden)

    J.C. Torres Huerta

    2010-02-01

    Full Text Available Introducción: El síndrome de dolor miofascial es uno de los principales problemas de dolor crónico en la práctica clínica, comúnmente asociado a un traumatismo o a microtraumatismos repetitivos. La toxina botulínica tipo A (Botox® es una alternativa aceptada como opción terapéutica. Objetivo: Valorar la funcionalidad de las actividades diarias mejorando la intensidad del dolor con el uso de la toxina botulínica tipo A, infiltrada en puntos gatillo, en pacientes con síndrome de dolor miofascial crónico. Material y métodos: 30 pacientes con síndrome de dolor miofascial crónico con edad entre 25 y 50 años de ambos sexos. A todos se les realizó infiltración de puntos gatillo mediante equipo de electrosonomiografía para la aplicación de toxina botulínica tipo A a una dilución de las 100 Um de toxina en 1 ml de solución salina infiltrando de 200 a 400 Um totales, dependiendo del sitio del dolor. Se valoró la calidad analgésica mediante la escala visual analógica (EVA y el índice de funcionalidad con el cuestionario de Oswestry durante 4 semanas. Resultados: La valoración de la EVA promedio inicial fue de 7,23 y la final de 3,13 (p Introduction: Myofascial syndrome is one of the main chronic pain syndromes encountered in clinical practice and is commonly associated with trauma or repetitive microtrauma. Botulinum toxin type A (Botox® is an accepted therapeutic option. Objective: To evaluate the use of botulinum toxin type A (Botox®, infiltrated in trigger points, as an option in the management of pain in patients with chronic myofascial syndrome. Material and Methods: Thirty men and women with myofascial pain syndrome, aged between 25 and 50 years were included. In all patients, botulinum toxin type A (Botox® was infiltrated in trigger points by means of electrosonomyographic equipment. A dilution of 100 Um toxin in 1 cc saline solution was used and a total of 200 to 400 Um was administered depending on the site of the

  9. Comparación de resultados obtenidos en el tratamiento del dolor miofascial de la cintura pélvica con toxina botulínica sola y asociada con lidocaína

    Directory of Open Access Journals (Sweden)

    I. Velázquez Rivera

    2014-10-01

    Full Text Available Objetivos: entre el 70 y el 85 % de la población adulta sufre de dolor de espalda alguna vez en su vida. El síndrome de dolor miofascial (SDM ha sido descrito recientemente definiéndose como dolor musculoesquelético no inflamatorio, localizado, desarrollado sin causa aparente, refractario a tratamientos farmacológicos y físicos, y se acompaña de la presencia de puntos gatillos y de bandas tensas palpables en el músculo. Su prevalencia se estima que varía entre un 30 y un 85 %. Los músculos psoas, cuadrado lumbar y piramidal son los más frecuentemente implicados en el SDM de cintura pélvica. Una de las principales alternativas para tratar el SDM es la toxina botulínica tipo A (TB, que actúa en la membrana sináptica en la placa neuromuscular, inhibiendo la liberación de acetilcolina, produciendo relajación muscular y alivio del dolor, aunque, en muchas ocasiones, su efecto no se hace evidente hasta transcurridos varios días. La lidocaína es un anestésico local (AL tipo amida con duración de acción intermedia que actúa impidiendo la propagación del impulso nervioso disminuyendo la permeabilidad de los canales de sodio. El objetivo de este estudio era comprobar si al añadir AL a ladosis de TB, conseguíamos un acortamiento en el tiempo dela reducción de la EVA y mejoría de la calidad de vida. Material y métodos: el diseño del estudio fue prospectivo, controlado, longitudinal y aleatorizado en el que se ha valorado la evolución de 20 pacientes divididos en dos grupos. Al primer grupo se les administró TB tipo A (grupo T. Al segundo grupo se les trató con TB tipo A y dosis adicional de lidocaína al 2% (grupo TL. Previamente, ambos grupos, habían respondido de forma positiva a un test con infiltración del músculo afecto con lidocaína al 2 %. El seguimiento de los pacientes se hizo secuencialmente a los 3, 7, 15 y 90 días de iniciado el tratamiento. Para el análisis estadístico se utilizó un análisis de la

  10. Eficácia do resfriamento da pele no alívio da dor desencadeada pela injeção de toxina botulínica tipo A nas distonias faciais Skin cooling efficacy on pain relief in periocular injections with botulinum toxin A in facial dystonias

    Directory of Open Access Journals (Sweden)

    Paula Barros Bandeira de Mello Monteiro

    2012-12-01

    Full Text Available OBJETIVO: Avaliar a eficácia do resfriamento da pele com gelo no alívio da dor desencadeada pela injeção de toxina botulínica tipo A na região periocular em pacientes portadores de distonia facial. MÉTODOS: Neste estudo prospectivo, 13 pacientes receberam injeção de toxina botulínica tipo A em região glabelar (m. prócero e periocular (m. orbicular para tratamento de distonia facial. Antes das aplicações, um lado da região glabelar foi resfriado com gelo durante 5 minutos, enquanto no outro lado foi aplicada pomada Epitezan®, funcionando como placebo. A aplicação foi feita primeiramente no lado resfriado. Após a aplicação em cada um dos lados os pacientes foram instruídos a dar uma nota para a dor desencadeada pela injeção, em uma escala de 0 a 10 onde 0 era ausência de dor e 10 a dor mais intensa. RESULTADOS: A média das notas dadas pelos pacientes à dor desencadeada pela injeção no lado onde foi aplicado placebo foi 3,92 ± 3,28. No local onde foi aplicado gelo a média das notas foi de 2,92 ± 2,18 (p PURPOSE: To evaluate the efficacy of skin cooling with ice on pain relief in periocular injection with botulinum toxin type A in patients with facial dystonias. METHODS: In this prospective study, 13 patients received botulinum toxin type A injection in glabela (procerus m. and periocular region (orbicular m. for facial dystonias treatment. Before the injections, one side of the glabela was submitted to a 5-minute cooling period, while the opposite side had Epitezan® cream applied, as a placebo. The application was done at the cooled side first. After the application on each side the patients were instructed to rate the pain associated with the injection on a scale from 0 to 10, with 0 indicating no pain and 10 the worst pain. RESULTS: The average pain score on the side where cold was applied was 3,92 ± 3,28, while on the control side the average pain score was 2,92 ± 2,18 (p < 0,0166. CONCLUSION: In this study

  11. Análise vocal em pacientes com disfonia espasmódica nos momentos pré e pós tratamento com toxina Botulínica A Vocal analysis in patients with spasmodic dysphonia before and after treatment with Botulinum toxin A

    Directory of Open Access Journals (Sweden)

    Ana Cristina Côrtes Gama

    2012-10-01

    Full Text Available OBJETIVO: avaliar de forma objetiva e subjetiva a voz de pacientes com disfonia espasmódica nos momentos pré e pós aplicação de toxina botulínica A. MÉTODO: as emissões vocais de onze pacientes do sexo feminino foram registradas antes e após (15 dias o tratamento. As amostras vocais foram analisadas por duas fonoaudiólogas com experiência em voz por meio da análise perceptivo-auditiva (escala GRBASI e da análise espectrográfica. RESULTADOS: na análise perceptivo-auditiva com vogal sustentada os parâmetros que alteraram após o tratamento foram o grau de severidade, tensão e instabilidade, enquanto na fala encadeada foram o grau de severidade e a tensão. Na análise espectrográfica ocorreu melhora do traçado após o tratamento sem significância estatística entre os parâmetros. CONCLUSÃO: ocorreu melhora significante dos aspectos perceptivo-auditivos após o tratamento e, portanto, as injeções de toxina botulínica A mostraram-se eficazes no tratamento da disfonia espasmódica no grupo estudado.PURPOSE: to analyze in an objective and subjective manner the voice of patients with spasmodic dysphonia in the moments before and after botulinum toxin A. METHOD: the vocal emissions of eleven women patients were recorded before and after (15 days treatment. The vocal samples were analyzed by two experienced speech therapists through the perceptual analysis (GRBASI scale and spectrographic analysis. RESULTS: in the perceptual analysis with subtended vowel, the altered parameters were degree of severity, strain and instability, while in connected speech only degree of severity and strain changed after treatment. In the perceptual analysis with sustained vowel, the parameters that have changed, were the degree of severity, strain and instability, while in connected speech only degree of severity and strain changed after treatment. The spectrographic analysis was improved after treatment with no statistical significance found among

  12. Bilateral lamellar keratoplasty in descemetocele treatment in dog with botulism by use of equine renal capsule and conjunctival pedicle graft Emprego de ceratoplastia lamelar bilateral no tratamento de descemetocele em cão com botulismo, utilizando-se cápsula renal eqüina e enxerto conjuntival pediculado

    Directory of Open Access Journals (Sweden)

    José Luiz Laus

    1999-06-01

    Full Text Available A 3-year-old, male mixed breed dog with botulism and bilateral descemetocele was submitted to lamellar keratoplasty with equine renal capsule preserved in glycerin in the right eye and conjunctival pedicle graft in the left eye. The evolution was satisfactory in both eyes, but better in the eye receiving the equine renal capsule, because the corneal transparence was more evident in that eye. On the other hand, the surgical period was more quickly in the eye receiving the equine renal capsule because the preparation of the conjunctival pedicle before the keratoplasty was not necessary.Um animal da espécie canina, macho, de 3 anos de idade, com botulismo e descemetocele bilateral foi submetido à ceratoplastia lamelar com cápsula renal eqüina preservada em glicerina no olho direito, e enxerto conjuntival pediculado no olho esquerdo. Ambos os olhos mostraram evolução satisfatória porém, o olho receptor da cápsula renal eqüina apresentou transparência corneana mais evidente.

  13. Utilización de la toxina botulínica para mejorar la funcionalidad y la expresión del labio en parálisis facial de larga evolución Use of botulinum toxin to improve the functionality and expression of the lip in long-term facial palsy

    Directory of Open Access Journals (Sweden)

    C. Gómez Martín

    2010-06-01

    Full Text Available La parálisis de la rama marginal del nervio facial en el contexto de una parálisis facial de larga evolución, produce una deformidad estética y funcional que puede ser mejorada con la inyección de toxina botulínica. Utilizamos esta técnica en 2 pacientes consiguiendo unos resultados casi inmediatos en lo que se refiere a la apertura bucal, a la expresión y a la continencia oral. Indicamos esta técnica en pacientes de edad avanzada, con múltiples operaciones previas y que aceptan este procedimiento no invasivo para mejorar su autoestima y su calidad de vida.Paralysis of the marginal branch of the facial nerve in the context of a long-term facial paralysis, produces an aesthetic and functional deformity that can be improved with botulinum toxin injection. We use this technique in 2 patients who achieved almost immediate results in terms of oral opening, oral expression and continence. Botulinum toxin injection can be used in elderly patients with multiple previous operations who accept this non-invasive procedure, improving their selfesteem and their quality of life.

  14. Botulinum toxin A and physiotherapy intervention in the treatment of the painful shoulder after stroke: case report Toxina botulínica A e intervenção fisioterapêutica no tratamento do ombro doloroso pós acidente vascular cerebral: relato de caso

    Directory of Open Access Journals (Sweden)

    Suellen M. Marinho dos Santos Andrade

    2007-10-01

    Full Text Available The syndrome of the painful shoulder is considered a common finding in patients who suffered stroke. Several therapeutic modalities are suggested for the improvement of the patients’ clinical condition. In this report, a case of syndrome of the painful shoulder will be discussed, whose treatment consisted of the use of botulinum toxin A associated to physiotherapy. After a four-month treatment, significant improvements occurred concerning pain, spasticity, range of motion and quality of life, suggesting that this therapeutic association is an efficient tool against the incapacitating effects related to this syndrome. A síndrome do ombro doloroso é considerada um achado comum em pacientes que sofreram acidente vascular cerebral. Várias modalidades terapêuticas são apontadas para melhoria do quadro clínico dos pacientes. Neste relato, será apresentado um caso de síndrome do ombro doloroso, cujo tratamento consistiu no emprego de toxina botulínica A associada à fisioterapia. Após quatro meses de tratamento, houve melhorias significativas quanto à dor, espasticidade, amplitude de movimento e qualidade de vida, e isso sugere ser essa associação terapêutica uma ferramenta eficaz contra os efeitos incapacitantes relacionados a esta síndrome.

  15. Efeitos adversos associados à aplicação de toxina botulínica na face: revisão sistemática com meta-análise Adverse effects associated with facial application of botulinum toxin: a systematic review with meta-analysis

    Directory of Open Access Journals (Sweden)

    Roberta Melissa Benetti Zagui

    2008-12-01

    Full Text Available OBJETIVO: Verificar a ocorrência dos efeitos adversos relacionados ao uso da toxina botulínica na face, por meio de revisão sistemática, usando meta-análise. MÉTODOS: Foi realizada pesquisa eletrônica de artigos publicados no MEDLINE e Cochrane Library até setembro de 2007. A ocorrência dos efeitos adversos foi verificada pela freqüência relativa para os relatos de casos e do risco relativo para os estudos randomizados. A heterogeneidade foi avaliada pelo teste Q e pelo índice I². Foi utilizado o teste de significância de Egger para identificar viés de publicação e a análise de sensibilidade para verificar o efeito dos viéses de publicação. RESULTADOS: Oito estudos randomizados e treze relatos de casos preencheram os critérios de inclusão. Na revisão sistemática dos relatos de casos, 1.003 pacientes foram estudados, dos quais 182 (18,14% apresentaram efeitos adversos. O efeito adverso mais freqüente foi a ptose palpebral ocorrendo em 34 (3,39% pacientes dos relatos de casos. Na meta-análise dos estudos randomizados, o risco relativo global para os efeitos adversos como cefaléia, ptose palpebral, reação local e infecção foi 1,07, 3,25, 0,99 e 0,94, respectivamente. Para todas as comparações, o valor de P foi maior que 0,05. CONCLUSÃO: O efeito adverso mais freqüente e que apresentou o maior risco relativo relacionado ao uso da toxina botulínica na face foi a ptose palpebral. A padronização dos efeitos adversos relatados é necessária a fim de melhor estabelecer as características dos mesmos.PURPOSE: To estimate the occurrence of adverse effects associated with the use of botulinum toxin by performing a systematic review and meta-analysis. METHODS: A systematic literature search of MEDLINE and Cochrane Library was conducted until September 2007. The occurrence of the adverse effects was estimated of the relative frequency for case report and of the relative risk for randomized trials. Heterogeneity was

  16. Quality of life of children with cerebral palsy treated with botulinum toxin: are well-being measures appropriate? Qualidade de vida em crianças com paralisia cerebral tratadas com toxina botulínica: estas avaliações são adequadas?

    Directory of Open Access Journals (Sweden)

    Taísa R. Simões de Assis

    2008-01-01

    Full Text Available AIM: To analyze quality of life (QOL of children with cerebral palsy (CP treated with botulinum toxin type A (BTXA. METHOD: Two QOL evaluation tools, translated into Portuguese, were used: Pediatric Outcomes Data Collection Instrument (PODCI and Child's Caregiver Questionnaire (CCQ. Questionnaires were answered by caregivers on two occasions. Patients were divided into 3 groups: I - patients who had been previously treated with BTXA and who underwent a session of BTXA; II - patients who used BTXA for the first time; III - patients previously treated with BTXA but did not in this interval. RESULTS: Sixty-eight patients were evaluated. In group I (n=26 the functional ability had improvement for all types of CP (p=0.04, and tetraplegic increased interaction/communication (p=0.02. In group II (n=14 positioning improved (p=0.02. Group III (n=28 showed no change in QOL. CONCLUSIONS: PODCI and CCQ are able to capture outcome in children with CP.OBJETIVO: Analisar a qualidade de vida (QV de crianças com paralisia cerebral tratadas com toxina botulínica do tipo A (TBA. MÉTODO: Dois instrumentos de QV, adaptados para a língua portuguesa, foram utilizados: Instrumento para Avaliação de Resultados de Reabilitação em Pediatria (IARRP e Questionário do Cuidador da Criança (CQC, sendo respondidos pelos cuidadores. Os pacientes foram divididos em 3 grupos: I - já haviam utilizado TBA e foram submetidos à aplicação neste intervalo; II - utilizaram TBA pela primeira vez; III - utilizaram TBA previamente, mas não neste intervalo. RESULTADOS: Sessenta e oito pacientes foram avaliados, no grupo I (n=26 houve melhora da capacidade funcional em todos os tipos de PC (p=0.04, e tetraplégicos tiveram ganho também na interação/comunicação (p=0.02. No grupo II (n=14 houve melhora em posicionamento (p=0.02. Não foram observadas mudanças na QV do grupo III (n=28. CONCLUSÃO: IARRP e CQC são capazes de avaliar resultados em crianças com PC.

  17. Toxina botulínica no tratamento de distonias faciais: avaliação da eficácia e da satisfação dos pacientes ao longo do tratamento Botulinum toxin in the treatment of facial dystonia: evaluation of its efficacy and patients' satisfaction along the treatment

    Directory of Open Access Journals (Sweden)

    Patrícia Gravito Costa

    2005-08-01

    Full Text Available OBJETIVO: Estudar a eficácia do tratamento com toxina botulínica nos pacientes com distonia facial e a satisfação com o tratamento ao longo do tempo. MÉTODOS: Estudo retrospectivo de 42 pacientes portadores de distonia facial acompanhados no setor de Plástica Ocular da Clínica Oftalmológica do Hospital das Clínicas da Universidade de São Paulo. RESULTADOS: Após as primeiras aplicações, 45,2% dos pacientes deram notas entre 9-10 para melhora do espasmo, 35,7% deram notas entre 7-8, 16,7% deram notas entre 5-6 e apenas um paciente deu nota 4. Em relação ao intervalo de reaparecimento do espasmo, 4,8% dos pacientes referiram entre 5-6 meses, 64,2% entre 3-4 meses e 31% entre 1-2 meses. Ao longo do tratamento, 76,1% dos pacientes referiram manter a mesma nota sobre a melhora do espasmo, 19,1% referiram melhora do resultado nas aplicações e apenas 4,8% referiram piora da eficácia nas aplicações atuais. Quanto ao tempo de retorno do espasmo após aplicação, 64,2% relataram não haver mudança ao longo do seguimento no serviço, 16,7% relataram aumento e 19,1% relataram diminuição do intervalo de remissão dos sintomas. Após aplicação, 19% dos pacientes apresentaram efeitos colaterais e 73,8% dos pacientes referiram desconforto apenas leve ou moderado em relação à aplicação. CONCLUSÕES: O uso da toxina botulínica foi eficaz e não houve alteração da eficácia ao longo do tempo. São poucos os efeitos colaterais e boa tolerância à administração. É boa alternativa para melhorar a qualidade de vida desses pacientes evitando a cegueira funcional causada por essas doenças.PURPOSE: To study the efficiency of botulinum toxin treatment in facial dystonia patients and their satisfaction along treatment. METHODS: Retrospective study of 42 facial dystonia cases followed at the Oculoplastic Surgery Department of the "Hospital das Clínicas" of the University of São Paulo. RESULTS: Following the first injections, 45.2% of

  18. Botulinum-A toxin in the treatment of painful post-stroke nocturnal paroxysmal dystonia triggered by periodic limb movements of sleep: case report Toxina botulínica tipo A no tratamento da distonia paroxística noturna dolorosa pós-isquemia cerebral desencadeada por movimentos periódicos do sono: relato de caso

    Directory of Open Access Journals (Sweden)

    Pedro A. Kowacs

    2006-12-01

    Full Text Available INTRODUCTION: Sleep disorders presenting involuntary movements may be very annoying to patients, apart from their negative influence on sleep. OBJECTIVE: To report the use of botulinum type-A toxin (BoNT-A to manage the case of a patient whose sleep was severely disrupted by episodes of dystonic posturing of the right lower limb triggered by periodic limb movements of sleep (PLMS. METHOD: A 79-year-old woman with mild post-stroke right hemiparesis presented with recurrent painful episodes of dystonia of the right lower limb, which disrupted her sleep. The dystonic episodes could also be voluntarily triggered by extension of the right hallux. Polysomnography confirmed that the dystonic episodes were triggered by PLMS. Twenty units of BoNT-A (20U/500U vial were injected into her right extensor hallucis longus. RESULTS: Shortly after BoNT-A was injected, the dystonic symptoms abated, and the patient achieved better sleep efficiency. CONCLUSION: The PLMS-related involuntary extension of the hallux was probably triggering the nocturnal post-stroke lower limb dystonic paroxysms. BoNT-A injection into the right extensor hallucis longus was effective in managing this condition and thus resolved the associated disruption of sleep.INTRODUÇÃO: Desordens do sono apresentando movimentos involuntários podem ser bastante perturbadoras aos pacientes, além de sua influência negativa no sono. OBJETIVO: Descrever o uso da toxina botulínica tipo-A (BoNT-A no manejo do caso de um paciente cujo sono estava gravemente fragmentado por episódios de distonia do membro inferior direito, desencadeados por movimentos periódicos do sono (MPS. MÉTODO: Uma paciente com 79 anos portadora de hemiparesia direita leve seqüelar a isquemia cerebral (AVCI procurou-nos por episódios dolorosos recorrentes de distonia noturna de seu membro inferior direito, os quais fragmentavam seu sono. Os episódios de distonia também podiam ser desencadeados voluntariamente, por extens

  19. Reabilitação fonatória do laringectomizado total: utilização de toxina botulínica na voz tráqueo-esofágica com prótese fonatória Botulinum toxin in speech rehabilitation with voice prosthesis after total laryngectomy

    Directory of Open Access Journals (Sweden)

    Carlos Takahiro Chone

    2008-04-01

    Full Text Available Na punção tráqueo-esofágica(PTE é realizada miotomia do músculo constritor da faringe, mas sua necessidade é entre 9% a 79% dos pacientes. Sua realização pode aumentar as taxas de fístula salivar no pós-operatório. A aplicação da TB é ambulatorial. OBJETIVO: Análise da eficácia da aplicação de toxina botulínica (TB, na reabilitação do laringectomizado total com voz tráqueo-esofágica(VTE com espasmo(E do segmento faringo-esofágico (SFE sem miotomia. MATERIAL E MÉTODOS: Análise de oito pacientes submetidos à laringectomia total (LT, reabilitados com VTE com prótese fonatória (PF, esforço para emissão de voz devido à E do SFE. Todos submetidos a tratamento dessa alteração motora com injeção de 100 unidades de TB no SFE. A avaliação constituiu-se de análise perceptiva de voz, videofluoroscopia (VF do SFE, análise acústica de voz e manometria computadorizada (MC do SFE, todos antes e após aplicação de TB. DESENHO DE ESTUDO: Estudo prospectivo. RESULTADOS: Houve diminuição na pressão à MC do SFE, após a injeção de TB. Análise acústica demonstrou melhora na qualidade de harmônicos após o tratamento. Houve emissão de voz sem esforço e melhora do E após o uso da TB. CONCLUSÃO: Todos os pacientes com E do SFE apresentaram melhora vocal após aplicação da TB neste SFE.In tracheo esophageal puncture (TEP, we carry out a myotomy of the pharynx constrictor muscle; however, about 9 to 79% of patients need such procedure. The consequence of such procedure is an increase in salivary fistula rates in the postoperative. Botulin toxin is used in an outpatient basis. AIM: analyzing the efficacy of botulin toxin (BT use in the rehabilitation of totally laryngectomized patients with tracheo-esophageal voice (TEV with spasms (S of the pharyngo-esophageal segment (PES without myotomy. MATERIALS AND METHODS: We analyzed eight patients submitted to total laryngectomy (TL, rehabilitated with TEV, with speech

  20. Uso de manometria computadorizada para estudo do espasmo do segmento faringoesofágico em pacientes com voz traqueoesofágica inadequada antes e após aplicação de toxina botulínica Computerized manometry use to evaluate spasm in pharyngoesophageal segment in patients with poor tracheoesophageal speech before and after treatment with botulinum toxin

    Directory of Open Access Journals (Sweden)

    Carlos T. Chone

    2009-04-01

    Full Text Available Voz traqueoesofágica (VTE com prótese fonatória (PF é método eficaz e reproduzível na reabilitação vocal após laringectomia total (LT, impedida pelo espasmo do segmento faringoesofágico (SFE. A manometria computadorizada (MC é novo método objetivo e direto de avaliação do SFE. OBJETIVO: Análise objetiva do espasmo do SFE, com MC, antes e após aplicação de toxina botulínica (TB. DESENHO DO ESTUDO: Prospectivo clínico. MATERIAL E MÉTODOS: Análise de oito pacientes consecutivos submetidos à LT com VTE e PF, sem emissão vocal, com espasmo do SFE à videofluoroscopia, considerado padrão ouro para detecção de espasmo. Todos trataram o espasmo com injeção de 100 unidades de TB no SFE. Avaliação constituiu-se de videofluoroscopia e MC do SFE, antes e após aplicação de TB. RESULTADOS: Houve diminuição na pressão do SFE à MC, após injeção de TB em todos. A média de pressão do SFE à MC, nos oito pacientes, antes da aplicação de TB foi de 25.36 mmHg e após foi de 14.31 mmHg (p=0,004. Houve emissão vocal sem esforço e melhora do espasmo do SFE à videofluoroscopia após o uso da TB. CONCLUSÃO: Foi observada diminuição na pressão do SFE após injeção da TB à MC em todos os pacientes, com melhora do espasmo à videofluoroscopia.Tracheoesophageal voice (TEV with voice prosthesis (VP is an efficient and reproducible method used in vocal rehabilitation after total laryngectomy (TL, prevented by spasms in the pharyngoesophageal segment (PES. Computerized Manometry (CM is a new, direct and objective method used to assess the PES. AIM: to carry out an objective analysis of the PES, with CM, before and after the injection of botulinum toxin (BT. STUDY DESIGN: clinical-prospective. MATERIALS AND METHODS: analysis of eight patients consecutively submitted to TL with TEV and VP, without vocal emission, with PES spasms seen through videofluoroscopy, considered the gold standard for spasm detection. All had their

  1. Análise estrutural da laringofaringe e suas implicações na miotomia do cricofaríngeo, na injeção de toxina botulínica e na dilatação por balão Laryngopharyngeal structural analysis and its morphofunctional correlation with cricopharyngeal myotomy, botulinum toxin injection and balloon dilation

    Directory of Open Access Journals (Sweden)

    Milton Melciades Barbosa Costa

    2003-06-01

    Full Text Available RACIONAL: O músculo cricofaríngeo é de tipo estriado esquelético, por conseguinte, incapaz de manter contração continuada por longos períodos. Apesar disto, tem sido considerado como o responsável pela zona de alta pressão registrada manometricamente na transição faringoesofágica. Em razão desta crença, tem sido alvo de terapêuticas cruentas que visam, por ruptura de sua integridade, franquear a comunicação entre a faringe e o esôfago. OBJETIVO: Dar as bases anatômicas que definam os limites de participação do músculo cricofaríngeo na função da transição faringoesofágica; considerar alternativa morfofuncional para explicar a zona de alta pressão desta transição e as implicações das miotomias sobre ela, uso de toxina botulínica e das dilatações pneumáticas. MATERIAL E MÉTODOS: O total de 24 peças obtidas de cadáveres de adultos de ambos os sexos fixados em formaldeído a 10%, teve a laringofaringe estudada quanto as suas características morfológicas e relações. RESULTADOS: O músculo cricofaríngeo apresenta suas inserções ântero-laterais nas bordas póstero-laterais da cartilagem cricóide, configurando morfologia em meia calha ou de uma letra C que não permite, quando de sua contração, a geração de pressão com predomínio anterior e posterior, como a encontrada na transição faringoesofágica. Este tipo de distribuição pressórica tem sustentação na relação de pinça exercida, por um lado, pela rigidez oferecida pelos corpos vertebrais, por outro, pelo contorno posterior da cartilagem cricóide. CONCLUSÕES: A organização muscular da laringofaringe permite afiançar que a miotomia alargada da transição faringoesofágica, aquela que se estende além do fascículo transverso do cricofaríngeo, lesa musculatura ejetora e em área cuja a já maior dimensão luminar dispensaria a secção parietal. Miotomia que tome somente o fascículo transverso do cricofaríngeo poderá contribuir

  2. Análise morfométrica da fenda palpebral de pacientes com retração palpebral na fase aguda da orbitopatia distireoidiana submetidos à injeção palpebral de toxina botulínica tipo A Morphometric analysis of eyelid fissure in patients with eyelid retraction in acute stage of dysthyroid orbitopathy after treatment with botulinum toxin type A

    Directory of Open Access Journals (Sweden)

    Patrícia Grativol Costa

    2008-08-01

    Full Text Available OBJETIVO: Apresentar dados morfométricos da fenda palpebral, antes e após a aplicação da toxina botulínica tipo A em pacientes com retração palpebral na fase aguda da orbitopatia distireoidiana. MÉTODOS: Estudo prospectivo com 12 indivíduos submetidos à aplicação de 5 UI/0,1 ml de toxina botulínica tipo A em uma das pálpebras superiores. O seguimento mínimo foi de 6 meses. A avaliação palpebral foi registrada por meio de captação de imagens com uma câmera filmadora de vídeo conectada a um microcomputador. RESULTADOS: As medidas da fenda palpebral vertical, distância da margem palpebral superior reflexo, área total da fenda palpebral e função do músculo levantador da pálpebra superior, apresentaram diminuição após a aplicação da droga. Houve diminuição, nos olhos tratados, da diferença entre a área lateral e a área medial da fenda palpebral. A distância margem palpebral inferior reflexo não mostrou alterações. No olho contralateral, houve aumento das medidas (fenda palpebral vertical, distância margem palpebral superior reflexo, área total da fenda palpebral até 2 semanas após a aplicação. CONCLUSÕES: Estes resultados mostram uma melhora da retração e do contorno palpebral superior, sem alterar o posicionamento da pálpebra inferior.PURPOSE: To compare morphometric data of eyelid fissure using computerized image analysis before and after application of botulinum toxin type A in patients with eyelid retraction caused by dysthyroid orbitopathy in acute stage. METHODS: This was a prospective study with 12 individuals that received transcutaneous 5 UI/0.1 ml injection of botulinum toxin in the upper eyelid. They were examined periodically for 6 months. Clinical eyelid examination was performed and re corded using a video camera connected to a microcomputer. RESULTS: Vertical eyelid fissure, upper eyelid margin to reflex distance and the eyelid area showed reduction in the treated eye. A decrease in

  3. EVOLUTION OF BOTULISM. I. BIOLOGICAL SIGNIFICANCE OF PATHOGENICITY,

    Science.gov (United States)

    nutritional conditions and as a result give rise to the formation of a pathogenic species. The occurrence of this character might have enabled the ancestors of ...sphere of existence. The decomposing carcass of an animal becomes a medium for multiplication and toxin formation and a source for the further... evolution toward the natural selection of forms possessing more pathogenic properties and different methods of adaptation suitable to the new way of life. (Author)

  4. [The clinical diagnosis 'wound botulism' in an injecting drug addict

    NARCIS (Netherlands)

    Rundervoort, R.S.; Ven, A.J.A.M. van der; Vermeulen, C.M.; Oostenbrugge, R.J. van

    2003-01-01

    A 38-year-old subcutaneous injecting heroin addict had subacute blurred vision, dysarthria and dysphagia. The next day she could not swallow or speak and developed weakness of all limbs and respiratory failure. Electromyography showed abnormalities compatible with a presynaptic neuromuscular transmi

  5. A review of research on Type C botulism among waterbirds

    Data.gov (United States)

    US Fish and Wildlife Service, Department of the Interior — After investigating a variety of possible alternatives, including "alkali poisoning", Kalmbach and Gunderson (1934) determined that "duck sickness" was the result Of...

  6. Predicting mobility gains among children with cerebral palsy after application of botulinum toxin A Predizendo ganhos de mobilidade em crianças com paralisia cerebral após aplicação de toxina botulínica A

    Directory of Open Access Journals (Sweden)

    VCR Cury

    2009-02-01

    Full Text Available BACKGROUND: Botulinum toxin A (BTA is commonly used to treat children with cerebral palsy (CP. However, the variables measured before BTA application and associated with motor function and independent mobility, known as predictors of functional outcomes, have not been well defined. OBJECTIVE: To identify clinical predictors of gains in functional motor skills and independence of mobility among children with CP, three and six months after BTA application. METHODS: This was a convenience sample of children with spastic CP (n=35. Measurements of quantitative gains in motor skills and independence of mobility were taken three and six months after BTA application. These outcomes were observed through repeated applications of two functional tests: GMFM (Gross Motor Function Measure and PEDI (Pediatric Evaluation of Disability Inventory. These tests evaluated gross motor function while sitting or standing and during transitions between these postures, and also during dynamic activities such as walking, running and jumping, along with the children's independence in mobility tasks. The independent variables included the children's characteristics such as age, severity, topographic diagnosis, neuromuscular-skeletal parameters (range of motion and spasticity, gait quality and performance in the functional tests before BTA. RESULTS: Four predictive models were developed (R² between 0.58 and 0.83; pCONTEXTUALIZAÇÃO: A toxina botulínica A (TBA é comumente utilizada em crianças com paralisia cerebral (PC, entretanto preditores de desfechos funcionais, ou seja, variáveis mensuradas pré-aplicação da TBA e associadas a ganho na função motora e independência na mobilidade não são bem definidos. OBJETIVO: Identificar preditores clínicos de ganho em habilidades motoras funcionais e independência em mobilidade em crianças com PC, aos três e seis meses pós-aplicação de TBA. MÉTODOS: Amostra de conveniência de crianças com PC espástica (n=35

  7. [Familial microepidemic of food-borne botulism in the Region of Madrid].

    Science.gov (United States)

    Jalda, D; Junco, A; Alvarez-Moreno, M; Rodero, I; Carneado-Ruiz, J

    2016-07-01

    Introduccion. El botulismo es un sindrome causado por la toxina del bacilo Clostridium botulinum. La toxina actua bloqueando las terminaciones colinergicas presinapticas de la placa motora y del sistema nervioso parasimpatico, y ocasiona una paralisis flacida y un fallo parasimpatico. El modo mas habitual de adquisicion de la enfermedad es por ingesta de toxina preformada presente en las conservas caseras mal esterilizadas, aunque otros mecanismos son posibles. Su incidencia actual en Espana es muy baja. Casos clinicos. Se describen tres miembros convivientes de una familia que presentaron un cuadro de botulismo alimentario. Las manifestaciones clinicas iniciales mostraron predileccion por la paresia ocular y por sintomatologia disautonomica de escasa especificidad, y la agregacion familiar fue el indicio fundamental que sugirio el diagnostico. Posteriormente, los pacientes empeoraron y dos de ellos presentaron afectacion de la funcion respiratoria y precisaron ingreso prolongado en la unidad de cuidados intensivos. Los tres pacientes convalecieron y se recuperaron sin secuelas. Se consiguio detectar la toxina botulinica por bioensayo en los restos de alimentos, lo que confiere al caso la categoria diagnostica de confirmado. Conclusiones. La microepidemia familiar presentada constituye un caso de afectacion inicial predominantemente ocular y disautonomica. Asimismo, ilustra varios aspectos tipicos de la enfermedad: la sospecha diagnostica ante pacientes convivientes que acuden simultaneamente por clinica similar, las complicaciones caracteristicas del proceso y su tratamiento, el diagnostico de laboratorio y su historia natural hacia la resolucion.

  8. Efecto de la Toxina Botulínica A en el tratamiento del dolor miofascial masticatorio.

    OpenAIRE

    Forteza González, Gabriel

    2006-01-01

    INTRODUCCIÓNEl Síndrome de Dolor Miofascial Masticatorio (SDMFM) - También denominado Dolor Facial Miogénico - es un cuadro que, según estudios, afecta hasta al 25% de la población. Afecta preferentemente a mujeres (entre el 75 y el 88,5 %), entre 20 y 40 años. Se caracteriza por la presencia de trismus, dolor facial, fatiga y limitación de la función en los músculos maseteros (79-84 %) y temporales (56-65 %), seguidos de los pterigoideos internos, externos y los digástricos. Puede afectar a ...

  9. Parálisis cerebral infantil: tóxina botulínica y fisioterapia

    OpenAIRE

    Frías González, Laura

    2014-01-01

    La Parálisis Cerebral Infantil es una encefalopatía secular con afectación predominantemente motriz, que consiste en una variada combinación de espasticidad, ataxia, distonía y otras discinesias [1]. La espasticidad es la mayor causante de discapacidad física, por lo que su tratamiento va a ser de vital importancia en los niños que la presentan. Para ello hay diferentes técnicas que podemos llevar a cabo, aunque siempre debemos tener en cuenta las características individuale...

  10. FDA Approves First Botulism Antitoxin for Use in Neutralizing All Seven Known Botulinum Nerve Toxin Serotypes

    Science.gov (United States)

    ... News & Events Home News & Events Newsroom Press Announcements FDA NEWS RELEASE For Immediate Release: March 22, 2013 ... Inquiries: Morgan Liscinsky, 301-796-0397, morgan.liscinsky@fda.hhs.gov Consumer Inquiries: 888-INFO-FDA, OCOD@ ...

  11. Desert bighorn sheep mortality due to presumptive type C botulism in California

    Science.gov (United States)

    Swift, P.K.; Wehausen, J.D.; Ernest, H.B.; Singer, R.S.; Pauli, A.M.; Kinde, H.; Rocke, T.E.; Bleich, V.C.

    2000-01-01

    During a routine telemetry flight of the Mojave Desert (California, USA) in August 1995, mortality signals were detected from two of 12 radio-collared female desert bighorn sheep (Ovis canadensis) in the vicinity of Old Dad Peak in San Bernardino County (California). A series of field investigations determined that at least 45 bighorn sheep had died near two artificial water catchments (guzzlers), including 13 bighorn sheep which had presumably drowned in a guzzler tank. Samples from water contaminated by decomposing bighorn sheep carcasses and hemolyzed blood from a fresh bighorn sheep carcass were tested for the presence of pesticides, heavy metals, strychnine, blue-green algae, Clostridium botulinum toxin, ethylene glycol, nitrates, nitrites, sodium, and salts. Mouse bioassay and enzyme-linked immunosorbent assay detected type C botulinum toxin in the hemolyzed blood and in fly larvae and pupae. This, coupled with negative results from other analyses, led us to conclude that type C botulinum poisoning was most likely responsible for the mortality of bighorn sheep outside the guzzler tank.

  12. Management of Animal Botulism Outbreaks: From Clinical Suspicion to Practical Countermeasures to Prevent or Minimize Outbreaks

    DEFF Research Database (Denmark)

    Anniballi, Fabrizio; Fiore, Alfonsina; Löfström, Charlotta

    2013-01-01

    and supportive therapies are used to treat sick animals. Once the diagnosis has been made, euthanasia is frequently advisable. Vaccine administration is subject to health authorities' permission, and it is restricted to a small number of animal species. Several measures can be adopted to prevent or minimize...

  13. Neurorehabilitación post toxina botulínica tipo A

    OpenAIRE

    Bugallo, Romina

    2014-01-01

    La espasticidad, como secuela neurológica, se comporta como una de las más importantes causas de invalidez en el adulto. El manejo de la espasticidad está dirigido por las necesidades de cada paciente en particular y sus metas funcionales. Determinados músculos espásticos pueden colaborar con una postura ventajosa funcionalmente, pero de forma inversa debe ser tratada cuando primen las desventajas, o sea, cuando existe interferencia en la función, posición, higiene y confort de...

  14. Gut content analysis of Lake Michigan waterbirds in years with avian botulism type E mortality, 2010–2012

    Science.gov (United States)

    Essian, David A.; Chipault, Jennifer G.; Lafrancois, Brenda M.; Leonard, Jill B.K.

    2016-01-01

    Waterbird die-offs caused by Clostridium botulinum neurotoxin type E (BoNT/E) have occurred sporadically in the Great Lakes since the late 1960s, with a recent pulse starting in the late 1990s. In recent die-offs, round gobies (Neogobius melanostomus) have been implicated as vectors for the transfer of BoNT/E to fish-eating birds due to the round goby invasion history and their importance as prey. Dreissenid mussels (Dreissena spp.) are also potentially involved in BoNT/E transmission to birds and round gobies. We examined gut contents of waterbirds collected in Lake Michigan during die-offs in 2010–2012, and the gut contents of culled, presumably BoNT/E-free double-crested cormorants (Phalacrocorax auritus). Round gobies were found in 86% of the BoNT/E-positive individuals, 84% of the BoNT/E-negative birds, and 94% of the BoNT/E-free cormorants examined. Double-crested cormorants, ring-billed gulls (Larus delewarensis), and common loons (Gavia immer) consumed larger-sized round gobies than horned and red-necked grebes (Podiceps auritus and Podiceps grisegena), white-winged scoters (Melanitta deglandi), and long-tailed ducks (Clangula hymealis). Other common prey included dreissenid mussels, terrestrial insects, and alewives (Alosa pseudoharengus). Our data emphasize the importance of round gobies and mussels in diets of Lake Michigan waterbirds and suggest they may play a role in the transfer of BoNT/E to waterbirds; however, round gobies and mussels were found in BoNT/E-positive, -negative, and -free individuals, suggesting that other factors, such as alternative trophic pathways for toxin transfer, bird migratory timing and feeding locations, prey behavior, and individual physiological differences across birds may affect the likelihood that a bird will succumb to BoNT/E intoxication.

  15. Dor miofascial dos músculos da mastigação e toxina botulínica

    OpenAIRE

    Dall' Antonia, Magali; Netto, Regina Martins de Oliveira; Sanches,Monique Lalue; Guimaraes, Antonio Sergio [UNIFESP

    2013-01-01

    BACKGROUND AND OBJECTIVES: Temporomandibular disorders (TMD) involve a set of craniofacial changes, which may involve temporomandibular joint (TMJ), jaw muscles and/or associated structures. Muscle TMD is the most frequent, and one of its subtypes is myofascial pain. Botulinum toxin type A (BoNT A), has been studied to control pain, including myofascial pain, and is related to pain relief mechanisms not only in neuromuscular junction receptors. This study aimed at evaluating articles addressi...

  16. Effect of 3,4-Diaminopyridine on the Survival of Mice Injected with Botulinum Neurotoxin Type A, B, E, or F,

    Science.gov (United States)

    2007-11-02

    botulism Uy caused by type A versus type B toxin have been described (Hughes et al., 1981). In a review of the clinical records from 55 cases of...intestine by C. botulinum followed by production of the toxin in vivo (Arnon et al., 1977). Occasionally, cases of human botulism result from...1966), di~e-ses similar to botulism in that neuromuscular transmission is compromised, guanidine was used to treat a case of human botulism (Cherington

  17. [Intoxication of botulinum toxin].

    Science.gov (United States)

    Chudzicka, Aleksandra

    2015-09-01

    Botulinum toxin is an egzotoxin produced by Gram positive bacteria Clostridium botulinum. It is among the most potent toxins known. The 3 main clinical presentations of botulism are as follows: foodborne botulism, infant botulism and wound botulism. The main symptom of intoxication is flat muscles paralysis. The treatment is supportive care and administration of antitoxin. In prevention the correct preparing of canned food is most important. Botulinum toxin is accepted as a biological weapon.

  18. Toxina botulínica e fisioterapia em crianças com paralisia cerebral espástica: revisão bibliográfica

    OpenAIRE

    Teles,Milena Silva; Mello,Enilda Marta Carneiro de Lima

    2011-01-01

    INTRODUÇÃO: A paralisia cerebral (PC) é definida como uma condição neurológica não progressiva originada em razão de uma lesão no encéfalo imaturo que compromete os movimentos e a postura. A espasticidade está presente em 75% dos casos. Essa patologia tem incidência na população de aproximadamente 2 em cada 1.000 nascidos vivos e pode chegar a até 7 por 1.000 em países em desenvolvimento. O objetivo do estudo foi realizar uma revisão bibliográfica por meio da seleção e análise criteriosa de a...

  19. 肉毒杆菌食物中毒五例误诊报告%Misdiagnosis Report of 5 Cases of Botulism Food Poisoning

    Institute of Scientific and Technical Information of China (English)

    贾丽君; 王泽惠

    2010-01-01

    目的 分析肉毒杆菌食物中毒的临床特点及误诊原因,探讨治疗方法.方法 对我科2010年3月收治的肉毒杆菌食物中毒5例的临床资料进行回顾性分析.结果 本组为群体发病,均为进食自家腌制的臭豆腐后起病.病初均表现为腹胀、咽干、咽痛、乏力,均于外院误诊为上呼吸道感染,2例于入院第2天出现双上肢抬举困难,考虑重症肌无力.随着病情进展均出现视物模糊、睁眼困难、眼睑下垂、顽固性便秘,于食用臭豆腐中检出肉毒杆菌,患者血清检出B型肉毒外毒素而确诊为肉毒杆菌食物中毒.明确诊断后予吸氧、鼻饲、清洁灌肠、抗感染治疗,予肉毒抗毒素B注射液治疗后全部治愈.结论 头晕、乏力、视物模糊、眼睑下垂、咀嚼无力、呼吸困难等是肉毒杆菌中毒神经系统的特征性表现,早期诊断并及时应用肉毒抗毒素是治疗成功的关键.

  20. Adeno-Associated Virus Transfer of a Gene Encoding SNAP-25 Resistant to Botulinum Toxin A Attenuates Neuromuscular Paralysis Associated with Botulism

    Science.gov (United States)

    2008-04-02

    refinement of the technology for application to genetic disorders of motor neurons. 15. SUBJECT TERMS Clostridium botulinum, neurotoxiin, serotype...peripherally transported transgenic protein successfully substituted for native cleavage-susceptible S25, as demonstrated by enhanced retention of nerve

  1. Beneficial effects of botulinum toxin type A in trigeminal neuralgia Beneficio de la toxina botulínica tipo A en neuralgia del trigemino

    OpenAIRE

    Carlos Zúñiga; Sergio Díaz; Fabián Piedimonte; Federico Micheli

    2008-01-01

    Botulinum toxin has been thoroughly studied as a potential tool in the treatment of several pain syndromes. Therefore, we assessed the clinical effects of botulinum toxin type A injections in 12 patients with otherwise unresponsive idiopathic trigeminal neuralgia. Patients were infiltrated with 20-50 units of botulinum toxin in trigger zones. Those who presented with mandibular involvement were also infiltrated in the masseter muscle. The patients were assessed on a weekly basis using the Vis...

  2. An Alternative Approach to Combination Vaccines: Intradermal Administration of Isolated Components for Control of Anthrax, Botulism, Plague and Staphylococcal Toxic Shock

    Science.gov (United States)

    2008-09-03

    retained potent antibody responses and were well- tolerated by rhesus macaques. Based on tracking of the adjuvant, the vaccines were transported from...shock were biocompatible in vivo, retained potent antibody responses, and were well tolerated by rhesus macaques. Vaccinated primates were completely...foodstuff into the trachea and lungs due to dysphagia secondary to cranial nerve paralysis after exposure to the toxin. White blood cell counts of the

  3. Identification and Biochemical Characterization of Small-Molecule Inhibitors of Clostridium Botulinum Neurotoxin Serotype A

    Science.gov (United States)

    2009-08-01

    botulism (31, 35). Worldwide, 1,000 cases of human BoNT poisoning, pre- dominantly caused by serotypes A and B, are reported yearly (17). In spite of...advances in food production and storage/ handling processes, cases of food-borne botulism persist, in- cluding a massive outbreak in Thailand (26) and...al. 2006. An outbreak of botulism in Thai- land: clinical manifestations and management of severe respiratory failure. Clin. Infect. Dis. 43:1247–1256

  4. Computer-Assisted Communication Device for Botulinum-Intoxicated Patients

    Science.gov (United States)

    2008-01-01

    1997; Sobel, 2005; Adler et al., 2007). The clinical manifestations of botulism consist of blurred vision, diplopia, dizziness, dry mouth, dysphasia...questions regarding diagnostic procedures or the need to adjust body position (Table 1). Many of these issues are applicable to botulism cases in general...Monma, C. and Kitamura, M. (2003) ‘A botulism case of a 12-year-old girl caused by intestinal colonization of Clostridium botulinum type Ab’, Jpn. J

  5. Foodborne Germs and Illnesses

    Science.gov (United States)

    ... 2020 and Food Safety Food Safety Modernization Act Foodborne Germs and Illnesses Recommend on Facebook Tweet Share Compartir Foodborne Germs Botulism Campylobacter Clostridium perfringens Cyclospora E. coli ...

  6. Comparación de resultados obtenidos en el tratamiento del dolor miofascial de la cintura pélvica con toxina botulínica sola y asociada con lidocaína

    OpenAIRE

    I. Velázquez Rivera; M. Muñoz Vico; L. Velázquez Clavarana; P. García Velasco; A. Zénner del Castillo; J. Ruiz Olivares

    2014-01-01

    Objetivos: entre el 70 y el 85 % de la población adulta sufre de dolor de espalda alguna vez en su vida. El síndrome de dolor miofascial (SDM) ha sido descrito recientemente definiéndose como dolor musculoesquelético no inflamatorio, localizado, desarrollado sin causa aparente, refractario a tratamientos farmacológicos y físicos, y se acompaña de la presencia de puntos gatillos y de bandas tensas palpables en el músculo. Su prevalencia se estima que varía entre un 30 y un 85 %. Los músculos p...

  7. Valoración del tratamiento del hombro doloroso espástico post ictus mediante la aplicación de toxina botulínica tipo A

    OpenAIRE

    Villamayor Blanco, Bibiana

    2013-01-01

    Introducción. El hombro doloroso espástico en pacientes con hemiparesia tras un ictus, es una entidad clínica frecuente. La incidencia en nuestro medio se encuentra entorno al 53%. Habitualmente se presenta una vez transcurridos los 2-3 primeros meses de evolución, aunque también se pude producir de forma precoz. El hombro doloroso en estos pacientes supone una reducción en la participación en las actividades funcionales, en el proceso rehabilitador y predice una menor recuperación funcional ...

  8. Cost-Effectiveness of Treating Upper Limb Spasticity Due to Stroke with Botulinum Toxin Type A: Results from the Botulinum Toxin for the Upper Limb after Stroke (BoTULS Trial

    Directory of Open Access Journals (Sweden)

    Nick Steen

    2012-11-01

    Full Text Available Stroke imposes significant burdens on health services and society, and as such there is a growing need to assess the cost-effectiveness of stroke treatment to ensure maximum benefit is derived from limited resources. This study compared the cost-effectiveness of treating post-stroke upper limb spasticity with botulinum toxin type A plus an upper limb therapy programme against the therapy programme alone. Data on resource use and health outcomes were prospectively collected for 333 patients with post-stroke upper limb spasticity taking part in a randomized trial and combined to estimate the incremental cost per quality adjusted life year (QALY gained of botulinum toxin type A plus therapy relative to therapy alone. The base case incremental cost-effectiveness ratio (ICER of botulinum toxin type A plus therapy was £93,500 per QALY gained. The probability of botulinum toxin type A plus therapy being cost-effective at the England and Wales cost-effectiveness threshold value of £20,000 per QALY was 0.36. The point estimates of the ICER remained above £20,000 per QALY for a range of sensitivity analyses, and the probability of botulinum toxin type A plus therapy being cost-effective at the threshold value did not exceed 0.39, regardless of the assumptions made.

  9. Study design and methods of the BoTULS trial: a randomised controlled trial to evaluate the clinical effect and cost effectiveness of treating upper limb spasticity due to stroke with botulinum toxin type A

    Directory of Open Access Journals (Sweden)

    Graham Laura

    2008-10-01

    Full Text Available Abstract Background Following a stroke, 55–75% of patients experience upper limb problems in the longer term. Upper limb spasticity may cause pain, deformity and reduced function, affecting mood and independence. Botulinum toxin is used increasingly to treat focal spasticity, but its impact on upper limb function after stroke is unclear. The aim of this study is to evaluate the clinical and cost effectiveness of botulinum toxin type A plus an upper limb therapy programme in the treatment of post stroke upper limb spasticity. Methods Trial design : A multi-centre open label parallel group randomised controlled trial and economic evaluation. Participants : Adults with upper limb spasticity at the shoulder, elbow, wrist or hand and reduced upper limb function due to stroke more than 1 month previously. Interventions : Botulinum toxin type A plus upper limb therapy (intervention group or upper limb therapy alone (control group. Outcomes : Outcome assessments are undertaken at 1, 3 and 12 months. The primary outcome is upper limb function one month after study entry measured by the Action Research Arm Test (ARAT. Secondary outcomes include: spasticity (Modified Ashworth Scale; grip strength; dexterity (Nine Hole Peg Test; disability (Barthel Activities of Daily Living Index; quality of life (Stroke Impact Scale, Euroqol EQ-5D and attainment of patient-selected goals (Canadian Occupational Performance Measure. Health and social services resource use, adverse events, use of other antispasticity treatments and patient views on the treatment will be compared. Participants are clinically reassessed at 3, 6 and 9 months to determine the need for repeat botulinum toxin type A and/or therapy. Randomisation : A web based central independent randomisation service. Blinding : Outcome assessments are undertaken by an assessor who is blinded to the randomisation group. Sample size : 332 participants provide 80% power to detect a 15% difference in treatment successes between intervention and control groups. Treatment success is defined as improvement of 3 points for those with a baseline ARAT of 0–3 and 6 points for those with ARAT of 4–56. Trial registration ISRCTN78533119 EudraCT 2004-002427-40 CTA 17136/0230/001 Funding National Institute for Health Research, Health Technology Assessment Programme. Ipsen Ltd provide botulinum toxin type A (Dysport®.

  10. Eficacia de las terapias conservadoras y la toxina botulínica en la parálisis braquial obstétrica. Revisión sistemática

    OpenAIRE

    Cruz Pedraja, Sandra

    2014-01-01

    Introducción: la parálisis braquial obstétrica (PBO) continúa siendo una de las causas más frecuentes de traumatismo obstétrico y constituye una de las lesiones más complejas de los nervios periféricos. Sin embargo, hasta la fecha no existe un acuerdo en cuanto a la estrategia de tratamiento más eficaz. Objetivos: realizar una búsqueda bibliográfica para valorar la efectividad del tratamiento conservador además de otras terapias alternativas como la Restricción – Inducción de Movimiento (C...

  11. Behaviour of individual spores of non proteolytic Clostridium botulinum as an element in quantitative risk assessment

    NARCIS (Netherlands)

    Smelt, J.P.; Stringer, S.C.; Brul, S.

    2013-01-01

    Botulism is a true food poisoning hazard. It is caused by a deadly neurotoxin produced in food by the spore forming organism Clostridium botulinum, which is found in soil all over the world. The frequency of botulism cases is rare, but each year a number of them occur. Ideally a quantitative microbi

  12. OCORRÊNCIA DE BOTULISMO EM BOVINOS CONFINADOS NO RIO GRANDE DO SUL

    Directory of Open Access Journals (Sweden)

    Franciele Maboni

    2010-12-01

    Full Text Available Botulism is the intoxication caused by a neurotoxin produced by the Clostridium botulinum, distinguished by flacid or complete skeletal musculature paralysis. This study reports a botulism outbrake in feedlot bovine, fed with corn silage. Samples of the liver, and of the intestinal and ruminal content from one of the bovine that presented typical clinical state for botulism, as well as a portion of corn silage were sent for bacterial analysis. In the laboratory, bioassay and serum neutralization were performed on rats, confirming the suspect for type C botulism. This report intends to warn veterinaries and breeders, which practice herd feedlot, because this procedure increases botulism susceptibility, and it is mainly related to the type and quality of the food ingested.

  13. Bacterial meningitis and diseases caused by bacterial toxins.

    Science.gov (United States)

    Rings, D M

    1987-03-01

    Bacterial meningitis most commonly occurs in young calves secondary to septicemia. Clinical signs of hyperirritability are usually seen. Meningitis can be confirmed by cerebrospinal fluid analysis and culture or by necropsy. Intoxications by the exotoxins of Clostridium perfringens types C and D, C. botulinum, and C. tetani are difficult to confirm. The clinical signs of these intoxications vary from flaccid paralysis (botulism) to muscular rigidity (tetanus). Treatment of affected cattle has been unrewarding in botulism and enterotoxemia, whereas early aggressive treatment of tetanus cases can often be successfully resolved. Botulism and enterotoxemia can be proved using mouse inoculation tests, whereas tetanus is diagnosed largely by ruling out other diseases.

  14. Primeiro caso de botulismo tipo F, em Portugal

    OpenAIRE

    Saraiva, Margarida; Lopes, Teresa Teixeira; Militão, André; Ribeiro, Rosa Santos; Coelho, Adelaide; Moura, Isabel Bastos; Pena, Cláudia; Bonito, Conceição Costa; Cunha, Isabel Campos; Sousa, Isabel; Toscano, Maria Manuel; Gomes, Carlos Orta; Soares, Elsa; Tavares, António; Calhau, Maria Antónia

    2016-01-01

    A nível mundial, estão descritos poucos casos de botulismo tipo F em humanos. Em julho de 2016 foi identificado o primeiro caso de botulismo tipo F, em Portugal. Foi detetada toxina botulínica tipo F (BoNT/F) nas fezes de um doente com quadro clínico típico de botulismo e isolada a estirpe de Clostridium botulinum produtora de BoNT/F. Worldwide few cases of type F botulism are described in humans. In July 2016 the first case of type F botulism in Portugal was identified. ...

  15. Botulinum Toxin; Bioterror and Biomedicinal Agent

    Directory of Open Access Journals (Sweden)

    Jiri Patocka

    2006-04-01

    Full Text Available Botulinum toxin is a group of seven homologous, highly poisonous proteins isolated fromfermentation of the anaerobic bacterium Clostridium botulinum, which naturally occurs in soiland can grow on many meats and vegetables. Botulinum toxin causes neuromuscular disordercalled botulism, which is a potentially lethal disease. There are three types of botulism: Food,wound, and infant botulism. It can lead to death unless appropriate therapy is done. Due to theseverity and potency of botulinum toxin, its importance as a biological weapon is of majorconcern to public health officials. Nevertheless, botulinum toxin is also medicament.

  16. [Botulinum toxin as a biological weapon].

    Science.gov (United States)

    Rossow, Heidi; Kinnunen, Paula M; Nikkari, Simo

    2012-01-01

    Botulism is caused by botulinum neurotoxin produced by the bacterium Clostridium botulinum. It is a flaccid paralysis in which consciousness and nociception are preserved. Natural botulism typically results from ingestion of inadequately heated or unheated vacuum-packed foods. In addition, botulinum toxin is one of the most feared biological weapons. In the diagnosis and treatment of botulism early suspicion is essential. Several coinciding or local clusters without a typical connecting source, or an uncommon type of toxin may indicate an intentionally caused epidemic.

  17. Backup information on disease losses : Bear River and Rainwater Basin

    Data.gov (United States)

    US Fish and Wildlife Service, Department of the Interior — These data are concerning the year, production, number of diseased birds picked up and estimated losses of birds to avian botulism. Data is for Bear River Migratory...

  18. Disease: H00339 [KEGG MEDICUS

    Lifescience Database Archive (English)

    Full Text Available ase in a dose-dependent fashion, resulting in symmetrical, descending, and progre...: foodborne, wound, infant botulism, and adult intestinal toxemia. Botulinum toxin blocks acetylcholine rele

  19. An investigation into the water quality of Long Lake National Wildlife Refuge, Burleigh and Kidder Counties, North Dakota

    Data.gov (United States)

    US Fish and Wildlife Service, Department of the Interior — Long Lake National Wildlife Refuge has a long history of severe botulism outbreaks killing as many as 50,000 birds in a single year. Water quality has been...

  20. Waterfowl disease contingency plan

    Data.gov (United States)

    US Fish and Wildlife Service, Department of the Interior — The purpose of this contingency plan is reduce waterfowl losses from disease, primarily avian botulism, along the eastern shore of the Great Salt Lake in Utah. This...

  1. 76 FR 29752 - Nomination of In Vitro Test Methods for Detection and Quantification of Botulinum Neurotoxins and...

    Science.gov (United States)

    2011-05-23

    ... substances, the determination of drug product potency, and/or the clinical diagnosis of botulism and (2... drugs on a case-by-case basis, subject to product-specific validation to demonstrate equivalence to...

  2. A survey of clostridium botulinum in food poisoning in Iran

    Directory of Open Access Journals (Sweden)

    Modarres Sh

    1997-09-01

    Full Text Available Food-borne botulism is one of the dangerous food poisonings in human in the world. The specimens of 115 patients (serum and stool with clinical symptoms of botulism, who were inpatient and outpatient were collected at some medical centers in Tehran and other areas of Iran, between April 1984 to August 1994. In this survey, specimens of 73 patients showed the toxin and spore of C.botulinum. Clostridium botulinum type E, was the most common causative agent in food-borne botulism, being responsible for 71.24% of all specimens; other etiologic types, in order of frequency were types A (16.43% and B (12.33%. The results of this study indicate, that the various kinds of fish, salted fish, smoked fish and canned fish, also cans of greenbeans and cucumber were causative of food-borne botulism in patients.

  3. Weakness

    Science.gov (United States)

    ... stroke After injury to a nerve During a flare-up of multiple sclerosis (MS) You may feel ... Duchenne) Myotonic dystrophy POISONING Botulism Poisoning ( insecticides , nerve gas) Shellfish poisoning OTHER Not enough healthy red blood ...

  4. Muscle function loss

    Science.gov (United States)

    ... Amyotrophic lateral sclerosis (ALS, or Lou Gehrig disease) Bell palsy Botulism Guillain-Barré syndrome Myasthenia gravis or Lambert-Eaton Syndrome Neuropathy Paralytic shellfish poisoning Periodic paralysis Focal nerve injury Polio Spinal cord injury Stroke

  5. Food poisoning

    Science.gov (United States)

    ... and toxins may cause food poisoning, including: Campylobacter enteritis Cholera E. coli enteritis Toxins in spoiled or tainted fish or shellfish ... Read More Botulism Campylobacter infection Cholera E. coli enteritis Fish tapeworm infection Pericarditis Salmonella enterocolitis Shigellosis Patient ...

  6. [Poisoning after eating sausage in observations from I Clinic of Infectious Diseases of the Slask Academy of Medicine in 1985-1992].

    Science.gov (United States)

    Oczko-Grzesik, B; Adamek, B; Kepa, L

    1993-01-01

    On the basis of our own material and the literature review the analysis of 10 cases of botulism is presented. A mild course of the disease was observed in 40%, a medium-severe course in 30% and a severe course also in 30% of patients. Fatal courses were not recorded. All patients were discharged from the Clinic in the good state of health. Etiopathogenesis, symptomatology and treatment of botulism is discussed. Attention is paid to new diagnostic method.

  7. Botulinum toxin A and physiotherapy intervention in the treatment of the painful shoulder after stroke: case report
    Toxina botulínica A e intervenção fisioterapêutica no tratamento do ombro doloroso pós acidente vascular cerebral: relato de caso

    OpenAIRE

    Suellen M. Marinho dos Santos Andrade; Mayara Dinamine França Dantas; Cristina Katya Dantas Torres; Karen Lúcia de Araújo Freitas Moreira

    2007-01-01

    The syndrome of the painful shoulder is considered a common finding in patients who suffered stroke. Several therapeutic modalities are suggested for the improvement of the patients’ clinical condition. In this report, a case of syndrome of the painful shoulder will be discussed, whose treatment consisted of the use of botulinum toxin A associated to physiotherapy. After a four-month treatment, significant improvements occurred concerning pain, spasticity, range of motion and quality of life,...

  8. Progress in Research on Methods for Determination of Bioactivity of Clostridium botulinum Toxin and Pathogenic Diagnosis of Botulism%肉毒毒素生物学活性及肉毒中毒病原检测方法的研究进展

    Institute of Scientific and Technical Information of China (English)

    张雪平; 王荫椿

    2009-01-01

    肉毒毒素生物学活性的检测和肉毒中毒诊断方法的研究进展迅速,对食品检验、肉毒中毒实验室诊断、生物反恐和肉毒毒素制品的开发及应用具有十分重要的意义.本文就肉毒毒素生物学活性及肉毒中毒病原检测方法的研究进展作一综述.

  9. Occurrence of Clostridium botulinum neurotoxin in chronic disease of dairy cows.

    Science.gov (United States)

    Seyboldt, Christian; Discher, Sabrina; Jordan, Eva; Neubauer, Heinrich; Jensen, Katharina Charlotte; Campe, Amely; Kreienbrock, Lothar; Scheu, Theresa; Wichern, Anika; Gundling, Frieder; DoDuc, Phuong; Fohler, Svenja; Abdulmawjood, Amir; Klein, Günter; Hoedemaker, Martina

    2015-06-12

    Botulism caused by neurotoxins of Clostridium (C.) botulinum is a rare, but serious life-threatening disease in humans and animals. Botulism in livestock is usually caused by the oral uptake of C. botulinum neurotoxins (BoNT) via contaminated feed and is characterized by flaccid paralysis. In the recent past a new syndrome caused by BoNT in dairy cattle was postulated. It was supposed that C. botulinum is able to colonize the lower intestine and may subsequently produce neurotoxin. The continuous resorption of small amounts of these BoNT may then provoke the so called syndrome of "chronic" or "visceral" botulism involving unspecific clinical symptoms, reduced performance of dairy cows and massive animal losses in the affected herd. To test this hypothesis a case-control study was conducted involving 92 affected farms and 47 control farms located in Northern Germany. Fecal samples of 1388 animals were investigated for the presence of BoNT to verify the key requirement of the hypothesis of chronic botulism. BoNT was not detected in any of the fecal samples using the most sensitive standard method for BoNT detection, the mouse bioassay. Therefore, the existence of "chronic" or "visceral" botulism could not be proven.

  10. Diversity of Group I and II Clostridium botulinum Strains from France Including Recently Identified Subtypes.

    Science.gov (United States)

    Mazuet, Christelle; Legeay, Christine; Sautereau, Jean; Ma, Laurence; Bouchier, Christiane; Bouvet, Philippe; Popoff, Michel R

    2016-06-13

    In France, human botulism is mainly food-borne intoxication, whereas infant botulism is rare. A total of 99 group I and II Clostridium botulinum strains including 59 type A (12 historical isolates [1947-1961], 43 from France [1986-2013], 3 from other countries, and 1 collection strain), 31 type B (3 historical, 23 recent isolates, 4 from other countries, and 1 collection strain), and 9 type E (5 historical, 3 isolates, and 1 collection strain) were investigated by botulinum locus gene sequencing and multilocus sequence typing analysis. Historical C. botulinum A strains mainly belonged to subtype A1 and sequence type (ST) 1, whereas recent strains exhibited a wide genetic diversity: subtype A1 in orfX or ha locus, A1(B), A1(F), A2, A2b2, A5(B2') A5(B3'), as well as the recently identified A7 and A8 subtypes, and were distributed into 25 STs. Clostridium botulinum A1(B) was the most frequent subtype from food-borne botulism and food. Group I C. botulinum type B in France were mainly subtype B2 (14 out of 20 historical and recent strains) and were divided into 19 STs. Food-borne botulism resulting from ham consumption during the recent period was due to group II C. botulinum B4. Type E botulism is rare in France, 5 historical and 1 recent strains were subtype E3. A subtype E12 was recently identified from an unusual ham contamination. Clostridium botulinum strains from human botulism in France showed a wide genetic diversity and seems to result not from a single evolutionary lineage but from multiple and independent genetic rearrangements.

  11. Shaping our future: animal health in a global trading environment

    Directory of Open Access Journals (Sweden)

    More Simon J

    2007-09-01

    Full Text Available Abstract In this study, the clinical findings and results of haematological and biochemical analyses of 26 cattle with botulism were evaluated. The most important clinical signs in the affected cattle included: decreased appetite, ataxia, difficulty to rise, loss of tongue tone, salivation and bradycardia. A definitive diagnosis of botulism was based on demonstration of the preformed toxin in ruminal and intestinal contents and feed materials including poultry litter, by mouse inoculation test. This study is the first confirmation, by direct toxin isolation, of Clostridium botulinum type C and Clostridium botulinum type D in cattle, in Turkey.

  12. Análise da ceratometria corneana em pacientes portadores de espasmo hemifacial

    OpenAIRE

    Pereira,Ivana Cardoso; Saraiva,Patrícia Grativol Costa; Saraiva,Fabio Petersen; MEDEIROS, Fabricio Witzel; Miki,Gustavo; Matayoshi,Suzana

    2011-01-01

    OBJETIVO: Determinar a variação da ceratometria em olhos de pacientes portadores de espasmo hemifacial submetidos a tratamento com toxina botulínica. MÉTODOS: Foram incluídos 18 pacientes portadores de espasmo hemifacial que foram submetidos ao exame oftalmológico completo, além da topografia corneana e Orbscan previamente à aplicação de toxina botulínica tipo A e 1 mês após o procedimento. RESULTADOS: Não houve diferença estatisticamente significante entre a ceratometria encontrada pela topo...

  13. BioWar: A City-Scale Multi-Agent Network Model of Weaponized Biological Attacks

    Science.gov (United States)

    2004-01-01

    Disorder Hysteria Staphylococcal Pneumonia Staphylococcal Scarlet Fever Toxic Shock Syndrome Streptococcal Pharyngitis Acute Streptococcus Pyogenes ...Pharyngitis Botulism Bronchial Asthma Bronchitis Chronic Simple Brucellosis Campylobacter Enteritis Cardiogenic Shock Acute CMU-ISRI-04-101 - 12 - CASOS...Simplex Encephalitis Hypertensive Heart Disease Hypovolemic Shock Immune Deficiency Syndrome Acquired Aids Infectious Mononucleosis Malaria

  14. Tratamento da espasticidade: uma atualização Treatment of spasticity: an update

    Directory of Open Access Journals (Sweden)

    HÉLIO A.G. TEIVE

    1998-12-01

    Full Text Available Apresentamos revisão sobre o tratamento atual da espasticidade, enfocando a terapêutica farmacológica, fisioterápica e através da utilização de toxina botulínica.We present an update about the treatment of spasticity, stressing the pharmacological treatment, physical therapy and botulinum toxin therapy.

  15. Postpartum Clostridium sordellii infection associated with fatal toxic shock syndrome

    DEFF Research Database (Denmark)

    Rørbye, C; Petersen, Ina Sleimann; Nilas, Lisbeth

    2000-01-01

    Clostridium bacteria are anaerobic Gram positive spore-form-ing bacilli, known to cause distinct clinical syndromes such as botulism, tetanus, pseudomembranous colitis and myonecrosis. The natural habitats of Clostridium species are soil, water and the gastrointestinal tract of animals and humans....... sorlellii associated toxic shock syndrome - the first recognized in Scandinavia....

  16. 75 FR 63655 - Countermeasures Injury Compensation Program (CICP): Administrative Implementation, Interim Final...

    Science.gov (United States)

    2010-10-15

    ...) botulism countermeasures; (4) the influenza antiviral drugs Tamiflu and Relenza when used for pandemic..., clinical testing or investigation, manufacture, labeling, distribution, formulation, packaging, marketing... meets the requirements of Sec. 110.3(n)(1). In the case of 2009 H1N1 vaccines, this inquiry...

  17. Project BioShield: Purposes and Authorities

    Science.gov (United States)

    2009-07-06

    billion to acquire countermeasures against anthrax, botulism , radiation, and smallpox. The HHS has also employed the emergency use authority...HHS to purchase unapproved and unlicensed countermeasures. It requires the HHS Secretary to determine that “... sufficient and satisfactory clinical ...identify cases of this disease.15 As of October 2008, antibiotic kits containing Doxycycline Hyclate are allowed to be distributed to certain people

  18. Technical Reference Manual: NATO Planning Guide for the Estimation of Chemical, Biological, Radiological, and Nuclear (CBRN), Casualties, Allied Medical Publication-8(C)

    Science.gov (United States)

    2010-08-01

    chemical blister agent HD (distilled mustard); the biological agents causing anthrax, botulism, pneumonic plague, smallpox, and Venezuelan equine ...Countermeasures—Vaccination/ Antibiotic Prophylaxis ............181 7. Literature Review and Parameter Development .......................................181 8...203 4. Venezuelan Equine Encephalitis (VEE) ....................................................212 E

  19. Research for a Swan Vaccine Serves as the Impetus for the Development of a Science and Reading Curriculum for K-16 and Adult Learners.

    Science.gov (United States)

    Funk, Fanchon F.; Bolin, Sheila A.

    2002-01-01

    In 1999, investigators from Florida's Regal Swan Project researched the care of captive swans in hotels, resorts, educational settings, and municipalities. This led to a vaccine to mitigate swan deaths from botulism and a book with standards and guidelines for swan keepers worldwide. Research was shared through a science and reading curriculum…

  20. The Medicinal Chemistry of Botulinum, Ricin and Anthrax Toxins

    Science.gov (United States)

    2005-01-01

    North Korea that botulism is the accurate diagnosis. Similar entities such and Syria are believed to be actively involved in the as Guillain - Barre ...Utniversitv ol"Liege. Liege, Belgium) Zbigniew J. Witezak (Wilkes University, Wilkes- Barre , LISA) Subscriptions: Current Medicinal Chemistry (ISSN: 0929-8673

  1. Clostridium botulinum neurotoxin type B is heat-stable in milk and not inactivated by pasteurization

    Science.gov (United States)

    Foodborne botulism is caused by the ingestion of foods containing botulinum neurotoxins (BoNTs). Currently, the only accepted assay to detect active C. botulinum neurotoxin is an in vivo mouse bioassay, which raises ethical concerns with regard to the use of experimental animals. Therefore, there is...

  2. The Characterization and Manipulation of the Reticulated Microbiome in Vertebrates

    DEFF Research Database (Denmark)

    Roggenbuck, Michael

    the tissue and easies the birds to feed large carrions. However, feeding on carcass is associated to the potential exposure of bacterial toxins, with severe outcome such as avian botulism. As Ley et al (2008) described – diet is the key driver of microbial composition of the digestive system in vertebrates...

  3. Defending the Military Food Supply Acquisition, Preparation, and Protection of Food at U.S. Military Installations

    Science.gov (United States)

    2009-09-01

    peppers from Mexico in the summer of 2008)5 can be an effective vector for illness. The cases mentioned above are due to lapses in food safety, so what...BIOTERRORISM AGENTS AND DISEASES CDC CATEGORY A17 CDC CATEGORY B18 SELECT HHS/USDA19 ANTHRAX CHOLERA BRUCELLOSIS BOTULISM E.COLI EPSILON TOXIN PLAGUE

  4. Summary of Notifiable Diseases, United States, 1995. Volume 44/No. 53

    Science.gov (United States)

    2007-11-02

    Shigellosis* Streptococcal disease, invasive, group A+ Streptococcus pneumoniae , drug-resistanf Streptococcal toxic-shock syndrome* Syphilis...regarding botulism, Escherichia co//0157:H7, Salmonella, Shigella, and penicillin -nonsusceptible S. pneumoniae [PNSP]) Division of HIV/AIDS Division of...and 229 children who had AIDS. Penicillin -Nonsusceptible S. pneumoniae The prevalence of cases of penicillin -nonsusceptible S. pneumoniae * (PNSP

  5. In situ detection of the Clostridium botulinum type C1 toxin gene in wetland sediments with a nested PCR assay

    Science.gov (United States)

    Williamson, J.L.; Rocke, T.E.; Aiken, Judd M.

    1999-01-01

    A nested PCR was developed for detection of the Clostridium botulinum type C1 toxin gene in sediments collected from wetlands where avian botulism outbreaks had or had not occurred. The C1 toxin gene was detected in 16 of 18 sites, demonstrating both the ubiquitous distribution of C. botulinum type C in wetland sediments and the sensitivity of the detection assay.

  6. Clostridium botulinum group I strain genotyping by 15-locus multilocus variable-number tandem-repeat analysis

    NARCIS (Netherlands)

    Fillo, S.; Giordani, F.; Anniballi, F.; Gorgé, O.; Ramisse, V.; Vergnaud, G.; Riehm, J.M.; Scholz, H.C.; Splettstoesser, W.D.; Kieboom, J.; Olsen, J.-S.; Fenicia, L.; Lista, F.

    2011-01-01

    Clostridium botulinum is a taxonomic designation that encompasses a broad variety of spore-forming, Gram-positive bacteria producing the botulinum neurotoxin (BoNT). C. botulinum is the etiologic agent of botulism, a rare but severe neuroparalytic disease. Fine-resolution genetic characterization of

  7. Type C and C/D toxigenic Clostridium botulinum is not normally present in the intestine of healthy broilers.

    Science.gov (United States)

    Hardy, Simon P; Kaldhusdal, Magne

    2013-08-30

    Toxigenic Clostridium botulinum spores are widely distributed in wetland environments and are frequently recovered from healthy wild birds, where ingestion of toxic maggots from carcasses is considered a major initiating factor for botulism outbreaks. Toxic carcasses can perpetuate an existing outbreak also in poultry, but their importance as an initiating factor for poultry botulism is less clear. Although toxigenic C. botulinum can be recovered from healthy broilers during outbreaks, there are almost no data on the prevalence in healthy broiler flocks (and, by extension, carcasses) and their environment. To test the hypothesis that toxigenic C. botulinum is frequently present in healthy broilers, we examined 100 healthy broiler flocks and environmental samples from 30 broiler houses 3 to 4 years after an epidemic of botulism in the broiler population. None of the 100 flocks yielded type C or C/D botulinum toxin genes using real time PCR whereas a flock house that had remained empty since the most recent outbreak yielded type C (or C/D) toxin genes. The absence of toxigenic C. botulinum in all examined flocks indicates that botulism is a sporadic and exogenously acquired event in this broiler population and unlikely to mirror the epidemiology in wild birds.

  8. Biodefense and Bioterrorism - Multiple Languages: MedlinePlus

    Science.gov (United States)

    ... sharing features on this page, please enable JavaScript. Amharic (amarunya) Arabic (العربية) Chinese - Simplified (简体中文) Chinese - Traditional ( ... Somali (af Soomaali) Spanish (español) Vietnamese (Tiếng Việt) Amharic (amarunya) Botulism English amarunya (Amharic) PDF Minnesota Department ...

  9. Development and Partial Characterization of High-affinity Monoclonal Antibodies for Botulinum Toxin Type A and their use in Analysis of Milk by Sandwich ELISA

    Science.gov (United States)

    Botulinum neurotoxins (BoNT), produced by the anaerobic bacterium Clostridium botulinum, cause severe neuroparalytic disease and are considered the most toxic biological agents known. While botulism is rare in the US, it often is fatal if not treated quickly, and recovery is long, requiring intensiv...

  10. The changes of serum proteome and tissular pathology in mouse induced by botulinum toxin E injection.

    Science.gov (United States)

    Wang, J F; Mao, X Y; Zhao, C

    2014-01-01

    The experiment were performed to investigate the poisoning-related proteins and main pathological changes after mouse suffered from injection of botulinum toxin serotype E. Dose of 0.75 LD50 botulinum toxin serotype E per mice were administrated by intraperitoneal injection. Survival mouse were picked as experimental group. The blood were collected from orbital blood and serum sample was separated by centrifugation. The heart, liver, spleen, lung, kidney were fixed in 10 % neutral buffered formalin and then developed paraffin sections. Serum protein components were analyzed by SDS-PAGE gel electrophoresis coupled with 2-DE SDS-PAGE gel electrophoresis. Differentially expressed proteins were analyzed by PDQUest8.0 software and subjected to ion trap mass spectrometry equipped with a high performance liquid chromatography system. The observation of pathological section showed that heart, liver, spleen, lung, kidney exhibited pathological changes in different degree, especially in heart, liver and lung tissues. Heart muscle tissue display serious inflammatory response, heart muscle fiber compulsively expanded and filled with erythrocyte and inflammatory exudates, some heart muscle fiber ruptured, even necrosis; hepatic cell in edge of liver occur apoptosis and some hepatic cell have disintegrated, and even died; pulmonary alveoli broken and partial vein filled with blood. Serum proteins component present a significant changes between control serum and botulism in 24 h by SDS-PAGE gel electrophoresis and 2-DE-SDS-PAGE gel electrophoresis. Twenty differentially expressed protein spots were observed in 2-DE profiles, in which 14 protein spots were undetectable in serum proteome under botulism, 3 protein spots exclusively expressed in state of botulism, 3 protein spots were low-expressed in serum proteome under botulism. Fourteen proteins have been identified among 20 spots elected on two-dimensional electrophoresis gels. Crystal proteins family exclusively expressed in

  11. Science, practice, and human errors in controlling Clostridium botulinum in heat-preserved food in hermetic containers.

    Science.gov (United States)

    Pflug, Irving J

    2010-05-01

    The incidence of botulism in canned food in the last century is reviewed along with the background science; a few conclusions are reached based on analysis of published data. There are two primary aspects to botulism control: the design of an adequate process and the delivery of the adequate process to containers of food. The probability that the designed process will not be adequate to control Clostridium botulinum is very small, probably less than 1.0 x 10(-6), based on containers of food, whereas the failure of the operator of the processing equipment to deliver the specified process to containers of food may be of the order of 1 in 40, to 1 in 100, based on processing units (retort loads). In the commercial food canning industry, failure to deliver the process will probably be of the order of 1.0 x 10(-4) to 1.0 x 10(-6) when U.S. Food and Drug Administration (FDA) regulations are followed. Botulism incidents have occurred in food canning plants that have not followed the FDA regulations. It is possible but very rare to have botulism result from postprocessing contamination. It may thus be concluded that botulism incidents in canned food are primarily the result of human failure in the delivery of the designed or specified process to containers of food that, in turn, result in the survival, outgrowth, and toxin production of C. botulinum spores. Therefore, efforts in C. botulinum control should be concentrated on reducing human errors in the delivery of the specified process to containers of food.

  12. Avian disease at the Salton Sea

    Science.gov (United States)

    Friend, M.

    2002-01-01

    A review of existing records and the scientific literature was conducted for occurrences of avian diseases affecting free-ranging avifauna within the Salton Sea ecosystem. The period for evaluation was 1907 through 1999. Records of the U.S. Department of Agriculture, Bureau of Biological Survey and the scientific literature were the data sources for the period of 1907a??1939. The narrative reports of the U.S. Fish and Wildlife Service's Sonny Bono National Wildlife Refuge Complex and the epizootic database of the U.S. Geological Survey's National Wildlife Health Center were the primary data sources for the remainder of the evaluation. The pattern of avian disease at the Salton Sea has changed greatly over time. Relative to past decades, there was a greater frequency of major outbreaks of avian disease at the Salton Sea during the 1990s than in previous decades, a greater variety of disease agents causing epizootics, and apparent chronic increases in the attrition of birds from disease. Avian mortality was high for about a decade beginning during the mid-1920s, diminished substantially by the 1940s and was at low to moderate levels until the 1990s when it reached the highest levels reported. Avian botulism (Clostridium botulinum type C) was the only major cause of avian disease until 1979 when the first major epizootic of avian cholera (Pasteurella multocidia) was documented. Waterfowl and shorebirds were the primary species affected by avian botulism. A broader spectrum of species have been killed by avian cholera but waterfowl have suffered the greatest losses. Avian cholera reappeared in 1983 and has joined avian botulism as a recurring cause of avian mortality. In 1989, avian salmonellosis (Salmonella typhimurium) was first diagnosed as a major cause of avian disease within the Salton Sea ecosystem and has since reappeared several times, primarily among cattle egrets (Bubulcus ibis). The largest loss from a single epizootic occurred in 1992, when an estimated

  13. El fisioterapeuta en la prevención de lesiones del deporte

    OpenAIRE

    Adamuz Cervera, Francisco Javier; Nerín Rotger, Mª Antonia

    2006-01-01

    Introducción: La parálisis cerebral es la causa más común de espasticidad en niños y la toxina botulínica A es un opción para su el tratamiento, ya que produce una parálisis local al ser inyectada en un músculo. Objetivo: Comprobar la eficacia de la aplicación de toxina botulínica y fisioterapia en la parálisis cerebral infantil. Material y método: Se ha realizado una búsqueda en diversas bases de datos electrónicas como son Freejournals, Doyma, Medline, Google y revistas de neuro...

  14. Being prepared: bioterrorism and mass prophylaxis: part II.

    Science.gov (United States)

    Weant, Kyle A; Bailey, Abby M; Fleishaker, Elise L; Justice, Stephanie B

    2014-01-01

    Although several biological agents have been recognized as presenting a significant threat to public health if used in a bioterrorist attack, those that are of greatest importance are known as the Category A agents: Bacillus anthracis (anthrax); variola major (smallpox); Yersinia pestis (plague); Francisella tularensis (tularemia); ribonucleic acid viruses (hemorrhagic fevers); and Clostridium botulinum (botulism toxin). In the previous issue, Part I of this review focused on the clinical presentation and treatment of anthrax, plague, and tularemia. In this second part of this 2-part review of these agents, the focus is on the clinical presentation and treatment of smallpox, viral hemorrhagic fevers, and botulism toxin. The utilization of mass prophylaxis to limit the morbidity and mortality associated with all these agents is also discussed along with the role emergency care personnel play in its implementation.

  15. Being prepared: bioterrorism and mass prophylaxis: part I.

    Science.gov (United States)

    Weant, Kyle A; Bailey, Abby M; Fleishaker, Elise L; Justice, Stephanie B

    2014-01-01

    Bioterrorism presents a real and omnipresent risk to public health throughout the world. More than 30 biological agents have been identified as possessing the potential to be deployed in a bioterrorist attack. Those that have been determined to be of the greatest concern and possess the greatest potential of use in this arena are known as the Category A agents: Bacillus anthracis (anthrax); Variola major (smallpox); Yersinia pestis (plague); Francisella tularensis (tularemia); viral hemorrhagic fevers; and Clostridium botulinum toxin (botulism toxin). Although the Centers for Disease Control and Prevention utilizes surveillance systems to identify illnesses, the weight of diagnosing, effectively treating, and notifying the appropriate public health officials lies squarely on the shoulders of emergency care personnel. Part I of this two-part review will focus on the clinical presentation and treatment of anthrax, plague, and tularemia. The subsequent Part II of this review will discuss smallpox, viral hemorrhagic fevers, botulism toxin, and the provision of mass prophylaxis.

  16. Comparative sequence analyses of the neurotoxin complex genes in Clostridium botulinum serotypes A, B, E, and F

    Directory of Open Access Journals (Sweden)

    Ajay K. Singh

    2012-09-01

    Full Text Available Neurotoxin complex (NTC genes are arranged in two known hemagglutinin (HA and open reading frame X (ORFX clusters. NTC genes have been analyzed in four serotypes A, B, E and F of Clostridium botulinum causing human botulism. Analysis of amino acid sequences of NT genes demonstrated significant differences among subtypes and four serotypes. Phylogram tree of NT genes reveals that serotypes A1 and B1 are much closer compared to serotype E1 and F1. However, non-toxic non-hemagglutinin (NTNH gene is highly conserved among four serotypes. Analysis of phylogram tree of NTNH gene reveals that serotypes A and F are more closely related compared to serotype B and E. Additionally, sequences of HAs and ORFX genes are very divergent but these genes are specific in subtypes and serotypes of Clostridium botulinum. Information derived from sequence analyses of NTC has direct implication in development of detection tools and therapeutic countermeasures for botulism.

  17. Risk Assessment Report, Davis Global Communications Site

    Science.gov (United States)

    1994-02-23

    selenium concentrations of 10 gg/l have been associated with impaired hatchability in shorebirds, and concentrations of 10 to 20 1&g/l have been associated...could include botulism outbreaks and selenium toxicity under certain conditions. I However, adherence to proper management practices should reduce...Medium Contaminnts Soil TPH 3 Groundwater Antimony IronI Lead Nickel Selenium Thallium 3 Soil gas None Notes: 3 Diesel is a COPC only in the soil piles

  18. Central Nervous System Toxicity After Botulinum Neurotoxin Injection

    Science.gov (United States)

    Ilkhchoui, Yashar; Ghaly, Ramsis F.; Knezevic, N. Nick; Candido, Kenneth D

    2013-01-01

    Since Its first description of botulism toxicity in 1820s, specific formulations of botulinum neurotoxin (BoNT) have been introduced with different clinical benefits. However, there is increasing number of adverse events reported to Food and Drug Administration. This report presents the case of 62-year-old woman with Parkinson’s disease who received BoNT injections to treat painful spasticity in her hands. She developed severe generalized dystonia shortly after BoNT injections. PMID:24223367

  19. Botulinum Neurotoxins

    Science.gov (United States)

    2012-03-28

    200,000 people were infected with an antibiotic -resistant strain of Salmonella caused by an inadvertent contamination at a single northern Illinois dairy...Fenecia et al., 1999). The disease has also been correlated with alteration of protective endogenous microflora by broad-spectrum antibiotics after... equine antitoxin, and discharged after 9 days. While not a naturally occurring form of the disease, inhalational botulism has implications as a

  20. NATO Planning Guide for the Estimation of Chemical, Biological, Radiological, and Nuclear (CBRN) Casualties (AMedP-8(C)) - Parameters for Estimation of Casualties from Exposure to Specified Biological Agents. Addenda to Allied Medical Publication 8

    Science.gov (United States)

    2011-01-01

    estimating the numbers of persons developing illness or dying from anthrax, botulism, Venezuelan equine encephalitis, plague, and smallpox. Five additional...the non-contagious biological agent explanation in Section 0106.7b, following the Venezuelan equine encephalitis (VEE) assumptions and limitations...comprehensive clinical studies of tularemia available were reported in the pre- antibiotic era before inhalation was understood to be a potential route of

  1. The resources of neurophysiological methods for diagnostic localization of nervous system lesion in children’s neuroinfections

    Directory of Open Access Journals (Sweden)

    V. N. Komantsev

    2010-01-01

    Full Text Available The algorithms of neurophysiological diagnostic of impairment localization of nervous system in acute phase of neuroinfection in children were elaborated. The combined some EMG and evoked potentials methods were reliable for diagnostic botulism, polyneuropathy, mononeuropathy, polyradiculopathy, poliomyelitis, inflammation myelopathy, myelitis, meningitis, encephalitis. The reliability of neuriphysiologic diagnostic was 81–93%.

  2. A descriptive study of reportable gastrointestinal illnesses in Ontario, Canada, from 2007 to 2009

    OpenAIRE

    Vrbova Linda; Johnson Karen; Whitfield Yvonne; Middleton Dean

    2012-01-01

    Abstract Background Gastrointestinal illnesses (GI) continue to pose a substantial burden in terms of morbidity and economic impact in Canada. We describe the epidemiology of reportable GI in Ontario by characterizing the incidence of each reportable GI, as well as associated demographics, clinical outcomes, seasonality, risk settings, and likely sources of infection. Methods Reports on laboratory confirmed cases of amebiasis, botulism, campylobacteriosis, cryptosporidiosis, cyclosporiasis, g...

  3. Production and evaluation of a recombinant chimeric vaccine against clostridium botulinum neurotoxin types C and D.

    Science.gov (United States)

    Gil, Luciana A F; da Cunha, Carlos Eduardo P; Moreira, Gustavo M S G; Salvarani, Felipe M; Assis, Ronnie A; Lobato, Francisco Carlos F; Mendonça, Marcelo; Dellagostin, Odir A; Conceição, Fabricio R

    2013-01-01

    Bovine botulism is a fatal disease that is caused by botulinum neurotoxins (BoNTs) produced by Clostridium botulinum serotypes C and D and that causes great economic losses, with nearly 100% lethality during outbreaks. It has also been considered a potential source of human food-borne illness in many countries. Vaccination has been reported to be the most effective way to control bovine botulism. However, the commercially available toxoid-based vaccines are difficult and hazardous to produce. Neutralizing antibodies targeted against the C-terminal fragment of the BoNT heavy chain (HC) are known to confer efficient protection against lethal doses of BoNTs. In this study, a novel recombinant chimera, consisting of Escherichia coli heat-labile enterotoxin B subunit (LTB), a strong adjuvant of the humoral immune response, fused to the HC of BoNT serotypes C and D, was produced in E. coli. Mice vaccinated with the chimera containing LTB and an equivalent molar ratio of the chimera without LTB plus aluminum hydroxide (Al(OH)3) developed 2 IU/mL of antitoxins for both serotypes. Guinea pigs immunized with the recombinant chimera with LTB plus Al(OH)3 developed a protective immune response against both BoNT/C (5 IU/mL) and BoNT/D (10 IU/mL), as determined by a mouse neutralization bioassay with pooled sera. The results achieved with guinea pig sera fulfilled the requirements of commercial vaccines for prevention of botulism, as determined by the Brazilian Ministry of Agriculture, Livestock and Food, Supply. The presence of LTB was essential for the development of a strong humoral immune response, as it acted in synergism with Al(OH)3. Thus, the vaccine described in this study is a strong candidate for the control of botulism in cattle.

  4. Production and evaluation of a recombinant chimeric vaccine against clostridium botulinum neurotoxin types C and D.

    Directory of Open Access Journals (Sweden)

    Luciana A F Gil

    Full Text Available Bovine botulism is a fatal disease that is caused by botulinum neurotoxins (BoNTs produced by Clostridium botulinum serotypes C and D and that causes great economic losses, with nearly 100% lethality during outbreaks. It has also been considered a potential source of human food-borne illness in many countries. Vaccination has been reported to be the most effective way to control bovine botulism. However, the commercially available toxoid-based vaccines are difficult and hazardous to produce. Neutralizing antibodies targeted against the C-terminal fragment of the BoNT heavy chain (HC are known to confer efficient protection against lethal doses of BoNTs. In this study, a novel recombinant chimera, consisting of Escherichia coli heat-labile enterotoxin B subunit (LTB, a strong adjuvant of the humoral immune response, fused to the HC of BoNT serotypes C and D, was produced in E. coli. Mice vaccinated with the chimera containing LTB and an equivalent molar ratio of the chimera without LTB plus aluminum hydroxide (Al(OH3 developed 2 IU/mL of antitoxins for both serotypes. Guinea pigs immunized with the recombinant chimera with LTB plus Al(OH3 developed a protective immune response against both BoNT/C (5 IU/mL and BoNT/D (10 IU/mL, as determined by a mouse neutralization bioassay with pooled sera. The results achieved with guinea pig sera fulfilled the requirements of commercial vaccines for prevention of botulism, as determined by the Brazilian Ministry of Agriculture, Livestock and Food, Supply. The presence of LTB was essential for the development of a strong humoral immune response, as it acted in synergism with Al(OH3. Thus, the vaccine described in this study is a strong candidate for the control of botulism in cattle.

  5. Pentavalent replicon vaccines against botulinum neurotoxins and tetanus toxin using DNA-based Semliki Forest virus replicon vectors

    OpenAIRE

    2014-01-01

    The clostridial neurotoxin (CNT) family includes botulinum neurotoxin (BoNT), serotypes A, B, E, and F of which can cause human botulism, and tetanus neurotoxin (TeNT), which is the causative agent of tetanus. This suggests that the greatest need is for a multivalent or multiagent vaccine that provides protection against all 5 agents. In this study, we investigated the feasibility of generating several pentavalent replicon vaccines that protected mice against BoNTs and TeNT. First, we evaluat...

  6. Summary of Notifiable Diseases, United States. Volume 45, Number 53.

    Science.gov (United States)

    1997-10-31

    the National Level During 1996 Acquired immunodeficiency syndrome Anthrax Botulism* Brucellosis Chancroid* Chlamydia trachomatis, genital...plague among humans, two of which were fatal, were re- ported in the United States (two cases in Arizona, one in Colorado, and two in New Mexico ). Both...13 cases per year) were reported in the United States. Of these cases, 80% occurred in the southwestern states of New Mexico , Arizona, and

  7. Detection, differentiation, and identification of botulinum neurotoxin serotypes C, CD, D, and DC by highly specific immunoassays and mass spectrometry.

    Science.gov (United States)

    Hansbauer, Eva-Maria; Skiba, Martin; Endermann, Tanja; Weisemann, Jasmin; Stern, Daniel; Dorner, Martin B; Finkenwirth, Friedrich; Wolf, Jessica; Luginbühl, Werner; Messelhäußer, Ute; Bellanger, Laurent; Woudstra, Cédric; Rummel, Andreas; Fach, Patrick; Dorner, Brigitte G

    2016-09-21

    Botulinum neurotoxin (BoNT) serotypes C and D and their mosaic variants CD and DC cause severe cases of botulism in animal husbandry and wildlife. Epidemiological data on the exact serotype or toxin variant causing outbreaks are rarely available, mainly because of their high sequence identity and the lack of fast and specific screening tools to detect and differentiate the four similar toxins. To fill this gap, we developed four highly specific sandwich enzyme-linked immunosorbent assays (ELISAs) able to detect and differentiate botulinum neurotoxins type BoNT/C, D, CD, and DC based on four distinct combinations of specific monoclonal antibodies targeting both conserved and divergent subdomains of the four toxins. Here, highly sensitive detection with detection limits between 2 and 24 pg mL(-1) was achieved. The ELISAs were extensively validated and results were compared with data obtained by quantitative real-time PCR using a panel of Clostridium botulinum strains, real sample materials from veterinary botulism outbreaks, and non-BoNT-producing Clostridia. Additionally, in order to verify the results obtained by ELISA screening, the new monoclonal antibodies were used for BoNT enrichment and subsequent detection (i) on a functional level by endopeptidase mass spectrometry (Endopep-MS) assays and (ii) on a protein sequence level by LC-MS/MS spectrometry. Based on all technical information gathered in the validation study, the four differentiating ELISAs turned out to be highly reliable screening tools for the rapid analysis of veterinary botulism cases and should aid future field investigations of botulism outbreaks and the acquisition of epidemiological data.

  8. Human and animal health on three continents--a biography of the early life of Karl Friedrich Meyer (1884-1974).

    Science.gov (United States)

    Pospischil, Andreas

    2015-08-01

    Karl Friedrich Meyer (KF) was born and educated as a veterinarian in Europe; he researched infectious diseases in Europe, South Africa and the United States. He is one of the true forefathers of the 'one health-one medicine' concept. The broad scope of his research covered botulism, leptospirosis, brucellosis, plague, ornithosis, Western equine encephalitis, mussel poisoning and clostridia. This manuscript adds some more details of his early biography.

  9. An Update on the Surgeons Scope and Depth of Practice to All Hazards Emergency Response

    Science.gov (United States)

    2006-06-01

    anthrax, botulism, plague, smallpox, tularemia, and the viral hemorrhagic fevers (filoviruses, e.g. Ebola; arenaviruses, e.g. Lassa fever )8–22 that...social change, acts that now would be considered acts of terrorism. The word “terrorism” was first used in 1795, deriving its origin from the French...Clostridium botulinum toxin) Plague (Yersinia pestis) Smallpox (variola major) Tularemia (Francisella tularensis) Viral hemorrhagic fevers (filoviruses e.g

  10. Detection of Clostridium botulinum neurotoxin genes (A-F) in dairy farms from Northern Germany using PCR: A case-control study.

    Science.gov (United States)

    Fohler, Svenja; Discher, Sabrina; Jordan, Eva; Seyboldt, Christian; Klein, Guenter; Neubauer, Heinrich; Hoedemaker, Martina; Scheu, Theresa; Campe, Amely; Charlotte Jensen, Katharina; Abdulmawjood, Amir

    2016-06-01

    Classical botulism in cattle mainly occurs after ingestion of feed contaminated with preformed toxin. In 2001 a form of botulism ("visceral botulism") was postulated to occur after ingestion of Clostridium (C.) botulinum cells or spores, followed by colonization of the intestine, and local production of botulinum neurotoxin (BoNT) causing chronic generalized disease. To verify the potential role of C. botulinum in the described syndrome, a case-control study was conducted, including 139 farms. Fecal samples, rumen content, water and silage samples were collected on each farm. Real time BoNT gene PCR assays were conducted after enrichment in RCM (Reinforced Clostridial Medium) at 37 °C and conventional PCRs after enrichment in MCM (Modified Cooked Meat Medium) at 30 °C. Furthermore, a direct detection of BoNT genes without prior enrichment was attempted. BoNT A, B, C, D, E and F genes were detected in animal samples from 25 (17.99%), 3 (2.16%), 0 (0.0%), 2 (1.44%), 1 (0.72%), and 3 (2.16%) farms, respectively. Eleven feed samples were positive for BoNT A gene. By enrichment a significant increase in sensitivity was achieved. Therefore, this should be an essential part of any protocol. No significant differences regarding BoNT gene occurrence could be observed between Case and Control farms or chronically diseased and clinically healthy animals within the particular category. Thus, the postulated form of chronic botulism in cows could not be confirmed. This study supports the general opinion that C. botulinum can occasionally be found in the rumen and intestine of cows without causing disease.

  11. Independent evolution of neurotoxin and flagellar genetic loci in proteolytic Clostridium botulinum

    Directory of Open Access Journals (Sweden)

    Twine Susan M

    2009-03-01

    Full Text Available Abstract Background Proteolytic Clostridium botulinum is the causative agent of botulism, a severe neuroparalytic illness. Given the severity of botulism, surprisingly little is known of the population structure, biology, phylogeny or evolution of C. botulinum. The recent determination of the genome sequence of C. botulinum has allowed comparative genomic indexing using a DNA microarray. Results Whole genome microarray analysis revealed that 63% of the coding sequences (CDSs present in reference strain ATCC 3502 were common to all 61 widely-representative strains of proteolytic C. botulinum and the closely related C. sporogenes tested. This indicates a relatively stable genome. There was, however, evidence for recombination and genetic exchange, in particular within the neurotoxin gene and cluster (including transfer of neurotoxin genes to C. sporogenes, and the flagellar glycosylation island (FGI. These two loci appear to have evolved independently from each other, and from the remainder of the genetic complement. A number of strains were atypical; for example, while 10 out of 14 strains that formed type A1 toxin gave almost identical profiles in whole genome, neurotoxin cluster and FGI analyses, the other four strains showed divergent properties. Furthermore, a new neurotoxin sub-type (A5 has been discovered in strains from heroin-associated wound botulism cases. For the first time, differences in glycosylation profiles of the flagella could be linked to differences in the gene content of the FGI. Conclusion Proteolytic C. botulinum has a stable genome backbone containing specific regions of genetic heterogeneity. These include the neurotoxin gene cluster and the FGI, each having evolved independently of each other and the remainder of the genetic complement. Analysis of these genetic components provides a high degree of discrimination of strains of proteolytic C. botulinum, and is suitable for clinical and forensic investigations of botulism

  12. Avaliação da toxigênese de c. botulinum em mortadela e presunto

    OpenAIRE

    Valéria Christina Junqueira Amstalden; Antônio de Melo Serrano; Maria Raquel Manhani

    1997-01-01

    The risk of transmitting botulism via mortadella and cooked ham was evaluated in this research. In a first phase, samples of mortadella and cooked ham were acquired at random from shops in the region of Campinas - SP. Twenty five samples of each product were acquired and examined in duplicate to determine the pH, water activity (Aw), sodium chloride and sodium nitrite concentrations and water content. The storage times and temperatures at the distributers were also determined in this phase. O...

  13. Expression and Purification of Clostridium botulinum Type B Light Chain

    Science.gov (United States)

    2005-10-26

    expression system Previously, tetanus toxin fragment C had been expressed in E. coli at 3–4% cell protein. The sequence for Clostridium tetani was...Protein Expression and PuriWcation 46 (2006) 256–267 www.elsevier.com/locate/yprepExpression, puriWcation, and characterization of Clostridium ...mechanical ventilation. Botulism is a neuroparalytic disease caused by seven immunologically distinct neurotoxins (types A-G) produced by Clostridium

  14. Consumers’ perception and knowledge of food safety: results of questionnaires accessible on IZSalimenTO website

    Directory of Open Access Journals (Sweden)

    Amaranta Traversa

    2015-04-01

    Full Text Available The present survey was undertaken to investigate consumers’ knowledge of the main foodborne agents and dietary regimen during pregnancy. Data were collected using monthly questionnaires available on IZSalimenTO website between March 2013 and January 2014. Hepatitis A virus questionnaire: 20 respondents (77% recognized berries as foodstuff linked to the outbreak of hepatitis A. The majority correctly indicated as precautionary advice to boil berries before consumption. Botulism questionnaire: 29 respondents (62% indicated pesto as food involved in botulism alert in July 2013. The risk of infant botulism in infant less than 1 year old due to honey consumption is known by 24 respondents (51%. Main foodborne disease questionnaire: the risk of infection by Salmonella after the consumption of foods made with raw eggs is known by the majority (94%; N=17 as well as the treatments to be applied in order to make fresh fish safe from parasites (76%. Pregnancy questionnaire: 20 respondents (74% believed that washing vegetables and fruits with sodium bicarbonate or chlorate solution is able to inactivate Toxoplasma; only 4 (15% reported both raw meat and vegetables washed with sodium bicarbonate as food at risk. Results indicate that all consumers should be trained on behaviour and dietary regimen to be adopted in pregnancy and in infant <1 year old. The website may be considered as a useful tool to assess consumers’ knowledge: both the news section and the contents published may be a source of information and education for consumers on food safety.

  15. From poison to remedy: the chequered history of botulinum toxin.

    Science.gov (United States)

    Erbguth, F J

    2008-01-01

    Botulinum toxin poisoning has afflicted mankind through the mists of time. However, the first incident of food-borne botulism was documented as late as the 18th century, when the consumption of meat and blood sausages gave rise to many deaths throughout the kingdom of Württemberg in South Western Germany. The district medical officer Justinus Kerner (1786--1862), who was also a well-known German poet, published the first accurate and complete descriptions of the symptoms of food-borne botulism between 1817 and 1822 and attributed the intoxication to a biological poison. Kerner also postulated that the toxin might be used for treatment purposes. In 1895, an outbreak of botulism in the small Belgian village of Ellezelles led to the discovery of the pathogen "Clostridium botulinum" by Emile Pierre van Ermengem. Modern botulinum toxin treatment was pioneered by Alan B. Scott and Edward J. Schantz in the early 1970s, when the type-A serotype was used in medicine to correct strabismus. Other preparations of the type-A toxin were developed and manufactured in the United Kingdom, Germany, and China, whereas a therapeutic type-B toxin was prepared in the United States. To date, the toxin has been used to treat a wide variety of conditions associated with muscular hyperactivity, glandular hypersecretions and pain.

  16. New Elements To Consider When Modeling the Hazards Associated with Botulinum Neurotoxin in Food.

    Science.gov (United States)

    Ihekwaba, Adaoha E C; Mura, Ivan; Malakar, Pradeep K; Walshaw, John; Peck, Michael W; Barker, G C

    2015-09-08

    Botulinum neurotoxins (BoNTs) produced by the anaerobic bacterium Clostridium botulinum are the most potent biological substances known to mankind. BoNTs are the agents responsible for botulism, a rare condition affecting the neuromuscular junction and causing a spectrum of diseases ranging from mild cranial nerve palsies to acute respiratory failure and death. BoNTs are a potential biowarfare threat and a public health hazard, since outbreaks of foodborne botulism are caused by the ingestion of preformed BoNTs in food. Currently, mathematical models relating to the hazards associated with C. botulinum, which are largely empirical, make major contributions to botulinum risk assessment. Evaluated using statistical techniques, these models simulate the response of the bacterium to environmental conditions. Though empirical models have been successfully incorporated into risk assessments to support food safety decision making, this process includes significant uncertainties so that relevant decision making is frequently conservative and inflexible. Progression involves encoding into the models cellular processes at a molecular level, especially the details of the genetic and molecular machinery. This addition drives the connection between biological mechanisms and botulism risk assessment and hazard management strategies. This review brings together elements currently described in the literature that will be useful in building quantitative models of C. botulinum neurotoxin production. Subsequently, it outlines how the established form of modeling could be extended to include these new elements. Ultimately, this can offer further contributions to risk assessments to support food safety decision making.

  17. Seasonal prevalence of Clostridium botulinum type C in the sediments of the northern California wetland

    Science.gov (United States)

    Sandler, Renee J.; Rocke, T.E.; Samuel, M.D.; Yuill, Thomas M.

    1993-01-01

    The prevalence of Clostridium botulinum type C (% of positive sediment samples) was determined in 10 marshes at Sacramento National Wildlife Refuge (SNWR), located in the Central Valley of California (USA), where avian botulism epizootics occur regularly. Fifty-two percent of 2,200 sediment samples collected over an 18-mo period contained C. botulinum type C (both neurotoxic and aneurotoxic) which was present throughout the year in all 10 marshes. The prevalence of C. botulinum type C was similar in marshes with either high or low botulism losses in the previous 5 yr. Marshes with avian botulism mortality during the study had similar prevalences as marshes with no mortality. However, the prevalence of C. botulinum type C was higher in marshes that remained flooded all year (permanent) compared with marshes that were drained in the spring and reflooded in the fall (seasonal). The prevalence of C. botulinum type C declined in seasonal marshes during the dry period. Similar declines did not occur in the permanently flooded marshes.

  18. Multiplex real-time PCR for detecting and typing Clostridium botulinum group III organisms and their mosaic variants.

    Science.gov (United States)

    Anniballi, Fabrizio; Auricchio, Bruna; Woudstra, Cédric; Fach, Patrick; Fiore, Alfonsina; Skarin, Hanna; Bano, Luca; Segerman, Bo; Knutsson, Rickard; De Medici, Dario

    2013-09-01

    Botulism is a neuroparalytic disease that can occur in all warm-blooded animals, birds, and fishes. The disease in animals is mainly caused by toxins produced by Clostridium botulinum strains belonging to group III, although outbreaks due to toxins produced by group I and II organisms have been recognized. Group III strains are capable of producing botulinum toxins of type C, D, and C/D and D/C mosaic variants. Definitive diagnosis of animal botulism is made by combining clinical findings with laboratory investigations. Detection of toxins in clinical specimens and feed is the gold standard for laboratory diagnosis. Since toxins may be degraded by organisms contained in the gastrointestinal tract or may be present at levels below the detection limit, the recovery of C. botulinum from sick animal specimens is consistent for laboratory confirmation. In this article we report the development and in-house validation of a new multiplex real-time PCR for detecting and typing the neurotoxin genes found in C. botulinum group III organisms. Validation procedures have been carried out according to ISO 16140, using strains and samples recovered from cases of animal botulism in Italy and France.

  19. Pré-compostagem de cadáveres de bovinos acometidos pelo botulismo The effect of composting cattle carcasses on botulinum spores and toxin content

    Directory of Open Access Journals (Sweden)

    Vera C.L.M. Curci

    2007-04-01

    Full Text Available Foram pré-compostados, em células individuais e isoladas, cinco cadáveres de bovinos acometidos pelo botulismo com a finalidade de monitorar a presença de esporos de Clostridium botulinum e de toxina botulínica antes e após o processo de decomposição em leira estática com fonte de carbono. O diagnóstico da intoxicação nos animais foi baseado nas características clínico-patológicas, epidemiológicas ou laboratoriais. Dos cinco bovinos com evolução clínica crônica de botulismo, cujos cadáveres foram pré-compostados, três foram acometidos pela toxina tipo D, um pelo complexo CD e um dos animais foi negativo na tentativa de detecção da toxina e de esporos da bactéria nas vísceras pelo bioensaio e neutralização em camundongo. O processo de pré-compostagem foi realizado em leira estática, com o uso de material carbonáceo umidificado como substrato e esquartejamento do animal, vedado individualmente com lona plástica e sem aeração por um período de 50 dias. A temperatura das leiras foi monitorada durante o período e oscilou de 40,5-52,4ºC. Após a abertura das leiras, pôde-se constatar a completa decomposição de todo material mole, com redução significativa do seu peso (de 26,5-44,5%, restando apenas os ossos. Não foi detectado esporo ou toxina botulínica no interior dos ossos (n=5 para cada cadáver. Nas 200 amostras examinadas do homogeneizado restante (n=40 para cada cadáver, em apenas duas amostras de uma leira foram detectados esporos de C. botulinum tipo C, enquanto que todas foram negativas para a tentativa de detecção da toxina botulínica pelo bioensaio em camundongo. Da forma como foi avaliado o processo de pré-compostagem de bovinos mortos pela intoxicação botulínica não contribuiu para a proliferação de C. botulinum.Five carcasses of cattle that died from botulism were composted in individual isolated beds with the purpose of monitoring the effect on spores of Clostridium botulinum and

  20. An Invisible Lethal Killer: Clostridium Botulinum and Botulinum Neurotoxins%一种致命的隐形杀手:肉毒杆菌与肉毒毒素

    Institute of Scientific and Technical Information of China (English)

    王景林

    2013-01-01

    2013年8月,因肉毒杆菌污染,问题奶粉再次进入公众视野.肉毒杆菌(Clostridium botulinum)是一种革兰阳性粗短杆菌,严格厌氧,有A~G7个亚型,每个亚型都可产生一种剧毒的大分子外毒素,即肉毒毒素(botulinum toxin).这种毒素可引起人和动物发生以松弛性麻痹为主症的肉毒中毒(botulism),虽然并不常见,但却是一种致命的中毒性疾病.本文综述了肉毒杆菌生物学特征、肉毒毒素结构与毒性、肉毒中毒临床表现以及检验鉴定等,并介绍了食品安全生产中肉毒杆菌与肉毒毒素的安全风险与控制措施.%The milkpowder contaminated by Clostridium botulinum once again go into the public view in August 2013.Clostridium botulinum,which is a strictly anaerobic gram-positive bacillus,is classified into seven main types from A through G according to exotoxins and they can produce antigenically distinct botulinum neurotoxins.It is a potent toxin that causes the most severe form of food poisoning with pronounced flaccid paralysis,called botulism.The review covers biological features of C.botulinum,structure and toxicity of toxin,clinical symptoms and identification of botulism as well as the risk and control of C.botulinum and toxins during food processing and preservation.

  1. Identification of novel linear megaplasmids carrying a ß-lactamase gene in neurotoxigenic Clostridium butyricum type E strains.

    Directory of Open Access Journals (Sweden)

    Giovanna Franciosa

    Full Text Available Since the first isolation of type E botulinum toxin-producing Clostridium butyricum from two infant botulism cases in Italy in 1984, this peculiar microorganism has been implicated in different forms of botulism worldwide. By applying particular pulsed-field gel electrophoresis run conditions, we were able to show for the first time that ten neurotoxigenic C. butyricum type E strains originated from Italy and China have linear megaplasmids in their genomes. At least four different megaplasmid sizes were identified among the ten neurotoxigenic C. butyricum type E strains. Each isolate displayed a single sized megaplasmid that was shown to possess a linear structure by ATP-dependent exonuclease digestion. Some of the neurotoxigenic C. butyricum type E strains possessed additional smaller circular plasmids. In order to investigate the genetic content of the newly identified megaplasmids, selected gene probes were designed and used in Southern hybridization experiments. Our results revealed that the type E botulinum neurotoxin gene was chromosome-located in all neurotoxigenic C. butyricum type E strains. Similar results were obtained with the 16S rRNA, the tetracycline tet(P and the lincomycin resistance protein lmrB gene probes. A specific mobA gene probe only hybridized to the smaller plasmids of the Italian C. butyricum type E strains. Of note, a ß-lactamase gene probe hybridized to the megaplasmids of eight neurotoxigenic C. butyricum type E strains, of which seven from clinical sources and the remaining one from a food implicated in foodborne botulism, whereas this ß-lactam antibiotic resistance gene was absent form the megaplasmids of the two soil strains examined. The widespread occurrence among C. butyricum type E strains associated to human disease of linear megaplasmids harboring an antibiotic resistance gene strongly suggests that the megaplasmids could have played an important role in the emergence of C. butyricum type E as a human

  2. Descompresión microvascular para el espasmo hemifacial 10 años de experiencia en el Instituto Nacional de Neurología y Neurocirugía

    OpenAIRE

    Arvizú Saldaña,Emiliano; Vales Hidalgo,Olivia; Hinojosa,Ramón; Reyes Moreno,Ignacio

    2004-01-01

    El espasmo hemifacial se caracteriza por contracciones paroxísticas e involuntarias de los músculos de expresión facial, es más frecuente en el lado izquierdo y en mujeres. Tiene un carácter progresivo y rara vez presenta regresión espontánea. Su manejo incluye el tratamiento medicamentoso, la inyección de toxina botulínica y la descompresión microvascular del nervio. Material y métodos: presentamos los resultados de 116 descompresiones microvasculares realizadas en 88 pacientes en los último...

  3. Medical Countermeasure Models. Volume 8. Botulinum Neurotoxin

    Science.gov (United States)

    2013-04-12

    were treated with antibiotics , 5,000 would be entered as identical treated individuals and 5,000 would be entered as identical untreated individuals...toxin as a biological weapon.” Journal of the American Medical Association. 285(1059). 2001. 24 Tacket CO et al. “ Equine Antitoxin Use and Other...antitoxin available for non-infant cases of botulism in the United States.69,70 HBAT, an equine antitoxin, targets BoNT serotypes A, B, C, D, E, F and G

  4. Psicopatologia obsessivo-compulsiva na distonia focal primária : aspectos neuropsiquiátricos de uma doença do movimento

    OpenAIRE

    Corrêa, João Bernardo Barahona

    2012-01-01

    RESUMO: pela contracção involuntária de grupos musculares de extensão variável, originando movimentos involuntários e posturas anómalas, por vezes dolorosas. O tratamento convencional consiste em injecções localizadas de toxina botulínica, podendo, em casos refractários, estar indicado o tratamento por estimulação cerebral profunda. A neurobiologia da distonia focal primária permanece incompletamente compreendida. Os estudos de neuro-imagem estrutural e funcional revelam alterações subtis da ...

  5. Estudio clínico y molecular de acalasia esofágica

    OpenAIRE

    Tejedor Cerdeña, María Auxiliadora

    2011-01-01

    [ES] Los objetivos de esta tesis doctoral son: - Conocer la evolución de los pacientes diagnosticados de acalasia, según hayan sido tratados con inyección de toxina botulínica, dilatación neumática o cirugía. - Evaluar la respuesta a los posibles tratamientos en términos clínicos, manométricos y radiológicos mediante el tránsito baritado. - Comparar la eficacia de las diferentes estrategias terapéuticas. - Establecer la implicación de citocinas proinflamatorias (IL-6, IL-4, TNFα),...

  6. Clinical and electrodiagnostic findings in cyhalothrine poisoning

    Directory of Open Access Journals (Sweden)

    Keivan Basiri

    2016-01-01

    Full Text Available Acute onset bulbar symptoms with respiratory failure and descending paralysis may occur in several neuromuscular disorders including variants of Guillain-Barre syndrome (GBS, diphtheria, botulism and toxins. We present a 51-year-old man who presented with complains of ptosis and dyspnea following pyrethroids spraying in an enclosed area for eradication of flea. Within 5-6 days of admission limb weakness, dysphagia, dysarthria, blurred vision, diplopia, tremor and respiratory distress added to previous symptoms. Temporal profile of events after exposure, development of similar symptoms in patient's son, electrodiagnostic findings and exclusion of other etiologies confirms intoxication etiology. We reviewed the literature and provide an extensive electrodiagnostic overview.

  7. "Isolation of Clostridum botiulinum (Types A, B, E) in Sediments from Coastal Areas in the North of Iran"

    OpenAIRE

    HR Tavakoli; V Razavilar

    2003-01-01

    Iranian J Publ Health, Vol. 32, No. 3, pp.37-40, 2003 Isolation of Clostridum botiulinum (Types A, B, E) in Sediments from Coastal Areas in the North of Iran *HR Tavakoli 1,V Razavilar 2 1Dept. of Nutrition and Food Hygiene,School of public health, Baghyatollah University of Medical Sciences, Tehran, Iran 2Dept. of Food Hygiene, School of Veterinary Medicine, Tehran University , Iran Clostridium botulinum has long been recognized as an etiological agent of food borne botulism and has been rep...

  8. Genomes, neurotoxins and biology of Clostridium botulinum Group I and Group II.

    Science.gov (United States)

    Carter, Andrew T; Peck, Michael W

    2015-05-01

    Recent developments in whole genome sequencing have made a substantial contribution to understanding the genomes, neurotoxins and biology of Clostridium botulinum Group I (proteolytic C. botulinum) and C. botulinum Group II (non-proteolytic C. botulinum). Two different approaches are used to study genomics in these bacteria; comparative whole genome microarrays and direct comparison of complete genome DNA sequences. The properties of the different types of neurotoxin formed, and different neurotoxin gene clusters found in C. botulinum Groups I and II are explored. Specific examples of botulinum neurotoxin genes are chosen for an in-depth discussion of neurotoxin gene evolution. The most recent cases of foodborne botulism are summarised.

  9. Association of toxin-producing Clostridium botulinum with the macroalga Cladophora in the Great Lakes.

    Science.gov (United States)

    Chun, Chan Lan; Ochsner, Urs; Byappanahalli, Muruleedhara N; Whitman, Richard L; Tepp, William H; Lin, Guangyun; Johnson, Eric A; Peller, Julie; Sadowsky, Michael J

    2013-03-19

    Avian botulism, a paralytic disease of birds, often occurs on a yearly cycle and is increasingly becoming more common in the Great Lakes. Outbreaks are caused by bird ingestion of neurotoxins produced by Clostridium botulinum, a spore-forming, gram-positive, anaerobe. The nuisance, macrophytic, green alga Cladophora (Chlorophyta; mostly Cladophora glomerata L.) is a potential habitat for the growth of C. botulinum. A high incidence of botulism in shoreline birds at Sleeping Bear Dunes National Lakeshore (SLBE) in Lake Michigan coincides with increasingly massive accumulations of Cladophora in nearshore waters. In this study, free-floating algal mats were collected from SLBE and other shorelines of the Great Lakes between June and October 2011. The abundance of C. botulinum in algal mats was quantified and the type of botulism neurotoxin (bont) genes associated with this organism were determined by using most-probable-number PCR (MPN-PCR) and five distinct bont gene-specific primers (A, B, C, E, and F). The MPN-PCR results showed that 16 of 22 (73%) algal mats from the SLBE and 23 of 31(74%) algal mats from other shorelines of the Great Lakes contained the bont type E (bont/E) gene. C. botulinum was present up to 15000 MPN per gram dried algae based on gene copies of bont/E. In addition, genes for bont/A and bont/B, which are commonly associated with human diseases, were detected in a few algal samples. Moreover, C. botulinum was present as vegetative cells rather than as dormant spores in Cladophora mats. Mouse toxin assays done using supernatants from enrichment of Cladophora containing high densities of C. botulinum (>1000 MPN/g dried algae) showed that Cladophora-borne C. botulinum were toxin-producing species (BoNT/E). Our results indicate that Cladophora provides a habitat for C. botulinum, warranting additional studies to better understand the relationship between this bacterium and the alga, and how this interaction potentially contributes to botulism

  10. Aspectos clínicos e terapêuticos em 135 pacientes com distonia: experiência do Setor de Distúrbios do Movimento do Hospital de Clínicas da Universidade Federal do Paraná

    OpenAIRE

    Fabiani,Giorgio; Teive, Hélio A. G.; GERMINIANI,FRANCISCO; Sá,Daniel; Werneck,Lineu C.

    1999-01-01

    Este estudo visa descrever aspectos clínicos e respostas terapêuticas de 135 pacientes com distonia. Quanto à classificação, 54% apresentava distonia focal, 17,8% segmentar, 8,1% hemidistonia, 1,5% multifocal e 18,6% generalizada. Vinte e seis por cento apresentavam distonia secundária; e 5,9% tinham história familiar. O tratamento das distonias idiopáticas divide-se em específico e sintomático, podendo ser local, com toxina botulínica; ou sistêmico, com drogas orais. As drogas utilizadas for...

  11. Espasmo hemifacial e impressão basilar associados a malformação de arnold-chiari relato de caso

    OpenAIRE

    Manoel Baldoino Leal Filho; Elza Dias-Tosta; Nasser Allan; Paulo Said; José Luis F. Mendonça; Fernando Guilhon Henriques

    1992-01-01

    Os autores relatam o caso de uma paciente com espasmo hemifacial e impressão basilar associados a malformação de Arnold-Chiari. Com a descompressão cirúrgica da fossa posterior, empregada no tratamento da impressão basilar, houve melhora do quadro clínico e o espasmo hemifacial se reduziu quanto à frequência, duração e intensidade. É enfatizada a necessidade do tratamento etiológico do espasmo hemifacial, antes de se recorrer à toxina botulínica.

  12. Espasmo hemifacial e impressão basilar associados a malformação de arnold-chiari relato de caso

    Directory of Open Access Journals (Sweden)

    Manoel Baldoino Leal Filho

    1992-09-01

    Full Text Available Os autores relatam o caso de uma paciente com espasmo hemifacial e impressão basilar associados a malformação de Arnold-Chiari. Com a descompressão cirúrgica da fossa posterior, empregada no tratamento da impressão basilar, houve melhora do quadro clínico e o espasmo hemifacial se reduziu quanto à frequência, duração e intensidade. É enfatizada a necessidade do tratamento etiológico do espasmo hemifacial, antes de se recorrer à toxina botulínica.

  13. Clinical and electrodiagnostic findings in cyhalothrine poisoning

    Science.gov (United States)

    Basiri, Keivan; Mohaghegh, Mohammad Reza; Teimouri, Somayyeh Sadat; Okhovat, Ali Asghar

    2016-01-01

    Acute onset bulbar symptoms with respiratory failure and descending paralysis may occur in several neuromuscular disorders including variants of Guillain-Barre syndrome (GBS), diphtheria, botulism and toxins. We present a 51-year-old man who presented with complains of ptosis and dyspnea following pyrethroids spraying in an enclosed area for eradication of flea. Within 5-6 days of admission limb weakness, dysphagia, dysarthria, blurred vision, diplopia, tremor and respiratory distress added to previous symptoms. Temporal profile of events after exposure, development of similar symptoms in patient's son, electrodiagnostic findings and exclusion of other etiologies confirms intoxication etiology. We reviewed the literature and provide an extensive electrodiagnostic overview. PMID:27099845

  14. Preferential entry of botulinum neurotoxin A Hc domain through intestinal crypt cells and targeting to cholinergic neurons of the mouse intestine.

    Directory of Open Access Journals (Sweden)

    Aurélie Couesnon

    Full Text Available Botulism, characterized by flaccid paralysis, commonly results from botulinum neurotoxin (BoNT absorption across the epithelial barrier from the digestive tract and then dissemination through the blood circulation to target autonomic and motor nerve terminals. The trafficking pathway of BoNT/A passage through the intestinal barrier is not yet fully understood. We report that intralumenal administration of purified BoNT/A into mouse ileum segment impaired spontaneous muscle contractions and abolished the smooth muscle contractions evoked by electric field stimulation. Entry of BoNT/A into the mouse upper small intestine was monitored with fluorescent HcA (half C-terminal domain of heavy chain which interacts with cell surface receptor(s. We show that HcA preferentially recognizes a subset of neuroendocrine intestinal crypt cells, which probably represent the entry site of the toxin through the intestinal barrier, then targets specific neurons in the submucosa and later (90-120 min in the musculosa. HcA mainly binds to certain cholinergic neurons of both submucosal and myenteric plexuses, but also recognizes, although to a lower extent, other neuronal cells including glutamatergic and serotoninergic neurons in the submucosa. Intestinal cholinergic neuron targeting by HcA could account for the inhibition of intestinal peristaltism and secretion observed in botulism, but the consequences of the targeting to non-cholinergic neurons remains to be determined.

  15. Foodborne hazards of microbial origin.

    Science.gov (United States)

    Foster, E M

    1978-10-01

    Foods can serve as vehicles of many pathogenic and toxigenic agents of disease. Bacterial agents comprise three groups: 1) those that grow in the food and produce an active toxin before consumption (e.g., clostridium botulinium); 2) those that merely exist as contaminants in the food but are able to initiate infection when swallowed (e.g., Salmonella spp.); and 3) those that multiply and produce large numbers of vegetative cells in the food, then release an active enterotoxin when they sporulate in the gut. A few parasitic (e.g., Trichinella spiralis) and viral agents (e.g., hepatitis A) also can be transmitted by food. Botulinum poisoning is the deadliest foodborne disease. The potential danger of botulism from cured meats is a major factor in the argument over use of nitrites as meat curing agents. A new disease called infant botulism has been recognized since 1976. Apparently it is not foodborne but results from intraintestinal growth of C. botulinum in very young infants. Salmonellosis is the most important of the foodborne diseases from the standpoint of overall human health. The primary vehicles are contaminated raw meat, poultry, and eggs. Faulty food handling practices are responsible for most food poisoning in the United States.

  16. Src Family Kinase Inhibitors Antagonize the Toxicity of Multiple Serotypes of Botulinum Neurotoxin in Human Embryonic Stem Cell-Derived Motor Neurons

    Science.gov (United States)

    Burnett, James C.; Nuss, Jonathan E.; Wanner, Laura M.; Peyser, Brian D.; Du, Hao T.; Gomba, Glenn Y.; Kota, Krishna P.; Panchal, Rekha G.; Gussio, Rick; Kane, Christopher D.; Tessarollo, Lino

    2015-01-01

    Botulinum neurotoxins (BoNTs), the causative agents of botulism, are potent inhibitors of neurotransmitter release from motor neurons. There are currently no drugs to treat BoNT intoxication after the onset of the disease symptoms. In this study, we explored how modulation of key host pathways affects the process of BoNT intoxication in human motor neurons, focusing on Src family kinase (SFK) signaling. Motor neurons derived from human embryonic stem (hES) cells were treated with a panel of SFK inhibitors and intoxicated with BoNT serotypes A, B, or E (which are responsible for >95 % of human botulism cases). Subsequently, it was found that bosutinib, dasatinib, KX2-391, PP1, PP2, Src inhibitor-1, and SU6656 significantly antagonized all three of the serotypes. Furthermore, the data indicated that the treatment of hES-derived motor neurons with multiple SFK inhibitors increased the antagonistic effect synergistically. Mechanistically, the small molecules appear to inhibit BoNTs by targeting host pathways necessary for intoxication and not by directly inhibiting the toxins’ proteolytic activity. Importantly, the identified inhibitors are all well-studied with some in clinical trials while others are FDA-approved drugs. Overall, this study emphasizes the importance of targeting host neuronal pathways, rather than the toxin’s enzymatic components, to antagonize multiple BoNT serotypes in motor neurons. PMID:25782580

  17. Identifying the origin of waterbird carcasses in Lake Michigan using a neural network source tracking model

    Science.gov (United States)

    Kenow, Kevin P.; Ge, Zhongfu; Fara, Luke J.; Houdek, Steven C.; Lubinski, Brian R.

    2016-01-01

    Avian botulism type E is responsible for extensive waterbird mortality on the Great Lakes, yet the actual site of toxin exposure remains unclear. Beached carcasses are often used to describe the spatial aspects of botulism mortality outbreaks, but lack specificity of offshore toxin source locations. We detail methodology for developing a neural network model used for predicting waterbird carcass motions in response to wind, wave, and current forcing, in lieu of a complex analytical relationship. This empirically trained model uses current velocity, wind velocity, significant wave height, and wave peak period in Lake Michigan simulated by the Great Lakes Coastal Forecasting System. A detailed procedure is further developed to use the model for back-tracing waterbird carcasses found on beaches in various parts of Lake Michigan, which was validated using drift data for radiomarked common loon (Gavia immer) carcasses deployed at a variety of locations in northern Lake Michigan during September and October of 2013. The back-tracing model was further used on 22 non-radiomarked common loon carcasses found along the shoreline of northern Lake Michigan in October and November of 2012. The model-estimated origins of those cases pointed to some common source locations offshore that coincide with concentrations of common loons observed during aerial surveys. The neural network source tracking model provides a promising approach for identifying locations of botulinum neurotoxin type E intoxication and, in turn, contributes to developing an understanding of the dynamics of toxin production and possible trophic transfer pathways.

  18. [Botulinum toxin A and physical therapy in gait in cerebral palsy].

    Science.gov (United States)

    García-Sánchez, Sandra Fabiola; Gómez-Galindo, María Teresa; Guzmán-Pantoja, Jaime Eduardo

    2017-01-01

    Introducción: La parálisis cerebral (PCI) es la principal causa de discapacidad en la infancia. La toxina botulínica tipo A (TBA) es un tratamiento para mejorar la función y patrón en la marcha, aunque con pocos estudios que cuantifiquen la mejoría. Métodos: Se realizó un estudio cuasiexperimental, de mayo de 2010 a septiembre de 2011, en un centro de rehabilitación integral, participaron 36 pacientes con PCI espástica. Se evaluó: funcionalidad de la marcha por la escala de Koman, velocidad de desplazamiento de la marcha, tono con escala de Ashworth y arcos de movilidad pasivas. Se les aplicó TBA y se les envió a 10 sesiones de terapia física, con mediciones antes, al mes 1 y 4. Resultados: 30 pacientes terminaron el estudio, con edades entre 2 y 12 años, la mayoría tuvieron mejoría en la funcionalidad de la marcha, tono, dorsiflexión y abducción de tobillos al mes, que se mantuvo a los 4 meses. Conclusiones: La toxina botulínica es un tratamiento eficaz para aumentar los arcos de movilidad y la funcionalidad de la marcha en los pacientes con hemiparesia y paraparesia espástica.

  19. Inhibiting oral intoxication of botulinum neurotoxin A complex by carbohydrate receptor mimics.

    Science.gov (United States)

    Lee, Kwangkook; Lam, Kwok-Ho; Kruel, Anna-Magdalena; Mahrhold, Stefan; Perry, Kay; Cheng, Luisa W; Rummel, Andreas; Jin, Rongsheng

    2015-12-01

    Botulinum neurotoxins (BoNTs) cause the disease botulism manifested by flaccid paralysis that could be fatal to humans and animals. Oral ingestion of the toxin with contaminated food is one of the most common routes for botulism. BoNT assembles with several auxiliary proteins to survive in the gastrointestinal tract and is subsequently transported through the intestinal epithelium into the general circulation. Several hemagglutinin proteins form a multi-protein complex (HA complex) that recognizes host glycans on the intestinal epithelial cell surface to facilitate BoNT absorption. Blocking carbohydrate binding to the HA complex could significantly inhibit the oral toxicity of BoNT. Here, we identify lactulose, a galactose-containing non-digestible sugar commonly used to treat constipation, as a prototype inhibitor against oral BoNT/A intoxication. As revealed by a crystal structure, lactulose binds to the HA complex at the same site where the host galactose-containing carbohydrate receptors bind. In vitro assays using intestinal Caco-2 cells demonstrated that lactulose inhibits HA from compromising the integrity of the epithelial cell monolayers and blocks the internalization of HA. Furthermore, co-administration of lactulose significantly protected mice against BoNT/A oral intoxication in vivo. Taken together, these data encourage the development of carbohydrate receptor mimics as a therapeutic intervention to prevent BoNT oral intoxication.

  20. New Insights into the Genetic Diversity of Clostridium botulinum Group III through Extensive Genome Exploration.

    Science.gov (United States)

    Woudstra, Cédric; Le Maréchal, Caroline; Souillard, Rozenn; Bayon-Auboyer, Marie-Hélène; Mermoud, Isabelle; Desoutter, Denise; Fach, Patrick

    2016-01-01

    Animal botulism is caused by group III Clostridium botulinum strains producing type C and D toxins, or their chimeric forms C/D and D/C. Animal botulism is considered an emerging disease in Europe, notably in poultry production. Before our study, 14 genomes from different countries were available in the public database, but none were from France. In order to investigate the genetic relationship of French strains with different geographical areas and find new potential typing targets, 17 strains of C. botulinum group III were sequenced (16 from France and one from New Caledonia). Fourteen were type C/D strains isolated from chickens, ducks, guinea fowl and turkeys and three were type D/C strains isolated from cattle. The New Caledonian strain was a type D/C strain. Whole genome sequence analysis showed the French strains to be closely related to European strains from C. botulinum group III lineages Ia and Ib. The investigation of CRISPR sequences as genetic targets for differentiating strains in group III proved to be irrelevant for type C/D due to a deficient CRISPR/Cas mechanism, but not for type D/C. Conversely, the extrachromosomal elements of type C/D strains could be used to generate a genetic ID card. The highest level of discrimination was achieved with SNP core phylogeny, which allowed differentiation up to strain level and provide the most relevant information for genetic epidemiology studies and discrimination.

  1. Functional dissection of the Clostridium botulinum type B hemagglutinin complex: identification of the carbohydrate and E-cadherin binding sites.

    Directory of Open Access Journals (Sweden)

    Yo Sugawara

    Full Text Available Botulinum neurotoxin (BoNT inhibits neurotransmitter release in motor nerve endings, causing botulism, a condition often resulting from ingestion of the toxin or toxin-producing bacteria. BoNTs are always produced as large protein complexes by associating with a non-toxic protein, non-toxic non-hemagglutinin (NTNH, and some toxin complexes contain another non-toxic protein, hemagglutinin (HA, in addition to NTNH. These accessory proteins are known to increase the oral toxicity of the toxin dramatically. NTNH has a protective role against the harsh conditions in the digestive tract, while HA is considered to facilitate intestinal absorption of the toxin by intestinal binding and disruption of the epithelial barrier. Two specific activities of HA, carbohydrate and E-cadherin binding, appear to be involved in these processes; however, the exact roles of these activities in the pathogenesis of botulism remain unclear. The toxin is conventionally divided into seven serotypes, designated A through G. In this study, we identified the amino acid residues critical for carbohydrate and E-cadherin binding in serotype B HA. We constructed mutants defective in each of these two activities and examined the relationship of these activities using an in vitro intestinal cell culture model. Our results show that the carbohydrate and E-cadherin binding activities are functionally and structurally independent. Carbohydrate binding potentiates the epithelial barrier-disrupting activity by enhancing cell surface binding, while E-cadherin binding is essential for the barrier disruption.

  2. Population estimates and monitoring guidelines for endangered Laysan Teal, Anas Laysanensis, at Midway Atoll: Pilot study results 2008-2010.

    Science.gov (United States)

    Reynolds, Michelle H.; Brinck, Kevin W.; Laniawe, Leona

    2011-01-01

    Accurate estimates of population size are often crucial to determining status and planning recovery of endangered species. The ability to detect trends in survival and population size over time enables conservation managers to make effective decisions for species and refuge management. During 2004–2007, the translocated population of endangered Laysan Teal (Anas laysanensis; also Laysan Duck) was fitted with radio transmitters providing known (―gold standard‖) measures of survival and reproduction. However, as the population grew, statistically rigorous monitoring protocols were needed that were less labor intensive than radio telemetry. A population die-off and alarmingly high number of carcasses (181) were recorded during a botulism epizootic in August–October 2008, which further reinforced the need for effective monitoring protocols since this endangered species is vulnerable to catastrophic population declines. In fall 2008, we initiated a pilot study using standardized surveys with uniquely marked birds to monitor abundance and estimate the population growth rate of the reintroduced Laysan Teal. Since few birds carried marks (leg bands) after the 2008 botulism die-off (only about 15% of the population), and standardized surveys were not yet implemented, the magnitude of the die-off on the population size was unknown.

  3. Towards an international standard for detection and typing botulinum neurotoxin-producing Clostridia types A, B, E and F in food, feed and environmental samples: a European ring trial study to evaluate a real-time PCR assay.

    Science.gov (United States)

    Fenicia, Lucia; Fach, Patrick; van Rotterdam, Bart J; Anniballi, Fabrizio; Segerman, Bo; Auricchio, Bruna; Delibato, Elisabetta; Hamidjaja, Raditijo A; Wielinga, Peter R; Woudstra, Cedric; Agren, Joakim; De Medici, Dario; Knutsson, Rickard

    2011-03-01

    A real-time PCR method for detection and typing of BoNT-producing Clostridia types A, B, E, and F was developed on the framework of the European Research Project "Biotracer". A primary evaluation was carried out using 104 strains and 17 clinical and food samples linked to botulism cases. Results showed 100% relative accuracy, 100% relative sensitivity, 100% relative specificity, and 100% selectivity (inclusivity on 73 strains and exclusivity on 31 strains) of the real-time PCR against the reference cultural method combined with the standard mouse bioassay. Furthermore, a ring trial study performed at four different European laboratories in Italy, France, the Netherlands, and Sweden was carried out using 47 strains, and 30 clinical and food samples linked to botulism cases. Results showed a concordance of 95.7% among the four laboratories. The reproducibility generated a relative standard deviation in the range of 2.18% to 13.61%. Considering the high level of agreement achieved between the laboratories, this real-time PCR is a suitable method for rapid detection and typing of BoNT-producing Clostridia in clinical, food and environmental samples and thus support the use of it as an international standard method.

  4. Camelid-derived heavy-chain nanobody against Clostridium botulinum neurotoxin E in Pichia pastoris.

    Science.gov (United States)

    Baghban, Roghayyeh; Gargari, Seyed Latif Mousavi; Rajabibazl, Masoumeh; Nazarian, Shahram; Bakherad, Hamid

    2016-01-01

    Botulinum neurotoxins (BoNTs) result in severe and often fatal disease, botulism. Common remedial measures such as equine antitoxin and human botulism immunoglobulin in turn are problematic and time-consuming. Therefore, diagnosis and therapy of BoNTs are vital. The variable domain of heavy-chain antibodies (VHH) has unique features, such as the ability to identify and bind specifically to target epitopes and ease of production in bacteria and yeast. The Pichia pastoris is suitable for expression of recombinant antibody fragments. Disulfide bond formation and correct folds of protein with a high yield are some of the advantages of this eukaryotic host. In this study, we have expressed and purified the camelid VHH against BoNT/E in P. pastoris. The final yield of P. pastoris-expressed antibody was estimated to be 16 mg/l, which is higher than that expressed by Escherichia coli. The nanobody expressed in P. pastoris neutralized 4LD50 of the BoNT/E upon i.p. injection in 25% of mice. The nanobody expressed in E. coli extended the mice's survival to 1.5-fold compared to the control. This experiment indicated that the quality of expressed protein in the yeast is superior to that of the bacterial expression. Favorable protein folding by P. pastoris seems to play a role in its better toxin-binding property.

  5. A Monoclonal Antibody Based Capture ELISA for Botulinum Neurotoxin Serotype B: Toxin Detection in Food

    Directory of Open Access Journals (Sweden)

    Larry H. Stanker

    2013-11-01

    Full Text Available Botulism is a serious foodborne neuroparalytic disease, caused by botulinum neurotoxin (BoNT, produced by the anaerobic bacterium Clostridium botulinum. Seven toxin serotypes (A–H have been described. The majority of human cases of botulism are caused by serotypes A and B followed by E and F. We report here a group of serotype B specific monoclonal antibodies (mAbs capable of binding toxin under physiological conditions. Thus, they serve as capture antibodies for a sandwich (capture ELISA. The antibodies were generated using recombinant peptide fragments corresponding to the receptor-binding domain of the toxin heavy chain as immunogen. Their binding properties suggest that they bind a complex epitope with dissociation constants (KD’s for individual antibodies ranging from 10 to 48 × 10−11 M. Assay performance for all possible combinations of capture-detector antibody pairs was evaluated and the antibody pair resulting in the lowest level of detection (L.O.D., ~20 pg/mL was determined. Toxin was detected in spiked dairy samples with good recoveries at concentrations as low as 0.5 pg/mL and in ground beef samples at levels as low as 2 ng/g. Thus, the sandwich ELISA described here uses mAb for both the capture and detector antibodies (binding different epitopes on the toxin molecule and readily detects toxin in those food samples tested.

  6. An Integrative Approach to Computational Modelling of the Gene Regulatory Network Controlling Clostridium botulinum Type A1 Toxin Production

    Science.gov (United States)

    Walshaw, John; Peck, Michael W.; Barker, Gary C.

    2016-01-01

    Clostridium botulinum produces botulinum neurotoxins (BoNTs), highly potent substances responsible for botulism. Currently, mathematical models of C. botulinum growth and toxigenesis are largely aimed at risk assessment and do not include explicit genetic information beyond group level but integrate many component processes, such as signalling, membrane permeability and metabolic activity. In this paper we present a scheme for modelling neurotoxin production in C. botulinum Group I type A1, based on the integration of diverse information coming from experimental results available in the literature. Experiments show that production of BoNTs depends on the growth-phase and is under the control of positive and negative regulatory elements at the intracellular level. Toxins are released as large protein complexes and are associated with non-toxic components. Here, we systematically review and integrate those regulatory elements previously described in the literature for C. botulinum Group I type A1 into a population dynamics model, to build the very first computational model of toxin production at the molecular level. We conduct a validation of our model against several items of published experimental data for different wild type and mutant strains of C. botulinum Group I type A1. The result of this process underscores the potential of mathematical modelling at the cellular level, as a means of creating opportunities in developing new strategies that could be used to prevent botulism; and potentially contribute to improved methods for the production of toxin that is used for therapeutics. PMID:27855161

  7. Validation of a real-time PCR based method for detection of Clostridium botulinum types C, D and their mosaic variants C-D and D-C in a multicenter collaborative trial.

    Science.gov (United States)

    Woudstra, Cedric; Skarin, Hanna; Anniballi, Fabrizio; Auricchio, Bruna; De Medici, Dario; Bano, Luca; Drigo, Ilenia; Hansen, Trine; Löfström, Charlotta; Hamidjaja, Raditijo; van Rotterdam, Bart J; Koene, Miriam; Bäyon-Auboyer, Marie-Hélène; Buffereau, Jean-Philippe; Fach, Patrick

    2013-08-01

    Two real-time PCR arrays based on the GeneDisc(®) cycler platform (Pall-GeneDisc Technologies) were evaluated in a multicenter collaborative trial for their capacity to specifically detect and discriminate Clostridium botulinum types C, D and their mosaic variants C-D and D-C that are associated with avian and mammalian botulism. The GeneDisc(®) arrays developed as part of the DG Home funded European project 'AnibioThreat' were highly sensitive and specific when tested on pure isolates and naturally contaminated samples (mostly clinical specimen from avian origin). Results of the multicenter collaborative trial involving eight laboratories in five European Countries (two laboratories in France, Italy and The Netherlands, one laboratory in Denmark and Sweden), using DNA extracts issued from 33 pure isolates and 48 naturally contaminated samples associated with animal botulism cases, demonstrated the robustness of these tests. Results showed a concordance among the eight laboratories of 99.4%-100% for both arrays. The reproducibility of the tests was high with a relative standard deviation ranging from 1.1% to 7.1%. Considering the high level of agreement achieved between the laboratories these PCR arrays constitute robust and suitable tools for rapid detection of C. botulinum types C, D and mosaic types C-D and D-C. These are the first tests for C. botulinum C and D that have been evaluated in a European multicenter collaborative trial.

  8. New Insights into the genetic diversity of Clostridium botulinum Group III through extensive genome exploration

    Directory of Open Access Journals (Sweden)

    Cédric eWoudstra

    2016-05-01

    Full Text Available Animal botulism is caused by group III Clostridium botulinum strains producing type C and D toxins, or their chimeric forms C/D and D/C. Animal botulism is considered an emerging disease in Europe, notably in poultry production. Before our study, 14 genomes from different countries were available in the public database, but none were from France. In order to investigate the genetic relationship of French strains with different geographical areas and find new potential typing targets, 17 strains of C. botulinum group III were sequenced (16 from France and one from New Caledonia. Fourteen were type C/D strains isolated from chickens, ducks, guinea fowl and turkeys and three were type D/C strains isolated from cattle. The New Caledonian strain was a type D/C strain. Whole genome sequence analysis showed the French strains to be closely related to European strains from C. botulinum group III lineages Ia and Ib. The investigation of CRISPR sequences as genetic targets for differentiating strains in group III proved to be irrelevant for type C/D due to a deficient CRISPR/Cas mechanism, but not for type D/C. Conversely, the extrachromosomal elements of type C/D strains could be used to generate a genetic ID card. The highest level of discrimination was achieved with SNP core phylogeny, which allowed differentiation up to strain level and provide the most relevant information for genetic epidemiology studies and discrimination.

  9. Análise da ceratometria corneana em pacientes portadores de espasmo hemifacial

    Directory of Open Access Journals (Sweden)

    Ivana Cardoso Pereira

    2011-12-01

    Full Text Available OBJETIVO: Determinar a variação da ceratometria em olhos de pacientes portadores de espasmo hemifacial submetidos a tratamento com toxina botulínica. MÉTODOS: Foram incluídos 18 pacientes portadores de espasmo hemifacial que foram submetidos ao exame oftalmológico completo, além da topografia corneana e Orbscan previamente à aplicação de toxina botulínica tipo A e 1 mês após o procedimento. RESULTADOS: Não houve diferença estatisticamente significante entre a ceratometria encontrada pela topografia corneana ou diferença no BFS ("best fit sphere" anterior e posterior e índice de Roush avaliados pelo Orbscan nos olhos acometidos pelo espasmo em relação ao olho contralateral quando comparados antes e após o procedimento. CONCLUSÃO: Neste estudo, não encontramos diferença entre olhos com espasmo hemifacial e olhos sem essa condição quando avaliados a ceratometria, o índice de Roush e o BFS corneano antes e após tratamento.

  10. The effect of pH on recombinant C-terminal domain of Botulinum Neurotoxin type E (rBoNT/E-HCC

    Directory of Open Access Journals (Sweden)

    Seyed Jafar Mousavy

    2013-12-01

    Full Text Available Recombinant proteins are tending to be the most favorable vaccine-candidates against botulism. Recombinant Carboxy-terminal of botulinum neurotoxin serotype E (rBoNT/E-HCC has been introduced as an efficient vaccine against botulism type E. In this report, we made an effort to investigate the effect of different pH on protein structure to assess if rBoNT/E-HCC could be used as a vaccine for oral administration. Initially, rBoNT/E-HCC was expressed and purified. Structural changes of rBoNT/E-HCC at several pH conditions were studied by various techniques including circular dichroism (CD, fluorescence, aggregation and UV-Vis spectroscopy. The results showed the more compact and more stable structure for rBoNT/E-HCC at acidic pH, and loosely folded structure at alkaline pH. Our finding as the first step of rBoNT/E-HCC evaluation, hopefully introduce it as a suitable vaccine candidate for oral administration.

  11. Botulinum Neurotoxin Serotypes Detected by Electrochemical Impedance Spectroscopy

    Science.gov (United States)

    Savage, Alison C.; Buckley, Nicholas; Halliwell, Jennifer; Gwenin, Christopher

    2015-01-01

    Botulinum neurotoxin is one of the deadliest biological toxins known to mankind and is able to cause the debilitating disease botulism. The rapid detection of the different serotypes of botulinum neurotoxin is essential for both diagnosis of botulism and identifying the presence of toxin in potential cases of terrorism and food contamination. The modes of action of botulinum neurotoxins are well-established in literature and differ for each serotype. The toxins are known to specifically cleave portions of the SNARE proteins SNAP-25 or VAMP; an interaction that can be monitored by electrochemical impedance spectroscopy. This study presents a SNAP-25 and a VAMP biosensors for detecting the activity of five botulinum neurotoxin serotypes (A–E) using electrochemical impedance spectroscopy. The biosensors are able to detect concentrations of toxins as low as 25 fg/mL, in a short time-frame compared with the current standard methods of detection. Both biosensors show greater specificity for their compatible serotypes compared with incompatible serotypes and denatured toxins. PMID:25954998

  12. Botulinum Neurotoxin Serotypes Detected by Electrochemical Impedance Spectroscopy

    Directory of Open Access Journals (Sweden)

    Alison C. Savage

    2015-05-01

    Full Text Available Botulinum neurotoxin is one of the deadliest biological toxins known to mankind and is able to cause the debilitating disease botulism. The rapid detection of the different serotypes of botulinum neurotoxin is essential for both diagnosis of botulism and identifying the presence of toxin in potential cases of terrorism and food contamination. The modes of action of botulinum neurotoxins are well-established in literature and differ for each serotype. The toxins are known to specifically cleave portions of the SNARE proteins SNAP-25 or VAMP; an interaction that can be monitored by electrochemical impedance spectroscopy. This study presents a SNAP-25 and a VAMP biosensors for detecting the activity of five botulinum neurotoxin serotypes (A–E using electrochemical impedance spectroscopy. The biosensors are able to detect concentrations of toxins as low as 25 fg/mL, in a short time-frame compared with the current standard methods of detection. Both biosensors show greater specificity for their compatible serotypes compared with incompatible serotypes and denatured toxins.

  13. Extraction and inhibition of enzymatic activity of botulinum neurotoxins /B1, /B2, /B3, /B4, and /B5 by a panel of monoclonal anti-BoNT/B antibodies

    Directory of Open Access Journals (Sweden)

    Kalb Suzanne R

    2011-11-01

    Full Text Available Abstract Background Botulism is caused by botulinum neurotoxins (BoNTs, extremely toxic proteins which can induce respiratory failure leading to long-term intensive care or death. Treatment for botulism includes administration of antitoxins, which must be administered early in the course of the intoxication; therefore, rapid determination of human exposure to BoNT is an important public health goal. In previous work, our laboratory reported on Endopep-MS, a mass spectrometry-based activity method for detecting and differentiating BoNT/A, /B, /E, and /F in clinical samples. We also demonstrated that antibody-capture is effective for purification and concentration of BoNTs from complex matrices such as clinical samples. However, some antibodies inhibit or neutralize the enzymatic activity of BoNT, so the choice of antibody for toxin extraction is critical. Results In this work, we evaluated 24 anti-BoNT/B monoclonal antibodies (mAbs for their ability to inhibit the in vitro activity of BoNT/B1, /B2, /B3, /B4, and /B5 and to extract those toxins. Among the mAbs, there were significant differences in ability to extract BoNT/B subtypes and inhibitory effect on BoNT catalytic activity. Some of the mAbs tested enhanced the in vitro light chain activity of BoNT/B, suggesting that BoNT/B may undergo conformational change upon binding some mAbs. Conclusions In addition to determining in vitro inhibition abilities of a panel of mAbs against BoNT/B1-/B5, this work has determined B12.2 and 2B18.2 to be the best mAbs for sample preparation before Endopep-MS. These mAb characterizations also have the potential to assist with mechanistic studies of BoNT/B protection and treatment, which is important for studying alternative therapeutics for botulism.

  14. Isolation and functional characterization of the novel Clostridium botulinum neurotoxin A8 subtype.

    Science.gov (United States)

    Kull, Skadi; Schulz, K Melanie; Weisemann, Jasmin; Kirchner, Sebastian; Schreiber, Tanja; Bollenbach, Alexander; Dabrowski, P Wojtek; Nitsche, Andreas; Kalb, Suzanne R; Dorner, Martin B; Barr, John R; Rummel, Andreas; Dorner, Brigitte G

    2015-01-01

    Botulism is a severe neurological disease caused by the complex family of botulinum neurotoxins (BoNT). Based on the different serotypes known today, a classification of serotype variants termed subtypes has been proposed according to sequence diversity and immunological properties. However, the relevance of BoNT subtypes is currently not well understood. Here we describe the isolation of a novel Clostridium botulinum strain from a food-borne botulism outbreak near Chemnitz, Germany. Comparison of its botulinum neurotoxin gene sequence with published sequences identified it to be a novel subtype within the BoNT/A serotype designated BoNT/A8. The neurotoxin gene is located within an ha-orfX+ cluster and showed highest homology to BoNT/A1, A2, A5, and A6. Unexpectedly, we found an arginine insertion located in the HC domain of the heavy chain, which is unique compared to all other BoNT/A subtypes known so far. Functional characterization revealed that the binding characteristics to its main neuronal protein receptor SV2C seemed unaffected, whereas binding to membrane-incorporated gangliosides was reduced in comparison to BoNT/A1. Moreover, we found significantly lower enzymatic activity of the natural, full-length neurotoxin and the recombinant light chain of BoNT/A8 compared to BoNT/A1 in different endopeptidase assays. Both reduced ganglioside binding and enzymatic activity may contribute to the considerably lower biological activity of BoNT/A8 as measured in a mouse phrenic nerve hemidiaphragm assay. Despite its reduced activity the novel BoNT/A8 subtype caused severe botulism in a 63-year-old male. To our knowledge, this is the first description and a comprehensive characterization of a novel BoNT/A subtype which combines genetic information on the neurotoxin gene cluster with an in-depth functional analysis using different technical approaches. Our results show that subtyping of BoNT is highly relevant and that understanding of the detailed toxin function might

  15. Isolation and functional characterization of the novel Clostridium botulinum neurotoxin A8 subtype.

    Directory of Open Access Journals (Sweden)

    Skadi Kull

    Full Text Available Botulism is a severe neurological disease caused by the complex family of botulinum neurotoxins (BoNT. Based on the different serotypes known today, a classification of serotype variants termed subtypes has been proposed according to sequence diversity and immunological properties. However, the relevance of BoNT subtypes is currently not well understood. Here we describe the isolation of a novel Clostridium botulinum strain from a food-borne botulism outbreak near Chemnitz, Germany. Comparison of its botulinum neurotoxin gene sequence with published sequences identified it to be a novel subtype within the BoNT/A serotype designated BoNT/A8. The neurotoxin gene is located within an ha-orfX+ cluster and showed highest homology to BoNT/A1, A2, A5, and A6. Unexpectedly, we found an arginine insertion located in the HC domain of the heavy chain, which is unique compared to all other BoNT/A subtypes known so far. Functional characterization revealed that the binding characteristics to its main neuronal protein receptor SV2C seemed unaffected, whereas binding to membrane-incorporated gangliosides was reduced in comparison to BoNT/A1. Moreover, we found significantly lower enzymatic activity of the natural, full-length neurotoxin and the recombinant light chain of BoNT/A8 compared to BoNT/A1 in different endopeptidase assays. Both reduced ganglioside binding and enzymatic activity may contribute to the considerably lower biological activity of BoNT/A8 as measured in a mouse phrenic nerve hemidiaphragm assay. Despite its reduced activity the novel BoNT/A8 subtype caused severe botulism in a 63-year-old male. To our knowledge, this is the first description and a comprehensive characterization of a novel BoNT/A subtype which combines genetic information on the neurotoxin gene cluster with an in-depth functional analysis using different technical approaches. Our results show that subtyping of BoNT is highly relevant and that understanding of the detailed

  16. Influence of disease on population model of mid-continent mallards

    Science.gov (United States)

    Samuel, Michael D.

    1992-01-01

    On numerous occasions, waterfowl deaths caused by disease were highly visible to wildlife managers and to the general public. Thousands of birds died during duck plague, avian botulism and avian cholera outbreaks. Undoubtedly, some disease occurred in waterfowl populations throughout their evolution; however, knowledge of disease epizootiology primarily developed during the past 40-50 years (Wobeser 1981) for diseases that cause massive die-offs (e.g., avian cholera, avian botulism and duck plague). Other diseases, such as avian tuberculosis, aspergillosis, parasite infection and lead poisoning, also occur at chronic levels, but the data remain meager on many of these less spectacular causes of mortality and sublethal forms of disease. However, because chronic losses occur throughout the year, their cumulative effect, as well as the large die-offs, are a potential threat to waterfowl populations (Bellrose 1976, Wobeser 1981). Previous studies (Anderson 1975) demonstrated that 50 percent of the annual mortality in mallard (Anas platyrhynchos) populations is from nonhunting causes. In addition to disease, these causes include predation, accidental deaths, inclement weather and other factors (Stout and Cornwell 1976), which can be confounded by disease. Determination of mortality rates from diseases has been difficult because many biases and inconsistencies are associated with the available data. Assessment of disease prevalence and magnitude of losses is complicated by the spatial and temporal variability of many diseases, the logistic difficulty of studying highly mobile waterfowl populations, and the potentially confounding influences of predation and scavenging on detecting disease-related mortality;. Unless losses are so extensive that they direct attention to a particular area, mortality from disease is easily overlooked (see Zwank et al. 1985). Even when die-offs are evident, mortality from disease may be underestimated because sick waterfowl become debilitated

  17. Aspectos clínicos e terapêuticos em 135 pacientes com distonia: experiência do Setor de Distúrbios do Movimento do Hospital de Clínicas da Universidade Federal do Paraná Clinical and therapeutical features in 135 patients with dystonia: experience of movement disorders unity of the Hospital de Clínicas da Universidade Federal do Paraná

    Directory of Open Access Journals (Sweden)

    GIORGIO FABIANI

    1999-09-01

    Full Text Available Este estudo visa descrever aspectos clínicos e respostas terapêuticas de 135 pacientes com distonia. Quanto à classificação, 54% apresentava distonia focal, 17,8% segmentar, 8,1% hemidistonia, 1,5% multifocal e 18,6% generalizada. Vinte e seis por cento apresentavam distonia secundária; e 5,9% tinham história familiar. O tratamento das distonias idiopáticas divide-se em específico e sintomático, podendo ser local, com toxina botulínica; ou sistêmico, com drogas orais. As drogas utilizadas foram anticolinérgicos e benzodiazepínicos, com resposta pobre em formas generalizadas. A toxina botulínica foi utilizada em 54 pacientes com distonia focal ou segmentar. Na distonia cervical o início do efeito (IE ocorreu em oito dias; obtendo-se efeito máximo (EM em 25,2 dias, e duração média do efeito (DME de 76,8 dias. Na síndrome de Meige e blefaroespasmo obtivemos resultados encorajadores: IE=4,5dias; EM=17,6dias; DME=87,6dias. Conclui-se que a toxina botulínica A é a primeira escolha para distonias focais e segmentares, enquanto formas generalizadas apresentam resposta pobre às drogas utilizadas.This study aims to describe the clinical patterns and therapeutic responses in 135 patients with dystonia. According to the classification, 54% were focal; 17.8% were segmental; 8.1% hemidistonia; 18.6% generalized and 1.5% were multifocal. There was a positive familial history in 5.9% of the cases. The treatment of the idiopathic dystonias is divided in: specific and symptomatic, and it can be local with botulinum toxin, or systemic with oral drugs. The most common drugs used in the treatment were anticholinergics and benzodiazepines, with poor responses in the generalized forms. Botulinum toxin A was the first line treatment for focal and segmental forms of dystonia. Meanwhile, the generalized forms of dystonia show poor response to the therapies utilized.

  18. Postpartum Clostridium sordellii infection associated with fatal toxic shock syndrome

    DEFF Research Database (Denmark)

    Rørbye, C; Petersen, Ina Sleimann; Nilas, Lisbeth

    2000-01-01

    . Clostridium sordellii is rarely encountered in clinical specimens (1% of Clostridium species), but it has been described as a human pathogen with fatal potential. Two toxins, a lethal and a hemorrhagic (that antigenically and pathophysiologically appear similar to Clostridium difficile toxins B and A......Clostridium bacteria are anaerobic Gram positive spore-form-ing bacilli, known to cause distinct clinical syndromes such as botulism, tetanus, pseudomembranous colitis and myonecrosis. The natural habitats of Clostridium species are soil, water and the gastrointestinal tract of animals and humans....... In 5-10% of all women, Clostridium species are also found to be normal inhabitants in the microbial flora of the female genital tract. In case of a non-sexually transmitted genital tract infection, Clostridium species are isolated in 4-20%, and clostridium welchii seems to be the most common isolate...

  19. Modificaciones de la marcha en un niño con diplejía espástica tras el tratamiento con reeducación postural global: a propósito de un caso.

    OpenAIRE

    Cazorla Guillén, Cristina

    2010-01-01

    Introducción: el objetivo de este artículo es comprobar si una técnica de estiramiento global como es la Reeducación Postural Global es efectiva en la modificación de la marcha en un niño de diez años con diplejía espástica. Presentación del caso: se describe que el paciente es derivado al Servicio de Fisioterapia del Hospital Universitario Príncipe de Asturias por un médico rehabilitador que pauta un tratamiento de ocho semanas tras la inyección de toxina botulínica. Se realiza la valora...

  20. Eficacia del tratamiento mediante toxina butolínica y fisioterapia en niños con parálisis cerebral. Una revisión sistemática

    OpenAIRE

    Duque Dehesa, Mireya

    2013-01-01

    RESUMEN Introducción. La parálisis cerebral (PC) es una de las causas más importantes de espasticidad en la musculatura de los niños que la sufren, siendo la causante de graves alteraciones en la alineación articular, en la funcionalidad y actividad del niño. Objetivo. El objetivo de este estudio es valorar el uso que existe hasta este momento de la toxina botulínica tipo A (TB-A) en combinación con la intervención fisioterapéutica como parte del tratamiento del niño con PC. Valorando l...

  1. Postpartum Clostridium sordellii infection associated with fatal toxic shock syndrome

    DEFF Research Database (Denmark)

    Rørbye, C; Petersen, Ina Sleimann; Nilas, Lisbeth

    2000-01-01

    Clostridium bacteria are anaerobic Gram positive spore-form-ing bacilli, known to cause distinct clinical syndromes such as botulism, tetanus, pseudomembranous colitis and myonecrosis. The natural habitats of Clostridium species are soil, water and the gastrointestinal tract of animals and humans......, respectively) are responsible for this potential. Reviewing the obstetric literature, only six cases of postpartum endometritis caused by C. sordellii, are described - all being fatal. In addition, one lethal case of spontaneous endometritis resulting from C. sordellii is reported. The clinical aspects....... In 5-10% of all women, Clostridium species are also found to be normal inhabitants in the microbial flora of the female genital tract. In case of a non-sexually transmitted genital tract infection, Clostridium species are isolated in 4-20%, and clostridium welchii seems to be the most common isolate...

  2. Blefaroespasmo essencial benigno

    Directory of Open Access Journals (Sweden)

    Lucci Lucia Miriam Dumont

    2002-01-01

    Full Text Available Blefaroespasmo essencial benigno é distonia focal caracterizada por espasmos involuntários progressivos do músculo orbicular oculi e músculos da região superior da face (corrugador e procerus. As contrações forçadas e crônicas dos músculos perioculares tornam o paciente debilitado e levam a alterações funcionais e cosméticas das pálpebras. O tratamento inclui uma variedade de modalidades e medicações orais que apresentam eficácia limitada. Injeções de toxina botulínica tipo A têm apresentado bons resultados temporários, enquanto a miectomia periocular tem demonstrado bons resultados em longo prazo.

  3. Head tremor in patients with cervical dystonia: different outcome? Tremor cefálico em pacientes com distonia cervical: evolução diferente?

    Directory of Open Access Journals (Sweden)

    Clecio Godeiro-Junior

    2008-12-01

    Full Text Available OBJECTIVE: The association of cervical dystonia (CD with other movement disorders have been already described, but data on clinical outcome regarding these patients are scant. The aim of this paper was to investigate whether patients with CD and head tremor (HT would have a different outcome regarding to botulinum toxin type-A (BTX-A treatment response and clinical and demographic parameters. METHOD: We retrospectively evaluated 118 medical charts of patients with CD and divided them into two groups: with (HT+ and without (HT- head tremor. We compared the following clinical and demographic parameters: age at onset, disease duration, progression of symptoms, etiology, familial history, presence of hand tremor. We also analyzed the response to BTX-A according to Tsui score in both groups. RESULTS: The occurrence of head tremor in our sample was of 38.2%. The occurrence of postural hand tremor in the patients from the HT+ group was higher than in the HT- one (p=0.015 and if we compare BTX-A response in each group, we observe that patients with HT present a better outcome in a setting of longer follow-up. In HT+ group, Tsui score pre treatment was 10 (6-12.5 and after follow-up was 8 (5.5-10.5; pOBJETIVO: A associação de distonia cervical (DC com outros transtornos do movimento já foi descrita, mas há poucos dados quanto à evolução clínica destes pacientes. Avaliamos se os pacientes com DC e tremor cefálico (TC apresentam características clínicas e demográficas, assim como a resposta ao tratamento com toxina botulínica tipo A, diferentes. MÉTODOS: Analisamos retrospectivamente 118 prontuários de pacientes com DC e os dividimos em dois grupos: com (TC+ e sem (TC- tremor cefálico. Comparamos os seguintes parâmetros clínicos e demográficos entre os grupos: idade de início, duração da doença, progressão de sintomas, etiologia, história familiar, presença de tremor em mãos. Também analisamos a resposta ao tratamento com toxina

  4. Relembrar o Botulismo

    OpenAIRE

    Almasqué, I

    1998-01-01

    A propósito do seu caso pessoal, a autora tece algumas considerações acerca da intoxicação alimentar por toxina botulínica, chamando a atenção para cinco pontos principais: 1) O botulismo não é uma infecção tão rara como se pensa; 2) Está longe de ser uma doença com a mortalidade que geralmente se lhe atribui; 3) O veículo desta intoxicação não se limita às tradicionais conservas caseiras ou industriais; 4) É uma doença pouco diagnosticada, não apenas porque o seu diagnóstico é difícil mas so...

  5. Tick paralysis: first zoonosis record in Egypt.

    Science.gov (United States)

    Mosabah, Amira A Abd El-rahman; Morsy, Tosson A

    2012-04-01

    Tick paralysis caused by the secretion of toxin with saliva while taking a blood meal is an important veterinary disease, but is rare in humans. Although it has certain geographical proclivities, it exists worldwide. Tick paralysis was demonstrated for the first time in Egypt among four children living in rural area at Giza Governorate. The clinical pictures were confused with rabies; myasthensia gravis; botulism; diphtheritic polyneuropathy encountered in rural areas. The recovery of tick infesting the four little children and negative clinical and laboratory data of all diseases denoted tick paralysis. The encountered ticks infesting their animals were Rhipicephalus sanguineus on dogs, Hyalomma dromedarii on camels and Hyalomma anatolicum excavatum and Haemaphysalis sp. on goats. The case was recognized as first record of tick paralysis in Egypt.

  6. Genomics of Clostridium

    Science.gov (United States)

    Jacobson, Mark Joseph; Johnson, Eric A.

    The clostridia have a rich history and contemporary importance in industrial, environmental, and medical microbiology. Due to their ability to form endospores, clostridia are ubiquitous in nature and are found in many environments, especially in soils and the intestinal tract of animals including humans. Many clostridia cause devastating diseases of humans and animals, such as botulism, tetanus, and gas gangrene, through the production of protein toxins. The clostridia produce more protein toxins that are lethal for humans and animals than any other bacterial genus (Johnson, 2005; Van Heyningen, 1950). Other species are important in the formation of solvents and organic acids by anaerobic fermentations or as a source of unique enzymes for biocatalysis (Bradshaw and Johnson, 2010; Hatheway and Johnson, 1998).

  7. Infectious disease morbidity in the US region bordering Mexico, 1990-1998.

    Science.gov (United States)

    Doyle, T J; Bryan, R T

    2000-11-01

    The United States and Mexico share an international boundary approximately 3000 km long. This border separates 2 nations with great differences in health status. The objective of this study was to assess morbidity due to infectious diseases in the US region bordering Mexico. The incidence between 1990 and 1998 of 22 nationally notifiable infectious diseases was compared between border and nonborder regions. Disease rates, reflected as rate ratios, were higher in the border region for botulism, brucellosis, diphtheria, hepatitis A, measles, mumps, rabies, rubella, salmonellosis, and shigellosis than in either of 2 nonborder comparison regions. These data indicate that incidence rates for a variety of infectious diseases of public health importance are significantly higher in the United States along the Mexican border than in nonborder regions. These results suggest that an inadequate public health infrastructure may contribute to excess morbidity due to infectious diseases in the border region.

  8. Electrophysiological Characterization of the Antarease Metalloprotease from Tityus serrulatus Venom

    Science.gov (United States)

    Zornetta, Irene; Scorzeto, Michele; Mendes Dos Reis, Pablo Victor; De Lima, Maria E.; Montecucco, Cesare; Megighian, Aram; Rossetto, Ornella

    2017-01-01

    Scorpions are among the oldest venomous living organisms and the family Buthidae is the largest and most medically relevant one. Scorpion venoms include many toxic peptides, but recently, a metalloprotease from Tityus serrulatus called antarease was reported to be capable of cleaving VAMP2, a protein involved in the neuroparalytic syndromes of tetanus and botulism. We have produced antarease and an inactive metalloprotease mutant in a recombinant form and analyzed their enzymatic activity on recombinant VAMP2 in vitro and on mammalian and insect neuromuscular junction. The purified recombinant antarease paralyzed the neuromuscular junctions of mice and of Drosophila melanogaster whilst the mutant was inactive. We were unable to demonstrate any cleavage of VAMP2 under conditions which leads to VAMP proteolysis by botulinum neurotoxin type B. Antarease caused a reduced release probability, mainly due to defects upstream of the synaptic vesicles fusion process. Paired pulse experiments indicate that antarease might proteolytically inactivate a voltage-gated calcium channel. PMID:28264432

  9. Flaccid paralysis in an infant associated with a dirty wound and application of honey

    Science.gov (United States)

    Joseph, Charlotte Jane; Khoo, Teik Beng

    2017-01-01

    An infant, who was born preterm at 36 weeks, presented with fever and ulcer at umbilical region which progressed to necrotising fasciitis of anterior abdominal wall. He was treated with intravenous penicillin, intravenous cloxacillin and local application of medicated honey. Subsequently, he required wound debridement. Postoperatively, he required prolonged invasive ventilation due to poor respiratory effort which was associated with hypotonia and areflexia. Nerve conduction study revealed absent responses. The diagnosis of infant botulism was made based on the clinical presentation, nerve conduction study and his clinical progress. Botulinum immunoglobulin was not available. He was treated with intravenous immunoglobulin and oral pyridostigmine. He was successfully extubated after 37 days, and currently the patient is doing well. PMID:28062435

  10. Infectious agents of bioterrorism: a review for emergency physicians.

    Science.gov (United States)

    Kman, Nicholas E; Nelson, Richard N

    2008-05-01

    The terrorist attacks on the United States in 2001 and the anthrax release soon after brought the issue of bioterrorism to the forefront in the medical community. Bioterrorism is the use of a biologic weapon to create terror and panic. Biologic weapons, or bioweapons, can be bacteria, fungi, viruses, or biologic toxins. Because the emergency department represents the front line of defense for the recognition of agents of bioterrorism, it is essential that emergency physicians have the ability to quickly diagnose victims of bioterrorism. This review examines the most deadly and virulent category A agents of bioterrorism, that is, anthrax, smallpox, plague, botulism, hemorrhagic fever viruses, and tularemia. The focus is on epidemiology, transmission, clinical manifestations, diagnosis, and treatment.

  11. [The strategic plan for preparedness and response to bioterrorism in Korea].

    Science.gov (United States)

    Hwang, Hyun Soon

    2008-07-01

    Following the Anthrax bioterrorism attacks in the US in 2001, the Korean government established comprehensive countermeasures against bioterrorism. These measures included the government assuming management of all infectious agents that cause diseases, including smallpox, anthrax, plaque, botulism, and the causative agents of viral hemorrhagic fevers (ebola fever, marburg fever, and lassa fever) for national security. In addition, the Korean government is reinforcing the ability to prepare and respond to bioterrorism. Some of the measures being implemented include revising the laws and guidelines that apply to the use of infectious agents, the construction and operation of dual surveillance systems for bioterrorism, stockpiling and managing products necessary to respond to an emergency (smallpox vaccine, antibiotics, etc.) and vigorously training emergency room staff and heath workers to ensure they can respond appropriately. In addition, the government's measures include improved public relations, building and maintaining international cooperation, and developing new vaccines and drugs for treatments of infectious agents used to create bioweapons.

  12. Myasthenia gravis and related disorders: Pathology and molecular pathogenesis.

    Science.gov (United States)

    Ha, James C; Richman, David P

    2015-04-01

    Disorders affecting the presynaptic, synaptic, and postsynaptic portions of the neuromuscular junction arise from various mechanisms in children and adults, including acquired autoimmune or toxic processes as well as genetic mutations. Disorders include autoimmune myasthenia gravis associated with acetylcholine receptor, muscle specific kinase or Lrp4 antibodies, Lambert-Eaton myasthenic syndrome, nerve terminal hyperexcitability syndromes, Guillain Barré syndrome, botulism, organophosphate poisoning and a number of congenital myasthenic syndromes. This review focuses on the various molecular and pathophysiological mechanisms of these disorders, characterization of which has been crucial to the development of treatment strategies specific for each pathogenic mechanism. In the future, further understanding of the underlying processes may lead to more effective and targeted therapies of these disorders. This article is part of a Special Issue entitled: Neuromuscular Diseases: Pathology and Molecular Pathogenesis.

  13. Effect of vacuum packaging on growth of Clostridium botulinum and Staphylococcus aureus in cured meats.

    Science.gov (United States)

    Christiansen, L N; Foster, E M

    1965-11-01

    Incrimination of vacuum-packaged smoked fish in outbreaks of botulism has raised questions about the safety of this process in comparison with other methods of packaging foods. It has been suggested, for example, that Clostridium botulinum may grow better in a vacuum-packaged product than in one that is packaged without vacuum. To evaluate this possibility, sliced bologna was inoculated with spores of C. botulinum type A, packaged in transparent plastic film with and without vacuum, and stored at temperatures within the growth range of the organism. There was no detectable difference in the rate of toxin development in the two types of packages. In contrast, vacuum packaging markedly inhibited the growth of Staphylococcus aureus on sliced ham. The results indicate that vacuum packaging has little if any effect on the ability of C. botulinum to grow in cured meats, but it may reduce the likelihood of staphylococcal food poisoning.

  14. Maximizing the usefulness of food microbiology research.

    Science.gov (United States)

    Roberts, T A

    1997-01-01

    Funding for food microbiology research often follows disease outbreaks: botulism from vacuum-packed white-fish chubs, listeriosis from soft cheeses, or illness due to Salmonella Enteritidis or Escherichia coli. As a consequence of research, detection, identification, and subtyping methods improve, and more is learned about pathogenicity and virulence. Research also explores the organisms' capacity to multiply or survive in food and to be killed by established or novel processes. However, rarely is there a critical overview of progress or trustworthy statements of generally agreed-on facts. That information is not maintained in a form that can readily be used by regulatory departments and the food industry to ensure a safe food supply. A centralized system is urgently needed that is accessible electronically and carries information in a standardized format on the essential properties of the organisms, including pathogenicity, methods of detection, enumeration and identification, alternative prevention and control methods, and growth and survival characteristics.

  15. Learning from the past: historical aspects of bacterial toxins as pharmaceuticals.

    Science.gov (United States)

    Pellett, Sabine

    2012-06-01

    Botulinum neurotoxins are the most poisonous substances known to humankind, but also are the bacterial toxins most frequently used as pharmaceuticals to benefit humans. The discovery of botulinum toxins and development into a useful drug is unique and fascinating, dating back to the early 19th century, when Justinus Kerner first recognized that botulism was caused by a biological toxin and suggested its use for medicinal purposes. This was translated into reality in 1980, when Alan Scott for the first time used the toxins to successfully treat strabismus. Now a subset of botulinum toxins are widely used for cosmetic applications, treatment of various movement disorders, pain and many other syndromes, and further developments using other botulinum toxins or recombinant molecules engineered from subdomains are promising.

  16. Prevalence of neurotoxic Clostridium botulinum type C in the gastrointestinal tracts of tilapis (Oreochromis mossambicus) in the Salton Sea

    Science.gov (United States)

    Nol, P.J.; Rocke, T.E.; Gross, K.; Yuill, Thomas M.

    2004-01-01

    Tilapia (Oreochromis mossambicus) have been implicated as the source of type C toxin in avian botulism outbreaks in pelicans (Pelecanus erythrorhynchos, Pelecanus occidentalis californicus) at the Salton Sea in southern California (USA). We collected sick, dead, and healthy fish from various sites throughout the Sea during the summers of 1999 through 2001 and tested them for the presence of Clostridium botulinum type C cells by polymerase chain reaction targeting the C1 neurotoxin gene. Four of 96 (4%), 57 of 664 (9%), and five of 355 (1%) tilapia tested were positive for C. botulinum type C toxin gene in 1999, 2000, and 2001, respectively. The total number of positive fish was significantly greater in 2000 than in 2001 (P<0.0001). No difference in numbers of positives was detected between sick and dead fish compared with live fish. In 2000, no significant relationships were revealed among the variables studied, such as location and date of collection.

  17. Poison as cure: a clinical review of botulinum toxin as an invaluable drug

    Directory of Open Access Journals (Sweden)

    J. Bali

    2005-12-01

    Full Text Available Botulinum toxin is the most potent toxin known. It is readily absorbed from mucosal surfaces. If dispersed as an aerosol or mixed in the food or water it can lead to a large outbreak of botulism. The disease presents as a symmetric descending paralysis in an afebrile patient. Cranial nerve involvement with diplopia, dysarthria, dysphonia, dysphagia and respiratory paralysis is seen after a variable incubation period. The treatment is mainly supportive. The source of the toxin is Clostridium botulinum, an anaerobic gram-positive spore-forming organism. Some other species of Clostridium like C. butyricum and C. baratii also produce the toxin. The toxin is heat labile and can be inactivated by heating at 100°C for 10 minutes. The toxin acts at the peripheral cholinergic nerve terminals at the neuromuscular junctions, postganglionic parasympathetic ganglia, etc, and affects neurotransmitter release by inhibiting exocytosis. Clinical uses in various medical fields were found for it.

  18. Purification and characterization of neurotoxin complex from a dual toxin gene containing Clostridium Botulinum Strain PS-5.

    Science.gov (United States)

    Singh, Ajay K; Sachdeva, Amita; Degrasse, Jeffrey A; Croley, Timothy R; Stanker, Larry H; Hodge, David; Sharma, Shashi K

    2013-04-01

    Botulinum neurotoxins are produced as a toxin complex (TC) which consists of neurotoxin (NT) and neurotoxin associated proteins. The characterization of NT in its native state is an essential step for developing diagnostics and therapeutic countermeasures against botulism. The presence of NT genes was validated by PCR amplification of toxin specific fragments from genomic DNA of Clostridium botulinum strain PS-5 which indicated the presence of both serotype A and B genes on PS-5 genome. Further, TC was purified and characterized by Western blotting, Digoxin-enzyme linked immunosorbent assay, endopeptidase activity assay, and Liquid chromatography-Mass spectrometry. The data showed the presence of serotype A specific neurotoxin. Based on the analysis of neurotoxin genes and characterization of TC, PS-5 strain appears as a serotype A (B) strain of C. botulinum which produces only serotype A specific TC in the cell culture medium.

  19. Tracking plant, fungal, and bacterial DNA in honey specimens.

    Science.gov (United States)

    Olivieri, Cristina; Marota, Isolina; Rollo, Franco; Luciani, Stefania

    2012-01-01

    Consuming honey can result in adverse effects owing to poisoning by bacterial (botulism) or plant toxins. We have devised a method to extract polymerase chain reaction (PCR) amplifiable DNA of up to c. 400 bp in length based on dialysis of a 15-mL honey sample for 18 h against deionized water followed by sequential extraction using phenol, phenol/chloroform/isoamyl alcohol, chloroform/isoamyl alcohol, and ether. Sequence analysis of PCR products obtained using "universal" plant, fungal, and bacterial primers targeted to the ribosomal RNA genes has allowed us to identify six different orders of plants (Apiales, Fabales, Asterales, Solanales, Brassicales, and Sapindales), two orders of fungi (Entylomatales and Saccharomycetales), and six orders of bacteria (Sphingomonadales, Burkholderiales, Pseudomonadales, Enterobacteriales, Actinomycetales, and Bifidobacteriales) in a single honey specimen.

  20. Regulation of toxin and bacteriocin synthesis in Clostridium species by a new subgroup of RNA polymerase sigma-factors.

    Science.gov (United States)

    Dupuy, Bruno; Matamouros, Susana

    2006-04-01

    Many Clostridium species are pathogenic for humans and animals, and most of the resulting diseases, such as tetanus, botulism, gas gangrene and pseudomembranous colitis, are due to the production of potent extracellular toxins. The biochemical mechanisms of action of Clostridium toxins have been extensively studied in the past ten years. However, detailed information about the regulation of toxin gene expression has only recently emerged. TcdR, BotR, TetR and UviA are now known to be related alternative RNA polymerase sigma factors that drive transcription of toxin A and toxin B genes in C. difficile, the neurotoxin genes in C. botulinum and C. tetani, and a bacteriocin gene in C. perfringens. Although the Clostridium sigma factors have some similarity to members of the ECF sigma factor group, they differ sufficiently in structure and function so that they have been assigned to a new group within the sigma(70)-family.

  1. Interaction of Botulinum Toxin with the Epithelial Barrier

    Directory of Open Access Journals (Sweden)

    Yukako Fujinaga

    2010-01-01

    Full Text Available Botulinum neurotoxin (BoNT is a protein toxin (~150 kDa, which possesses a metalloprotease activity. Food-borne botulism is manifested when BoNT is absorbed from the digestive tract to the blood stream and enters the peripheral nerves, where the toxin cleaves core proteins of the neuroexocytosis apparatus and elicits the inhibition of neurotransmitter release. The initial obstacle to orally ingested BoNT entering the body is the epithelial barrier of the digestive tract. Recent cell biology and molecular biology studies are beginning to elucidate the mechanism by which this large protein toxin crosses the epithelial barrier. In this review, we provide an overview of the structural features of botulinum toxins (BoNT and BoNT complex and the interaction of these toxins with the epithelial barrier.

  2. "Isolation of Clostridum botiulinum (Types A, B, E in Sediments from Coastal Areas in the North of Iran"

    Directory of Open Access Journals (Sweden)

    HR Tavakoli

    2003-09-01

    Full Text Available Iranian J Publ Health, Vol. 32, No. 3, pp.37-40, 2003 Isolation of Clostridum botiulinum (Types A, B, E in Sediments from Coastal Areas in the North of Iran *HR Tavakoli 1,V Razavilar 2 1Dept. of Nutrition and Food Hygiene,School of public health, Baghyatollah University of Medical Sciences, Tehran, Iran 2Dept. of Food Hygiene, School of Veterinary Medicine, Tehran University , Iran Clostridium botulinum has long been recognized as an etiological agent of food borne botulism and has been reported as an important food safety hazard. The aim of this study was to obtain information about C. botulinum distribution in north areas sediments of Iran in order to ascertain the risks associated with consumption and processing of fish from these waters. Two hundred and seventy samples of sediments from coastal areas of "Gilan" and "Mazandaran" provinas of Iran were collected and analyzed. The supernatants were inoculated into cooked meat media and then , grown specimens were stained and cheked microscopically. After centrifuge ,the supernatants were divided into three (untreated ,heated , and tripsinised and toxicity of them were tested by mouse bioassay. All mice controlled for 4 days for symptoms of botulism. Monovalent standard antitoxins were used for detection of toxin type. The present study revealed that the prevalence of C. botulinum (types A, B and E in sediments from different areas of Gillan and Mazandaran was 3.6% and 4.6% respectively, Mean prevalence of C. botulinum in sediments from north regions of Iran was 4.1%. It is also demonstrated that C. botulinum type E is predominant type seen in aquatic environments of the coastal areas of Iran. This is the first report of C. botulinum distribution in the sediments coastal areas of Iran. Introduction *Corresponding author: +98 21 4811483

  3. São os membros superiores na Paralisia Cerebral negligenciados?

    Directory of Open Access Journals (Sweden)

    Ubiratan Brum Castro

    2014-06-01

    Full Text Available Objetivo: Avaliar se num serviço de atendimento especializado, o membro superior é preterido ou negligenciado no tratamento das alterações motoras da Paralisia Cerebral. Casuística e métodos: Foram analisados 80 pacientes portadores de Paralisia Cerebral menores de dezessete anos tratados institucionalmente. Foram avaliados pelo mesmo examinador quanto à classificação e tratamentos (cirúrgico ou não do aparelho locomotor. Resultados: O membro superior teve a seguinte abordagem terapêutica considerando o grupo de mão comprometida, 1 (2% foi submetido a transferência tendinosa no punho e 53 (98% não foram operados. Quanto a órteses, 9 (17% usavam estabilizadores de punho e 45 (83% não usavam. Quanto à toxina botulínica não houve aplicação nos membros superiores. Nos membros inferiores, considerando o total de pacientes, 16 (20% foram submetidos à cirurgia e 64(80% não foram operados. As cirurgias foram um tratamento cirúrgico de luxação do quadril, 7 a alongamentos múltiplos em membros inferiores, 5 alongamento de tendão calcâneo, 3 tenotomia de adutores. Quanto ao uso de órteses, 49 (61% faziam uso e 31(39% não utilizavam. Dos pacientes que faziam uso de órteses, 48 usavam tala estabilizadora de tornozelo, um usava estabilizador de joelho. Quanto à  o uso de toxina botulínica: 32 tiveram aplicação (40% e 48 não receberam aplicação (60%. Conclusão: No presente estudo, o tratamento do membro superior foi negligenciado.

  4. Botulinum Toxin Type a as a Therapeutic Agent against Headache and Related Disorders.

    Science.gov (United States)

    Luvisetto, Siro; Gazerani, Parisa; Cianchetti, Carlo; Pavone, Flaminia

    2015-09-01

    Botulinum neurotoxin A (BoNT/A) is a toxin produced by the naturally-occurring Clostridium botulinum that causes botulism. The potential of BoNT/A as a useful medical intervention was discovered by scientists developing a vaccine to protect against botulism. They found that, when injected into a muscle, BoNT/A causes a flaccid paralysis. Following this discovery, BoNT/A has been used for many years in the treatment of conditions of pathological muscle hyperactivity, like dystonias and spasticities. In parallel, the toxin has become a "glamour" drug due to its power to ward off facial wrinkles, particularly frontal, due to the activity of the mimic muscles. After the discovery that the drug also appeared to have a preventive effect on headache, scientists spent many efforts to study the potentially-therapeutic action of BoNT/A against pain. BoNT/A is effective at reducing pain in a number of disease states, including cervical dystonia, neuropathic pain, lower back pain, spasticity, myofascial pain and bladder pain. In 2010, regulatory approval for the treatment of chronic migraine with BoNT/A was given, notwithstanding the fact that the mechanism of action is still not completely elucidated. In the present review, we summarize experimental evidence that may help to clarify the mechanisms of action of BoNT/A in relation to the alleviation of headache pain, with particular emphasis on preclinical studies, both in animals and humans. Moreover, we summarize the latest clinical trials that show evidence on headache conditions that may obtain benefits from therapy with BoNT/A.

  5. Neutralization of Botulinum Neurotoxin Type E by a Humanized Antibody

    Directory of Open Access Journals (Sweden)

    Yağmur Derman

    2016-09-01

    Full Text Available Botulinum neurotoxins (BoNTs cause botulism and are the deadliest naturally-occurring substances known to humans. BoNTs have been classified as one of the category A agents by the Centers for Disease Control and Prevention, indicating their potential use as bioweapons. To counter bio-threat and naturally-occurring botulism cases, well-tolerated antibodies by humans that neutralize BoNTs are relevant. In our previous work, we showed the neutralizing potential of macaque (Macaca fascicularis-derived scFv-Fc (scFv-Fc ELC18 by in vitro endopeptidase immunoassay and ex vivo mouse phrenic nerve-hemidiaphragm assay by targeting the light chain of the botulinum neurotoxin type E (BoNT/E. In the present study, we germline-humanized scFv-Fc ELC18 into a full IgG hu8ELC18 to increase its immunotolerance by humans. We demonstrated the protection and prophylaxis capacity of hu8ELC18 against BoNT/E in a mouse model. A concentration of 2.5 ng/mouse of hu8ELC18 protected against 5 mouse lethal dose (MLD in a mouse protection assay and complete neutralization of 1 LD50 of pure BoNT/E toxin was achieved with 8 ng of hu8ELC18 in mouse paralysis assay. Furthermore, hu8ELC18 protected mice from 5 MLD if injected up to 14 days prior to intraperitoneal BoNT/E administration. This newly-developed humanized IgG is expected to have high tolerance in humans.

  6. Monoclonal Antibodies that Inhibit the Proteolytic Activity of Botulinum Neurotoxin Serotype/B

    Directory of Open Access Journals (Sweden)

    Yongfeng Fan

    2015-08-01

    Full Text Available Existing antibodies (Abs used to treat botulism cannot enter the cytosol of neurons and bind to botulinum neurotoxin (BoNT at its site of action, and thus cannot reverse paralysis. However, Abs targeting the proteolytic domain of the toxin could inhibit the proteolytic activity of the toxin intracellularly and potentially reverse intoxication, if they could be delivered intracellularly. As such, antibodies that neutralize toxin activity could serve as potent inhibitory cargos for therapeutic antitoxins against botulism. BoNT serotype B (BoNT/B contains a zinc endopeptidase light chain (LC domain that cleaves synaoptobrevin-2, a SNARE protein responsible for vesicle fusion and acetylcholine vesicle release. To generate monoclonal Abs (mAbs that could reverse paralysis, we targeted the protease domain for Ab generation. Single-chain variable fragment (scFv libraries from immunized mice or humans were displayed on yeast, and 19 unique BoNT/B LC-specific mAbs isolated by fluorescence-activated cell sorting (FACS. The equilibrium dissociation constants (KD of these mAbs for BoNT/B LC ranged from 0.24 nM to 14.3 nM (mean KD 3.27 nM. Eleven mAbs inhibited BoNT/B LC proteolytic activity. The fine epitopes of selected mAbs were identified by alanine-scanning mutagenesis, revealing that inhibitory mAbs bound near the active site, substrate-binding site or the extended substrate-binding site. The results provide mAbs that could prove useful for intracellular reversal of paralysis and identify epitopes that could be targeted by small molecules inhibitors.

  7. Monoclonal Antibodies Targeting the Alpha-Exosite of Botulinum Neurotoxin Serotype/A Inhibit Catalytic Activity.

    Directory of Open Access Journals (Sweden)

    Yongfeng Fan

    Full Text Available The paralytic disease botulism is caused by botulinum neurotoxins (BoNT, multi-domain proteins containing a zinc endopeptidase that cleaves the cognate SNARE protein, thereby blocking acetylcholine neurotransmitter release. Antitoxins currently used to treat botulism neutralize circulating BoNT but cannot enter, bind to or neutralize BoNT that has already entered the neuron. The light chain endopeptidase domain (LC of BoNT serotype A (BoNT/A was targeted for generation of monoclonal antibodies (mAbs that could reverse paralysis resulting from intoxication by BoNT/A. Single-chain variable fragment (scFv libraries from immunized humans and mice were displayed on the surface of yeast, and 19 BoNT/A LC-specific mAbs were isolated by using fluorescence-activated cell sorting (FACS. Affinities of the mAbs for BoNT/A LC ranged from a KD value of 9.0×10-11 M to 3.53×10-8 M (mean KD 5.38×10-9 M and median KD 1.53×10-9 M, as determined by flow cytometry analysis. Eleven mAbs inhibited BoNT/A LC catalytic activity with IC50 values ranging from 8.3 ~73×10-9 M. The fine epitopes of selected mAbs were also mapped by alanine-scanning mutagenesis, revealing that the inhibitory mAbs bound the α-exosite region remote from the BoNT/A LC catalytic center. The results provide mAbs that could prove useful for intracellular reversal of paralysis post-intoxication and further define epitopes that could be targeted by small molecule inhibitors.

  8. Neutralization of Botulinum Neurotoxin Type E by a Humanized Antibody

    Science.gov (United States)

    Derman, Yağmur; Selby, Katja; Miethe, Sebastian; Frenzel, André; Liu, Yvonne; Rasetti-Escargueil, Christine; Avril, Arnaud; Pelat, Thibaut; Urbain, Remi; Fontayne, Alexandre; Thullier, Philippe; Sesardic, Dorothea; Lindström, Miia; Hust, Michael; Korkeala, Hannu

    2016-01-01

    Botulinum neurotoxins (BoNTs) cause botulism and are the deadliest naturally-occurring substances known to humans. BoNTs have been classified as one of the category A agents by the Centers for Disease Control and Prevention, indicating their potential use as bioweapons. To counter bio-threat and naturally-occurring botulism cases, well-tolerated antibodies by humans that neutralize BoNTs are relevant. In our previous work, we showed the neutralizing potential of macaque (Macaca fascicularis)-derived scFv-Fc (scFv-Fc ELC18) by in vitro endopeptidase immunoassay and ex vivo mouse phrenic nerve-hemidiaphragm assay by targeting the light chain of the botulinum neurotoxin type E (BoNT/E). In the present study, we germline-humanized scFv-Fc ELC18 into a full IgG hu8ELC18 to increase its immunotolerance by humans. We demonstrated the protection and prophylaxis capacity of hu8ELC18 against BoNT/E in a mouse model. A concentration of 2.5 ng/mouse of hu8ELC18 protected against 5 mouse lethal dose (MLD) in a mouse protection assay and complete neutralization of 1 LD50 of pure BoNT/E toxin was achieved with 8 ng of hu8ELC18 in mouse paralysis assay. Furthermore, hu8ELC18 protected mice from 5 MLD if injected up to 14 days prior to intraperitoneal BoNT/E administration. This newly-developed humanized IgG is expected to have high tolerance in humans. PMID:27626446

  9. Advances in botulinum toxin detection method in vitro%肉毒毒素体外检测方法的研究进展

    Institute of Scientific and Technical Information of China (English)

    叶婷(综述); 张雪平(审校)

    2016-01-01

    肉毒毒素是肉毒梭状芽胞杆菌在生长繁殖过程中产生的一种神经毒素,对人和动物具有强毒性和高致死性,在世界范围内,肉毒中毒的案例时有发生,病情严重者一般2~3d即可死亡。肉毒毒素产品所用的体内检测方法(小鼠生物法)的结果变异系数大,不利于肉毒毒素产品含量的标准化控制。因而,建立准确且灵敏度高的肉毒毒素体外检测方法,在临床治疗及制品的质量控制方面都具有重要意义,现就常用的肉毒毒素体外检测方法作一阐述。%Botulinum toxin is a neurotoxin generated in the growth of the clostridium botulinum, which has an extremely tox-icity and seriously lethal effect for human and animal. Botulism cases frequently occur in the worldwide, few serious pa-tients will die in two to three days. In addition, the detection method for botulinum toxin product is carried out the mouse bioassay in vivo which has a higher coefficient of variations, so it is not conducive to the standardization of qality control for content of botulinum toxin product. Therefore, it has a great significance to set up accurate and sensitive detection methods in vitro in clinical treatment of botulism and quality control of botulinum toxin product. The paper summarizes the latest progress in detection methods for botulinum toxin in vitro.

  10. Substrate Binding Mode and its Implication on Drug Design for Botulinum Neurotoxin A

    Energy Technology Data Exchange (ETDEWEB)

    Kumaran, D.; Rawat, R; Ahmed, A; Swaminathan, S

    2008-01-01

    The seven antigenically distinct serotypes of Clostridium botulinum neurotoxins, the causative agents of botulism, block the neurotransmitter release by specifically cleaving one of the three SNARE proteins and induce flaccid paralysis. The Centers for Disease Control and Prevention (CDC) has declared them as Category A biowarfare agents. The most potent among them, botulinum neurotoxin type A (BoNT/A), cleaves its substrate synaptosome-associated protein of 25 kDa (SNAP-25). An efficient drug for botulism can be developed only with the knowledge of interactions between the substrate and enzyme at the active site. Here, we report the crystal structures of the catalytic domain of BoNT/A with its uncleavable SNAP-25 peptide 197QRATKM202 and its variant 197RRATKM202 to 1.5 A and 1.6 A, respectively. This is the first time the structure of an uncleavable substrate bound to an active botulinum neurotoxin is reported and it has helped in unequivocally defining S1 to S5? sites. These substrate peptides make interactions with the enzyme predominantly by the residues from 160, 200, 250 and 370 loops. Most notably, the amino nitrogen and carbonyl oxygen of P1 residue (Gln197) chelate the zinc ion and replace the nucleophilic water. The P1?-Arg198, occupies the S1? site formed by Arg363, Thr220, Asp370, Thr215, Ile161, Phe163 and Phe194. The S2? subsite is formed by Arg363, Asn368 and Asp370, while S3? subsite is formed by Tyr251, Leu256, Val258, Tyr366, Phe369 and Asn388. P4?-Lys201 makes hydrogen bond with Gln162. P5?-Met202 binds in the hydrophobic pocket formed by the residues from the 250 and 200 loop. Knowledge of interactions between the enzyme and substrate peptide from these complex structures should form the basis for design of potent inhibitors for this neurotoxin.

  11. Substrate binding mode and its implication on drug design for botulinum neurotoxin A.

    Directory of Open Access Journals (Sweden)

    Desigan Kumaran

    Full Text Available The seven antigenically distinct serotypes of Clostridium botulinum neurotoxins, the causative agents of botulism, block the neurotransmitter release by specifically cleaving one of the three SNARE proteins and induce flaccid paralysis. The Centers for Disease Control and Prevention (CDC has declared them as Category A biowarfare agents. The most potent among them, botulinum neurotoxin type A (BoNT/A, cleaves its substrate synaptosome-associated protein of 25 kDa (SNAP-25. An efficient drug for botulism can be developed only with the knowledge of interactions between the substrate and enzyme at the active site. Here, we report the crystal structures of the catalytic domain of BoNT/A with its uncleavable SNAP-25 peptide (197QRATKM(202 and its variant (197RRATKM(202 to 1.5 A and 1.6 A, respectively. This is the first time the structure of an uncleavable substrate bound to an active botulinum neurotoxin is reported and it has helped in unequivocally defining S1 to S5' sites. These substrate peptides make interactions with the enzyme predominantly by the residues from 160, 200, 250 and 370 loops. Most notably, the amino nitrogen and carbonyl oxygen of P1 residue (Gln197 chelate the zinc ion and replace the nucleophilic water. The P1'-Arg198, occupies the S1' site formed by Arg363, Thr220, Asp370, Thr215, Ile161, Phe163 and Phe194. The S2' subsite is formed by Arg363, Asn368 and Asp370, while S3' subsite is formed by Tyr251, Leu256, Val258, Tyr366, Phe369 and Asn388. P4'-Lys201 makes hydrogen bond with Gln162. P5'-Met202 binds in the hydrophobic pocket formed by the residues from the 250 and 200 loop. Knowledge of interactions between the enzyme and substrate peptide from these complex structures should form the basis for design of potent inhibitors for this neurotoxin.

  12. Botulinum Toxin Type A as a Therapeutic Agent against Headache and Related Disorders

    Directory of Open Access Journals (Sweden)

    Siro Luvisetto

    2015-09-01

    Full Text Available Botulinum neurotoxin A (BoNT/A is a toxin produced by the naturally-occurring Clostridium botulinum that causes botulism. The potential of BoNT/A as a useful medical intervention was discovered by scientists developing a vaccine to protect against botulism. They found that, when injected into a muscle, BoNT/A causes a flaccid paralysis. Following this discovery, BoNT/A has been used for many years in the treatment of conditions of pathological muscle hyperactivity, like dystonias and spasticities. In parallel, the toxin has become a “glamour” drug due to its power to ward off facial wrinkles, particularly frontal, due to the activity of the mimic muscles. After the discovery that the drug also appeared to have a preventive effect on headache, scientists spent many efforts to study the potentially-therapeutic action of BoNT/A against pain. BoNT/A is effective at reducing pain in a number of disease states, including cervical dystonia, neuropathic pain, lower back pain, spasticity, myofascial pain and bladder pain. In 2010, regulatory approval for the treatment of chronic migraine with BoNT/A was given, notwithstanding the fact that the mechanism of action is still not completely elucidated. In the present review, we summarize experimental evidence that may help to clarify the mechanisms of action of BoNT/A in relation to the alleviation of headache pain, with particular emphasis on preclinical studies, both in animals and humans. Moreover, we summarize the latest clinical trials that show evidence on headache conditions that may obtain benefits from therapy with BoNT/A.

  13. Bacterial spores as possible contaminants of biomedical materials and devices. [Bacillus anthracis, clostridium botulinum, C. perfringens, C. tetani

    Energy Technology Data Exchange (ETDEWEB)

    Grecz, N.; Kang, T.

    1973-01-01

    Destruction of spores on biomedical devices in drugs, and biologicals is essential for prevention of infection of patients with pathogenic sporeformers. Of particular concern are Clostridium tetani, C. perfringens, C. botulinum, Bacillus anthracis and other sporeforming pathogens. Spores are ubiquitous in nature and contamination of biomedical devices varies depending on manufacturing process, handling, raw materials and other variables. In the last 20 years the number of cases per year of specific notifiable diseases in the United States was as follows: tetanus, 120 to 500 cases, botulism, 7 to 47 cases, and anthrax, 2 to 10 cases. Gas gangrene is caused by a mixed flora consisting predominantly of sporeformers. C botulinum, which usually acts as saprophytic agent of food poisoning, may also initiate pathogenic processes; there are nine cases on record in the United States of botulism wound infections almost half of which ended in death. The spores of these organisms are distinguished by high radiation resistance and their erradication often requires severe radiation treatments. Representative bacterial spores in various suspending media show D/sub 10/ values (dose necessary to destroy 90 percent of a given population) ranging from approximately 0.1 to 0.4 Mrad. Some viruses show D/sub 10/ values up to greater than 1 Mrad. The D/sub 10/-values of spores vary depending on physical, chemical and biological factors. This variability is important in evaluation and selection of biological indicator organisms. Radiation sterilization of biomedical devices and biomedical materials must provide safety from infectious microorganisms including radiation resistant spores and viruses.

  14. Arrangement of the Clostridium baratii F7 toxin gene cluster with identification of a σ factor that recognizes the botulinum toxin gene cluster promoters.

    Science.gov (United States)

    Dover, Nir; Barash, Jason R; Burke, Julianne N; Hill, Karen K; Detter, John C; Arnon, Stephen S

    2014-01-01

    Botulinum neurotoxin (BoNT) is the most poisonous substances known and its eight toxin types (A to H) are distinguished by the inability of polyclonal antibodies that neutralize one toxin type to neutralize any of the other seven toxin types. Infant botulism, an intestinal toxemia orphan disease, is the most common form of human botulism in the United States. It results from swallowed spores of Clostridium botulinum (or rarely, neurotoxigenic Clostridium butyricum or Clostridium baratii) that germinate and temporarily colonize the lumen of the large intestine, where, as vegetative cells, they produce botulinum toxin. Botulinum neurotoxin is encoded by the bont gene that is part of a toxin gene cluster that includes several accessory genes. We sequenced for the first time the complete botulinum neurotoxin gene cluster of nonproteolytic C. baratii type F7. Like the type E and the nonproteolytic type F6 botulinum toxin gene clusters, the C. baratii type F7 had an orfX toxin gene cluster that lacked the regulatory botR gene which is found in proteolytic C. botulinum strains and codes for an alternative σ factor. In the absence of botR, we identified a putative alternative regulatory gene located upstream of the C. baratii type F7 toxin gene cluster. This putative regulatory gene codes for a predicted σ factor that contains DNA-binding-domain homologues to the DNA-binding domains both of BotR and of other members of the TcdR-related group 5 of the σ70 family that are involved in the regulation of toxin gene expression in clostridia. We showed that this TcdR-related protein in association with RNA polymerase core enzyme specifically binds to the C. baratii type F7 botulinum toxin gene cluster promoters. This TcdR-related protein may therefore be involved in regulating the expression of the genes of the botulinum toxin gene cluster in neurotoxigenic C. baratii.

  15. Study of crotoxin on the induction of paralysis in extraocular muscle in animal model Estudo da crotoxina na indução de paralisia da musculatura extraocular em modelo animal

    Directory of Open Access Journals (Sweden)

    Geraldo de Barros Ribeiro

    2012-10-01

    crotoxina é a principal toxina do veneno da cobra cascavel sul-americana Crotalus durissus terrificus e causa bloqueio da neurotransmissão na junção neuromuscular. O objetivo deste estudo foi avaliar a ação e aplicabilidade da crotoxina na indução de paralisia da musculatura extrínseca ocular, e comparar seus efeitos com os da toxina botulínica do tipo A (TB-A. MÉTODOS: A crotoxina, com DL50 de 1,5 µg, foi aplicada no músculo reto superior direito de dez coelhos da raça neozelandesa, em concentrações que variaram de 0,015 µg a 150 µg. Em dois coelhos, utilizou-se 2 unidades de toxina botulínica do tipo A para análise comparativa. A avaliação da paralisia foi realizada através de eletromiografia seriada. Após a recuperação, que ocorreu em dois meses, seis coelhos foram sacrificados para estudo anátomopatológico. RESULTADOS: Os animais não apresentaram sinais de intoxicação sistêmica. Ptose palpebral transitória foi observada em quase todos os animais e permaneceu por até 14 dias. As toxinas causaram um bloqueio imediato da captação dos potenciais elétricos. A recuperação foi gradativa no período aproximado de um mês, observando-se sinais evidentes de regeneração no registro eletromiográfico. Os efeitos da crotoxina na paralização do músculo injetado foram proporcionais à concentração. A crotoxina, na concentração de 1,5 µg, induziu alterações semelhantes às da toxina botulínica do tipo A. Os achados anátomo-patológicos foram localizados somente na região em que se aplicou as toxinas, não havendo necrose de fibras musculares em nenhuma amostra analisada. As alterações causadas pela crotoxina também foram proporcionais à concentração utilizada e similares a toxina botulínica do tipo A na concentração de 1,5 µg. CONCLUSÃO: A crotoxina foi capaz de induzir paralisia transitória do músculo reto superior. Este efeito foi caracterizado pela redução na amplitude dos potenciais de ação e sinais inespec

  16. Esporos de Clostridium botulinum em mel comercializado no Estado de São Paulo e em outros Estados brasileiros Clostridium botulinum spores in honey commercialized in São Paulo and other Brazilian states

    Directory of Open Access Journals (Sweden)

    Adriana Valim Ferreira Ragazani

    2008-04-01

    Full Text Available O botulismo infantil tem afetado crianças abaixo de um ano de idade em várias regiões do mundo, e o mel tem sido identificado como uma das mais importantes fontes de intoxicação alimentar. Apesar disso, há dados escassos sobre o botulismo entre crianças no Brasil, especialmente no tipo de alimento comercial mais implicado nesta patologia. Este estudo pretendeu investigar a presença de esporos de Clostridium botulinum em mel comercializado no Brasil. Cem amostras de mel comercializado em seis diferentes Estados brasileiros (SP, MG, GO, CE, MT, SC foram pesquisados para a presença de esporos de Clostridium botulinum, usando o choque térmico, seguido pela inoculação em caldo Cooked Meat Medium (Difco® e incubado em condições anaeróbias. As culturas positivas foram analisadas através de esfregaços corados pelo Gram e semeadas em placas de Reinforced Clostrideo Agar (Difco® e placas de Sulfito Polimixina Sulfadiazina -SPS (Difco®, as quais foram incubadas em condições anaeróbicas para obter colônias desta bactéria. As colônias positivas foram submetidas a teste de toxicidade através da inoculação em camundongos susceptíveis e caracterização bioquímica. Foram encontradas colônias de Clostridium botulinum que produzem toxinas ativas em 7% das amostras de mel comercial, realçando a relevância deste microrganismo para a saúde pública devido ao alto risco potencial de o mel comercializado nestas regiões brasileiras causar o botulismo infantil, especialmente em crianças abaixo de um ano de idade.Infant botulism has been affecting children under one year of age in several regions of the world and honey has been identified as one of the most important source of this food borne disease. Despite this, there are scarce data about botulism among children in Brazil, specially the type commercial food most implicated in this pathology. This study aimed at investigating the presence of spores of Clostridium botulinum in honey

  17. Distonias: aspectos terapêuticos Dystonias: therapeutic aspects

    Directory of Open Access Journals (Sweden)

    João Carlos Papaterra Limongi

    1996-03-01

    Full Text Available Diversas abordagens terapêuticas são utilizadas em pacientes com distonias. Sempre que possível, causas específicas devem ser identificadas e tratadas. As modalidades de tratamento sintomático podem ser agrupadas em três categorias: tratamento farmacológico, cirúrgico e injeções locais de toxina botulínica. Cada uma dessas modalidades apresenta algumas vantagens e limitações. Formas generalizadas, particularmente as de ocorrência na infância, podem se beneficiar com drogas anticolinérgicas ou, em alguns casos, com a levodopa ou outros agentes tais como antagonistas da dopamina, baclofeno e benzodiazepínicos. As formas focais não respondem adequadamente ao tratamento farmacológico sistêmico mas beneficiam-se significativamente com injeções de toxina botulínica nos grupos musculares acometidos. Cerca de 90% dos pacientes com blefarospasmo e 70% daqueles com distonia cervical apresentam resposta satisfatória a esse tipo de terapia. O tratamento cirúrgico tem sido utilizado em algumas formas de distonias generalizadas (lesões estereotáxicas, axiais (rizotomias ou focais (miectomias e neurectomias com resultados variáveis.Several approaches have been employed for the treatment of dystonias. Possible specific causes should be searched for and specific treatment should be instituted. Different types of symptomatic treatment are grouped according to the following categories: pharmacological systemic therapy, surgical therapy and botulinum toxin injections in the affected muscles. Each of these approaches has its advantages and limitations. Generalized dystonias should be treated with anticholinergic agents. In some cases, levodopa or other drugs such as dopamine antagonists, baclofen and benzodiazepines should be preferred. Focal dystonias respond dramatically to local injections of botulinum toxin. Over 90% of patients with blepharospasm and 70% of patients with cervical dystonia present a satisfactory response to this

  18. Tratamento farmacológico da gagueira: evidências e controvérsias Pharmacologic treatment of stuttering: evidences and controversies

    Directory of Open Access Journals (Sweden)

    Camila Vila-Nova

    2006-01-01

    Full Text Available OBJETIVO: Este artigo tem por objetivo analisar a situação do tratamento farmacológico da gagueira, mostrando a eficácia de diferentes abordagens baseadas em drogas psiquiátricas, além de evidenciar a utilização de outros fármacos no tratamento dessa enfermidade. MÉTODOS: Revisão de literatura em base de dados Medline, utilizando os termos stuttering treatment, disfluency, disfluency treatments, botulinum toxin and stuttering treatment, botulinum toxin and disfluency treatment. RESULTADOS: Foram encontrados estudos envolvendo as seguintes drogas: citalopram + clomipramina, paroxetina, olanzapina, citalopram + alprazolam, pimozida, risperidona, tiaprida, clomipramina e desipramina, levetiracetam, divalproato de sódio, clonidina e betanecol, além de ensaios clínicos com a utilização de toxina botulínica tipo A e anestésicos. Os estudos envolvendo citalopram + clomipramina, paroxetina, olanzapina, citalopram + alprazolam, risperidona, clomipramina e desipramina, levetiracetam, divalproato de sódio, lidocaína e toxina botulínica tipo A demonstraram resultados positivos. A maioria das pesquisas relativas ao tratamento farmacológico da gagueira se restringe a estudos de caso e ensaios clínicos com pequenas amostras. CONCLUSÃO: Não existem evidências suficientes que justifiquem a utilização de um tratamento específico para a gagueira. Os estudos apresentados indicam a necessidade da realização de mais ensaios clínicos duplo-cegos e controlados com placebo envolvendo amostras maiores.OBJECTIVE: This article analyzes the pharmacologic treatment of stuttering, assessing the effectiveness of different treatments using psychiatric drugs and further evidences of other drugs in the treatment of this disorder. METHODS: Search in Medline database, using the terms stuttering treatment, disfluency, disfluency treatments, botulinum toxin and stuttering treatment, botulinum toxin and disfluency treatment. RESULTS: Studies involving

  19. Estudio anatómico y clínico del músculo depresor de la punta nasal Anatomic and clinical study of the depressor septi nasi muscle

    Directory of Open Access Journals (Sweden)

    J.H. Soria

    2012-09-01

    Full Text Available Investigamos la relación entre el síndrome rino-gingivo-labial y el músculo depresor de la punta nasal. Realizamos identificación y disección del músculo a través de una incisión intersepto-columelar ampliada sobre el piso nasal en un grupo de 62 pacientes a los cuales se les practicó rinoplastia, divididos en 3 grupos, teniendo en cuenta la presencia o ausencia, durante la gesticulación facial, de: 1-curvatura del dorso nasal. 2-descenso de la punta nasal. 3-acortamiento de la columela. 4-movilidad notoria de la punta nasal al hablar. 5-labio superior corto. 6-aparición de un surco horizontal en el labio superior. 7-sobrexposición gingival. Observamos que en el 20 % de los casos, el músculo tenía un mayor desarrollo con una inserción distal más próxima a la punta nasal. La conducta quirúrgica indicada es su miotomía o miectomía o bien el tratamiento con toxina botulínica, logrando resultados estéticos buenos o muy buenos, con una gran aceptación de parte de los pacientes.The relationship between the rhino-gingivolabial syndrome and the hypertrophy of the depressor septi nasi muscle was investigated. We identified and dissected this muscle through a transfixion interseptum-collumelar incision extended laterally along the vestibular floor in 62 patients submitted to rhynoplasty and divided in 3 groups according to the appearance or absence during facial mimic of: 1-curvature of nasal dorsum; 2-descending nasal tip; 3-shortened columella; 4-inferior displacement of the nasal tip when speech; 5-shortened upper lip; 6-transverse crease in the mid-philtral area. 7-increased maxillary gingival show during the facial animation. We found a 20 % of hypertrophic muscle, with a more anterior distal insertion. Furthermore of muscle division or resection as surgical indication, botulism toxin, can be used to treat this condition with patient´s satisfaction.

  20. Botulinum toxin for treating muscular temporomandibular disorders: a systematic review

    Directory of Open Access Journals (Sweden)

    Eduardo Machado

    2012-12-01

    Full Text Available OBJECTIVE: This study, through a systematic literature review, aims to analyze the effectiveness of Botulinum Toxin as a treatment for masticatory myofascial pain and muscles temporomandibular disorders (TMD. METHODS: Survey in research bases: MEDLINE, Cochrane, EMBASE, Pubmed, Lilacs and BBO, between the years of 1966 and April 2011, with focus in randomized or quasi-randomized controlled clinical trials, blind or double-blind. RESULTS: After applying the inclusion criteria, 4 articles comprised the final sample: 3 were double-blind randomized controlled clinical trials and 1 was single-blind randomized controlled clinical trial. CONCLUSIONS: According to the literature, there is lack of evidence about the real effectiveness of botulinum toxin in the treatment of masticatory myofascial pain and muscular TMD. Thus, further randomized controlled clinical trials, with representative samples and longer follow-up time, to assess the real effectiveness of the technique are needed.OBJETIVO: este trabalho, por meio de uma revisão sistemática da literatura, teve como objetivo analisar a efetividade da toxina botulínica como tratamento para dor miofascial mastigatória e disfunções temporomandibulares (DTM musculares. MÉTODOS: pesquisa nas bases de dados Medline, Cochrane, Embase, Pubmed, Lilacs e BBO, no período entre 1966 e abril de 2011, com enfoque em estudos clínicos controlados randomizados ou quase-randomizados, cegos ou duplo-cegos. RESULTADOS: após a aplicação dos critérios de inclusão, chegou-se a 4 artigos, sendo que 3 eram estudos clínicos controlados randomizados duplo-cego e 1 era estudo clínico controlado randomizado simples-cego. CONCLUSÕES: pela análise da literatura, verificou-se um número reduzido de evidências significativas sobre a real efetividade da toxina botulínica no tratamento da dor miofascial e de DTM musculares. Assim, são necessários novos estudos clínicos controlados randomizados, com amostras

  1. Esporos e toxinas de Clostridium botulinum dos tipos C e D em cacimbas no Vale do Araguaia, Goiás

    Directory of Open Access Journals (Sweden)

    Souza Aires M.

    2006-01-01

    Full Text Available Foram avaliadas a ocorrência e distribuição de esporos e toxinas de Clostridium botulinum tipos C e D em 300 cacimbas empregadas como bebedouro de bovinos em 130 propriedades rurais localizadas em 12 municípios do Vale do Araguaia, Estado de Goiás. A presença de esporos foi determinada indiretamente pelo cultivo em meio de cultura, seguido da inoculação e neutralização em camundongo das amostras de sedimento do interior das cacimbas, e do solo superficial e fezes de bovinos, coletadas ao seu redor. A presença de toxina foi avaliada diretamente pela inoculação em camundongo do sedimento filtrado das cacimbas, também seguida da neutralização em camundongo com antitoxinas C e D. A presença de esporos de C. botulinum foi significativamente maior (p<0,05 nas fezes de bovinos (31%, quando comparadas com os resultados das amostras de solo superficial (19% e dos sedimentos (10%. Foram detectadas toxinas botulínicas dos tipos C, D, ou classificadas como pertencentes ao complexo CD, em seis amostras (2% das 300 cacimbas. Das 130 propriedades trabalhadas, em 122(93,85% foram encontrados esporos ou toxinas de Clostridium botulinum em pelo menos uma das variáveis pesquisadas, enquanto somente 8(6,15% não apresentaram qualquer contaminação A idade e profundidade das cacimbas estiveram associadas com a freqüência de detecção de esporos e toxinas. Assim, quanto mais velhas e rasas, maior a freqüência do isolamento de esporos e toxinas. A contaminação das cacimbas do Vale do Araguaia goiano com esporos e toxinas do Clostridium botulinum tipos C e D demonstra o risco potencial permanente e crescente para a ocorrência da intoxicação botulínica de origem hídrica nos bovinos.

  2. Intoxicación por alimentos, plantas y setas Poisoning by foodstuffs, plants and mushrooms

    Directory of Open Access Journals (Sweden)

    M.A. Pinillos

    2003-01-01

    Full Text Available La intoxicación alimentaria se define como aquella intoxicación provocada por cualquier alimento o producto alimenticio que por contener sustancias tóxicas, gérmenes, metales, aditivos, hormonas, etc. provocan una intoxicación. Supone una parte muy importante de la Toxicología Clínica, aunque en la mayoría de las estadísticas, las toxiinfecciones alimentarias provocada por bacterias, protozoos y virus no son contabilizadas como intoxicaciones, ya que son provocadas por gérmenes y son recogidas como infecciones. En este tema se hace referencia a todos los tipos de patologías debidas a los alimentos, haciendo hincapié en el botulismo, comentando el cuadro clínico en sus diferentes formas clínicas, pero sobre todo en la forma adulta y contraída mediante el consumo de alimentos mal conservados o poco cocinados; la intoxicación por pescado y por marisco. Se describen también los cuadros toxicológicos a los que puede avocar el consumo de plantas que contienen sustancias tóxicas, encuadradas por las diferentes sintomatologías que producen; por último, se exponen las intoxicaciones por setas según el periodo de incubación y las posibles confusiones.Food poisoning is defined as poisoning caused by any foodstuff or alimentary product that causes poisoning because it contains toxic substances, germs, metals, additives, hormones, etc. It forms an important part of Clinical Toxicology, although in the majority of statistics, alimentary toxic infections provoked by bacteria, protozoa and viruses are not classified as poisonings, since they are caused by germs, and are classified as infections. Reference is made within this subject to all types of pathologies due to food, with special emphasis given to botulism. The clinical picture of botulism is discussed in its different clinical forms, but above all in its adult form which is contracted through the consumption of undercooked or badly preserved foods; poisoning by fish and seafood

  3. Crystal structure of the receptor binding domain of the botulinum C-D mosaic neurotoxin reveals potential roles of lysines 1118 and 1136 in membrane interactions

    Energy Technology Data Exchange (ETDEWEB)

    Zhang, Yanfeng; Buchko, Garry W.; Qin, Ling; Robinson, Howard; Varnum, Susan M.

    2011-01-07

    The botulinum neurotoxins (BoNTs) produced by different strains of the bacterium Clostridium botulinum are responsible for the disease botulism and include a group of immunologically distinct serotypes (A, B, E, and F) that are considered to be the most lethal natural proteins known for humans. Two BoNT serotypes, C and D, while rarely associated with human infection, are responsible for deadly botulism outbreaks afflicting animals. Also associated with animal infections is the BoNT C-D mosaic protein (BoNT/CD), a BoNT subtype that is essentially a hybrid of the BoNT/C (~two-thirds) and BoNT/D (~one-third) serotypes. While the amino acid sequence of the heavy chain receptor binding (HCR) domain of BoNT/CD (BoNT/CD-HCR) is very similar to the corresponding amino acid sequence of BoNT/D, BoNT/CD-HCR binds synaptosome membranes better than BoNT/D-HCR. To obtain structural insights for the different membrane binding properties, the crystal structure of BoNT/CD-HCR (S867-E1280) was determined at 1.56 Å resolution and compared to previously reported structures for BoNT/D-HCR. Overall, the BoNT/CD-HCR structure is similar to the two sub-domain organization observed for other BoNT HCRs: an N-terminal jellyroll barrel motif and a C-terminal β-trefoil fold. Comparison of the structure of BoNT/CD-HCR with BoNT/D-HCR indicates that K1118 has a similar structural role as the equivalent residue, E1114, in BoNT/D-HCR, while K1136 has a structurally different role than the equivalent residue, G1132, in BoNT/D-HCR. Lysine-1118 forms a salt bridge with E1247 and may enhance membrane interactions by stabilizing the putative membrane binding loop (K1240-N1248). Lysine-1136 is observed on the surface of the protein. A sulfate ion bound to K1136 may mimic a natural interaction with the negatively changed phospholipid membrane surface. Liposome-binding experiments demonstrate that BoNT/CD-HCR binds phosphatidylethanolamine liposomes more tightly than BoNT/D-HCR

  4. Universal and specific quantitative detection of botulinum neurotoxin genes

    Directory of Open Access Journals (Sweden)

    Arnon Stephen S

    2010-10-01

    Full Text Available Abstract Background Clostridium botulinum, an obligate anaerobic spore-forming bacterium, produces seven antigenic variants of botulinum toxin that are distinguished serologically and termed "serotypes". Botulinum toxin blocks the release of acetylcholine at neuromuscular junctions resulting in flaccid paralysis. The potential lethality of the disease warrants a fast and accurate means of diagnosing suspected instances of food contamination or human intoxication. Currently, the Food and Drug Administration (FDA-accepted assay to detect and type botulinum neurotoxins (BoNTs is the mouse protection bioassay. While specific and sensitive, this assay requires the use of laboratory animals, may take up to four days to achieve a diagnosis, and is unsuitable for high-throughput analysis. We report here a two-step PCR assay that identifies all toxin types, that achieves the specificity of the mouse bioassay while surpassing it in equivalent sensitivity, that has capability for high-throughput analysis, and that provides quantitative results within hours. The first step of our assay consists of a conventional PCR that detects the presence of C. botulinum regardless of the neurotoxin type. The second step uses quantitative PCR (qPCR technology to determine the specific serotype of the neurotoxin. Results We assayed purified C. botulinum DNA and crude toxin preparations, as well as food and stool from healthy individuals spiked with purified BoNT DNA, and one stool sample from a case of infant botulism for the presence of the NTNH gene, which is part of the BoNT gene cluster, and for the presence of serotype-specific BoNT genes. The PCR surpassed the mouse bioassay both in specificity and sensitivity, detecting positive signals in BoNT preparations containing well below the 1 LD50 required for detection via the mouse bioassay. These results were type-specific and we were reliably able to quantify as few as 10 genomic copies. Conclusions While other studies

  5. Crystal Structure of the Receptor Binding Domain of the botulinum C-D Mosiac Neurotoxin Reveals Potential Roles of Lysines 1118 and 1136 in Membrane Interactions

    Energy Technology Data Exchange (ETDEWEB)

    Y Zhang; G Buchko; L Qin; H Robinson; S Varnum

    2011-12-31

    The botulinum neurotoxins (BoNTs) produced by different strains of the bacterium Clostridium botulinum are responsible for the disease botulism and include a group of immunologically distinct serotypes (A, B, E, and F) that are considered to be the most lethal natural proteins known for humans. Two BoNT serotypes, C and D, while rarely associated with human infection, are responsible for deadly botulism outbreaks afflicting animals. Also associated with animal infections is the BoNT C-D mosaic protein (BoNT/CD), a BoNT subtype that is essentially a hybrid of the BoNT/C ({approx}two-third) and BoNT/D ({approx}one-third) serotypes. While the amino acid sequence of the heavy chain receptor binding (HCR) domain of BoNT/CD (BoNT/CD-HCR) is very similar to the corresponding amino acid sequence of BoNT/D, BoNT/CD-HCR binds synaptosome membranes better than BoNT/D-HCR. To obtain structural insights for the different membrane binding properties, the crystal structure of BoNT/CD-HCR (S867-E1280) was determined at 1.56 {angstrom} resolution and compared to previously reported structures for BoNT/D-HCR. Overall, the BoNT/CD-HCR structure is similar to the two sub-domain organization observed for other BoNT HCRs: an N-terminal jellyroll barrel motif and a C-terminal {beta}-trefoil fold. Comparison of the structure of BoNT/CD-HCR with BoNT/D-HCR indicates that K1118 has a similar structural role as the equivalent residue, E1114, in BoNT/D-HCR, while K1136 has a structurally different role than the equivalent residue, G1132, in BoNT/D-HCR. Lysine-1118 forms a salt bridge with E1247 and may enhance membrane interactions by stabilizing the putative membrane binding loop (K1240-N1248). Lysine-1136 is observed on the surface of the protein. A sulfate ion bound to K1136 may mimic a natural interaction with the negatively changed phospholipid membrane surface. Liposome-binding experiments demonstrate that BoNT/CD-HCR binds phosphatidylethanolamine liposomes more tightly than BoNT/D-HCR.

  6. CAUSE OF IMMEDIATE DEATH BY LARGE DOSES OF BOTULINUS TOXIN.

    Science.gov (United States)

    Bronfenbrenner, J J; Schlesinger, M J; Orr, P F

    1924-06-30

    Parenteral introduction of amounts of the culture filtrate of Bacillus botulinus greatly in excess of the minimum lethal dose has been observed to cause the practically immediate death of mice. This result is due to the presence in the filtrates of a chemical poison possessing properties distinct from those of the contained botulinus toxin which itself acts only after a well defined period of incubation. This chemical poison is not neutralized by botulinus antitoxin; it is effective only when large amounts of the culture filtrate are given; it is thermostable, not being destroyed when heated in the autoclave in a sealed tube, though when it is heated in an open container its toxicity diminishes with a coincidental volatilization of basic material. The volatile substance can be identified as ammonia. Death resulting from the injection of comparatively large amounts of ammonium salts (0.1 gm.) is easily distinguished from that due to botulism, both through the character of the symptoms and the absence of an incubation period. However, when the amount of toxic salts injected is smaller (0.01 gm.), the symptoms of poisoning are not so characteristic and death may be delayed long enough to suggest a period of incubation similar to that observed in botulism (Table IV). This circumstance is of importance in connection with the examination of partly decomposed food products in which the presence of botulinus toxin is suspected. As a rule such suspected material is injected in massive doses (0.5 to 1 cc.) in mice. It is conceivable that such spoiled foods may be contaminated with common putrefactive bacteria yielding ammonia during their growth and thus may cause death of the test animals. If in such tests mice passively protected by the preliminary injection of an excess of antitoxin be used in addition to normal animals, the chances of an error in the interpretation of the results will be materially reduced, though not ruled out. Unfortunately for such a procedure

  7. Application of botulinum toxin to treat sialorrhea in amyotrophic lateral sclerosis patients: a literature review.

    Science.gov (United States)

    Oliveira, Ademar Francisco de; Silva, Gêssyca Adryene de Menezes; Almeida, Débora Milenna Xavier

    2016-01-01

    Amyotrophic lateral sclerosis is a progressive and fatal neurodegenerative disease characterized by the degeneration of motor neurons, which are the central nervous system cells that control voluntary muscle movements. The excessive salivation (sialorrhea) is present in approximately 50% of amyotrophic lateral sclerosis cases. Thus, some alternative therapeutic methods are sought, such as anticholinergic drugs and surgery. Recently the use of botulinum toxin applied at a midpoint of the salivary glands, often guided by ultrasound, have demonstrated positive results. The objective was to review the literature to demonstrate an alternative method to treatments of sialorrhea in patients with amyotrophic lateral sclerosis. In recent studies, the efficacy of botulinum toxin is confirmed, although new applications are required. Since the side effects are negligible, this is an alternative to treat amyotrophic lateral sclerosis, and other patients with diseases that present sialorrhea. RESUMO Esclerose lateral amiotrófica é uma doença neurodegenerativa progressiva e fatal, caracterizada pela degeneração dos neurônios motores, as células do sistema nervoso central que controlam os movimentos voluntários dos músculos. A salivação excessiva (sialorreia) está presente em cerca de 50% dos casos de esclerose lateral amiotrófica. Dessa forma, surgem medidas terapêuticas alternativas como drogas anticolinérgicas e cirurgia, e recentemente, o uso da toxina botulínica, aplicada em um ponto central das glândulas salivares, muitas vezes guiado por ultrassonografia, demostrou resultados positivos. Objetivou-se revisar a literatura no intuito de demonstrar um método alternativo aos tratamentos de sialorreia em pacientes com esclerose lateral amiotrófica. Em estudos recentes, a eficácia do tratamento com toxina botulínica foi confirmada e, mesmo requerendo novas aplicações, os efeitos colaterais são ínfimos. Ela surge então como alternativa não só ao

  8. Potent new small-molecule inhibitor of botulinum neurotoxin serotype A endopeptidase developed by synthesis-based computer-aided molecular design.

    Directory of Open Access Journals (Sweden)

    Yuan-Ping Pang

    Full Text Available Botulinum neurotoxin serotype A (BoNTA causes a life-threatening neuroparalytic disease known as botulism. Current treatment for post exposure of BoNTA uses antibodies that are effective in neutralizing the extracellular toxin to prevent further intoxication but generally cannot rescue already intoxicated neurons. Effective small-molecule inhibitors of BoNTA endopeptidase (BoNTAe are desirable because such inhibitors potentially can neutralize the intracellular BoNTA and offer complementary treatment for botulism. Previously we reported a serotype-selective, small-molecule BoNTAe inhibitor with a K(i (app value of 3.8+/-0.8 microM. This inhibitor was developed by lead identification using virtual screening followed by computer-aided optimization of a lead with an IC(50 value of 100 microM. However, it was difficult to further improve the lead from micromolar to even high nanomolar potency due to the unusually large enzyme-substrate interface of BoNTAe. The enzyme-substrate interface area of 4,840 A(2 for BoNTAe is about four times larger than the typical protein-protein interface area of 750-1,500 A(2. Inhibitors must carry several functional groups to block the unusually large interface of BoNTAe, and syntheses of such inhibitors are therefore time-consuming and expensive. Herein we report the development of a serotype-selective, small-molecule, and competitive inhibitor of BoNTAe with a K(i value of 760+/-170 nM using synthesis-based computer-aided molecular design (SBCAMD. This new approach accounts the practicality and efficiency of inhibitor synthesis in addition to binding affinity and selectivity. We also report a three-dimensional model of BoNTAe in complex with the new inhibitor and the dynamics of the complex predicted by multiple molecular dynamics simulations, and discuss further structural optimization to achieve better in vivo efficacy in neutralizing BoNTA than those of our early micromolar leads. This work provides new insight

  9. Antibiotic, Pesticide, and Microbial Contaminants of Honey: Human Health Hazards

    Directory of Open Access Journals (Sweden)

    Noori Al-Waili

    2012-01-01

    Full Text Available Agricultural contamination with pesticides and antibiotics is a challenging problem that needs to be fully addressed. Bee products, such as honey, are widely consumed as food and medicine and their contamination may carry serious health hazards. Honey and other bee products are polluted by pesticides, heavy metals, bacteria and radioactive materials. Pesticide residues cause genetic mutations and cellular degradation and presence of antibiotics might increase resistant human or animal's pathogens. Many cases of infant botulisms have been attributed to contaminated honey. Honey may be very toxic when produced from certain plants. Ingestion of honey without knowing its source and safety might be problematic. Honey should be labeled to explore its origin, composition, and clear statement that it is free from contaminants. Honey that is not subjected for analysis and sterilization should not be used in infants, and should not be applied to wounds or used for medicinal purposes. This article reviews the extent and health impact of honey contamination and stresses on the introduction of a strict monitoring system and validation of acceptable minimal concentrations of pollutants or identifying maximum residue limits for bee products, in particular, honey.

  10. Botulinum neurotoxin type A in the masseter muscle: Effects on incisor eruption in rabbits

    Science.gov (United States)

    Navarrete, Alfonso L.; Rafferty, Katherine L.; Liu, Zi Jun; Ye, Wenmin; Greenlee, Geoffrey M.; Herring, Susan W.

    2015-01-01

    Introduction Botulinum neurotoxins are responsible for the paralytic food poisoning, botulism. Commercial formulations such as botulinum neurotoxin type A are increasingly used for various conditions, including cosmetic recontouring of the lower face by injection of the large masseter muscles. The paralysis of a major muscle of mastication lowers occlusal force and thus might affect tooth eruption. The purpose of this study was to investigate the effects of unilateral masseter muscle injection of botulinum neurotoxin type A on the rate of eruption of incisors in a rabbit model. We hypothesized that the teeth would overerupt in an underloaded environment. Methods Forty rabbits were injected with either botulinum neurotoxin type A or saline solution in 1 masseter muscle. Mastication and muscle force production were monitored, and incisor eruption rate was assessed by caliper measurement of grooved teeth. Results The injection of saline solution had no effect. The masseter muscle injected with botulinum neurotoxin type A showed a dramatic loss of force 3 weeks after injection despite apparently normal mastication. Incisor eruption rate was significantly decreased for the botulinum neurotoxin type A group, an effect attributed to decreased attrition. Conclusions This study has implications for orthodontics. Although findings from ever-growing rabbit incisors cannot be extrapolated to human teeth, it is clear that botulinum neurotoxin type A caused a decrease in bite force that could influence dental eruption. PMID:23561411

  11. Recommended Mass Spectrometry-Based Strategies to Identify Botulinum Neurotoxin-Containing Samples

    Directory of Open Access Journals (Sweden)

    Suzanne R. Kalb

    2015-05-01

    Full Text Available Botulinum neurotoxins (BoNTs cause the disease called botulism, which can be lethal. BoNTs are proteins secreted by some species of clostridia and are known to cause paralysis by interfering with nerve impulse transmission. Although the human lethal dose of BoNT is not accurately known, it is estimated to be between 0.1 μg to 70 μg, so it is important to enable detection of small amounts of these toxins. Our laboratory previously reported on the development of Endopep-MS, a mass-spectrometric‑based endopeptidase method to detect, differentiate, and quantify BoNT immunoaffinity purified from complex matrices. In this work, we describe the application of Endopep-MS for the analysis of thirteen blinded samples supplied as part of the EQuATox proficiency test. This method successfully identified the presence or absence of BoNT in all thirteen samples and was able to successfully differentiate the serotype of BoNT present in the samples, which included matrices such as buffer, milk, meat extract, and serum. Furthermore, the method yielded quantitative results which had z-scores in the range of −3 to +3 for quantification of BoNT/A containing samples. These results indicate that Endopep-MS is an excellent technique for detection, differentiation, and quantification of BoNT in complex matrices.

  12. Simultaneous and sensitive detection of six serotypes of botulinum neurotoxin using enzyme-linked immunosorbent assay-based protein antibody microarrays

    Energy Technology Data Exchange (ETDEWEB)

    Zhang, Yanfeng; Lou, Jianlong; Jenko, Kathryn L.; Marks, James D.; Varnum, Susan M.

    2012-11-15

    Botulinum neurotoxins (BoNTs), produced by Clostridium botulinum, are a group of seven (A-G) immunologically distinct proteins and cause the paralytic disease botulism. These toxins are the most poisonous substances known to humans and are potential bioweapon agents. Therefore, it is necessary to develop highly sensitive assays for the detection of BoNTs in both clinical and environmental samples. In the present study, we have developed an ELISA-based protein antibody microarray for the sensitive and simultaneous detection of BoNT serotype A, B, C, D, E and F. With engineered high-affinity antibodies, the assays have sensitivities in buffer of 8 fM (1.2 pg/mL) for serotypes A and B, and 32 fM (4.9 pg/mL) for serotypes C, D, E, and F. Using clinical and environmental samples (serum and milk), the microarray is capable of detecting BoNT/A-F to the same levels as in standard buffer. Cross reactivity between assays for individual serotype was also analyzed. These simultaneous, rapid, and sensitive assays have the potential to measure botulinum toxins in a high-throughput manner in complex clinical or environmental samples.

  13. Extraction of BoNT/A, /B, /E, and /F with a single, high affinity monoclonal antibody for detection of botulinum neurotoxin by Endopep-MS.

    Directory of Open Access Journals (Sweden)

    Suzanne R Kalb

    Full Text Available Botulinum neurotoxins (BoNTs are extremely potent toxins that are capable of causing respiratory failure leading to long-term intensive care or death. The best treatment for botulism includes serotype-specific antitoxins, which are most effective when administered early in the course of the intoxication. Early confirmation of human exposure to any serotype of BoNT is an important public health goal. In previous work, we focused on developing Endopep-MS, a mass spectrometry-based endopeptidase method for detecting and differentiating the seven serotypes (BoNT/A-G in buffer and BoNT/A, /B, /E, and /F (the four serotypes that commonly affect humans in clinical samples. We have previously reported the success of antibody-capture to purify and concentrate BoNTs from complex matrices, such as clinical samples. However, to check for any one of the four serotypes of BoNT/A, /B, /E, or /F, each sample is split into 4 aliquots, and tested for the specific serotypes separately. The discovery of a unique monoclonal antibody that recognizes all four serotypes of BoNT/A, /B, /E and /F allows us to perform simultaneous detection of all of them. When applied in conjunction with the Endopep-MS assay, the detection limit for each serotype of BoNT with this multi-specific monoclonal antibody is similar to that obtained when using other serotype-specific antibodies.

  14. Progress on Clostridium butyricum research%酪酸梭菌的研究进展

    Institute of Scientific and Technical Information of China (English)

    李碧云; 傅思武; 王金丰

    2013-01-01

    酪酸梭菌为革兰阳性厌氧芽孢杆,作为微生态制剂,在临床有着广泛的应用,可以调理人体胃肠功能;能大幅度降低伪膜性肠炎的发病率;对菌群失调引起的腹泻、抗生素相关性肠炎、便秘等有良好疗效.然而,关于酪酸梭菌引起肉毒中毒,使得酪酸梭菌再次成为研究热点.本研究就酪酸梭菌研究历史、临床应用、致病性等方面作一个简要综述.%Clostridium butyricum is a gram-positive anaerobic bacillus. As a kind of probiotics widely used in clinical, it can not only adjust gastrointestinal function of human, but also greatly reduce the incidence of pseudomembranous colitis. In addition, it has a good effect on the flora dysbacteriosis caused by diarrhea, antibiotic associated colitis, and constipation, etc. . However, Clostridium butyricum becomes a hotspot of research again for Clostridium butyricum Botulism. This paper presents a brief review of Clostridium butyricum concerning its history of research, clinical application, pathogenicity and other advances.

  15. Enhancing the Pharmacokinetic Properties of Botulinum Neurotoxin Serotype A Protease Inhibitors Through Rational Design.

    Science.gov (United States)

    Capek, Petr; Zhang, Yan; Barlow, Deborah J; Houseknecht, Karen L; Smith, Garry R; Dickerson, Tobin J

    2011-06-15

    Botulinum neurotoxin (BoNT), the etiological agent that causes the neuroparalytic disease botulism, has become a highly studied drug target in light of the potential abuse of this toxin as a weapon of bioterrorism. In particular, small molecule inhibitors of the light chain metalloprotease of BoNT serotype A have received significant attention and a number of small molecule and biologic inhibitors have been reported. However, all small molecules reported have been identified from either primary screens or medicinal chemistry follow-up studies, and the pharmacokinetic profiles of these compounds have not been addressed. In this study, we have removed the pharmacologic liabilities of one of the best compounds reported to date, 2,4-dichlorocinnamate hydroxamic acid, and in the process, uncovered a related class of benzothiophene hydroxamic acids that are significantly more potent inhibitors of the BoNT/A light chain, while also possessing greatly improved ADME properties, with the best compound showing the most potent inhibition of BoNT/A light chain reported (K(i) = 77 nM). Using a strategy of incorporating traditional drug development filters early into the discovery process, potential liabilities in BoNT/A lead compounds have been illuminated and removed, clearing the path for advancement into further pharmacologic optimization and in vivo efficacy testing.

  16. BACTERIA CARRIED BY CHRYSOMYA MEGACEPHALA (FABRICIUS, 1794 (DIPTERA: CALLIPHORIDAE IN SINOP, MATO GROSSO, BRAZIL

    Directory of Open Access Journals (Sweden)

    J. S. Carneiro

    2014-07-01

    Full Text Available Chrysomya megacephala (Diptera: Calliphoridae, popularly known as blowfly, has a great capacity for dispersion and, due to factors such as food abundance and favorable climate, it colonizes Brazil completely in a short time. These insects are important to the sectors of epidemiology, public health and forensics, especially due to carrying microorganisms such as bacteria, viruses, protozoa and helminthes, which are responsible for the spread of diseases such as dysentery, cholera, botulism, typhoid fever, brucellosis, polio, smallpox and tuberculosis. The objective of this study was to verify the diversity of bacteria carried by this species in the Federal University of Mato Grosso – Campus of Sinop during the month of January of 2012. The flies were collected using two traps baited with 100 g of fresh sardines on each and maintained in the field for 24 hours. Twenty specimens of C. megacephala were placed in Petri dishes, to walk for two minutes upon Nutrient Agar (NA. After establishment of the colonies, isolation of the bacteria on the NA medium and their multiplication in test tubes containing the same culture medium was performed, and later sent to identification by gas chromatography. The bacteria encountered were Aquaspirillum polymorphum; Burkholderia ambifaria; Burkholderia anthina; Burkholderia cepacia; Burkholderia cenocepacia; Burkholderia pyrrocinia; Burkholderia stabilis; Paenibacillus macerans; Virgibacillus pantothenticus, Bacillus subtilis e Photorhabdus luminescens luminescens, with the last two species considered of importance in the plant protection sector.

  17. Pharyngeal-cervical-brachial variant of Guillain-Barre syndrome.

    Science.gov (United States)

    Wakerley, Benjamin R; Yuki, Nobuhiro

    2014-03-01

    The pharyngeal-cervical-brachial (PCB) variant of Guillain-Barré syndrome is defined by rapidly progressive oropharyngeal and cervicobrachial weakness associated with areflexia in the upper limbs. Serial nerve conduction studies suggest that PCB represents a localised subtype of Guillain-Barré syndrome characterised by axonal rather than demyelinating neuropathy. Many neurologists are unfamiliar with PCB, which is often misdiagnosed as brainstem stroke, myasthenia gravis or botulism. The presence of additional ophthalmoplegia and ataxia indicates overlap with Fisher syndrome. Half of patients with PCB carry IgG anti-GT1a antibodies which often cross-react with GQ1b, whereas most patients with Fisher syndrome carry IgG anti-GQ1b antibodies which always cross-react with GT1a. Significant overlap between the clinical and serological profiles of these patients supports the view that PCB and Fisher syndrome form a continuous spectrum. In this review, we highlight the clinical features of PCB and outline new diagnostic criteria.

  18. High-level expression, purification, crystallization and preliminary X-ray crystallographic studies of the receptor binding domain of botulinum neurotoxin serotype D

    Energy Technology Data Exchange (ETDEWEB)

    Zhang, Yanfeng; Gao, Xiaoli; Qin, Lin; Buchko, Garry W.; Robinson, Howard; Varnum, Susan M.

    2010-12-01

    Botulinum neurotoxins (BoNTs) are highly toxic proteins for humans and can cause neuroparalytic disease botulism. Due to the limitations of production and manipulation of holoenzymes, expressing non-toxic heavy chain receptor binding domains (HCR) has become a common strategy for vaccine and antibody development. Meanwhile, large quantities and highly purified soluble proteins are required for research areas such as antibody maturation and structural biology. We present high level expression and purification of the BoNT serotype D HCR in E. coli using a codon-optimized cDNA. By varying expression conditions, especially at low temperature, the protein was expressed at a high level with high solubility. About 150-200 mg protein was purified to >90% purity from 1 L cell culture. The recombinant D_HCR was crystallized and the crystals diffracted to 1.65 Å resolution. The crystals belong to space group P212121 with unit cell dimensions a = 60.8 Å, b = 89.7 Å, c = 93.9 Å. Preliminary crystallographic data analysis revealed one molecule in asymmetric unit.

  19. Toosendanin interferes with pore formation of botulinum toxin type A in PC12 cell membrane

    Institute of Scientific and Technical Information of China (English)

    Mu-feng LI; Yu-liang SHI

    2006-01-01

    Aim: Botulinum neurotoxins (BoNT) abort the process of neurotransmitter release at presynaptic motor nerve terminals, causing muscle paralysis. The ability of botulinum toxin to produce its effect is dependent on the ability of the light chain to cleave the SNARE proteins associated with transmitter release. Translocation of the light chain protease through the heavy chain-formed channel is a pivotal step in the intoxication process. Toosendanin (TSN), a triterpenoid derivative extracted from a Chinese traditional medicine, has been demonstrated to be an effective cure for experimental botulism. This study was designed to explore the antibotulismic mechanisms of toosendanin. Methods: The inside-out singlechannel recording patch-clamp technique was used to record the BoNT/A-induced currents in the presence and absence of TSN. Results: Channel formation was delayed and the sizes of the channels were reduced in the TSN-treated PC12cell membrane. Conclusion: The antibotulismic effect of TSN might occur via interference with toxin translocation.

  20. 一株C型肉毒梭菌的分离和鉴别%The isolation and identification of a type C strain of clostridium botulinum

    Institute of Scientific and Technical Information of China (English)

    冉枭; 钟权涛; 傅思武

    2013-01-01

    OBJECTIVE The study is examined for distribution of clostridium botulinum in Northwest,China.METHODS All soils from Gansu Province were washed by 0.2% gelatin phosphate buffer,and then carried out with the methods of bacteria-proliferating,isolating culture repeatedly.The isolated strain was identified by toxin determination and biochemical characteristics.RESULTS 2 of the 175 soil specimens appeared typical symptoms of botulism,and only 1 could be completely neutralized by type C botulinum antitoxin.CONCLUSION The strain is identified as type C clostridium botulinum.%目的 为了解肉毒梭菌在我国西北地区的分布情况.方法 对从甘肃省采集的所有土壤样品用0.2%的明胶磷酸盐缓冲液冲洗后,反复增菌、分离培养,并对分离菌株进行毒素测定和生化特性分析.结果 在采集的175份样品中有2份样品出现典型的肉毒中毒症状,1株与C型肉毒抗毒素完全中和.结论 分离得到的菌株经鉴定为C型肉毒梭菌.

  1. Microbiological food safety: a dilemma of developing societies.

    Science.gov (United States)

    Akhtar, Saeed; Sarker, Mahfuzur R; Hossain, Ashfaque

    2014-11-01

    Current food safety issues are deleteriously reshaping the life style of the population in the developing world. Socioeconomic status of the population in poorer economies is one of the major determinants to delineate the availability of safe food to the vulnerable population. Assessment of the prevalence of foodborne illness in developing world is the most neglected area to control disease. Botulism, Shigellosis, Campylobacteriosis, Escherichia coli infection, Staphylococcus aureus infection, Salmonellosis, Listeriosis and Cholerae are extensively prevalent and pose a major threat to human health in underdeveloped communities. The existing food safety status of many African, South Asian, Central, and South American developing countries is distressing therefore; it seems much timely to highlight the areas for the improvement to ensure the supply of safe food to the population in these regions. Extensive literature search at PubMed, Science Direct and Medline was carried out during the current year to catch on relevant data from 1976 to date, using selective terms like food safety, South East Asia, Africa, Central and South America, and foodborne illness etc. Efforts were made to restrict the search to low income countries of these regions with reference to specific foodborne pathogens. This report briefly discusses the present food safety situation in these developing countries and associated consequences as prime issues, suggesting foodborne illness to be the most distressing threat for human health and economic growth.

  2. LA ASOCIACIÓN DE DIVERTÍCULO DE ZENKER Y ACALASIA Zenker`s diverticulum and acalasia

    Directory of Open Access Journals (Sweden)

    Juan David Martínez Marín

    2008-03-01

    Full Text Available Se presenta el caso de un paciente de 88 años, con disfagia y antecedentes de acalasia no tratada de veinte años de evolución y síntomas de disfagia oro faríngea. Los exámenes radiológicos y endoscópicos identificaron además de la acalasia un divertículo de Zenker. Se realizó terapia paliativa con inyección de toxina botulínica en el esfínter esofágico inferior, con mejoría de los síntomas. Se hace una revisión de la rara coexistencia de estas dos patologías.An 88 year old patient has been observed. He is suffering from dysphagia and has a medical history of achalasia, which has had an evolution and has not bee treated for twenty years. He also has oropharynx dysphagia symptoms. In addition to the achalasia, the X-ray and endoscopy exams identified a Zenker diverticulum. Palliative or mitigating therapy was realized using botulinum toxin injection in the lower esophageal sphincter, with symptom improvement. A study is being made concerning the rare co-existence of these two pathologies.

  3. Avaliação da toxigênese de c. botulinum em mortadela e presunto

    Directory of Open Access Journals (Sweden)

    Valéria Christina Junqueira Amstalden

    1997-08-01

    Full Text Available Na presente pesquisa foi realizada uma avaliação do risco de transmissão de botulismo por consumo de mortadela e presunto. Numa primeira fase, 25 amostras de mortadela e presunto cozido, coletadas ao acaso no varejo do município de Campinas - SP, foram analisadas quanto ao pH, atividade de água (Aa, concentração de cloreto de sódio e de nitrito de sódio e umidade. Nesta fase, ainda foram determinados o tempo e a temperatura de estocagem na revenda. Considerando-se isoladamente os fatores que controlam o desenvolvimento do C. botulinum, apenas quatro (16% amostras de mortadela coletadas no varejo apresentaram valores de atividade de água capazes de irnpedir a oxigênese, ou seja, inferiores a 0,94. Na segunda fase, mortadela e presunto foram preparados em usina experimental e artificialmente contaminados com 10(4 esporos de C botulinum tipos A e B por amostra. A seguir, foram submetidos à estocagem inadequada, à temperatura de 30°C. A formação de toxina botulínica foi observada nas amostras de presunto artificialmente contaminadas, após 12 dias de estocagem à temperatura de 30°C. Nas amostras de mortadela não foi detectada toxina ao fim de 28 dias de estocagem, à mesma temperatura.

  4. Enfermidades do sistema nervoso dos ruminantes no sul do Rio Grande do Sul Neurological diseases in ruminants in southern Brazil

    Directory of Open Access Journals (Sweden)

    Franklin Riet-Correa

    1998-06-01

    Full Text Available Descrevem-se os aspectos epidemiológicos, clínicos e patológicos das enfermidades do sistema nervoso central dos ruminantes, diagnosticadas na região Sul do Rio Grande do Sul, incluindo: abiotrofia cerebelar; hipoplasia cerebelar; hipermetria hereditária; artrogripose; hipomielinogênese congênita; abscesso cerebral; listeriose; tétano; botulismo; necrose simétrica focal; raiva; leucose; encefalite por herpesvírus bovino-5; febre catarral maligna; intoxicações por Solanum fastigiatum, Claviceps paspali, Ramaria flavo-brunnescens, Halimium brasiliense e Diplodia maydis; encefalopatia hepática causada por Senecio spp. e Echium plantagineum; cetose; coenurose; e síndrome espinhal.The main epidemiological, clinical and pathologic aspects of the diseases of the nervous system in cattle in Southern Rio Grande do Sul are described, including, the following conditions: cerebellar abiotrophy; cerebellar hypoplasia; congenital hypermetria; arthrogryposis; congenital hypomyelinogenesis; brain abscess; listeriose; tetanus; botulism; focal symmetrical encephalomalacia; rabies; leucosis; encephalitis by Herpesvirus Bovine-5; bovino malignant catarrh; intoxications by Solanum fastigiatum, Claviceps paspali, Halimium brasiliense, Diplodia maydis, and Ramaria flavo-brunnescens; hepatoencephalopaty caused by Senecio spp. and Echium plantagineum; ketosis; coenurosis; and spinal syndrome.

  5. Observations on the distribution and ecology of Clostridium botulinum type E in Alaska.

    Science.gov (United States)

    Miller, L G

    1975-06-01

    Environmental samples collected along the coastline and from the interior of Alaska were examined for the presence of Clostridium botulinum. Clostridium botulinum type E was detected in soils from 5 of 12 beaches; in 7 of 115 non-coastal soil samples; in sediments from six of eight locales; in gills of salmon from two fishing areas; and in the feces of 1 of 44 colonic samples from marine mammals. The basic biochemical characteristics of the isolates were determined. Tube tests for demonstrating gelatin liquefaction proved insensitive with these strains, whereas a plate test detected gelatinase in all isolates. The presence of multiple nidi and the continual discharge of organic materials into the environment may contribute to the perpetuation of botulinum spores by which foods prepared form marine animals become contaminated. An emphasis should be placed upon the need for measures to reduce environmental contamination, to reduce contamination during food preparation, and to alert continually the population of the hazard wherever botulism is endemic.

  6. Algal chloroplast produced camelid VH H antitoxins are capable of neutralizing botulinum neurotoxin.

    Science.gov (United States)

    Barrera, Daniel J; Rosenberg, Julian N; Chiu, Joanna G; Chang, Yung-Nien; Debatis, Michelle; Ngoi, Soo-Mun; Chang, John T; Shoemaker, Charles B; Oyler, George A; Mayfield, Stephen P

    2015-01-01

    We have produced three antitoxins consisting of the variable domains of camelid heavy chain-only antibodies (VH H) by expressing the genes in the chloroplast of green algae. These antitoxins accumulate as soluble proteins capable of binding and neutralizing botulinum neurotoxin. Furthermore, they accumulate at up to 5% total soluble protein, sufficient expression to easily produce these antitoxins at scale from algae. The genes for the three different antitoxins were transformed into Chlamydomonas reinhardtii chloroplasts and their products purified from algae lysates and assayed for in vitro biological activity using toxin protection assays. The produced antibody domains bind to botulinum neurotoxin serotype A (BoNT/A) with similar affinities as camelid antibodies produced in Escherichia coli, and they are similarly able to protect primary rat neurons from intoxication by BoNT/A. Furthermore, the camelid antibodies were produced in algae without the use of solubilization tags commonly employed in E. coli. These camelid antibody domains are potent antigen-binding proteins and the heterodimer fusion protein containing two VH H domains was capable of neutralizing BoNT/A at near equimolar concentrations with the toxin. Intact antibody domains were detected in the gastrointestinal (GI) tract of mice treated orally with antitoxin-producing microalgae. These findings support the use of orally delivered antitoxins produced in green algae as a novel treatment for botulism.

  7. A unique restriction site in the flaA gene allows rapid differentiation of group I and group II Clostridium botulinum strains by PCR-restriction fragment length polymorphism analysis.

    Science.gov (United States)

    Paul, Catherine J; Tran, Shulin; Tam, Kevin J; Austin, John W

    2007-09-01

    Clostridium botulinum produces the potent botulinum neurotoxin, the causative agent of botulism. Based on distinctive physiological traits, strains of C. botulinum can be divided into four groups: however, only groups I and II are associated with human illness. Alignment of the flaA gene sequences from 40 group I and 40 group II strains identified a single BsrG1 restriction cut site that was present at base pair 283 in all group II flaA sequences and was not found in any group I sequence. The flaA gene was amplified by rapid colony PCR from 22 group I strains and 18 group II strains and digested with BsrGI restriction enzyme. Standard agarose gel electrophoresis with ethidium bromide staining showed two fragments, following restriction digestion of group II flaA gene amplicons with BsrGI, but only a single band of uncut flaA from group I strains. Combining rapid colony PCR with BsrGI restriction digest of the flaA gene at 60 degrees C is a significant improvement over current methods, such as meat digestion or amplified fragment length polymorphism, as a strain can be identified as either group I or group II in under 5 h when starting with a visible plated C. botulinum colony.

  8. Potent tetravalent replicon vaccines against botulinum neurotoxins using DNA-based Semliki Forest virus replicon vectors.

    Science.gov (United States)

    Yu, Yun-Zhou; Guo, Jin-Peng; An, Huai-Jie; Zhang, Shu-Ming; Wang, Shuang; Yu, Wei-Yuan; Sun, Zhi-Wei

    2013-05-07

    Human botulism is commonly associated with botulinum neurotoxin (BoNT) serotypes A, B, E and F. This suggests that the greatest need is for a tetravalent vaccine that provides protection against all four of these serotypes. In current study, we investigated the feasibility of generating several tetravalent vaccines that protected mice against the four serotypes. Firstly, monovalent replicon vaccine against BoNT induced better antibody response and protection than that of corresponding conventional DNA vaccine. Secondly, dual-expression DNA replicon pSCARSE/FHc or replicon particle VRP-E/FHc vaccine was well resistant to the challenge of BoNT/E and BoNT/F mixture as a combination vaccine composed of two monovalent replicon vaccines. Finally, the dual-expression DNA replicon or replicon particle tetravalent vaccine could simultaneously and effectively neutralize and protect the four BoNT serotypes. Protection correlated directly with serum ELISA titers and neutralization antibody levels to BoNTs. Therefore, replicon-based DNA or particle might be effective vector to develop BoNT vaccines, which might be more desirable for use in clinical application than the conventional DNA vaccines. Our studies demonstrate the utility of combining dual-expression DNA replicon or replicon particle vaccines into multi-agent formulations as potent tetravalent vaccines for eliciting protective responses to four serotypes of BoNTs.

  9. The clinical differentiation of nervous and muscular locomotor disorders of sheep in Australia.

    Science.gov (United States)

    Bourke, C A

    1995-06-01

    Many of the nervous and muscular locomotor disorders that affect sheep throughout Australia are commonly referred to as "staggers" syndromes. The range of clinical signs displayed by sheep suffering these disorders is sufficiently diverse to enable each syndrome to be graded into one of 5 progressive clinical groups. The first group, the limb paresis syndromes, includes the primary myopathies associated with the ingestion of Ixiolaena brevicompta, Malva parviflora, and Trachymene ochracea, as well as selenium and Vitamin E disorders, Paroo virus staggers, congenital progressive muscular dystrophy, humpy back, hypocalcaemic muscle weakness, Tribulus terrestris staggers and tetanus. The second group is characterised by limb paresis with knuckling of the fetlocks, and includes the plant-associated toxicities of Romulea rosea, Stachys arvensis, Trachyandra divaricata, and Tribulus micrococcus, together with haloxon toxicity, enzootic ataxia (copper deficiency), and the probably genetic disorders of segmental axonopathy, neuroaxonal dystrophy, and degenerative thoracic myelopathy. Other locomotor disorders that fit more loosely into this group are listerial myelitis (post-dipping staggers), vitamin A deficiency, cervico-thoracic vertebral subluxation Stypandra glauca toxicity, Ipomoea spp toxicity, ivermectin toxicity, and botulism. The third group, the falling syndromes, includes the probably genetic disorders of thalamic cerebellar neuropathy, cerebellar abiotrophy, and globoid cell leucodystrophy, together with Swainsona spp toxicity. The fourth group, the falling syndromes, includes the plant associated toxicities of phalaris staggers, perennial rye grass staggers and nervous ergotism (Claviceps paspali).(ABSTRACT TRUNCATED AT 250 WORDS)

  10. An aggressive approach to limb dystonia: a case report.

    Science.gov (United States)

    Moberg-Wolff, E A

    1998-05-01

    A 15-year-old boy presented with a severe fluctuating foot and ankle dystonia resulting from a basal ganglia insult at the age of 4. This followed an embolic event related to an undiagnosed prolapsed mitral valve. Functionally, the patient was ambulatory with rocker bottom crutches and an ankle-foot orthosis, but there were periods of up to a year when pain and increased dystonic deformity required him to use a wheelchair. A new orthotic was made nearly every month because the orthotist could find no material that would withstand his tone without breaking, yet he could not ambulate without one. Multiple interventions, including biofeedback, contrast baths, stretching and strengthening, oral lioresal (Baclofen), diazepam (Valium), benztropine mesylate (Cogentin), carbidopa-levodopa (Sinemet), carbamazepine (Tegretol), and injections of botulism toxin (BOTOX) were tried, all with minimal effects. Amputation was recommended, based on anatomic and functional considerations. The patient and his family adjusted well to this decision, although not all orthopedists and therapists adjusted easily to the choice. The patient is now functionally independent with a prosthesis and has a normal teenage lifestyle for the first time.

  11. Mortality patterns in endangered Hawaiian geese (Nene; Branta sandvicensis)

    Science.gov (United States)

    Work, Thierry M.; Dagenais, Julie; Rameyer, Robert; Breeden, Renee

    2015-01-01

    Understanding causes of death can aid management and recovery of endangered bird populations. Toward those ends, we systematically examined 300 carcasses of endangered Hawaiian Geese (Nene; Branta sandvicensis) from Hawaii, Maui, Molokai, and Kauai between 1992 and 2013. The most common cause of death was emaciation, followed by trauma (vehicular strikes and predation), and infectious/inflammatory diseases of which toxoplasmosis (infection with Toxoplasma gondii) predominated. Toxicoses were less common and were dominated by lead poisoning or botulism. For captive birds, inflammatory conditions predominated, whereas emaciation, trauma, and inflammation were common in free-ranging birds. Mortality patterns were similar for males and females. Trauma predominated for adults, whereas emaciation was more common for goslings. Causes of death varied among islands, with trauma dominating on Molokai, emaciation and inflammation on Kauai, emaciation on Hawaii, and inflammation and trauma on Maui. Understanding habitat or genetic-related factors that predispose Nene (particularly goslings) to emaciation might reduce the impact of this finding. In addition, trauma and infection with T. gondii are human-related problems that may be attenuated if effectively managed (e.g., road signs, enforcement of speed limits, feral cat [Felis catus] control). Such management actions might serve to enhance recovery of this endangered species.

  12. Safer and healthier foods.

    Science.gov (United States)

    1999-10-15

    During the early 20th century, contaminated food, milk, and water caused many foodborne infections, including typhoid fever, tuberculosis, botulism, and scarlet fever. In 1906, Upton Sinclair described in his novel The Jungle the unwholesome working environment in the Chicago meat-packing industry and the unsanitary conditions under which food was produced. Public awareness dramatically increased and led to the passage of the Pure Food and Drug Act. Once the sources and characteristics of foodborne diseases were identified--long before vaccines or antibiotics--they could be controlled by handwashing, sanitation, refrigeration, pasteurization, and pesticide application. Healthier animal care, feeding, and processing also improved food supply safety. In 1900, the incidence of typhoid fever was approximately 100 per 100,000 population; by 1920, it had decreased to 33.8, and by 1950, to 1.7 (Figure 1). During the 1940s, studies of autopsied muscle samples showed that 16% of persons in the United States had trichinellosis; 300-400 cases were diagnosed every year, and 10-20 deaths occurred. Since then, the rate of infection has declined markedly; from 1991 through 1996, three deaths and an average of 38 cases per year were reported.

  13. [Toxinology of bovine paraplegic syndrome].

    Science.gov (United States)

    Sevcik, C; Brito, J C; D'Suze, G; Mijares, A J; Domínguez, M G

    1993-01-01

    A clinical entity named "Bovine Paraplegic Syndrome" ("Síndrome Parapléjico de los Bovinos") has spread alarmingly, in the cattle growing areas of the central and eastern plains of Venezuela. Approximately four million cattle are bread in the area were the disease occurs. The mortality index due to the disease ranges 5 to 25% of the animals at risk, mostly cows, pregnant or lactating. The principal characteristic of the bovine paraplegic syndrome is decubitus, ventral or sternal, in animals that make vane efforts to stand when stimulated. The diagnosis is established ruling out, clinically and with laboratory findings, that the animals are suffering known diseases with similar symptoms such as paralytic rabies, botulism and blood parasites such Trypanosoma sp., Babesia sp., and Anaplasma sp.. Death occurs always, usually after few days, and to this date there is no known treatment able to save the sick cows. In this work, we describe results that suggest the presence of a toxin in the cattle suffering and prone to suffer the syndrome; it is a natural toxin produced by ruminal bacteria. In squid giant axons under voltage clamp conditions, this toxin is very specific to block sodium current during nerve electrical activity.

  14. Toxicology of a bovine paraplegic syndrome.

    Science.gov (United States)

    Sevcik, C; Brito, J C; D'Suze, G; Domínguez-Bello, M G; Lovera, M; Mijares, A J; Bónoli, S

    1993-12-01

    A clinical entity named 'bovine paraplegic syndrome' ('síndrome parapléjico de los bovinos') has spread alarmingly in the cattle-growing areas of the central and eastern plains of Venezuela. It is estimated that four million cattle are bred in the area where the disease occurs. The mortality ranges from 5 to 25% of the animals at risk, mostly pregnant or lactating cows. The principal characteristic of the bovine paraplegic syndrome is ventral or sternal decubitus, in animals that make vain efforts to stand when stimulated. The diagnosis is established when all other possible causes (e.g. paralytic rabies, botulism and blood parasites such as Anaplasma marginal, Babesia bovis, B. bigemina, and Trypanosoma vivax) have been ruled out clinically and by laboratory tests. Death always occurs, usually after a few days, and there is no known treatment. In this work, we describe results that show the presence of a toxin in the cattle suffering from, or liable to suffer from the syndrome. The toxin is produced by ruminal bacteria. In squid giant axons under voltage clamp conditions, the toxin blocks the sodium current. We detected the toxin analytically by absorbance measurements at 340 nm after reacting with picrylsulfonic acid. We obtained a good separation of the toxin with isocratic high pressure liquid chromatography, using 40% methanol in water on phenylborasil columns.

  15. Mode of VAMP substrate recognition and inhibition of Clostridium botulinum neurotoxin F.

    Science.gov (United States)

    Agarwal, Rakhi; Schmidt, James J; Stafford, Robert G; Swaminathan, Subramanyam

    2009-07-01

    Clostridium botulinum neurotoxins (BoNTs) cleave neuronal proteins responsible for neurotransmitter release, causing the neuroparalytic disease botulism. BoNT serotypes B, D, F and G cleave and inactivate vesicle-associated membrane protein (VAMP), each at a unique peptide bond. The specificity of BoNTs depends on the mode of substrate recognition. We have investigated the mechanism of substrate recognition of BoNT F by determining the crystal structures of its complex with two substrate-based inhibitors, VAMP 22-58/Gln58D-cysteine and 27-58/Gln58D-cysteine. The inhibitors bind to BoNT F in the canonical direction (as seen for BoNTs A and E substrates) but are positioned specifically via three major exosites away from the active site. The cysteine sulfur of the inhibitors interacts with the zinc and exists as sulfinic acid in the inhibitor VAMP 27-58/Gln58D-cysteine. Arg133 and Arg171, which form part of two separate exosites, are crucial for substrate binding and catalysis.

  16. Síndrome de dolor miofascial de la cintura pélvica Pelvic Myofascial Pain Syndrome

    Directory of Open Access Journals (Sweden)

    E. Gil

    2007-06-01

    Full Text Available El síndrome de dolor miofascial pese a haber sido descrito recientemente representa un porcentaje importante de los pacientes que acuden a las Unidades de Dolor, presentando este cuadro hasta el 80% de los que acuden por dolor lumbar crónico, siendo además su diagnóstico clínico, basado en una cuidadosa historia y exploración físicas. El tratamiento de este síndrome ha supuesto un gran desafío, aunque el desarrollo y uso de la toxina botulínica purificada muestra un futuro prometedor. En este trabajo hacemos una revisión de la información disponible sobre la fisiopatología y las opciones terapéuticas disponibles así como una exposición de los protocolos usados por nuestra unidad.The myofascial pain síndrome although only recently des-cribed represents a sizeable number of cases attending Pain Units, up to 80% of the patients suffering of chronic back pain. Moreover, diagnostic can be only reached after a careful clinical history and physical examination. The treatment of this complex syndrome has been challenge, but the development of the purified botulin toxin shows great promise. In this paper we make a review of the available knowledge on the phisiopathology and treatment of this syndrome as well as the treatment strategies as used in our unit.

  17. Use of Monoclonal Antibodies in the Sensitive Detection and Neutralization of Botulinum Neurotoxin Serotype B

    Directory of Open Access Journals (Sweden)

    Luisa W. Cheng

    2015-11-01

    Full Text Available Botulinum neurotoxins (BoNT are some of nature’s most potent toxins. Due to potential food contamination, and bioterrorism concerns, the development of detection reagents, therapeutics and countermeasures are of urgent interest. Recently, we have developed a sensitive electrochemiluminescent (ECL immunoassay for BoNT/B, using monoclonal antibodies (mAbs MCS6-27 and anti-BoNT/B rabbit polyclonal antibodies as the capture and detector. The ECL assay detected as little as 1 pg/mL BoNT/B in the buffer matrix, surpassing the detection sensitivities of the gold standard mouse bioassays. The ECL assay also allowed detection of BoNT/B in sera matrices of up to 100% sera with negligible matrix effects. This highly-sensitive assay allowed the determination of the biological half-lives of BoNT/B holotoxin in vivo. We further tested the toxin neutralization potential of our monoclonal antibodies using the mouse systemic and oral intoxication models. A combination of mAbs protected mice in both pre- and post-exposure models to lethal doses of BoNT/B. MAbs were capable of increasing survival of animals when administered even 10 h post-intoxication in an oral model, suggesting a likely time for BoNT/B complexes to reach the blood stream. More sensitive detection assays and treatments against BoNT intoxication will greatly enhance efforts to combat botulism.

  18. Role of Nitrite in Processed Meat Products and its Degradation during their Storage

    Directory of Open Access Journals (Sweden)

    ILIRJANA BOCI

    2014-06-01

    Full Text Available This paper represents the analytical data of nitrite level obtained from the experimental work done on meat processed samples taken from a meat processing plant in Tirana. There has been a long debate and health concern about the nitrite content in meat products. Nitrite is added to e.g. sausages, and hams and other meat products to preserve these products and keep them free from dangerous bacteria. Among the aims are preventing botulism, a dangerous food poison. But also it’s important to use the smallest possible amount of nitrite as a preservative because nitrite in meat can also form nitrosamines, which can damage the health. That’s why the role of nitrite in processed meat and its recommended level conform to new EC Regulations are given in the introduction part of this paper. It is important that the nitrite level be monitored during all the processing steps up to the end consumers. This makes the objective of this paper. It gives the analytical data on nitrite level on meat processed samples taken and tested during their storage and ripening period of time. Different kinds of meat products are taken and tested to evaluate the influence of various parameters (storage time, time until to the end consumers, various kinds of packing in the degradation rate of ingoing nitrite.

  19. Investigations of a large scale eared grebe (Podiceps nigricollis) die-off at the Salton Sea, California in 1992

    Science.gov (United States)

    Meteyer, C.U.; Audet, D.J.; Rocke, T.E.; Radke, W.; Creekmore, L.H.; Duncan, R.

    2004-01-01

    An estimated 150,000 Eared Grebes (Podiceps nigricollis) died at the Salton Sea between 16 December 1991 and 21 April 1992. This represented the largest documented mortality event of Eared Grebes at the time and approximately 6% of the North American population. During the die-off, grebes exhibited several uncharacteristic behaviors, such as congregating at freshwater tributaries, repeatedly gulping freshwater, preening excessively, moving onto land, and allowing close approach and/or capture. Avian cholera was diagnosed in Eared Grebes collected along the north and west shoreline of the Sea late in the die-off but not from the majority of the Eared Grebes dying along the south shore. Gross and histological examinations and diagnostic testing for viruses, bacteria, and parasites did not identify the cause of mortality in the majority of Eared Grebes examined from the south shore of the Sea. Liver concentrations of arsenic, chromium, DDE, mercury, selenium, and zinc were elevated in some Eared Grebes, but none of those contaminants exceeded known thresholds for independent lethality. Poisoning by heavy metals, organochlorine, organophosphorus, or carbamate pesticides, avian botulism, and salt were ruled out as the cause of mortality. Hypotheses for the die-off are interactive effects of contaminants, immunosuppression, a yet unidentified biotoxin or pathogen present in the Salton Sea, impairment of feather waterproofing leading to hypothermia, or a unique manifestation of avian cholera that evades laboratory detection.

  20. Rapid Microfluidic Assay for the Detection of Botulinum Neurotoxin in Animal Sera

    Directory of Open Access Journals (Sweden)

    Lmar Babrak

    2016-01-01

    Full Text Available Potent Botulinum neurotoxins (BoNTs represent a threat to public health and safety. Botulism is a disease caused by BoNT intoxication that results in muscle paralysis that can be fatal. Sensitive assays capable of detecting BoNTs from different substrates and settings are essential to limit foodborne contamination and morbidity. In this report, we describe a rapid 96-well microfluidic double sandwich immunoassay for the sensitive detection of BoNT-A from animal sera. This BoNT microfluidic assay requires only 5 μL of serum, provides results in 75 min using a standard fluorescence microplate reader and generates minimal hazardous waste. The assay has a <30 pg·mL−1 limit of detection (LOD of BoNT-A from spiked human serum. This sensitive microfluidic BoNT-A assay offers a fast and simplified workflow suitable for the detection of BoNT-A from serum samples of limited volume in most laboratory settings.

  1. 肉毒杆菌及肉毒毒素研究进展%Progress in Research on Bacillus botulinus and Botulinum Toxins

    Institute of Scientific and Technical Information of China (English)

    赵思俊; 李雪莲; 曹旭敏; 王娟; 王玉东; 王君玮; 曲志娜

    2013-01-01

    肉毒杆菌是一种致命病菌,能引起肉毒中毒症。肉毒杆菌作为影响食品安全的一个重要风险因素,尤其是在新西兰恒天然公司部分产品受到肉毒杆菌污染事件发生后,肉毒杆菌及肉毒毒素受到了普遍关注。现就肉毒杆菌及肉毒毒素的生物学特性、中毒机制、诊断及治疗研究进展进行综述。%Bacillus botulinus is a deadly bacteria,can cause botulism disease by botulinum toxin which is among the most powerful known poisons. As an important risk factor for food safety,especially the in-cident of the product for Fonterra by botulinum toxin contamination was occured,Bacillus botulinus and botulinum toxin has been widespread concerned. The paper reviews the progress of biological characteris-tics,toxic mechanism,diagnosis and treatment for Bacillus botulinus and botulinum toxin.

  2. Use of immunofluorescence and animal tests to detect growth and toxin production by Clostridum botulinum type E in food.

    Science.gov (United States)

    Midura, T; Taclindo, C; Nygaard, G S; Bodily, H L; Wood, R M

    1968-01-01

    The appearance of Clostridium botulinum type E organisms and of toxin in experimentally inoculated packages of turkey roll was followed to study the time relationship between the presence of vegetative cells and the demonstration of toxin. The presence of vegetative cells was determined by immunofluorescence, and animal tests were used to assay toxin production. Growth initiated from detoxified spores of C. botulinum type E resulted in toxin formation within 24 hr. Presence of fluorescing vegetative cells and of toxin coincided from 1 to 14 days of incubation. Beginning with the next testing date, day 21, differences were observed. Toxin could be detected for a longer time than vegetative cells. Neither toxin nor organisms could be found after 56 days of incubation. The mouse lethal dose tests (MLD per gram of turkey roll) showed fluctuations in the amount of toxin present throughout the period of testing. Maximal amounts of toxin were present during the period when fluorescing organisms were also more numerous. The applications of immunofluorescence in the study and in the diagnosis of botulism is discussed.

  3. Peptide inhibitors of botulinum neurotoxin serotype A: design, inhibition, cocrystal structures, structure-activity relationship and pharmacophore modeling

    Energy Technology Data Exchange (ETDEWEB)

    Kumar G.; Swaminathan S.; Kumaran, D.; Ahmed, S. A.

    2012-05-01

    Clostridium botulinum neurotoxins are classified as Category A bioterrorism agents by the Centers for Disease Control and Prevention (CDC). The seven serotypes (A-G) of the botulinum neurotoxin, the causative agent of the disease botulism, block neurotransmitter release by specifically cleaving one of the three SNARE (soluble N-ethylmaleimide-sensitive factor attachment protein receptor) proteins and induce flaccid paralysis. Using a structure-based drug-design approach, a number of peptide inhibitors were designed and their inhibitory activity against botulinum serotype A (BoNT/A) protease was determined. The most potent peptide, RRGF, inhibited BoNT/A protease with an IC{sub 50} of 0.9 {micro}M and a K{sub i} of 358 nM. High-resolution crystal structures of various peptide inhibitors in complex with the BoNT/A protease domain were also determined. Based on the inhibitory activities and the atomic interactions deduced from the cocrystal structures, the structure-activity relationship was analyzed and a pharmacophore model was developed. Unlike the currently available models, this pharmacophore model is based on a number of enzyme-inhibitor peptide cocrystal structures and improved the existing models significantly, incorporating new features.

  4. Disulfide bond reduction corresponds to dimerization and hydrophobicity changes of Clostridium botulinum type A neurotoxin

    Institute of Scientific and Technical Information of China (English)

    Jiunn-jye WEY; Shiao-shek TANG; Tzong-yuan WU

    2006-01-01

    Aim: To determine the structure factors that mediate the intoxication process of botulinum neurotoxin type A (BoNT/A). Methods: Triton X-114 phase separation experiments and 1-anilino-8-naphthalene sulfonate binding assay were used to study the structural factor that corresponds to the hydrophobicity change of BoNT/A. In addition, sucrose density gradient centrifugation and a chemical crosslinking study were employed to determine the quaternary structure of BoNT/A. Results: Our results demonstrated that in other than acidic conditions, the disulfide reduction is the structural factor that corresponds to the hydrophobicity change of BoNT/A. The quaternary structure of BoNT/A exists as a dimmer in acidic solution (pH 4.5), although the monomeric structure of BoNT/A was reported based on X-ray crystallography. Conclusion: Disulfide bond reduction is critical for BoNT/A's channel formation and ability to cross endosome membranes. This result implies that compounds that block this disulfide bond reduction may serve as potential therapeutic agents for botulism.

  5. Identification and genetic characterization of Clostridium botulinum serotype A strains from commercially pasteurized carrot juice.

    Science.gov (United States)

    Marshall, Kristin M; Nowaczyk, Louis; Raphael, Brian H; Skinner, Guy E; Rukma Reddy, N

    2014-12-01

    Clostridium botulinum is an important foodborne pathogen capable of forming heat resistant endospores and producing deadly botulinum neurotoxins (BoNTs). In 2006, C. botulinum was responsible for an international outbreak of botulism attributed to the consumption of commercially pasteurized carrot juice. The purpose of this study was to isolate and characterize strains of C. botulinum from the adulterated product. Carrot juice bottles retrieved from the manufacturing facility were analyzed for the presence of BoNT and BoNT-producing isolates using DIG-ELISA. Toxigenic isolates from the carrot juice were analyzed using pulsed-field gel electrophoresis (PFGE) and DNA microarray analysis to determine their genetic relatedness to the original outbreak strains CDC51348 and CDC51303. PFGE revealed that isolates CJ4-1 and CJ10-1 shared an identical pulsotype with strain CDC51303, whereas isolate CJ5-1 displayed a unique restriction banding pattern. DNA microarray analysis identified several phage related genes unique to strain CJ5-1, and Southern hybridization analysis of XhoI digested and nondigested DNA showed their chromosomal location, while a homolog to pCLI_A009 of plasmid pCLI of C. botulinum serotype Langeland F, was located on a small plasmid. The acquisition or loss of bacteriophages and other mobile genetic elements among C. botulinum strains has epidemiological and evolutionary implications.

  6. Role of csp genes in NaCl, pH, and ethanol stress response and motility in Clostridium botulinum ATCC 3502.

    Science.gov (United States)

    Derman, Yağmur; Söderholm, Henna; Lindström, Miia; Korkeala, Hannu

    2015-04-01

    Clostridium botulinum is a notable food pathogen and responsible for botulism due to production of botulinum neurotoxin. Strains of C. botulinum can adapt to and survive in stress conditions and food processing. The cold shock protein coding genes (csp) are involved in growth at low temperature, but they may also possess other functions. In this mutational analysis we show that cspB and cspC, but not cspA, are important for NaCl, pH and ethanol stress responses and for motility of C. botulinum ATCC 3502. In all NaCl concentrations tested, the cspB mutant had lower maximum growth rate and, together with the cspC mutant, a longer lag phase compared to the wild-type strain. At low pH, the cspB and cspC mutants showed either lower maximum growth rates or longer lag phases compared to the wild type. In all ethanol concentrations tested, the cspB mutant had lower maximum growth rates and the cspC mutant had a longer lag phase than the wild-type strain. Motility was reduced in cspA and cspC mutants, and flagella formation was affected. The results suggest that cspB plays a universal role in stress response and cspC aids C. botulinum in NaCl, pH and ethanol stress in C. botulinum ATCC 3502.

  7. Inability of non-proteolytic Clostridium botulinum to grow in mussels inoculated via immersion and packaged in high oxygen atmospheres.

    Science.gov (United States)

    Newell, Carter R; Doyle, Michael; Ma, Li

    2015-04-01

    A series of botulism challenge studies were conducted to determine if botulinum toxin would be produced in mussels (Mytilus edulis) inoculated with non-proteolytic Clostridium botulinum spores and held under modified atmosphere (MA) packaging conditions at normal (4 °C) and abusive (12 °C) temperatures. Spore mixtures of six strains of non-proteolytic C. botulinum were introduced into live mussels through immersion in a seawater solution with cultured algae. Mussels were packed in a commercial high-oxygen (60-65% O2) MA-package with a buffer, and also packed under a vacuum. Feeding live mussels cultured algae (10(4) cells/ml) with a C. botulinum spore suspension (10(3) spores/ml) in seawater at 4 °C for 6 h resulted in the uptake of spores into mussel tissue (500/g) and the mussel GI tract (100/g). Under all of the experimental conditions evaluated, none of the fresh mussels became toxic, even after spoilage and in the absence of oxygen. However, control samples using tuna or cooked mussel meats became toxic in the absence of oxygen. Botulinum toxin was not produced in fresh mussels packaged under the MA-packaging conditions evaluated, even at an abusive storage temperature (12 °C) for at least 12 days or at normal storage temperate (4 °C) for at least 21 days, which is beyond their shelf life.

  8. Domain Organization in Clostridium botulinum Neurotoxin Type E is Unique: Its Implication in Faster Translocation

    Energy Technology Data Exchange (ETDEWEB)

    Kumaran, D.; Eswaramoorthy, S; Furey, W; Navaza, J; Sax, M; Swaminathan, S

    2009-01-01

    Clostridium botulinum produces seven antigenically distinct neurotoxins [C. botulinum neurotoxins (BoNTs) A-G] sharing a significant sequence homology. Based on sequence and functional similarity, it was believed that their three-dimensional structures will also be similar. Indeed, the crystal structures of BoNTs A and B exhibit similar fold and domain association where the translocation domain is flanked on either side by binding and catalytic domains. Here, we report the crystal structure of BoNT E holotoxin and show that the domain association is different and unique, although the individual domains are similar to those of BoNTs A and B. In BoNT E, both the binding domain and the catalytic domain are on the same side of the translocation domain, and all three have mutual interfaces. This unique association may have an effect on the rate of translocation, with the molecule strategically positioned in the vesicle for quick entry into cytosol. Botulism, the disease caused by BoNT E, sets in faster than any other serotype because of its speedy internalization and translocation, and the present structure offers a credible explanation. We propose that the translocation domain in other BoNTs follows a two-step process to attain translocation-competent conformation as in BoNT E. We also suggest that this translocation-competent conformation in BoNT E is a probable reason for its faster toxic rate compared to BoNT A. However, this needs further experimental elucidation.

  9. Analysis of the genetic distribution among members of Clostridium botulinum group I using a novel multilocus sequence typing (MLST) assay.

    Science.gov (United States)

    Olsen, Jaran S; Scholz, Holger; Fillo, Silvia; Ramisse, Vincent; Lista, Florigio; Trømborg, Anette K; Aarskaug, Tone; Thrane, Ingjerd; Blatny, Janet M

    2014-01-01

    Clostridium botulinum is the etiological agent of botulism. Due to food-borne poisoning and the potential use of the extremely toxic botulinum neurotoxin (BoNT) from C. botulinum in bioterror or biocrime related actions, reliable high resolution typing methods for discriminating C. botulinum strains are needed. Partial sequencing of the adk, atpH, gyrB, proC, rpoD and spo0A genes from 51 various C. botulinum/sporogenes isolates was performed, resulting in 37 different sequence types (STs). Analysis of the sequence data revealed a genetic distribution in five larger clusters with a loose correlation to the BoNT serotypes. The developed MLST assay had a slightly lower resolution ability when compared to the MLVA (multilocus variable number of tandem repeat analysis), but the two methods resulted in similar subclusters of the strains possessing the BoNT serotypes A, B and F. The current work presents the development of a novel MLST assay useful for genotyping C. botulinum related to basic phylogenetic research and trace-back analysis in microbial forensic studies.

  10. Genetic diversity among Clostridium botulinum strains harboring bont/A2 and bont/A3 genes.

    Science.gov (United States)

    Lúquez, Carolina; Raphael, Brian H; Joseph, Lavin A; Meno, Sarah R; Fernández, Rafael A; Maslanka, Susan E

    2012-12-01

    Clostridium botulinum type A strains are known to be genetically diverse and widespread throughout the world. Genetic diversity studies have focused mainly on strains harboring one type A botulinum toxin gene, bont/A1, although all reported bont/A gene variants have been associated with botulism cases. Our study provides insight into the genetic diversity of C. botulinum type A strains, which contain bont/A2 (n = 42) and bont/A3 (n = 4) genes, isolated from diverse samples and geographic origins. Genetic diversity was assessed by using bont nucleotide sequencing, content analysis of the bont gene clusters, multilocus sequence typing (MLST), and pulsed-field gel electrophoresis (PFGE). Sequences of bont genes obtained in this study showed 99.9 to 100% identity with other bont/A2 or bont/A3 gene sequences available in public databases. The neurotoxin gene clusters of the subtype A2 and A3 strains analyzed in this study were similar in gene content. C. botulinum strains harboring bont/A2 and bont/A3 genes were divided into six and two MLST profiles, respectively. Four groups of strains shared a similarity of at least 95% by PFGE; the largest group included 21 out of 46 strains. The strains analyzed in this study showed relatively limited genetic diversity using either MLST or PFGE.

  11. C型、D型肉毒梭菌毒素的研究进展

    Institute of Scientific and Technical Information of China (English)

    苏文金

    1995-01-01

    @@ 肉毒中毒(Botulism)是由肉毒梭菌(Clostridium botulinum,下简称Cb)引起的,以中枢神经系统症状为主的一种人兽共患疾病,其发病是由Cb所产生的神经毒素所致.肉毒中毒可分为食物肉毒中毒,创伤肉毒中毒和婴儿肉毒中毒[1],其中婴儿肉毒中毒自1976年首次报道以来,已在除非洲外的各大陆皆有报告[2].虽然肉毒中毒以欧、美大陆发病较多,但我国不少省份也有发现,其死亡率较高,毒性强烈,仍应引起人们的高度重视[3].

  12. Structure of a bimodular botulinum neurotoxin complex provides insights into its oral toxicity.

    Directory of Open Access Journals (Sweden)

    Kwangkook Lee

    Full Text Available Botulinum neurotoxins (BoNTs are produced by Clostridium botulinum and cause the fatal disease botulism, a flaccid paralysis of the muscle. BoNTs are released together with several auxiliary proteins as progenitor toxin complexes (PTCs to become highly potent oral poisons. Here, we report the structure of a ∼760 kDa 14-subunit large PTC of serotype A (L-PTC/A and reveal insight into its absorption mechanism. Using a combination of X-ray crystallography, electron microscopy, and functional studies, we found that L-PTC/A consists of two structurally and functionally independent sub-complexes. A hetero-dimeric 290 kDa complex protects BoNT, while a hetero-dodecameric 470 kDa complex facilitates its absorption in the harsh environment of the gastrointestinal tract. BoNT absorption is mediated by nine glycan-binding sites on the dodecameric sub-complex that forms multivalent interactions with carbohydrate receptors on intestinal epithelial cells. We identified monosaccharides that blocked oral BoNT intoxication in mice, which suggests a new strategy for the development of preventive countermeasures for BoNTs based on carbohydrate receptor mimicry.

  13. Genomic characterization of Italian Clostridium botulinum group I strains.

    Science.gov (United States)

    Giordani, Francesco; Fillo, Silvia; Anselmo, Anna; Palozzi, Anna Maria; Fortunato, Antonella; Gentile, Bernardina; Azarnia Tehran, Domenico; Ciammaruconi, Andrea; Spagnolo, Ferdinando; Pittiglio, Valentina; Anniballi, Fabrizio; Auricchio, Bruna; De Medici, Dario; Lista, Florigio

    2015-12-01

    Clostridium botulinum is a gram-positive bacterium capable of producing the botulinum neurotoxin, a powerful poison that causes botulism, a severe neuroparalytic disease. Its genome has been sequenced entirely and its gene content has been analyzed. To date, 19 full genomes and 64 draft genomes are available. The geographical origin of these genomes is predominantly from the US. In the present study, 10 Italian genomes of C. botulinum group I were analyzed and compared with previously sequenced group I genomes, in order to genetically characterize the Italian population of C. botulinum group I and to investigate the phylogenetic relationships among different lineages. Using the suites of software ClonalFrame and ClonalOrigin to perform genomic analysis, we demonstrated that Italian C. botulinum group I population is phylogenetically heterogeneous encompassing different and distant lineages including overseas strains, too. Moreover, a high recombination rate was demonstrated in the evolution of C. botulinum group I species. Finally, genome sequencing of the strain 357 led us to identify a novel botulinum neurotoxin subtype, F8.

  14. Glyphosate suppresses the antagonistic effect of Enterococcus spp. on Clostridium botulinum.

    Science.gov (United States)

    Krüger, Monika; Shehata, Awad Ali; Schrödl, Wieland; Rodloff, Arne

    2013-04-01

    During the last 10-15 years, an increase of Clostridium botulinum associated diseases in cattle has been observed in Germany. The reason for this development is currently unknown. The normal intestinal microflora is a critical factor in preventing intestinal colonisation by C. botulinum as shown in the mouse model of infant botulism. Numerous bacteria in the gastro-intestinal tract (GIT) produce bacteriocines directed against C. botulinum and other pathogens: Lactic acid producing bacteria (LAB) such as lactobacilli, lactococci and enterococci, generate bacteriocines that are effective against Clostridium spp. A reduction of LAB in the GIT microbiota by ingestion of strong biocides like glyphosate could be an explanation for the observed increase in levels of C. botulinum associated diseases. In the present paper, we report on the toxicity of glyphosate to the most prevalent Enterococcus spp. in the GIT. Ingestion of this herbicide could be a significant predisposing factor that is associated with the increase in C. botulinum mediated diseases in cattle.

  15. Mode of VAMP Substrate Recognition and Inhibition of Clostridium botulinum Neurotoxin F

    Energy Technology Data Exchange (ETDEWEB)

    Agarwal, R.; Schmidt, J; Stafford, R; Swaminathan, S

    2009-01-01

    Clostridium botulinum neurotoxins (BoNTs) cleave neuronal proteins responsible for neurotransmitter release, causing the neuroparalytic disease botulism. BoNT serotypes B, D, F and G cleave and inactivate vesicle-associated membrane protein (VAMP), each at a unique peptide bond. The specificity of BoNTs depends on the mode of substrate recognition. We have investigated the mechanism of substrate recognition of BoNT F by determining the crystal structures of its complex with two substrate-based inhibitors, VAMP 22-58/Gln58D-cysteine and 27-58/Gln58D-cysteine. The inhibitors bind to BoNT F in the canonical direction (as seen for BoNTs A and E substrates) but are positioned specifically via three major exosites away from the active site. The cysteine sulfur of the inhibitors interacts with the zinc and exists as sulfinic acid in the inhibitor VAMP 27-58/Gln58D-cysteine. Arg133 and Arg171, which form part of two separate exosites, are crucial for substrate binding and catalysis.

  16. Phospholipase C Produced by Clostridium botulinum Types C and D:Comparison of Gene, Enzymatic, and Biological Activities with Those of Clostridium perfringens Alpha-toxin

    Directory of Open Access Journals (Sweden)

    Sakurai,Jun

    2013-02-01

    Full Text Available Clostridium botulinum type C and D strains recently have been found to produce PLC on egg yolk agar plates. To characterize the gene, enzymatic and biological activities of C. botulinum PLCs (Cb-PLCs, the cb-plc genes from 8 strains were sequenced, and 1 representative gene was cloned and expressed as a recombinant protein. The enzymatic and hemolytic activities of the recombinant Cb-PLC were measured and compared with those of the Clostridium perfringens alpha-toxin. Each of the eight cb-plc genes encoded a 399 amino acid residue protein preceded by a 27 residue signal peptide. The protein consists of 2 domains, the N- and C-domains, and the overall amino acid sequence identity between Cb-PLC and alpha-toxin was greater than 50%, suggesting that Cb-PLC is homologous to the alpha-toxin. The key residues in the N-domain were conserved, whereas those in the C-domain which are important in membrane interaction were different than in the alpha-toxin. As expected, Cb-PLC could hydrolyze egg yolk phospholipid, p-nitrophenylphosphorylcholine, and sphingomyelin, and also exhibited hemolytic activity;however, its activities were about 4- to over 200-fold lower than those of alpha-toxin. Although Cb-PLC showed weak enzymatic and biological activities, it is speculated that Cb-PLC might play a role in the pathogenicity of botulism or for bacterial survival.

  17. CRYSTAL STRUCTURE OF CLOSTRIDIUM BOTULINUM NEUROTOXIN SEROTYPE B.

    Energy Technology Data Exchange (ETDEWEB)

    SWAMINATHAN,S.; ESWARAMOORTHY,S.

    2001-11-19

    The toxigenic strains of Clostridium botulinum produce seven serologically distinct types of neurotoxins labeled A - G (EC 3.4.24.69), while Clostridium tetani produces tetanus neurotoxin (EC 3.4.24.68). Botulinum and tetanus neurotoxins (BoNTs and TeNT) are produced as single inactive chains of molecular mass of approximately 150 kDa. Most of these neurotoxins are released after being cleaved into two chains, a heavy chain (HI) of 100 kDa and a light chain (L) of 50 kDa held together by an interchain disulfide bond, by tissue proteinases. BoNT/E is released as a single chain but cleaved by host proteinases [1]. Clostvidium botulinum neurotoxins are extremely poisonous proteins with their LD{sub 50} for humans in the range of 0.1 - 1 ng kg{sup -1} [2]. Botulinum neurotoxins are responsible for neuroparalytic syndromes of botulism characterized by serious neurological disorders and flaccid paralysis. BoNTs block the release of acetylcholine at the neuromuscular junction causing flaccid paralysis while TeNT blocks the release of neurotransmitters like glycine and {gamma}-aminobutyric acid (GABA) in the inhibitory interneurons of the spinal cord resulting in spastic paralysis. In spite of different clinical symptoms, their aetiological agents intoxicate neuronal cells in the same way and these toxins have similar structural organization [3].

  18. Hemifacial spasm in a patient with neurofibromatosis and Arnold-Chiari malformation: a unique case association Espasmo hemifacial em paciente com neurofibromatose e malformação de Arnold-Chiari: uma associação rara

    Directory of Open Access Journals (Sweden)

    Andre Carvalho Felício

    2007-09-01

    Full Text Available BACKGROUND: The association of hemifacial spasm (HFS, Chiari type I malformation (CIM and neurofibromatosis type 1 (NF1 has not been described yet. CASE REPORT: We report the case of a 31-year-old woman with NF1 who developed a right-sided HFS. On magnetic resonance imaging (MRI a CIM was seen without syringomyelia. The patient has been successfully treated with botulinum toxin type A injections for 5 years without major side effects. CONCLUSION:Clinical features of HFS, CMI and NF1 are highlighted together with their possible relationship. Also, therapeutic strategies are also discussed.INTRODUÇÃO: A associação entre espasmo hemifacial (EHF, malformação de Chiari tipo I (MCI e neurofibromatose tipo I (NFI ainda não foi descrita. RELATO DO CASO: Relatamos o caso de mulher com 31 anos com NFI que desenvolveu EHF à direita. Na ressonância magnética (RM foi observada MCI sem seringomielia associada. A paciente foi tratada com sucesso com toxina botulínica tipo A por 5 anos sem efeitos colaterais. CONCLUSÃO: Ressaltamos as características clínicas do EHF, MCI e NFI assim como uma possível relação entre elas. Além disto, discutimos também estratégias terapêuticas.

  19. Preliminary characterization of digestive enzymes in freshwater mussels

    Science.gov (United States)

    Sauey, Blake W.; Amberg, Jon J.; Cooper, Scott T.; Grunwald, Sandra K.; Newton, Teresa J.; Haro, Roger J.

    2015-01-01

    Resource managers lack an effective chemical tool to control the invasive zebra mussel Dreissena polymorpha. Zebra mussels clog water intakes for hydroelectric companies, harm unionid mussel species, and are believed to be a reservoir of avian botulism. Little is known about the digestive physiology of zebra mussels and unionid mussels. The enzymatic profile of the digestive glands of zebra mussels and native threeridge (Amblema plicata) and plain pocketbook mussels (Lampsilis cardium) are characterized using a commercial enzyme kit, api ZYM, and validated the kit with reagent-grade enzymes. A linear correlation was shown for only one of nineteen enzymes, tested between the api ZYM kit and a specific enzyme kit. Thus, the api ZYM kit should only be used to make general comparisons of enzyme presence and to observe trends in enzyme activities. Enzymatic trends were seen in the unionid mussel species, but not in zebra mussels sampled 32 days apart from the same location. Enzymatic classes, based on substrate, showed different trends, with proteolytic and phospholytic enzymes having the most change in relative enzyme activity.

  20. Naturally occurring and experimentally induced castor bean (Ricinus communis) poisoning in ducks

    Science.gov (United States)

    Jensen, W.I.; Allen, J.P.

    1981-01-01

    Castor bean (Ricinus communis) poisoning accounted for the death of several thousand ducks in the Texas panhandle in the fall and winter months of 1969-1971. Signs of intoxication resembled those of botulism, except for mucoid, blood-tinged excreta. The most common lesions were severe fatty change in the liver, widely distributed internal petechial hemorrhages or ecchymoses, and catarrhal enteritis. Nearly intact castor beans were found in the stomach of one duck during field necropsy. Fragments of seed coat resembling castor bean were found in the stomachs of 10 of 14 ducks examined in the laboratory. Clinical signs and postmortem lesions observed in wild ducks were induced experimentally in mallards (Anas platyrhynchos) by force-feeding intact castor beans. Toxicity titrations were erratic, but the LD50 appeared to be between three and four seeds. The mouse toxicity test, used to detect Clostridium botulinum toxin in the blood serum of intoxicated ducks, was negative in every case. Hemagglutination and precipitin tests generally failed to detect castor bean in extracts of excreta or intestinal contents of experimentally intoxicated ducks.

  1. Iterative structure-based peptide-like inhibitor design against the botulinum neurotoxin serotype A.

    Directory of Open Access Journals (Sweden)

    Jorge E Zuniga

    Full Text Available The botulinum neurotoxin serotype A light chain (BoNT/A LC protease is the catalytic component responsible for the neuroparalysis that is characteristic of the disease state botulism. Three related peptide-like molecules (PLMs were designed using previous information from co-crystal structures, synthesized, and assayed for in vitro inhibition against BoNT/A LC. Our results indicate these PLMS are competitive inhibitors of the BoNT/A LC protease and their K(i values are in the nM-range. A co-crystal structure for one of these inhibitors was determined and reveals that the PLM, in accord with the goals of our design strategy, simultaneously involves both ionic interactions via its P1 residue and hydrophobic contacts by means of an aromatic group in the P2' position. The PLM adopts a helical conformation similar to previously determined co-crystal structures of PLMs, although there are also major differences to these other structures such as contacts with specific BoNT/A LC residues. Our structure further demonstrates the remarkable plasticity of the substrate binding cleft of the BoNT/A LC protease and provides a paradigm for iterative structure-based design and development of BoNT/A LC inhibitors.

  2. Development of an Innovative in Vitro Potency Assay for Anti-Botulinum Antitoxins.

    Science.gov (United States)

    Rosen, Osnat; Ozeri, Eyal; Barnea, Ada; David, Alon Ben; Zichel, Ran

    2016-09-24

    Botulinum neurotoxins are bacterial proteins that cause botulism, a life-threatening disease. Therapy relies mostly on post-intoxication antibody treatment. The only accepted method to measure the potency of, and to approve, antitoxin preparations is the mouse lethality neutralization bioassay. However, this assay is time-consuming, labor-intensive, costly, and raises ethical issues related to the large numbers of laboratory animals needed. Until now, all efforts to develop an alternative in vitro assay have not provided a valid replacement to the mouse potency assay. In the present study, we report the development of an innovative in vitro assay for determining botulinum antitoxin potency, using botulinum type B as a model. The concept of the assay is to mimic two fundamental steps in botulinum intoxication: receptor binding and catalytic activity. By simulating these steps in vitro we were able to accurately determine the potency of antitoxin preparations. The reproducibility of the assay was high with a CV vitro assay highly correlated with that measured by the standard in vivo mouse assay (r = 0.9842, p vitro assay has the potential to be considered, after validation, as a replacement to the mouse assay for quantitating neutralizing antibody concentrations in pharmaceutical botulinum antitoxin preparations. Future adoption of this in vitro assay would minimize the use of laboratory animals, speed up the time, and reduce the cost of botulinum antitoxin approval.

  3. Outbreak of necrotizing fasciitis due to Clostridium sordellii among black-tar heroin users.

    Science.gov (United States)

    Kimura, Akiko C; Higa, Jeffrey I; Levin, Robert M; Simpson, Gail; Vargas, Yolanda; Vugia, Duc J

    2004-05-01

    In California, black tar heroin (BTH) use among injection drug users (IDUs) has resulted in an increased number of cases of wound botulism due to Clostridium botulinum, tetanus due to Clostridium tetani, and necrotizing soft-tissue infections due to a variety of clostridia. From December 1999 to April 2000, nine IDUs in Ventura County, California, developed necrotizing fasciitis; 4 died. Cultures of wound specimens from 6 case patients yielded Clostridium sordellii. Some of the patients appeared to have the toxic shock syndrome previously reported to be characteristic of toxin-mediated C. sordellii infection, which is characterized by hypotension, marked leukocytosis, and hemoconcentration. The suspected source of this outbreak was contaminated BTH that was injected subcutaneously or intramuscularly ("skin popped"). This outbreak of C. sordellii infection serves as another example of how BTH can potentially serve as a vehicle for transmitting severe and often deadly clostridial infections, and reinforces the need to educate IDUs and clinicians about the risks associated with skin popping of BTH.

  4. Botulinum toxin: bioweapon & magic drug.

    Science.gov (United States)

    Dhaked, Ram Kumar; Singh, Manglesh Kumar; Singh, Padma; Gupta, Pallavi

    2010-11-01

    Botulinum neurotoxins, causative agents of botulism in humans, are produced by Clostridium botulinum, an anaerobic spore-former Gram positive bacillus. Botulinum neurotoxin poses a major bioweapon threat because of its extreme potency and lethality; its ease of production, transport, and misuse; and the need for prolonged intensive care among affected persons. A single gram of crystalline toxin, evenly dispersed and inhaled, can kill more than one million people. The basis of the phenomenal potency of botulinum toxin is enzymatic; the toxin is a zinc proteinase that cleaves neuronal vesicle associated proteins responsible for acetylcholine release into the neuromuscular junction. As a military or terrorist weapon, botulinum toxin could be disseminated via aerosol or by contamination of water or food supplies, causing widespread casualties. A fascinating aspect of botulinum toxin research in recent years has been development of the most potent toxin into a molecule of significant therapeutic utility . It is the first biological toxin which is licensed for treatment of human diseases. In the late 1980s, Canada approved use of the toxin to treat strabismus, in 2001 in the removal of facial wrinkles and in 2002, the FDA in the United States followed suit. The present review focuses on both warfare potential and medical uses of botulinum neurotoxin.

  5. Phospholipase C produced by Clostridium botulinum types C and D: comparison of gene, enzymatic, and biological activities with those of Clostridium perfringens alpha-toxin.

    Science.gov (United States)

    Fatmawati, Ni Nengah Dwi; Sakaguchi, Yoshihiko; Suzuki, Tomonori; Oda, Masataka; Shimizu, Kenta; Yamamoto, Yumiko; Sakurai, Jun; Matsushita, Osamu; Oguma, Keiji

    2013-01-01

    Clostridium botulinum type C and D strains recently have been found to produce PLC on egg yolk agar plates. To characterize the gene, enzymatic and biological activities of C. botulinum PLCs (Cb-PLCs), the cb-plc genes from 8 strains were sequenced, and 1 representative gene was cloned and expressed as a recombinant protein. The enzymatic and hemolytic activities of the recombinant Cb-PLC were measured and compared with those of the Clostridium perfringens alpha-toxin. Each of the eight cb-plc genes encoded a 399 amino acid residue protein preceded by a 27 residue signal peptide. The protein consists of 2 domains, the N- and C-domains, and the overall amino acid sequence identity between Cb-PLC and alpha-toxin was greater than 50%, suggesting that Cb-PLC is homologous to the alpha-toxin. The key residues in the N-domain were conserved, whereas those in the C-domain which are important in membrane interaction were different than in the alpha-toxin. As expected, Cb-PLC could hydrolyze egg yolk phospholipid, p-nitrophenylphosphorylcholine, and sphingomyelin, and also exhibited hemolytic activity;however, its activities were about 4- to over 200-fold lower than those of alpha-toxin. Although Cb-PLC showed weak enzymatic and biological activities, it is speculated that Cb-PLC might play a role in the pathogenicity of botulism or for bacterial survival.

  6. Unique Ganglioside Recognition Strategies for Clostridial Neurotoxins

    Energy Technology Data Exchange (ETDEWEB)

    Benson, Marc A.; Fu, Zhuji; Kim, Jung-Ja P.; Baldwin, Michael R. (MCW); (UMC)

    2012-03-15

    Botulinum neurotoxins (BoNTs) and tetanus neurotoxin are the causative agents of the paralytic diseases botulism and tetanus, respectively. The potency of the clostridial neurotoxins (CNTs) relies primarily on their highly specific binding to nerve terminals and cleavage of SNARE proteins. Although individual CNTs utilize distinct proteins for entry, they share common ganglioside co-receptors. Here, we report the crystal structure of the BoNT/F receptor-binding domain in complex with the sugar moiety of ganglioside GD1a. GD1a binds in a shallow groove formed by the conserved peptide motif E ... H ... SXWY ... G, with additional stabilizing interactions provided by two arginine residues. Comparative analysis of BoNT/F with other CNTs revealed several differences in the interactions of each toxin with ganglioside. Notably, exchange of BoNT/F His-1241 with the corresponding lysine residue of BoNT/E resulted in increased affinity for GD1a and conferred the ability to bind ganglioside GM1a. Conversely, BoNT/E was not able to bind GM1a, demonstrating a discrete mechanism of ganglioside recognition. These findings provide a structural basis for ganglioside binding among the CNTs and show that individual toxins utilize unique ganglioside recognition strategies.

  7. 青海省2005-2011年食物中毒事件流行特征分析%Analysis on epidemiological characteristics of food poisoning in Qinghai province during 2005 to 2011

    Institute of Scientific and Technical Information of China (English)

    郭学斌

    2012-01-01

    Objective To analyze the epidemiological characteristics of food poisoning in Qinghai province during 2005 to 2011, provide basis for further prevention and control. Method Epidemiological and medical statistics methods was applied to analyzed the food poisoning cases in Qinghai province during 2005 to 2011. Results There were 14 cases of food poisoning in Qinghai province during 2005 to 2011 and 280 people were poisoned, the annual morbidity was 0. 75 /lakh and the fatality rate was 6.43%. The second and third quarter were the peak seasons. The places of food poisoning were mainly in households, which accounted for 64. 29% , followed by building sites (28. 57% ) . The main causative agent was botulism, which accounted for 42. 86% , the second was beans ( 28. 57% ) . Conclusions The food poisoning in Qinghai province were mainly occurred in households and building sites, the mainly causative agents were botulism and beans. Enhancing the food hygiene health promotion, strengthening the health management in building sites and improving the public consciousness were the effective ways to prevention and control of food poisoning.%目的 对近年青海省食物中毒事件流行特征进行分析,为预防与控制食物中毒提供科学依据.方法 应用流行病学和医学统计学方法对2006-2011年青海省发生的食物中毒事件进行分析.结果 青海省2005-2011年共发生食物中毒14起,中毒人数280人,年均发病率为0.75/10万,病死率为6.43%;中毒多发生在第二、三季度;中毒发生场所以家庭为主,占64.29%,其次是工地食堂,占28.57%.致病因素以肉毒中毒为主,占42.86%,其次是豆角加工不当引起的食物中毒,占28.57%.结论 青海省食物中毒以藏区家庭发生的肉毒中毒及建筑工地食堂集体发生的豆角加工不当引起的食物中毒为主;加大食品卫生宣传力度、加强工地食堂卫生监管、提高人们群众卫生意识是预防及控制食物中毒的有效途径.

  8. Sôbre a patogenia da Grangrena gasona

    Directory of Open Access Journals (Sweden)

    Genésio Pacheco

    1954-06-01

    Full Text Available Since von Hibler gas grangrene has been considered a local infection with systemic symptoms. When we consider some of the symptoms of gas gangrene, those of the central nervous system are in evidence beeing similar to those observed in tetanus and botulism. It is likely therefore that gas gangrene intoxication and the disease caused by it are of neurotoxic nature. With Almeida Cardoso and Araujo Costa we were able to demonstrate lesions in the central nervous system of animals wich had been intoxicated during a short period of time as well in those with intoxication of longer duration. In acute intoxication, after intracreneal inoculation, severe alterations were seen within 20 to 30 minutes in the cells of the spinal cord, specially in motor cells and also in some cells of the posterior cord and spinal bulb. The changes consisted in chromatolysis and picnosis and were more marked in animals intoxicated with Clostridium histolyticum and Cl. perfringens toxines. Myelin sheet was unchanged. in delayed intoxication with greater and repeated dosis lesions of the central nervous system (brain, protuberance, medula ablongate and medula spinal were observed. They consisted in hyperemia, perivascular hemorrages in white and grey substances, oedema, accumulation of glia cells with enlarged and hyperchromatic nuclei, fragmentation of the myelin sheet and balooning degeneration of the described by Spielmeyer. Such changes were found in the swollen and hemorragic zones and were generally similar to those found in the acute type of Spielmeyer 9acute swelling and liquefation. Other changes found sometimes were agglutination of Nissl's bodies, sinous appearence of the dendritic endings, shruncken cells of Spielmeyer and neuronophagy around "ghost" cells. In short the changes...

  9. Marcha em pontas idiopática em idade pediátrica

    Directory of Open Access Journals (Sweden)

    Sara Domingues

    2016-03-01

    Full Text Available A marcha em pontas tem uma incidência de 7-24% na população pediátrica em geral e é uma causa relativamente frequente de referenciação à consulta de neurologia pediátrica. A marcha em pontas idiopática ocorre em crianças saudáveis, sem espasticidade e com reflexos osteotendinosos normais; é evidente desde o início da marcha autónoma, sempre bilateral e não progressiva. A sua etiologia é desconhecida, pelo que se trata de um diagnóstico de exclusão. Assim, na avaliação destas crianças é essencial estar alerta para sinais sensoriais ou motores, pois este padrão de marcha pode ser o primeiro sinal de patologia tal como paralisia cerebral, distrofia muscular congénita ou perturbação do espectro do autismo. As opções terapêuticas passam por tratamentos conservadores, como fisioterapia, utilização de calçado formativo, talas ou ortóteses, ou tratamentos mais invasivos, como uso de gessos seriados, aplicação de toxina botulínica ou cirurgia. Neste artigo de atualização pretende-se: abordar alguns aspetos epidemiológicos e fisiopatológicos, rever a apresentação clinica e diagnósticos diferenciais e propor orientações para o seguimento e tratamento em idade pediátrica.

  10. Causes of mortality in laying hens in different housing systems in 2001 to 2004

    Directory of Open Access Journals (Sweden)

    Etterlin Pernille

    2009-01-01

    Full Text Available Abstract Background The husbandry systems for laying hens were changed in Sweden during the years 2001 – 2004, and an increase in the number of submissions for necropsy from laying hen farms was noted. Hence, this study was initiated to compare causes of mortality in different housing systems for commercial laying hens during this change. Methods Based on results from routine necropsies of 914 laying hens performed at the National Veterinary Institute (SVA in Uppsala, Sweden between 2001 and 2004, a retrospective study on the occurrence of diseases and cannibalism, i.e., pecking leading to mortality, in different housing systems was carried out. Using the number of disease outbreaks in caged flocks as the baseline, the expected number of flocks with a certain category of disease in the other housing systems was estimated having regard to the total number of birds in the population. Whether the actual number of flocks significantly exceeded the expected number was determined using a Poisson distribution for the variance of the baseline number, a continuity correction and the exact value for the Poisson distribution function in Excel 2000. Results Common causes of mortality in necropsied laying hens included colibacillosis, erysipelas, coccidiosis, red mite infestation, lymphoid leukosis and cannibalism. Less common diagnoses were Newcastle Disease, pasteurellosis and botulism. Considering the size of the populations in the different housing systems, a larger proportion of laying hens than expected was submitted for necropsy from litter-based systems and free range production compared to hens in cages (P P P Conclusion The results of the present study indicated that during 2001–2004 laying hens housed in litter-based housing systems, with or without access to outdoor areas, were at higher risk of infectious diseases and cannibalistic behaviour compared to laying hens in cages. Future research should focus on finding suitable prophylactic

  11. Tuberculosis in wild birds: implications for captive birds

    Science.gov (United States)

    Converse, K. A.; Dein, F. J.

    1990-01-01

    The geographic distribution of avian tuberculosis is widespread but the lack of visible epizootics makes assessment of its impact on wild birds difficult. Generally a low prevalence, widely-scattered, individual animal disease, avian tuberculosis is caused by the same agent in wild and domestic birds. Thus there exists the potential for disease transfer between these two groups in situations that result in direct contact such as wild animals newly captured or transferred from rehabilitation centers, and wild and captive animals intermingling in exhibit areas. During the past 7 yr, tuberculosis caused by Mycobacterium avium, was diagnosed in 64 birds submitted to the National Wildlife Health Research Center from 16 states; avian tuberculosis was the primary diagnosis in 52 of the 64 birds, while the remaining 12 isolates were incidental findings. Twenty-eight of these birds were picked up during epizootics caused by other disease agents including avian cholera, botulism type C, and lead, organophosphorus compound, and cyanide poisoning. Twelve birds were found incidental to birds collected during disease monitoring programs and research projects, and 10 birds were collected by hunters or found sick and euthanatized. Tuberculosis lesions occurred (in order of decreasing frequency) in the liver, intestine, spleen, lung, and air sacs. Several unusual morphological presentations were observed in the gizzard, shoulder joint, jugular vein, face, nares and bill, ureter and bone marrow. Infected birds were collected during all 12 mo of the yr from a variety of species in the Anseriformes, Podicipediformes, Gruiformes, and Falconiformes. Nine of the 46 known age birds were immature indicating that lesions can develop during the first year.

  12. Improving immunogenicity, efficacy and safety of vaccines through innovation in clinical assay development and trial design: the Phacilitate Vaccine Forum, Washington D.C. 2011.

    Science.gov (United States)

    Moldovan, Ioana R; Tary-Lehmann, Magdalena

    2011-06-01

    The 9th Annual Vaccine Forum organized by Phacilitate in Washington D.C. 2011 brought together 50+ senior level speakers and over 400 participants representing all the key stakeholders concerning vaccines. The main focus of the meeting was to define priorities in the global vaccines sector from funding to manufacturing and evaluation of vaccine efficacy. A special session was devoted to improving immunogenicity, efficacy and safety of vaccines through innovation in clinical assay development and trial design. The current regulatory approach to clinical assay specification, validation and standardization that enable more direct comparisons of efficacy between trials was illustrated by the success in meningococcal vaccine development. The industry approach to validation strategies was exemplified by a new serologic test used on the diagnostic of pneumococcal pneumonia. The application of the Animal Rule to bridge clinical and non-clinical studies in botulism has allowed significant progress in developing one of the first vaccines to seek approval under the FDA Animal Efficacy Rule. An example of pushing the boundaries in the correlation of immunological responses and efficacy points was represented by a recent cell-based influenza vaccine for which the same correlates of protection apply as for the traditional, egg-based flue vaccine. In the field of HIV phase 2b studies are underway, based on promising results obtained with some vaccine candidates. The conclusion of this session was that creativity in vaccine design and evaluation is beneficial and can lead to innovative new vaccine designs as well as to validated assays to assess vaccine efficacy.

  13. The use of upconverting phosphors in point-of-care (POC) testing

    Science.gov (United States)

    Tanke, Hans J.; Zuiderwijk, Michel; Wiesmeijer, Karien C.; Breedveld, Robert N.; Abrams, William R.; de Dood, Claudia J.; Tjon Kon Fat, Elisa M.; Corstjens, Paul L. A. M.

    2014-03-01

    Point-of-care (POC) testing is increasingly applied as a cost effective alternative to many diagnostic tests. Key in POC testing is to create sufficient assay sensitivity with relatively low cost reagents and equipment. For this purpose we have employed a unique reporter, upconverting phosphor (UCP) particles, in combination with lateral flow (LF) assays. UCPs, submicron ceramic particles doped with rare earth ions (lanthanides), convert infrared to visible light and do not suffer from autofluorescence which limits conventional fluorescence based assays. Low cost handheld readers and microfluidics were evaluated in various applications. Designed assays are well suited for applications outside diagnostic laboratories, in resource poor settings, and can even be used by patients at home. Using two distinctly different UCP-LF assay formats, we focussed on assays for infectious diseases based on the detection of pathogen-specific antibodies and/or antigens including nucleic acids to demonstrate active infection with HIV. Only minor adaptation of the standard UCP-LF assay format is needed to render the format suitable for applications involving low affinity capture antibodies (e.g. in the detection of neurotoxin, botulism), capture of small molecules (e.g. detection of melatonin, a key hormone in chronopharmacology) or the use of dry UCP reagents (e.g. detection of protein based fruit-ripening markers, of economic interest in agriculture). Finally, we anticipate on developments in healthcare (personalized medicine) by discussing the potential of one of the UCP-LF assay formats to measure serum trough levels of immunodrugs (e.g. infliximab or adalimumab) in patients treated for inflammatory bowel disease and rheumatoid arthritis.

  14. Incidents of potential public health significance identified using national surveillance of US poison center data (2008–2012)

    Science.gov (United States)

    LAW, R. K.; SHEIKH, S.; BRONSTEIN, A.; THOMAS, R.; SPILLER, H. A.; SCHIER, J. G.

    2015-01-01

    Background The Centers for Disease Control and Prevention (CDC) and the American Association of Poison Control Centers conduct national surveillance on data collected by US poison centers to identify incidents of potential public health significance (IPHS). The overarching goals of this collaboration are to improve CDC’s national surveillance capacity for public health threats, identify early markers of public health incidents and enhance situational awareness. The National Poison Data System (NPDS) is used as a surveillance system to automatically identify data anomalies. Purpose To characterize data anomalies and IPHS captured by national surveillance of poison center data over 5 years. Methods Data anomalies are identified through three surveillance methodologies: call-volume, clinical effect, and case-based. Anomalies are reviewed by a team of epidemiologists and clinical toxicologists to determine IPHS using standardized criteria. The authors reviewed IPHS identified by these surveillance activities from 2008 through 2012. Results Call-volume surveillance identified 384 IPHS; most were related to gas and fume exposures (n=229; 59.6%) with the most commonly implicated substance being carbon monoxide (CO) (n=92; 22.8%). Clinical-effect surveillance identified 138 IPHS; the majority were related to gas and fume exposures (n=58; 42.0%) and gastrointestinal complaints (n=84; 16.2%), and the most commonly implicated substance was CO (n=20; 14.4%). Among the 11 case-based surveillance definitions, the botulism case definition yielded the highest percentage of identified agent-specific illness. Conclusions A small proportion of data anomalies were designated as IPHS. Of these, CO releases were the most frequently reported IPHS and gastrointestinal syndromes were the most commonly reported illness manifestations. poison center data surveillance may be used as an approach to identify exposures, illnesses, and incidents of importance at the national and state level

  15. Crystal Structure of the Receptor-Binding Domain of Botulinum Neurotoxin Type HA, Also Known as Type FA or H

    Directory of Open Access Journals (Sweden)

    Guorui Yao

    2017-03-01

    Full Text Available Botulinum neurotoxins (BoNTs, which have been exploited as cosmetics and muscle-disorder treatment medicines for decades, are well known for their extreme neurotoxicity to humans. They pose a potential bioterrorism threat because they cause botulism, a flaccid muscular paralysis-associated disease that requires immediate antitoxin treatment and intensive care over a long period of time. In addition to the existing seven established BoNT serotypes (BoNT/A–G, a new mosaic toxin type termed BoNT/HA (aka type FA or H was reported recently. Sequence analyses indicate that the receptor-binding domain (HC of BoNT/HA is ~84% identical to that of BoNT/A1. However, BoNT/HA responds differently to some potent BoNT/A-neutralizing antibodies (e.g., CR2 that target the HC. Therefore, it raises a serious concern as to whether BoNT/HA poses a new threat to our biosecurity. In this study, we report the first high-resolution crystal structure of BoNT/HA-HC at 1.8 Å. Sequence and structure analyses reveal that BoNT/HA and BoNT/A1 are different regarding their binding to cell-surface receptors including both polysialoganglioside (PSG and synaptic vesicle glycoprotein 2 (SV2. Furthermore, the new structure also provides explanations for the ~540-fold decreased affinity of antibody CR2 towards BoNT/HA compared to BoNT/A1. Taken together, these new findings advance our understanding of the structure and function of this newly identified toxin at the molecular level, and pave the way for the future development of more effective countermeasures.

  16. Small-molecule quinolinol inhibitor identified provides protection against BoNT/A in mice.

    Directory of Open Access Journals (Sweden)

    Padma Singh

    Full Text Available Botulinum neurotoxins (BoNTs, etiological agents of the life threatening neuroparalytic disease botulism, are the most toxic substances currently known. The potential for the use as bioweapon makes the development of small-molecule inhibitor against these deadly toxins is a top priority. Currently, there are no approved pharmacological treatments for BoNT intoxication. Although an effective vaccine/immunotherapy is available for immuno-prophylaxis but this cannot reverse the effects of toxin inside neurons. A small-molecule pharmacological intervention, especially one that would be effective against the light chain protease, would be highly desirable. Similarity search was carried out from ChemBridge and NSC libraries to the hit (7-(phenyl(8-quinolinylaminomethyl-8-quinolinol; NSC 84096 to mine its analogs. Several hits obtained were screened for in silico inhibition using AutoDock 4.1 and 19 new molecules selected based on binding energy and Ki. Among these, eleven quinolinol derivatives potently inhibited in vitro endopeptidase activity of botulinum neurotoxin type A light chain (rBoNT/A-LC on synaptosomes isolated from rat brain which simulate the in vivo system. Five of these inhibitor molecules exhibited IC(50 values ranging from 3.0 nM to 10.0 µM. NSC 84087 is the most potent inhibitor reported so far, found to be a promising lead for therapeutic development, as it exhibits no toxicity, and is able to protect animals from pre and post challenge of botulinum neurotoxin type A (BoNT/A.

  17. Tratamento cirúrgico do blefaroespasmo essencial: relato de dois pacientes Surgical treatment of blepharospasm: report of two patients

    Directory of Open Access Journals (Sweden)

    HENRI FRIEDHOFER

    1999-06-01

    Full Text Available Blefaroespasmo essencial pode ser tratado por diversas opções terapêuticas: clínicas em que se destaca entre outros o uso da toxina botulínica com suas vantagens e limitações, e algumas opções de tratamento cirúrgico. A técnica cirúrgica proposta por Gillum e Anderson oferece uma alternativa a pacientes resistentes ao tratamento clínico ou que durante a evolução da doença apresentem complicações secundárias. São analisados dois casos em que se indicou a miectomia dos músculos orbicular da pálpebra, prócero e corrugador do supercílio associados à blefaroplastia e ritidoplastia frontal por terem apresentado diminuição da resposta ao tratamento clínico. Ambos obtiveram bons resultados, retornando às suas atividades normais.Essential blepharospasm can be approached by several types of treatment: clinical in which the most important is the botulinum toxin with advantages and limitations; and some options of surgical treatment. The surgical technique described by Gillum and Anderson offers an alternative to patients resistant to the clinical treatment or with secondary complications. Two cases are analysed. Myectomy of all accessible orbicularis oculi, procerus and corrugator superciliaris muscle associated with blepharoplastic surgery and frontal lifting was indicated due to poor answer to clinical treatment. The results were satisfactory and both patients returned to their normal activities.

  18. Surtos de botulismo em bovinos no Brasil associados à ingestão de água contaminada

    Directory of Open Access Journals (Sweden)

    Dutra Iveraldo S.

    2001-01-01

    Full Text Available Botulismo em bovinos resulta da ingestão de toxina previamente formada. No presente trabalho são descritos sete surtos da intoxicação onde os dados clínico-patológicos, epidemiológicos e os achados laboratoriais indicaram a possível ingestão da toxina através da água contaminada. O coeficiente médio de mortalidade foi de 20,1%, com letalidade de 99,92%, e morbidade de 31,62%. Dos cerca de 9.000 bovinos envolvidos nos surtos, 2.844 morreram com quadro clínico predominantemente superagudo e agudo. A alta morbidade e mortalidade foram registradas num curto período de tempo e envolveram todas as categorias animais, com quadro clínico-patológico caracterizado por paresia e paralisia da musculatura da locomoção, deglutição e mastigação e ausência de lesões macroscópicas. As circunstâncias em que ocorreram os surtos estiveram relacionadas com a existência de carcaças de animais decompostas ou matéria orgânica vegetal na água de dessedentação. Foram detectadas toxinas botulínicas C e/ou D nas coleções de água, nas vísceras e no soro sangüíneo de parte considerável dos materiais examinados.

  19. Efeito da acidificação, fermentação e adição de cálcio na qualidade de couve-flor (Brassica oleraceae L. processada pelo calor Effect of acidification, fermentation and addition of calcium on the quality of canned cauliflower (Brassica oleraceae L.

    Directory of Open Access Journals (Sweden)

    J.N. Nogueira

    1993-05-01

    Full Text Available O presente trabalho foi desenvolvido com o objetivo de fornecer informações, não encontradas na literatura, sobre o efeito da acidificação (cinco ácidos orgânicos, fermentação e adição de cálcio na qualidade de couve-flor (cultivar Shiromaru III, processada pelo calor. A qualidade da couve-flor processada foi avaliada através de análise física, química, microbiológica e sensorial, após dois meses de armazenamento à temperatura ambiente. Os resultados mostraram a possibilidade de processar couve-flor enlatada, de alta qualidade, em pequenas indústrias, com redução de gastos em equipamentos, instalações e energia. O procedimento da acidificação oferece também uma segurança maior para o consumidor, pois elimina possíveis riscos de incidência do botulismo.The present work was developed to provide information currently lacking in the literature on the effect of acidification (five organic acids, fermentation and addition of calcium on the quality of canned cauliflower (cultivar Shiromaru III. Quality evaluation of the processed cauliflowers was determined by physical, chemical, microbiological and sensorial analysis, after a two month storage period at room temperature. The results showed the possibility of processing high quality canned cauliflowers by small canneries with low cost equipment and less energy requirement. The acidification procedure also implies in minor risks due to potential botulism incidence.

  20. Insights into the evolutionary origins of clostridial neurotoxins from analysis of the Clostridium botulinum strain A neurotoxin gene cluster

    Directory of Open Access Journals (Sweden)

    Meiering Elizabeth M

    2008-11-01

    Full Text Available Abstract Background Clostridial neurotoxins (CNTs are the most deadly toxins known and causal agents of botulism and tetanus neuroparalytic diseases. Despite considerable progress in understanding CNT structure and function, the evolutionary origins of CNTs remain a mystery as they are unique to Clostridium and possess a sequence and structural architecture distinct from other protein families. Uncovering the origins of CNTs would be a significant contribution to our understanding of how pathogens evolve and generate novel toxin families. Results The C. botulinum strain A genome was examined for potential homologues of CNTs. A key link was identified between the neurotoxin and the flagellin gene (CBO0798 located immediately upstream of the BoNT/A neurotoxin gene cluster. This flagellin sequence displayed the strongest sequence similarity to the neurotoxin and NTNH homologue out of all proteins encoded within C. botulinum strain A. The CBO0798 gene contains a unique hypervariable region, which in closely related flagellins encodes a collagenase-like domain. Remarkably, these collagenase-containing flagellins were found to possess the characteristic HEXXH zinc-protease motif responsible for the neurotoxin's endopeptidase activity. Additional links to collagenase-related sequences and functions were detected by further analysis of CNTs and surrounding genes, including sequence similarities to collagen-adhesion domains and collagenases. Furthermore, the neurotoxin's HCRn domain was found to exhibit both structural and sequence similarity to eukaryotic collagen jelly-roll domains. Conclusion Multiple lines of evidence suggest that the neurotoxin and adjacent genes evolved from an ancestral collagenase-like gene cluster, linking CNTs to another major family of clostridial proteolytic toxins. Duplication, reshuffling and assembly of neighboring genes within the BoNT/A neurotoxin gene cluster may have lead to the neurotoxin's unique architecture. This